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Summary 
 
The survival of microorganisms on surfaces is well documented, potentially acting as a 
reservoir for the dissemination of healthcare-associated infections (HCAIs). 
Antimicrobial surfaces aim to control surface bioburden and lower HCAI rates. The 
existing antimicrobial surface efficacy test (JIS Z 2801) is an initial screening test; 
however, its set up (35°C, >90% relative humidity (RH)) bears little relationship to 
conditions in practice. This study aimed to develop new surface efficacy tests using wet 
and dried microbial inocula, reflecting conditions within a healthcare setting. 
 
Changes in surface RH, temperature and bioburden were measured over one year at a 
hospital, allowing realistic parameters to be set for the new tests. Wet and dry inocula 
tests were developed and validated to mimic aerosol deposition and dry-touch 
contamination on surfaces, respectively. Aerosols of S. aureus, A. baumannii and B. 
subtilis spores and dry inocula of S. aureus and A. baumannii were tested against copper 
alloys and control stainless steel surfaces. Surviving bacteria were enumerated after 
varying contact times, and under in-use and JIS Z 2801 test conditions. FACS 
experiments were conducted to understand the mechanism of action of copper against 
dried microbial inocula. 
 
Wet inoculum testing showed copper alloys presented significantly reduced activity 
against S. aureus aerosols at in-use conditions (>4 log10 after 60 min) compared to JIS Z 
2801 test conditions (>4 log10 after 30 min). A >4 log10 reduction in A. baumannii was 
observed within 30 min but copper alloys were not sporicidal at in-use conditions. Dry 
inoculum testing showed a <2 log10 reduction in S. aureus and A. baumannii after 24 h 
at in-use conditions with potential mechanisms of action including; membrane damage, 
DNA damage and arrested cellular respiration. 
 
The new tests developed provide realistic, second-tier tests to the JIS Z 2801. Copper 
was antimicrobial against both wet and dry inocula but was overall more efficacious 
against a wet inoculum, which suggests a liquid interface enhanced antimicrobial 
activity. It is recommended that antimicrobial surfaces are tested under in-use 
conditions against both wet and dry inocula to confidently predict their performance in 
practice. 
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CHAPTER 1 GENERAL INTRODUCTION 
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1.1 Healthcare-associated infections 
 
Healthcare-associated infections (HCAIs), or nosocomial pathogens, are ‘any infectious 
agent acquired as a consequence of a person’s treatment by a healthcare provider, or 
which is acquired by a healthcare worker in the course of their duties’ (National Audit 
Office (NAO), 2009). It is likely a nosocomial pathogen has been acquired if symptoms 
develop 48 hours after admission to hospital (Murray et al., 2007). HCAIs were 
previously referred to as ‘hospital-acquired infections’ but the term ‘healthcare-
associated infections’ is now preferred since many medical procedures are not limited to 
the hospital setting (Website 1, publication date unavailable). 
 
Common HCAIs include methicillin-resistant Staphylococcus aureus (MRSA), 
Clostridium difficile (C. difficile), Acinetobacter species (spp.), Pseudomonas 
aeruginosa (P. aeruginosa), coagulase negative staphylococci,  Klebsiella spp. and 
Enterococcocus spp. (NAO, 2009).  
 
HCAIs have a great impact on the economy and pose a financial burden on the National 
Health Service (NHS) costing around £1 billion a year (NAO, 2008). This high cost is 
associated with the length of hospital stay, cost of treating the infected patient and 
additional laboratory costs in the diagnosis of an HCAI (Shorr, 2007). It has been 
reported that each HCAI costs the NHS £4300 (NAO, 2009). In addition, the NHS has 
paid out £17 million between 2004 and 2008 in litigation costs (NAO, 2009). 
 
The NHS previously stated one of its five main national priorities to be ‘improving 
cleanliness and reducing healthcare-associated infections’ (Website 2, 2009). In June 
2009 ‘The Revised Healthcare Cleaning Manual’ published by The National Patient 
Safety Agency, was published to help NHS Trusts provide a safe and clean working 
environment and to control HCAIs (National Patient Safety Agency, 2009).  An updated 
version was published in 2012, although this manual is not as detailed and in depth, thus 
for this chapter the 2009 manual will be referred to. In addition, The Health Act 2006: 
Code of Practice for the Prevention and Control of Health Care Associated Infections 
outlines the policies and duties of NHS bodies in reducing HCAIs.  
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Figure 1.1 shows an increase in the total number of cases of bacteraemia in England 
between 2003 and 2007. Notable increases in the number of bacteraemia were in E. coli 
and coagulase negative staphylococci. Between 2006 and 2007 there was a slight 
decrease in the number of bacteraemia cases of Staphylococcus aureus (S. aureus) and 
Enterococcus spp. Overall, the data indicates the historical need to focus on the 
management of HCAIs within the clinical environment and explore all avenues of 
practical control measures, either at the patient level or via potential transmission routes. 
 
Figure 1.1- Graph showing the number of cases of bacteraemia episodes due to 
coagulase negative staphylococci, Klebsiella spp., Streptococcus pneumonia, E. coli, S. 
aureus and Enterococcus spp. (HPA, 2009) 
 
 
 
For the purpose of this study the focus was geared towards three HCAIs; S. aureus, A. 
baumannii (A. baumannii) and C. difficile. In addition, B. subtilis was used as a spore-
forming model organism. 
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1.1.1 Routes of infection 
 
Figure 1.2 is a diagram showing the transmission routes of infections in a healthcare 
setting from a review article by Otter et al. (2011). Patients can become infected directly 
by direct contact between patients or indirectly via contaminated surfaces, air or via 
healthcare workers (HCW) (Otter et al., 2011). 
 
Figure 1.2 – Routes of transmission of microorganisms in healthcare environments 
(Otter et al. 2011) 
 
 
1.2 Staphylococcus aureus 
 
S. aureus belongs to the Staphylococcus genus of bacteria. S. aureus is a Gram-positive, 
catalase-positive, non-motile cocci (Murray et al., 2007). S. aureus colonises the 
anterior nares in around 20 % of the population (Gordon and Lowy, 2008). As a 
pathogen S. aureus is associated with skin and soft tissue infections, urinary tract 
infections, toxic shock syndrome, lung infections, deep-site infections (bones, joints, 
heart valves) and food poisoning (Murray et al., 2007). 
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1.2.1 Methicillin-resistant Staphylococcus aureus (MRSA) 
 
1.2.1.1 Origin 
MRSA is not susceptible to the β-lactam antibiotic methicillin (Hiramatsu et al., 2001). 
The β-lactam class of antibiotics functions by binding to penicillin-binding proteins 
(PBP) on the cell wall to prevent elongation of the bacterial peptidoglycan (Deurenberg 
et al., 2007). This will no longer result in cross-linking of the peptidoglycan. Penicillin, 
a β-lactam antibiotic, was first introduced in the 1940s, however, the emergence of 
resistance to this drug in S. aureus in 1942 prompted the development of methicillin in 
1960 (Woodford, 2005; Deurenberg et al., 2007). In 1961 the first strain of MRSA was 
identified in the United Kingdom (UK) (Hiramatsu et al., 2001; Deurenberg et al., 
2007). The development of methicillin-resistance in S. aureus is due to the acquisition 
of a large genetic element, the staphylococcal chromosomal cassette mec (SCCmec) 
(Hiramatsu et al., 2001; Woodford, 2005). This fragment of DNA integrates at a highly 
conserved site known as attBscc orfX found near oriC. Located on this cassette is a gene 
of 2.1 kb in size called mecA. This gene is responsible for the coding of a new 
penicillin-binding protein 2a (PBP2a) (Deurenberg et al., 2007). β-lactams are not 
effective against MRSA due to their low binding affinity to PBP2a, thus peptidoglycan 
synthesis is maintained (Hiramatsu et al., 2001). There are five types of SCCmec (I-V) 
of varying size. Types I, IV and V are responsible for β-lactam resistance only whereas 
Types II and III carry further antibiotic resistance genes (Deurenberg et al., 2007).    
 
1.2.1.2 Community-acquired-MRSA 
Community-acquired (CA)-MRSA has emerged in patients lacking the normal risk 
factors associated with MRSA including no hospitalisation, intravenous drug use or 
recent surgery (Hawkey, 2009). CA-MRSA is normally more susceptible to antibiotics 
than hospital-acquired (HA)-MRSA. In terms of SCCmec type, CA-MRSA possesses 
Type IV compared to Type II present in HA-MRSA (Weber, 2005). CA-MRSA 
infection can result in necrotising pneumonia, skin infections and sepsis due to the 
presence of the genes lukS-PV and lukF-PV that code for Panton-Valentine Leukocidin, 
a necrotising cytotoxin that lyses white blood cells (Weber, 2005; Boyle-Vavra and 
Daum, 2006; Elliot et al., 2007).  
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1.2.1.3 Treatment of MRSA infection 
According to the British National Formulary (BNF) the recommended guidelines for 
MRSA treatment depends on the sensitivity of the strain. Tetracyclines are 
recommended for skin and soft tissue infections and urinary tract infections (British 
National Formulary, 2013). Glycopeptides are recommended for pneumonia and 
septicaemia (British National Formulary, 2013). Other factors influencing treatment 
include local policy, the patient’s risk to others, the patient’s own risk factors (for 
example, immunosuppression) and whether a patient is infected or colonised with 
MRSA (Royal College of Nursing, 2005). 
 
1.2.1.4 Surveillance of MRSA bacteraemia 
Figures 1.3 - 1.6 show data released by the Health Protection Agency (HPA, now Public 
Health England, PHE) regarding the number of MRSA bacteraemia cases over the past 
several years.  The latest data to date are shown. Since April 2001 the Department of 
Health (DH) instructed all English acute NHS hospital Trusts to annually publish the 
number of cases of MRSA bloodstream infections (NAO, 2009). In 2004 the DH set a 
target of reducing MRSA infections by 50 % by 2008 and extended surveillance across 
all acute and foundation NHS Trusts (HPA, 2009). In 2005 the DH requested monthly 
figures of MRSA bacteraemia cases to be released to provide comprehensive data on 
MRSA and encourage high infection control. (Website 3, 2005). Currently data are 
published quarterly. 
 
Figure 1.3, taken from a 2009 HPA report to the NAO, shows the number of MRSA 
bacteraemia cases collected by mandatory surveillance from 2002 to 2008. The number 
of bacteraemia cases peaked in the October/December 2003 period at 2000. The average 
number of bacteraemia cases in 2003/4 was 1925; this figure was used by the DH as a 
baseline figure for reduction targets. By the first quarter of 2008 there was a 57 % 
reduction in reported bacteraemia cases; thus meeting the DH’s target of 50 % (HPA, 
2009). 
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Figure 1.3 – Graph showing the number of MRSA bacteraemia cases reported to the 
mandatory surveillance system from April 2002 to September 2008 (HPA 2009b) 
 
 
 
Quarterly counts of Trust-apportioned reports and all other reports of MRSA 
bacteraemia cases from the third quarter of 2008 to the third quarter of 2010 are shown 
in Figure 1.4. Over this reporting period there was a 46 % decrease in the overall 
number of MRSA bacteraemia cases. There was a 52 % decrease in Trust-apportioned 
reports and a 38 % reduction in all other reports (HPA, 2010). 
 
Figure 1.4 - Quarterly counts of Trust-apportioned and all other reports of MRSA 
bacteraemia cases from July 2008 to September 2010 (HPA 2010) 
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Figure 1.5 shows the continued general trend is a decrease in the number of MRSA 
bacteraemia cases between the reporting period of July 2009 to September 2011. 
Overall the HPA states there has been a 56.1 % decrease in the number of Trust-
apportioned reported cases of MRSA bacteraemia between July 2009 to September 
2011. All other reports presented a 28.4 % decrease in reported cases (HPA, 2011).  
 
Figure 1.5 - Graph showing the number of Trust-apportioned reports and all other 
reports of MRSA bacteraemia cases between July 2009 and September 2011 (HPA 
2011) 
 
 
Figure 1.6 shows the reported cases of MRSA bacteraemia per 100,000 population, as 
published by PHE between the final quarter of 2011 to the third quarter of 2013. As 
between 2008 - 11 the continued trend is a decrease in the number of cases of MRSA 
bacteraemia. From the third quarter of 2012 to the third quarter of 2013 there was a 12 
% decrease in MRSA bacteraemia cases (PHE, 2013a) 
 
Figure 1.6 – Graph showing all reports of MRSA bacteraemia cases from the final 
quarter of 2011 to third quarter of 2013 (PHE, 2013a)  
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The HPA states it is difficult to determine exactly what has caused the fall in MRSA 
bacteraemia but they believe improved screening and decolonisation of patients, 
individual Trust guidelines and national campaigns such as ‘cleanyourhands’ (see 
section 1.6.1.7 ) are all contributing factors (HPA, 2009). 
 
1.2.2 Deaths related to S. aureus including MRSA 
 
Figure 1.7, produced by The Office for National Statistics, reports the number of deaths 
where S. aureus is mentioned on death certificates in England and Wales between 1993 
and 2012. The graph includes data for S. aureus and MRSA. The highest number of 
deaths involving S. aureus or MRSA was in 2006. From 2007 to 2011 a five-fold 
decrease in the number of deaths involving MRSA occurred (Website 4, 2012). In 1993 
12 % of deaths were due to MRSA, however by 2012 this figure rose to 52 %. Between 
2011 and 2012 there was 20 % decrease in deaths due to MRSA. Overall between 2008 
and 2012 only 0.2 % of hospital deaths were related to MRSA (Website 5, 2012). 
 
Figure 1.7 – Number of deaths in England and Wales between 1993 and 2012 due to S. 
aureus (Website 5, 2012) 
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1.3 Acinetobacter baumannii 
 
A. baumannii belongs to the Acinetobacter genus, which are short, strictly aerobic, non-
motile, Gram-negative bacilli (Elliot et al., 2007; Perez et al., 2007).  Natural habitats 
for Acinetobacter spp., such as Acinetobacter johnsonii and Acinetobacter lwoffii 
include human skin flora, water, soil and vegetables (Peleg et al., 2008). There are 
misconceptions that A. baumannii can be found in the above mentioned environments, 
however, its natural habitat is not yet fully understood (Peleg et al., 2008). 
 
Due to its multidrug-resistant (MDR) nature A. baumannii is a nosocomial pathogen and 
the source of major outbreaks in healthcare settings (Perez et al., 2007). Risk factors for 
A. baumannii colonisation and infection include ICU (intensive care unit) stay, surgery, 
invasive procedures, antimicrobial therapy, prolonged hospital stay and mechanical 
ventilation (Perez et al., 2007). A. baumannii infection can result in urinary tract 
infections, bacteraemia, pneumonia, meningitis and wound infections (Maragakis and 
Perl, 2008). Other studies have shown that central nervous system, skin and soft tissue 
and bone infections are associated with A. baumannii infection (Peleg et al., 2008). 
 
1.3.1 Resistance of A. baumannii to antibiotics 
 
The resistance of A. baumannii to many antibiotics (MDR) has made its control and 
treatment difficult (Maragakis and Perl, 2008). A. baumannii is resistant to a wide range 
of antimicrobial classes. Its mechanisms of antibiotic resistance include the production 
of β-lactamases to breakdown β-lactam antibiotics such as pencillin, cephalosporins and 
carbapenems (Maragakis and Perl, 2008). Changes in outer membrane proteins, such as 
CarO, a 29-kDa protein, have been linked to imipenem and meropenem resistance 
(Limansky et al., 2002; Mussi et al., 2005; Siroy et al., 2005).  The modification of 
target binding sites is another mechanism of resistance. For example, gyrA mutations, 
which codes DNA gyrase and parC mutations in the ParC subunit of topoisomerase IV 
affect the binding of quinolone antibiotics (Vila et al., 1997; Seward and Towner, 1998; 
Hamouda and Amyes, 2004). Another example of altered target site is 16S rRNA 
methylation by aminoglycoside-modifying enzymes that inhibit aminoglycoside 
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antibiotics such as gentamicin from binding to their target (Doi and Arakawa, 2007). 
Aminoglycosides normally impair protein synthesis by binding to 16S rRNA regions 
within 30S ribosomal subunits (Doi and Arakawa, 2007). A. baumannii encodes a 
resistance nodulation division (RND) efflux pump called AdeABC that confers 
multidrug resistance to β-lactams, aminoglycosides, and tetracyclines (Marchand et al., 
2004; Nemec et al., 2007; Peleg et al., 2007).  
 
1.3.2 Treatment of A. baumannii infection 
 
There are currently no guidelines for the treatment of A. baumannii infection in the 
BNF. Peleg et al. (2008) suggest carbapenems are used for the treatment of serious A. 
baumannii infections. However, due to the emergence of carbapenem-resistance they 
recommend newer approaches. Sulbactam is a β-lactamase inhibitor that is normally 
combined with β-lactams such as ampicillin or cefoperazone. Polymixins, for example 
colistin, are antimicrobial peptides that are normally administered via a nebuliser. Their 
target site is anionic lipopolysaccharide molecules in the outer membrane resulting in 
membrane damage and osmotic imbalance. Combination therapy, including the 
administration of colistin with other antimicrobials that act in synergy, is also 
recommended (Peleg et al., 2008).  
 
1.3.3 Surveillance of Acinetobacter spp. bacteraemia 
 
Unlike for MRSA, surveillance of Acinetobacter spp. is voluntary. Figure 1.8, produced 
by PHE, shows the rate per 100,000 population of reported Acinetobacter spp. 
bacteraemia in England, Wales and Northern Ireland from 2008 to 2012. Over this 
reporting period there was a 33 % decrease in the number of cases. In 2008 66 % of 
cases were identified according to their species. By 2012 72 % of cases were species-
identified. The majority of species each year were Acinetobacter 
calcoaceticus/baumannii (31 % in 2008, 23 % in 2012) (PHE, 2013b). 
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Figure 1.8 – Graph showing rate per 100,000 population of Acinetobacter bacteraemia 
in England, Wales and Northern Ireland from 2008 to 2012 (PHE, 2013a) 
 
 
1.4 Clostridium difficile 
 
C. difficile belongs to the genus Clostridium. C. difficile is an anaerobic, spore-forming, 
Gram-positive bacillus (Murray et al., 2007). It was first isolated from healthy newborn 
babies in 1935 and known as Bacillus difficilis, however, it was not until the late 1970s 
that its clinical manifestations were recognised (Aktories and Wilkins, 2000; Voth and 
Ballard, 2005). 
 
1.4.1 C. difficile infection 
 
In the majority of cases C. difficile infection is linked to antibiotic usage, which disrupts 
the normal gut flora (Borriello, 1998). Upon C. difficile exposure and colonisation 
toxins are released and cause damage to the colonic musoca (Kelly and LaMont, 1998). 
Two toxins are responsible for clinical disease; Toxin A and Toxin B (Borriello, 1998). 
C. difficile is associated with hospital-acquired diarrhoea; ranging from mild to severe 
watery diarrhoea with abdominal pain (Borriello, 1998). In serious cases of infection a 
life-threatening condition called antibiotic-associated pseudomembranous colitis may 
develop (Murray et al., 2007). The onset of symptoms may occur around 4 - 10 days 
from the start of antibiotic treatment. C. difficile may be transmitted via the faecal-oral 
route or by contaminated surfaces (Murray et al., 2007).  
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Risk factors associated with C. difficile infection include increasing age, intensive 
therapy unit (ITU) stay, length of hospital stay and multiple antibiotic usage (Bignardi, 
1998; Aktories and Wilkins, 2000). Other drugs related to C. difficile infection include 
cytotoxic drugs, antacids and stool softeners (Aktories and Wilkins, 2000).  
 
1.4.2 Treatment of C. difficile infection  
 
If possible C. difficile infection can be treated by discontinuing antibiotics in order to 
restore the body’s normal gut flora (Kelly and LaMont, 1998). The administration of 
drugs to treat C. difficile is based on the severity of the infection. Metronidazole is given 
to treat mild and moderate C. difficile infection and vancomycin is administered for the 
treatment of severe infections (HPA, 2009a; British National Formulary, 2013). 
Metronidazole is the preferred first line treatment due to costs and the emergence of 
VRE (vancomycin resistant Enterococci) (Al-Nassir et al., 2008). One method used to 
restore the body’s flora is faecal bacteriotherapy, also known as faecal transplant; 
microflora from a healthy donor is transplanted to an infected patient (Floch, 2010). 
This procedure was first tested in 1958 by Eiseman et al. (1958) and produced a 100 % 
success rate. There are several advantages of faecal bacteriotherapy; the treatment 
requires minimal technology, it is cheaper than antimicrobial therapy and eliminates the 
risk of the antibiotic resistance developing (Bakken, 2009). 
 
1.4.3 Surveillance of C. difficile infection 
 
As with MRSA it is mandatory for NHS Trusts to publish quarterly the number of cases 
of C. difficile infections. Similarly to MRSA the number of reported cases of C. difficile 
infection is decreasing. Surveillance of C. difficile began in 2004 based on toxin-
positive stool samples in patients aged 65 or above. Enhanced surveillance in 2007 
included C. difficile toxin-positive results in patients aged 2 and above (HPA, 2009a). 
More recent guidance for reporting C. difficile infection were outlined in 2012 and 
include; toxin-positive diarrhoeal stools, toxin-positive toxic megacolon or ileostomy, 
pseudomembranous colitis, colonic histopathology showing typical signs of C. difficile 
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infection and samples collected post-mortem including toxin-positive stool (Website 6, 
2012).   
 
Figure 1.9 shows the data collected from voluntary and mandatory surveillance between 
2000 and 2008 (HPA, 2009b). Voluntary surveillance showed an overall increase in C. 
difficile infections up to 2007 before a decrease in the number of cases. Since the 
introduction of mandatory surveillance in 2004 the number of cases has fluctuated; 
seasonal peaks are apparent during winter months. Between 2006 and 2008 there was a 
41 % decrease in the number of reported C. difficile infections (HPA, 2009b). 
 
Figure 1.9 – Voluntary and mandatory surveillance data of C. difficile infections from 
2000 to 2008 (HPA, 2009b) 
 
 
Figure 1.10 shows the quarterly number of reported cases of C. difficile infection 
between 2008 and 2011. Overall the number of reports has decreased over time, but 
seasonal increases are apparent (HPA, 2011). 
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Figure 1.10– Graph showing Trust-apportioned reported and all other reported cases of 
C. difficile infection (HPA 2011)  
 
 
Figure 1.11 shows the surveillance data, from the final quarter of 2011 to the third 
quarter of 2013, published by PHE. Over this surveillance period cases of C. difficile 
infection decreased by 27.2 %, despite peaks in the third quarter of both 2012 and 2013 
(PHE, 2013a). 
 
Figure 1.11 - Graph showing all reports of C. difficile infections from end July 2011 to 
September 2013 (PHE, 2013a) 
 
 
 
1.4.4 Deaths related to C. difficile 
 
Figure 1.12 shows the mortality rate per 1,000,000 population for deaths that mentioned 
C. difficile on death certificates. The number of deaths increased between 2004 and 
2007 from 2238 to 8324. Since its peak in 2007 the number of deaths relating to C. 
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difficile is continuously decreasing with 1646 deaths recorded in 2012 (Website 7, 
2013). 
 
Figure 1.12 – Mortality rate per 1,000,000 in England and Wales related to C. difficile 
infection between 2002 and 2012 (Website 7, 2013) 
 
 
 
 
 
 
 
 
 
 
1.4.5 C. difficile spores  
 
The production of spores aids the transmission and survival of C. difficile (Burns et al., 
2010). Spores are highly resistant to antimicrobial agents, which is due to their 
morphological phenotype (Russell, 1990). The structure of a bacterial spore is 
represented in Figure 1.13.  
 
Figure 1.13 – Diagram showing bacterial spore structure (Leggett et al. 2012) 
 
17 
 
Most research regarding sporulation and germination has been studied in Bacillus 
subtilis (B. subtilis) but the basic processes are applicable to C. difficile and are 
described in section 1.5.1  The process of sporulation involves the transition of a 
vegetative cell to a spore (Russell, 1990). Germination is the converse; a spore 
irreversibly loses it properties and becomes a vegetative cell (Burns et al., 2010).  
 
1.5 Bacillus subtilis 
 
B. subtilis is a member of the Bacillus genus. B. subtilis is a Gram-positive, rod-shaped, 
spore-forming, aerobic microorganism (Elliot et al., 2007). B. subtilis can be found in 
the air, water and soil (Website 8, 1997). The US Environmental Protection Agency 
(US EPA) considers B. subtilis a safe microorganism and not toxigenic or pathogenic to 
humans, animals and plants (Website 8, 1997). The spore structure outlined in Figure 
1.13 is applicable to spores of B. subtilis. Other members of the Bacillus genus that are 
notable pathogens include B. cereus, a food poisoning agent and B. anthracis, which is 
the causative agent of anthrax (Elliot et al., 2007).  
 
1.5.1 Sporulation and germination 
 
Sporulation is triggered by nutrient starvation (Errington, 1993). The process of 
sporulation has most widely been studied in B. subtilis and the stages of the process are 
described in Figure 1.14, taken from a review article by Leggett et al. (2012). At Stage 
0 the cell is vegetative. It then goes through asymmetric cell division; splitting into two 
cells that are separated by a septum (Stage I/II). The smaller of the two cells is called 
the prespore. During the next stage (Stage III) the prespore is engulfed by the larger, 
mother cell to become a forespore. At this stage there are distinct inner and outer 
membranes. Next, the spore cortex (Stage IV) forms between the inner and outer 
membranes. After this the spore coat forms and matures (Stages V and VI), before 
release from the mother cell (Stage VII) (Leggett et al., 2012).  
 
The process of germination is triggered by nutrients named germinants, such as a 1:1 
chelate of Ca
2+
 and dipicolinic acid (DPA), sugars, amino acids and purine nucleosides  
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(Paidhungat and Setlow, 2000; Setlow, 2003). Non-nutrients, such as high pressure, can 
also trigger germination (Paidhungat et al., 2002). Once in the presence of germinants 
spores begin germination and outgrowth (Leggett et al., 2012). During spore 
germination cations and Ca
2+
-DPA are released, the cell becomes hydrated, the cortex is 
hydrolysed, the core expands and the resistant and dormant properties of the spore are 
lost (Setlow, 2003). During outgrowth spore metabolism, macromolecular synthesis, 
spore swelling, escape of spore coats and escape and growth of the new cell in the 
vegetative form take place (Setlow, 2003; Leggett et al., 2012). 
 
Figure 1.14 – Diagram showing the stages of the sporulation process of vegetative cells 
(Leggett et al. 2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.6 Infection control in UK hospitals  
 
The DH states the main aims of cleaning are ‘to remove surface soil to achieve an 
aesthetically pleasing environment, contributing to patient safety and confidence, to 
remove the microorganisms that spread disease and to remove harmful chemical 
residues, and the dust, dirt and grime upon which microorganisms may feed and grow’ 
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(DH, 2007a).  
 
The NHS produced a guidance document in 2007, ‘The national specifications for 
cleanliness in the NHS: a framework for setting and measuring performance outcomes’ 
detailing its cleanliness standards in NHS hospitals. It states ‘providing a clean and safe 
environment for healthcare’ is a key priority. The comprehensive guidance document 
details areas and items in hospital wards that necessitate cleaning, the standard to which 
they should be cleaned and how frequently. The document lists items of close or direct 
contact to patients, fixed assets, flooring, electrical items, furnishing, kitchen items and 
bathrooms that should be cleaned completely showing no visible blood, body 
substances, dust, dirt, debris or spillages. The guidelines highlight the minimum 
cleaning frequency of very high-risk, high-risk, significant-risk and low-risk areas. For 
example, if a door is considered a very high- to significant-risk, daily cleaning is 
recommended compared to weekly recommended cleaning if considered low-risk (DH, 
2007a). 
 
In addition to these guidelines an NHS guidance document titled ‘Standard Infection 
Control Precautions’ details more instructions for hospitals regarding infection control. 
It describes areas that require cleaning, referred to as the ‘environment’, to include 
frequently touched surfaces in all rooms (e.g. treatment, physiotherapy, sluice, store, 
patient changing and dental/doctor surgeries), any horizontal surfaces in the patients 
environment, furniture (e.g. beds, trolleys, chairs, bedside televisions), toilets and 
commodes, items in shower rooms (e.g. sinks, baths, showers), floors, doors and door 
handles, paintwork, curtains, screens, window blinds, light fittings and switches and 
kitchen areas (NHS, 2010). 
 
1.6.1 Current cleaning and infection control measures in UK hospitals 
 
Cleaning schedules and cleaning agents are normally determined by each hospital Trust 
under its local policies. The NHS recommends cleaning takes place in accordance with 
local policy and when surfaces are visibly dirty, after spillages and when a patient is 
discharged (NHS, 2010). Described in sections 1.6.1.1 to 1.6.1.6 are currently used 
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surface cleaning measures across NHS hospitals. The NHS recommends audits are 
carried out regularly to monitor cleaning in hospitals and assess performance (NHS, 
2007). The proposed recommendation, after cleaning, for surface contamination on 
hospital surfaces is <5 colony forming units per centimetre squared (cfu/cm
2
) (Dancer, 
2004) but others have suggested <2.5 cfu/cm
2
 (Griffith et al., 2000). 
 
1.6.1.1 Liquid disinfection 
Liquid disinfection is the most commonly used method of surface disinfection and is 
normally applied to surfaces via mops, cloths and wipes. As with general cleaning 
guidelines, the cleaning agent of choice is normally determined by individual Trusts, 
however the NHS does have basic recommendations. It states ‘the choice of cleaning 
agent that best meets overall needs is important and should be included in local cleaning 
procedure’ (NHS, 2010). In addition, it recommends general detergents for routine 
cleaning as opposed to disinfectants. It discourages the use of chlorhexidine for 
disinfection and alcohol and detergent wipes for large surface cleaning (NHS, 2010). 
The guidance document states cleaning solutions must be prepared according to 
manufacturers’ guidelines and kept for a maximum of 12 hours (NHS, 2010).  
 
A disinfectant can be defined as ‘a product capable of chemical disinfection, which is a 
reduction of the number of microorganisms in or on an inanimate matrix, achieved by 
the irreversible action of a product on their structure or metabolism, to a level judged to 
be appropriate for a defined purpose’. This definition is taken from EN 14885:2006 
‘Chemical disinfectants and antiseptics - Application of European Standards for 
chemical disinfectants and antiseptics’, which is the standard to which products have to 
conform to in order to support claims for antimicrobial activity. 
 
Whilst liquid disinfection has its obvious advantages in that it is quick, effective and 
easy, there are some disadvantages too. Firstly, the product needs to be compatible with 
the intended surface of use as some products, particularly chlorine-containing ones may 
have corrosive properties (Otter et al., 2011). Secondly, some products may be 
hazardous (e.g. chlorine-based products), thus they need to be handled with care and 
used appropriately according to Material Safety Data Sheets (MSDS) and local rules 
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(Otter et al., 2011). The shelf-life and stability of products varies so products must be 
used carefully according to manufacturers’ guidelines. In addition, since some products 
need to be prepared in solution it is important staff are properly trained to ensure that 
products are prepared correctly and at the required concentration. Finally, a limitation of 
liquid disinfection is the potential for transfer of bacteria from one surface area to 
another, depending on what is used to apply the disinfectant to a surface. A study by 
Williams et al. (2009) highlighted this as a potential problem and suggest a 1 wipe, 1 
application per surface policy. 
 
1.6.1.2 Microfibre cloths and mops 
Microfibre cloths and mops are composed of synthetic fibres and are used for general 
cleaning (DH, 2007a). In comparison to woven cloths they are very fine and have a 
much larger surface area, which allows cleaning inside crevices and cleaning of 
microscopic debris (DH, 2007a; National Patient Safety Agency, 2009). The natural 
static charge on microfibre cloths allows for the removal of dirt by electrostatic 
attraction and more is removed than by normal cloths and mops (DH, 2007a; National 
Patient Safety Agency, 2009). Advantages of microfibre cloths are they are strong and 
do not tear, snag or lint when used correctly (DH, 2007a). They are ergonomic too due 
their low weight and are machine washable (75-100 washes) making them re-usable 
(DH, 2007a; Sattar, 2010). In addition, hospitals have reported a decrease in cleaning 
time due to the use of microfibre cloths (National Patient Safety Agency, 2009).  A 
study by Smith et al. (2011) found microfibre cloths were effective at removing 
microorganisms. Ten different microfibre cloths were tested against a range of surfaces 
(stainless steel, white ceramic glazed tiles and furniture laminate) inoculated with E. 
coli, MRSA and C. difficile; a range of approximately >1 – 3 log10 reductions were 
observed (Smith et al., 2011). A disadvantage of microfibre cloths is they are only to be 
used dry or with dampened water; biocidal agents must not be added since they can 
degrade the fibres (DH, 2007a). Therefore, they should only be used for general 
cleaning and not for disinfection or removal of bodily fluids (DH, 2007a). Another 
disadvantage is the cloths will snag if used over an old or damaged surface (National 
Patient Safety Agency, 2009). The Revised Healthcare Cleaning Manual suggests they 
are used for general maintenance of surfaces (National Patient Safety Agency, 2009). 
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Finally, microfibre cloths must be used in a manner that reduces the spread of bacteria 
to cleaned areas, for example, it is recommended the least contaminated area should be 
wiped first (Bergen et al., 2009). 
 
1.6.1.3 Antimicrobial wipes 
Antimicrobial wipes are wipes that are pre-soaked with disinfectant (Sattar and 
Maillard, 2013). A range of factors influence the efficacy of surface cleaning by 
antimicrobial wipes, such as; type and frequency of wiping, pressure applied to the 
wipe, types of target microorganisms and the ratio between the disinfectant and the 
wipe. Studies have shown that whilst antimicrobial wipes were effective at reducing 
microbial burden on surfaces, they may be implicated in microbial transfer if re-used 
(Williams et al., 2009). Similarly to microfibre mops and cloths use, ‘one wipe – one 
application – one direction’ is recommended for antimicrobial wipes to prevent bacterial 
transfer (Siani et al., 2011).  
 
1.6.1.4 Fumigation 
Hydrogen peroxide vapour (HPV) fumigation is a relatively new cleaning technology. It 
works by vapourising 30 % w/w aqueous hydrogen peroxide that reaches a 
concentration of 0.2 mg/L (DH/NHS, 2009; National Patient Safety Agency, 2009). 
Vapourised hydrogen peroxide is deposited on to surfaces then converted to oxygen and 
water (Boyce et al., 2008). The system used in NHS hospitals in the Bioquell model 
(DH/NHS, 2009). The Revised Cleaning Manual suggests HPV is used during periods 
of infection outbreaks (National Patient Safety Agency, 2009). 
 
An advantage of using HPV is that it is has proved to be effective against pathogens and 
is sporicidal against C. difficile spores, which are normally resistant to routinely used 
cleaning products (Boyce et al., 2008; National Patient Safety Agency, 2009; Otter and 
French, 2009). A disadvantage of HPV is that rooms need to be emptied and sealed 
before treatment since the vapour is toxic (National Patient Safety Agency, 2009). Since 
wards need to be evacuated prior to cleaning HPV is most likely only suitable for 
terminal cleaning (Weber and Rutala, 2012). In addition surfaces must be positioned 
correctly to receive the vapour (DH/NHS, 2009). Another disadvantage is the process is 
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time-consuming. For example, a patient room can take 3 - 4 hours, whilst an entire ward 
up to 12 hours (Boyce et al., 2008). In addition, surfaces must be cleaned beforehand 
since the vapour cannot pass through organic loads, thus HPV treatment must take place 
alongside normal cleaning (National Patient Safety Agency, 2009). Finally, the cost of 
the equipment and engineers is high; for example, a managed service by Bioquell is 
£15,000/month for the use of three vapourisers, assistance from engineers and 
consumables (DH/NHS, 2009).  
 
A study by Malinowska and Holah (2010) found the efficacy of HPV depends on the 
hydrogen peroxide concentration utilised; at low concentrations (10 - 20 g/m
3
) HPV 
was less effective than at higher concentrations (30 - 40 g/m
3
) against both Listeria 
monocytogenes and P. aeruginosa (≤3 log10 reductions compared to >4 log10 
reductions). However, an increase in hydrogen peroxide concentration had no 
significant effect on S. aureus viability, which the authors suggest may be due to 
aggregation. In addition, all microorganisms tested in this study are catalase-positive, 
which may explain the resistance observed at low hydrogen peroxide concentrations 
(Malinowska and Holah, 2010).  
 
1.6.1.5 Steam cleaning 
Steam cleaning works by delivering superheated, pressurised dry steam to surfaces. The 
steam acts as both a cleaning and disinfectant product. Steam is a good cleaner as it is 
able to remove dirt and grease that is later vacuumed and the high temperature (>140 
°C) is effective at killing pathogens (DH, 2007a; National Patient Safety Agency, 2009). 
In Scotland steam cleaners have been issued to every NHS Board for the cleaning of 
beds and curtains (NHS Scotland, 2009). The DH recommends steam cleaning for 
periodic deep-cleaning as opposed to daily, routine cleaning (DH, 2007a). An advantage 
of steam cleaning is that it can be used to disinfect areas that are normally difficult to 
clean, for example, between bed rails and crevices (DH, 2007a). A disadvantages of the 
use of steam cleaners includes the cost of the machinery; it is estimated that steam 
cleaners cost up to £2200 (DH, 2007a). In addition, staff training is essential for the 
correct use of the machinery (DH, 2007a).  
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1.6.1.6 Combined detergents and disinfectants 
The use of products containing both detergent and disinfectant agents are more recently 
being used in favour of two separate products. A surfactant is added to a detergent 
combined with a chlorine-based product to allow chlorine release. Chlorine 
concentration is usually at 1000 parts per million (ppm) (National Patient Safety 
Agency, 2009). These dual function products are mostly used for terminal cleaning but 
some hospitals utilise them for normal cleaning (National Patient Safety Agency, 2009). 
A major advantage of this technology is that is it less time consuming than using a 
detergent first followed by a disinfectant. A disadvantage is the health hazards 
associated with chlorine. The Revised Cleaning Manual suggests rooms are well 
ventilated prior to cleaning (National Patient Safety Agency, 2009).  
 
As an example, the Cardiff and Vale University Health Board’s policy is as follows; 
Actichlor Plus (a dual product containing detergent and a disinfectant; sodium 
hypochlorite at 1000 ppm) is used daily on all inpatient wards or twice daily if there are 
infected patients or outbreaks. This product is also used for cleaning patient equipment 
when patients are known to have an infection and on all commodes and beds after 
patient discharge. For all other areas a general purpose detergent is used (personal 
communication from Senior Nurse for Infection Prevention and Control at University 
Hospital of Wales, Cardiff).  
 
1.6.1.7 Control of airborne microorganisms 
The control of airborne microorganisms is described in detail in Chapter 4, section 
4.1.4. 
 
1.6.1.8 Other infection control measures 
The importance of good hand hygiene to staff, patients and visitors is strongly 
emphasised as a major part of infection control and as a vital factor in reducing HCAIs 
(NAO, 2009). The NHS Standard Infection Control Precautions guidance document 
states most contamination from surfaces to patients and HCWs is by hand (NHS, 2010). 
Many national campaigns have raised awareness of the importance of good hand 
hygiene. The National Patient Safety Agency introduced two campaigns; 
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‘cleanyourhands’ in 2004 and ‘Clean Hands Saves Lives’ in 2008. The former was to 
install alcohol hand gels in all wards and promote good hand hygiene amongst HCWs 
(NAO, 2009). The NAO considers the ‘cleanyourhands’ campaign to be successful in 
two ways; it has been a cost-effective in terms of improving hand hygiene and it states 
there has been a subsequent reduction in the number of MRSA cases. The ‘Clean Hands 
Save Lives’ campaign was launched in 2008 to re-emphasise the importance of hand 
hygiene, particularly at the point of patient care (National Patient Safety Agency, 2010). 
 
An MRSA screening programme is present in all NHS hospitals; all patients for elective 
and emergency admissions are screened (Website 9, 2008). Swabs are collected from 
patients (primarily from the nose, however the armpit or groin are other areas of S. 
aureus colonisation) and sent to laboratories for analysis. If a MRSA-positive result is 
observed the patient is normally treated and kept in isolation or separated from MRSA-
negative patients (NHS, 2006).  
 
For C. difficile infections the HPA and DH recommend patients are kept in isolation 
until they do not present diarrhoea for a minimum of 48 hours (HPA, 2009a). The HPA 
also recommends that rooms or bed spaces of patients infected with C. difficile are 
cleaned thoroughly and daily with cleaning products containing at least 1000ppm 
available chlorine (HPA, 2009a). 
 
Fomites, from the Latin fomes, is a term used to describe inanimate objects with the 
ability to carry infection (Salcido, 2007; Tacconelli, 2011). In the healthcare 
environment objects such as doctors’ white coats, stethoscopes, pagers, patient charts, 
curtains to separate beds and tables have been identified as vectors for the transmission 
of pathogens (Huang et al., 2006; Treakle et al., 2009; Pimental, 2011; Tacconelli, 
2011). Mobile phones and other new technological devices also have the potential to 
transmit microorganisms (Tacconelli, 2011). Surfaces are another example of fomites; 
contaminated surfaces are a cause of cross-contamination between patients and HCWs 
(Treakle et al., 2009; Tacconelli, 2009).  A study by Desai et al. (2011) investigated the 
survival and transmission of MRSA from fomites. Porous fomites such as towels, 
shoulder pads and bed sheets and non-porous fomites including ceramic, plastic toys 
and vinyl were subject to the test. The study showed MRSA can survive on fomites and 
26 
 
is quickly transmitted from fomites to humans. Transmissibility was greater from non-
porous fomites than from porous fomites; surfaces were still contaminated up to eight 
weeks after initial contamination (Desai et al., 2011). In the UK in 2007 new guidelines 
by the DH discouraged clinical workers from wearing long sleeves, jewellery, watches 
and rings in order to promote good hygiene and prevent contamination of such objects. 
The new policy introduced became widely known as ‘bare below the elbows’ (DH, 
2007b, 2010).  
 
1.6.2 Role of cleaning in infection control 
 
It is difficult to suggest a ‘dirty’ hospital ward is linked to an increase in infections due 
to the lack of comprehensive investigations into the cleanliness of hospitals (Dancer, 
2004). Some investigations show there may be an association between contaminated 
surfaces and the dissemination of microorganisms. For example, a clinical study in a 
university hospital showed HCWs to be indirectly contaminated with MRSA after 
touching contaminated surfaces (Boyce et al., 1997).  
 
However, there is evidence cleaning and disinfection of surfaces contributes to reduced 
surface contamination and transmission of microorganisms. For example, the use of 
HPV, as mentioned in section 1.6.1.4, possibly contributed to reduced C. difficile 
transmission; the number of cases of C. difficile-associated diarrhoea (CDAD) was 
significantly lower following the use of HPV than the period before without HPV 
decontamination (Boyce et al., 2008). In another study the use of hypochlorite solutions 
instead of quaternary ammonium compounds (QACs) resulted in a significant decrease 
of CDAD from 8.6 cases to 3.3 cases per 1000 patient-days. A reverse back to QACs 
resulted in an increase in CDAD rates to 8.1 cases per 1000 patient-days. The authors 
believe the switch to hypochlorite caused a decrease in surface contamination and 
subsequent transmission (Mayfield et al., 2000).  
 
Dancer et al. (2009) suggest enhanced cleaning is sufficient to control infection rates; 
they found the employment of an extra cleaner on two surgical wards with endemic 
MRSA resulted in a 26.6 % reduction in new MRSA cases. There were nine cases of 
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MRSA during normal cleaning periods compared to four during the enhanced cleaning 
period. There was also a 32.5 % reduction in surface contamination on ten hand-touched 
sites including patient lockers, overbed tables and bed frames (all within patient 
vicinity), computer keyboard, desk and patient notes (by nurses station), patient hoist 
and infusion pump and blood pressure stands (clinical equipment) and door handles. 
The extra cleaner was instructed to clean hand-touch sites within patient vicinity two to 
three times a day, equipment by the nurse’s station 1 - 2 times a times a day, clinical 
equipment 1 - 2 times a day and door handles 2 - 3 times a day. This cleaning took place 
alongside routine cleaning carried out by nurses. The authors suggest the addition of an 
extra cleaner within the two wards was cost-effective; the salary of the cleaner was less 
than the cost of treating MRSA infected patients throughout the period of this study 
(Dancer et al., 2009). In a different study the effect of enhanced cleaning to reduce VRE 
in an ICU at a university hospital was investigated. The study showed enhanced 
cleaning of accessible surfaces with a QAC disinfectant, education, monitoring of 
housekeeping and a hand hygiene campaign resulted in a significant reduction of VRE 
surface contamination, a decrease in VRE hand contamination amongst HCWs and a 
decrease in the number of patients acquiring VRE (Hayden et al., 2006). 
 
Despite the above mentioned examples it is sometimes difficult to determine the link 
between hospital cleanliness and infection control due to a lack of standard methods 
(Mulvay et al., 2011). Current methods for determining levels of surface contamination 
include adenosine triphosphate (ATP) bioluminescence monitors and microbiological 
screening (Mulvay et al., 2011). ATP monitors are increasingly being used in NHS 
hospitals for monitoring and how they work is described in detail in Chapter 3, section 
3.1.3. Briefly, a surface is swabbed, the swab is placed inside the monitor and a reading 
(relative light unit, RLU) is given that corresponds to the amount of ATP collected on 
the swab. Visual screening is also used to monitor cleanliness during audits in UK 
hospitals, however, this method is unreliable due to the microscopic nature of 
microorganisms and the fact that their presence does not necessarily equate to apparent 
dirt (Griffith et al., 2000; Dancer, 2009). For example, a study by Griffith et al. (2000) 
evaluated different methods for assessing environmental contamination and suggested 
visual screening is insufficient. The authors sampled 113 sites before and after cleaning 
across an operating theatre and surgical ward by three methods; visual screening, ATP 
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bioluminesence and microbiological assessment. Readings taken after cleaning showed 
18 % of surfaces were unacceptable by visual screening whereas the percentages of sites 
deemed unacceptable by microbiological screening and ATP bioluminescence sampling 
were 70 % and 76 %, respectively. The authors suggest visual screening of surfaces 
should be undertaken more stringently, for example, if a site appears clean but is of 
high-risk then assessment by other means including ATP bioluminescence is 
recommended (Griffith et al., 2000).  
 
Advantages of ATP monitors are that they provide quantitative, real-time results, they 
are good for staff training and their use can improve standards of cleanliness (Boyce et 
al., 2009; National Patient Safety Agency, 2009). Disadvantages include the fact that 
the monitor cannot differentiate between bacterial ATP and organic soiling, or between 
dead and live microorganisms (National Patient Safety Agency, 2009). In addition, the 
criteria for a ‘pass’ or ‘fail’ are not clear (National Patient Safety Agency, 2009). 
However, Mulvey et al. (2011) do recommend a value of 100 RLU to correspond with 
<2.5 cfu/cm
2
. 
 
1.7 Application of antimicrobial surfaces in the healthcare setting 
 
Antimicrobial surfaces, or biocide-impregnated surfaces, are surfaces coated or 
impregnated with a biocide. A biocide can be defined as ‘an active chemical molecule 
to control the growth of or kill bacteria in a biocidal product’ (SCENIHR, 2009). These 
substances are not antibiotics since they are not intended for use during antimicrobial 
therapy, they provide more of a preventative measure to limit the spread of infection 
(Levy, 2001). In contrast to antibiotics that target specific structures or process, biocides 
tend to have an unspecific, multiple mode of action (Meyer and Cookson, 2010). 
 
Common biocides incorporated into surfaces include copper, triclosan and silver and 
these are detailed in sections 1.8.1, 1.8.2 and 1.8.3, respectively. In addition, the use of 
light-activated antimicrobial agents and photosensitisers has been explored. These are 
discussed in section 1.9. 
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Antimicrobial surfaces potentially have an important role in infection control in clinical 
settings by controlling surface bioburden and reducing the transfer of microorganisms 
from surfaces to patients or HCWs (see Figure 1.15, the ‘nosocomial infection loop’) 
(Page et al., 2009).  
 
Table 1.1 shows examples of antimicrobial surfaces and the incorporated biocide. Also, 
if known, the antimicrobial surface efficacy test used for testing the antimicrobial 
activity of surfaces is noted. The table shows antimicrobial surfaces within a clinical 
setting can be found in numerous areas of a typical ward or theatre room. The standard 
test utilised by the majority of manufacturers for determining antimicrobial activity is 
the ISO22196 (International Organisation for Standardisation), which derives from the 
Japanese Industry Standard (JIS Z 2801). The ISO22196 and JIS Z 2801 tests are 
described in detail in section 1.11.1.  
 
Medical devices such as catheters, endotracheal tubes and surgical masks can be coated 
with biocides to prevent the dissemination of pathogens. Silver nanoparticles are an 
example of an effective antimicrobial coating used on such devices (Li et al., 2006; Roe 
et al., 2008; Monteiro et al., 2009). For the purpose of this study antimicrobial surfaces 
on hard, environmental surfaces in the healthcare setting will only be discussed. 
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Table 1.1 -Examples of antimicrobial surfaces, supplier name, antimicrobial agent utilised and efficacy test 
Surface Supplier Biocide Efficacy test (if known) Reference 
Door handle Allgood (London, UK) 
BioCote Silver 
Technology 
ISO22196 Website 10, 2006 
 
Biomaster (Stafford, UK) Silver ISO22196 Website 11, 2011 
 
Ingersoll Rand (Co. Dublin, 
Ireland) 
Silver - Website 12, 2008 
 
Microban (Huntersville, US) Triclosan - Website 13, 2014 
Door push 
plate 
Aalco Ltd (Birmingham, UK) Copper (70%) - Website 14, 2014 
Grab rail Allgood (London, UK) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
Hand dryer Dyson (Mamelsbury, UK) 
BioCote Silver 
Technology 
ISO22916 Website 16, 2006 
Light switch KME (Firenze, Italy) Copper 
 
Website 17, 2012 
 
Iles (UK) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
Waste bin 
Environmental Hygiene Products 
Ltd (Ross-Shire, UK) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
Locker Link Lockers (Telford, UK) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
Radiator guard Contour Castings (Telford, UK) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
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Table 1.1 continued -Examples of antimicrobial surfaces, supplier name, antimicrobial agent utilised and efficacy test 
Surface Supplier Biocide Efficacy test (if known) Reference 
Ceiling and 
wall cladding 
Alvo (Śmigiel, Poland) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
Walls 
Suspended Ceiling Restoration Ltd. 
(Sheffield, UK) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
Tap Rada (Cheltenham, UK) 
BioCote Silver 
Technology 
ISO22916 Website 15, publication date unavailable 
 
Avilion Ltd (Birmingham, UK) Copper (60%) - Casey et al. 2010 
Toilet seat 
Mercury Composite LLC (CA, 
USA) 
Copper (70%) - Casey et al. 2010 
Computer 
keyboard 
BioSafe (Pittsburgh, UK) Triclosan, silver - Website 18, 2014 
Computer 
keyboard wrist 
support 
Fellowes (Itasca, US) Triclosan - Website 15, publication date unavailable 
Over-bed table Sidhil (Halifax, UK) 
BioCote Silver 
Technology 
ISO22916 Website 19, 2014 
Healthcare 
furniture 
Copper Development Association 
(Hemel Hempstead, UK) 
Copper/copper 
alloys 
- Website 20, 2014 
 
NB. All websites accessed February 2014 
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The diagram on the left hand side of Figure 1.15 represents the ‘nosocomial infection 
loop’, as termed by Page et al (2009). It shows that microorganisms can be directly 
transferred to and from surfaces and HCWs. If a surface is contaminated then 
microorganisms can be transmitted to a patient then on to a HCW or vice versa. The 
idea of an antimicrobial surface is that the spread of microorganisms can be controlled. 
The red crosses on the diagram on the right hand side of Figure 1.15 represent the 
desired effect of introducing antimicrobial surfaces; the transmission of microorganisms 
from surfaces to HCWs and patients is prevented and the ‘nosocomial infection loop’ is 
interrupted (Page et al., 2009). 
 
Figure 1.15 – The nosocomial infection loop and the role of antimicrobial surfaces 
(Page et al. 2009) 
 
 
 
Studies have shown that MRSA can persist on dry surfaces from anytime between seven 
days to seven months, and C. difficile spores can survive up to five months (Kramer et 
al., 2006). Indeed surfaces have been described as an ideal ‘reservoir’ for pathogens 
(Dancer, 2004). Antimicrobial surfaces aim to provide continuous disinfection 
alongside routine cleaning practices (Page et al., 2009; Weber and Rutala, 2013).  
 
The advantages and disadvantages of introducing antimicrobial surfaces in healthcare 
settings are discussed in detail in Chapter 6, section 6.5.
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1.8 Antimicrobial surfaces currently being explored for potential future use 
in UK hospitals 
 
This section will discuss three antimicrobial surfaces noted in Table 1.1; copper, 
triclosan and silver. It can be seen that in terms of product numbers, the majority of 
example surfaces in Table 1.1 contain BioCote® silver antimicrobial technology; its 
mechanism of action is described later (section 1.9.3.1).  
 
1.8.1 Copper 
 
Copper, Cu, a transition metal element is a well-known antimicrobial. Copper has a 
wide range of domestic, industrial and agricultural uses and is in high demand for 
applications such as plumbing and wiring (Elguindi et al., 2011). It is thought that 
around 10 % of copper use is based solely on the antimicrobial properties of the metal 
(Elguindi et al., 2011). The Egyptians noted the use of copper for wound healing around 
1500 BC in the Ebers Papyrus, an ancient Egyptian book of medical recordings (Sipos 
et al., 2004). Many other ancient civilisations including the Greeks and the Romans 
explored the antimicrobial properties of copper (Dollwet and Sorenson, 1985). Copper 
is used as an antimicrobial agent in agriculture; it is added to bactericides and fungicides 
to protect fruits and vegetables (Elguindi et al., 2011). Copper is utilised as an 
antimicrobial in water distribution and irrigation systems to prevent water-borne 
infections. It is also used to control algae levels in swimming pools, rivers, lakes and 
canals; studies have shown algae are susceptible to copper salts (Elguindi et al., 2011). 
Copper and copper alloy surfaces have recently been subject to extensive laboratory and 
clinical investigations to assess the biocidal efficacy of the metal as a suitable 
antimicrobial surface.  
 
The Copper Development Association (CDA) is an organisation promoting the use of 
antimicrobial copper surfaces in healthcare settings (Website 20, 2014).  
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1.8.1.1 Copper-containing antimicrobial surfaces – laboratory findings 
Noyce et al. (2006a) found pure copper is an effective antimicrobial surface in 
comparison to stainless steel. After 45 min exposure MRSA (NCTC 10442) was not 
detected on copper. Epidemic-MRSA-1 (EMRSA) and EMRSA-16 were also killed 
after 60 and 90 min exposure times, respectively, whereas all strains were viable after 
72 h on the stainless steel surfaces. These tests were carried out at room temperature 
(Noyce et al., 2006a).  
 
In the same study Noyce et al. (2006a) also investigated the use of copper alloys as 
antimicrobial surfaces using the same three MRSA strains mentioned above. Brass 
(containing 80 % copper) was compared to pure copper and stainless steel. Brass did 
produce an antimicrobial effect on the strains at room temperature but a significant 
decrease in activity was only apparent after 3 h. Complete kill of MRSA and EMRSA-1 
occurred after 4.5 h suggesting that copper alloys present slower antimicrobial activity 
than pure copper. Additionally, EMRSA-16, the most epidemic strain in the UK, 
appeared to show tolerance to brass (Noyce et al., 2006a). Copper and copper alloys 
have also shown to be effective against P. aeruginosa, another important nosocomial 
pathogen (Elguindi et al., 2009).  Complete kill was achieved after 120 min on 99.9 % 
and 88.6 % copper. There was no link between copper content and antimicrobial 
activity; an alloy containing 94.8 % copper presented the slowest activity requiring 240 
min for complete kill (Elguindi et al., 2009). 
 
The survival of C. difficile on surfaces has also been documented, although information 
is limited. Weaver et al. (2008) have shown C. difficile can survive on stainless steel for 
up to one week without a significant decrease in viability. The same study investigated 
the survival of C. difficile vegetative cells and spores (total cells) and purified spores on 
pure copper and copper alloy surfaces; 100 % kill was observed on pure copper in less 
than 24 h and on copper alloy (95 % Cu) within 48 h for both total cells and purified 
spores (Weaver et al., 2008). 
 
As mentioned in section 1.3.1 the emergence of MDR bacteria such as A. baumannii is 
a major cause for concern. The efficacy of copper surfaces against five clinical isolates 
of carbapenemase-producing A. baumannii showed 99 % copper was bactericidal in 
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under 2 h and 63 % copper in 6 h. Other nosocomial isolates including K. pneumoniae, 
P. aeruginosa, E. coli and Enterococcus spp. were also tested. Antimicrobial activity of 
99 % copper was quickest against A. baumannii isolates, with other complete kill times 
ranging from 3 to 6 h. The authors of this study suggest the use of copper antimicrobial 
surfaces in high-touch areas near high-risk patients may, in addition to existing infection 
control, potentially reduce surface bioburden and prevent the acquisition of nosocomial 
infections (Souli et al., 2013).  
 
All the above mentioned findings involved the inoculation of a 20 or 25 µL droplet of 
bacterial suspension on to test and control surfaces. This makes all these tests ‘wet 
inoculum’ tests. The efficacy of copper surfaces against dry bacterial inocula is 
described later in Chapter 5, section 5.1.3. 
 
Copper-containing surfaces may be useful in the food industry to help reduce food-
borne infections. Salmonella is a common food-borne pathogen that can cause self-
limiting gastroenteritis (Foley and Lynne, 2008). A study tested the antimicrobial 
efficacy of copper alloy surfaces against copper-resistant and –sensitive strains of 
Salmonella. The surfaces were tested against a wet inoculum and a wet inoculum 
allowed to dry. Both wet and dry inocula were killed quicker by alloys containing a 
high copper content than by a low copper content; although kill was slower on moist 
surfaces. This study also found copper alloys were more effective in the absence of 
organic load; it was proposed organic compounds bind to copper ions thus decreasing 
their bioavailability causing a reduced toxic effect on bacterial cells (Zhu et al., 2011). 
 
1.8.1.2 Mechanism of action 
It is thought that there are several mechanisms of action of antimicrobial copper. At low 
concentrations, copper is an important nutrient for prokaryotic and eukaryotic 
organisms; it acts as a catalytic cofactor for enzymes (Pena et al., 1999; Faúndez et al., 
2004; Santo et al., 2010). At higher concentrations, copper is toxic to living organisms 
as it produces highly reactive oxidative species that in turn results in damage to lipid 
membranes by peroxidation, conformational change to nucleic acids and proteins, 
alteration of osmotic homeostasis and the displacement of vital metals from their native 
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binding sites (Pena et al., 1999; Faúndez et al., 2004). Copper is active in two oxidative 
states; Cu(I) (Cu2O, cuprous) and Cu(II) (CuO, cupric). Aerobically, the formation of 
hydroxyl radicals responsible for cell toxicity is represented in the following two 
equations (Santo et al., 2008): 
 
Cu(II) + O2
-
 → Cu(I) + O2 
Then: Cu(I) + H2O2 → Cu(II) + O2 + OH
-
 + OH
· 
 
In terms of copper action on MRSA, the metal is thought to act on the cell membrane; 
the site of lipid membrane peroxidation (Weaver et al., 2010). It has been suggested that 
carotenoids to counteract the action of copper free-radicals, may contribute to bacterial 
resistance to copper at the lipid membrane (Weaver et al., 2010).  Weaver et al. (2010) 
found that after 18 h exposure of MRSA to copper surfaces the lipid membrane was not 
disrupted but rather the degradation of genomic DNA and damage to cellular respiration 
were responsible for cytotoxicity. Copper has shown to bind to the double-helix of 
DNA at two different sites with differing affinities and high specificity (Sagripanti et 
al., 1991). 
 
More information of the mechanism of action of copper is detailed in Chapter 5, section 
5.1.3.  
 
1.8.1.3 Trials in clinical areas 
A trial at Selly Oak Hospital in Birmingham, UK explored the use of copper as an 
antimicrobial surface in a clinical setting. Toilet seats, tap handles and door push plates 
in an acute ward were coated with pure copper/resin composite of ~70 % Cu, 60 % Cu 
and 70 % Cu, respectively. The surfaces were installed six months before the trial was 
carried out to enable HCWs to accustom to the fittings. The surfaces were sampled for 
microbial contamination once a week for 10 weeks at the same time of the day on each 
occasion. The trial produced promising results; a significant difference was observed 
between the number of microorganisms detected on the copper-containing surfaces and 
on the control surfaces. The control surfaces were in the same ward, which according to 
the authors standardised the microbial challenge presented to both test and control 
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surfaces. There was a 90 – 100 % reduction in the number of microorganisms compared 
to control surfaces. In addition, MRSA, C. difficile, methicillin-sensitive 
Staphylococcus aureus (MSSA), VRE and E. coli were not detected on the copper alloy 
surfaces over the 10-week period (Casey et al., 2010).   
 
Following on from this trial, a crossover study investigated the antimicrobial efficacy of 
copper alloy surface fittings in relation to standard fittings in an acute medical ward at a 
university hospital. Copper alloy surfaces were installed in high-contact areas such as 
toilet handles, door push plates, grab rails and commodes for 12 weeks. After the trial 
period copper alloy fittings were switched over with stainless steel standard fittings. The 
study showed reduced microbial counts on the copper alloy fittings; with more than half 
showing significantly decreased counts (Karpanen et al., 2012).  
 
Another clinical trial was conducted by the same team from Birmingham, UK that 
compared microbial contamination on the surfaces of pens used by nurses in two critical 
care units at University Hospital Birmingham. Nurses were provided with copper-alloy 
coated or stainless steel pens for the duration of their 12.5 hour shifts. The initial level 
of contamination was determined and microbial load was measured immediately after 
the shift was over. In addition, a different set of pens was distributed but pens were 
stored for 11 hours at room temperature after the 12.5 hour shift to take into account 
non-use between shifts. Pens were chosen as the object of study as they are handled 
frequently and between users yet rarely decontaminated. The study showed that a 
significant reduction in microbial load was apparent with copper-containing pens than 
stainless steel pens in the samples collected immediately once the shift was over. The 
copper-containing pens sampled 11 hours after the shift ended also presented lower 
microbial counts than stainless steel pens after 11 hour storage. The authors of this 
study stated the copper-containing pens significantly reduced microbial load, however, 
more studies are required to prove a link between copper and reduced infection rates 
(Casey et al., 2011).  
 
Another trial was conducted in a primary healthcare clinic in a rural area in South 
Africa rather than a hospital ward. Two consulting rooms were chosen; one as a test 
containing copper fittings on touch surfaces including desks, trolleys, window sills and 
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cupboards and a control room with standard stainless steel, wood and tile finishings for 
comparison. Overall, a 71 % reduction in microbial load was observed on copper 
surfaces compared to control surfaces. All copper surfaces presented a statistically 
significant decrease in microbial load (Marais et al., 2010). 
 
A large trial over a 43-month period in three hospitals in the United States assessed the 
role of copper in reducing microbial burden. The large study was divided into two parts; 
first the microbial burden of six high-touch surfaces from 16 rooms across three 
hospitals was monitored weekly by microbiological screening. At month 23 the six 
high-touch surfaces in half the test rooms were surfaced with copper or copper alloys. 
The study found copper significantly reduced microbial burden by 83 % in comparison 
to control surfaces (Schmidt et al., 2012).  
 
1.8.1.4 Copper antimicrobial surfaces in practice 
In 2008 the US EPA first approved the use of copper and copper alloys as antimicrobial 
surfaces by registering five copper alloy products for potential use in healthcare and 
other settings (Website 21, 2008). Currently there are 479 copper alloys with US EPA 
approval (Website 22, 2012).  
 
In January 2010, St. Francis hospital, a private hospital in County Westmeath, Ireland 
was the first hospital worldwide to permanently install copper door handles throughout 
and since then many healthcare establishments (both public and private) around the 
world, have installed copper and copper alloy fittings to potentially control 
environmental contamination and reduce the spread of microorganisms (Website 23, 
2012). 
 
1.8.1.5 Bacterial resistance to copper 
A major concern with the increasing use of biocides in the healthcare environment is the 
emergence of bacterial resistance to the antimicrobial agent. The removal of copper ions 
by efflux pumps is one resistance mechanism. Gram-positive and -negative bacteria 
both express efflux pumps; channels utilised to expel toxic substances from the cell 
(Webber and Piddock, 2003). There are five families of efflux pumps; ATP binding 
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cassette (ABC), multidrug and toxic efflux (MATE), major facilitator superfamily 
(MFS), resistance nodulation division (RND) and small multidrug resistance (SMR) 
(Webber and Piddock, 2003). Efflux is a common resistance mechanism used by many 
bacteria and also contributes to the development of MDR (Piddock, 2006). A subfamily 
of RND efflux pumps has been identified as heavy-metal efflux (HME) (Long et al., 
2010). An example of an HME pump is CusCBA; it can expel both copper and silver 
ions. Studies on the structure of the pump show in an inactive state it is closed but opens 
once bound by copper or silver ions due a change in conformation of the periplasmic 
and membrane domains of the pump (Long et al., 2010). Another method of copper 
resistance is the removal of copper ions by putative copper-translocating P-type 
ATPases (Adenosine Triphosphatase). P-type ATPases contributing to copper resistance 
in E. coli are encoded by the gene copA (Rensing et al., 2000). CopA P-type ATPase 
pumps out Cu(I) from the cytosol to the periplasm (Rensing et al., 2000). It is thought 
copA originates from Pseudomonas syringae and is found on an operon containing three 
other genes, copABCD (Cooksey, 1993).  
 
1.8.2 Triclosan 
 
Triclosan, 2,4,4’-trichloro-2’-hydroxydiphenylether, is a synthetic, broad spectrum 
biocide  that inhibits the synthesis of bacterial fatty acids (Heath et al., 1999; Levy et 
al., 1999). Triclosan is a heat-stable compound, soluble in organic solvents, and 
insoluble in acidic, aqueous solutions (Schweizer, 2001). It is considered to be mainly 
an antibacterial agent, but it also used as an antiviral or antifungal (Glaser, 2004).  
 
Microban is a company that manufactures products with a triclosan-containing coating 
(Website 24, 2013). 
 
1.8.2.1 Mechanism of action 
Bacteria utilise the type II fatty acid synthase system; a multi-step process to synthesise 
fatty acids (Rock and Jackowski, 2002). There are four main steps in fatty acid 
elongation. To begin with acetyl-acyl carrier protein (ACP) is converted to acetoacetyl-
ACP and CO2 by interacting with malonyl-ACP (Campbell and Cronan Jr, 2001). This 
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is a condensation reaction and is catalysed by FabK, β-ketoacyl ACP synthase III (Rock 
and Jackowski, 2002). Following this, β-ketoacyl-ACP is reduced by FabG. Next β-
hydroxyacyl-ACP is dehydrated to form trans-2-enoyl-ACP. This reaction is catalysed 
by FabA or FabZ. Finally, FabI, an enoyl-acyl-carrier protein reductase (ENR), is 
involved in the nicotinamide adenine dinucleotide plus hydrogen (NADH)-dependent 
concluding step of elongation. There are four ENR isozymes present in bacteria; FabI, 
FabL, FabK and FabV. FabI, FabK and FabL are members of the short-chain 
dehydrogenase/reductase family (Zhu et al., 2010). 
 
At low concentrations triclosan prevents bacterial fatty acid synthesis by binding to 
ENR reductase, FabI. Inhibition is achieved by the binding of the biocide to the active 
site of enoyl-ACP reductase (Schweizer, 2001); in turn this will prevent the final step of 
the elongation cycle of fatty acid synthesis. The association of triclosan with FabI- 
nicotinamide adenine dinucleotide (NAD+) was first determined in E. coli by x-ray 
crystallography (Heath et al., 1999). The interaction is strong and the structure forms a 
stable ternary complex (Heath et al., 1999; Campbell and Cronan Jr, 2001; Scweizer, 
2001). FabI has been identified in S. aureus (saFabI) and showed similarity to that of E. 
coli (Heath et al., 2000). At higher concentrations triclosan acts at non-specific sites to 
exert its bactericidal effect (Gilbert and McBain, 2002). Membrane damage to cells is 
thought to occur after exposure to high concentrations of triclosan (Villala  in et al., 
2001).  
 
1.8.2.2 Uses of triclosan 
Originally triclosan was used in hospitals as a surgical scrub in 1972 (Glaser, 2004). 
Since then it has been added to many consumer products and within the household 
triclosan can be found in toothpaste, liquid soaps, bar soaps, creams, shower gel, 
cosmetics, deodorant, and on the surfaces of pizza-cutters, cutting boards, mattresses, 
sheets and pillows (Levy, 2001; Scweizer; 2001; Webber et al., 2008). Møretrø et al., 
(2011) have demonstrated an approximate 1.5 log10 reduction in Salmonella on 
triclosan-containing cutting boards after 24 h at 70 % relative humidity. In NHS 
hospitals triclosan-containing antimicrobial surfaces can be found on door handles; 
these were first introduced in 2006 (Page et al., 2009). Table 1.1 shows triclosan is not 
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commonly impregnated into surfaces in a clinical setting anymore, perhaps due to the 
emergence of bacterial resistance to the biocide (Page et al., 2009). The EU Cosmetics 
Directive 76/768/EEC advises the highest concentration of triclosan for use in cosmetics 
is 0.3 % (Scientific Committee on Consumer Safety (SCCS, 2010). Triclosan 
concentration in food contact materials is limited to 5 mg/kg of food (SCENIHR, 2009). 
Issues regarding the safety of triclosan have been raised, particularly as it is included in 
many products intended for personal use. Triclosan is non-toxic in humans but cases of 
skin irritation and sunlight photoallergic contact dermatitis as a result of both triclosan 
and sunlight exposure to skin have been highlighted (Glaser, 2004). Triclosan is readily 
absorbed into the body and has a half-life of 21 hours in plasma (Allmyr et al., 2006). It 
is not thought to present a long-term threat to human health; as of yet it has not proven 
to be carcinogenic, mutagenic or teratogenic; however, studies in vitro showed triclosan 
to inhibit phase I metabolising enzymes in the liver and possibly have an effect on 
thyroid hormone metabolism in rats and mice, respectively (Bhargava and Leonard, 
1996; Glaser, 2004; Allmyr et al., 2006).  
 
1.8.2.3 Triclosan-antibiotic cross-resistance 
There are concerns biocide resistance may select for antibiotic resistance; this is 
primarily due to the similarity in their resistance mechanisms (Fraise, 2002). Recently 
the SCCS produced a guidance document on the safety of triclosan. The Committee 
identified four major hazards associated with triclosan use; triclosan can trigger 
resistance genes in bacteria, it can promote cross-resistance to biocides and antibiotics, 
high concentrations of triclosan have been identified in the environment and triclosan is 
resistant to bacterial biofilms (SCCS, 2010). In Mycobacterium smegmatis triclosan 
targets a FabI homologue, InhA, which is also an enoyl reductase and the target of the 
drug isoniazid. Mutations in inhA which encodes for InhA resulted in resistance to 
triclosan and isoniazid (McMurry et al., 1999). Another example of cross-resistance is 
in Mycobacterium tuberculosis (M. tuberculosis) that also contains InhA, whereby 
resistance to isoniazid by means of inhA mutation conferred resistance to the antibiotic 
rifampicin; a mutation in the rpoB gene, the target of rifampicin, is likely to occur 
directly as a consequence of isoniazid resistance (Heym et al., 1994). 
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1.8.3 Silver 
 
Silver, Ag, is a transition metal element. As with copper the antimicrobial properties of 
silver have been explored for millennia. Silver nitrate (AgNO3) was first used to treat 
ulcers in the 18
th
 century and later in 1884 by K.S.F Crédé, a German physician, who 
used silver nitrate as a prophylactic to gonorrhoeal infections in newborns (Silver et al., 
2006; Chopra, 2007). Nowadays, silver is commonly incorporated into wound dressings 
and is used to treat burns and diabetic ulcers (Silver et al., 2006). BioCote® is a 
commercially available antimicrobial surface coating that incorporates silver ion 
technology (Website 25, publication date unavailable). Numerous examples of 
environmental surfaces in the healthcare setting incorporating this technology are listed 
in Table 1.1. 
 
1.8.3.1 Mechanism of action 
Silver is active as an antimicrobial in the form of an ion, Ag
+
 (Edwards-Jones, 2009). It 
is thought silver acts at several targets within a bacterial cell. At the cell membrane low 
concentrations of Ag
+
 can cause cell death by inhibiting the proton motive force and 
inducing the loss of protons from the cell by affecting the permeability of the membrane 
(Percival et al., 2005; Edwards-Jones, 2009).  In E. coli Ag
+ 
has been shown to 
uncouple the respiratory electron transport chain from oxidative phosphorylation 
(Percival et al., 2005; Edwards-Jones, 2009).  
 
1.8.3.2 Trials in clinical areas 
A trial at the Heart of England NHS Trust in Birmingham, UK investigated the 
antimicrobial efficacy of BioCote® treated surfaces compared to untreated surfaces. 
Similarly to the copper trial at Selly Oak, the surfaces were fitted well in advance of the 
trial commencing. Swabs were taken regularly over 16 weeks from treated and 
untreated surfaces including doors, door handles, furniture, electrical switches and 
waste bins. The results of the trial showed a 95.8 % reduction in the number of viable 
bacteria on surfaces coated with BioCote® compared with those left untreated (Taylor 
et al., 2009). 
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1.8.3.3 Bacterial resistance to silver 
An issue with the use of silver in medicine is the emergence of bacterial resistance to 
the biocide. The first report of silver resistance was observed in Gram-negative bacilli in 
burns patients treated with silver nitrate (Cason et al., 1966). Another case of resistance 
was observed in Salmonella enterica serovar Typhimurium in a burns unit in the USA 
(Silver, 2003). Resistance was plasmid-mediated, by IncH1 on the plasmid pMG101, 
which also conferred MDR (Chopra, 2007). Following sequencing of this plasmid nine 
genes were identified that conferred bacterial resistance to silver (Silver, 2003). The 
resistance genes code for numerous products, for example, silCBA that encodes an RND 
efflux pump with homologues to that of AcrB in E. coli (Silver, 2003). As a result the 
cell can expel silver ions to render the bacterium resistant. The plasmid also contains the 
gene silE, which codes for the periplasmic silver-binding protein, SilE (Silver et al., 
2006). This protein is thought to bind Ag
+ 
with high specificity causing a 
conformational change in the structure of SilE thus resulting in silver resistance (Silver, 
2003).  
 
1.9 Light-activated antimicrobial agents (LAAAs) 
 
An alternative approach in reducing microbial surface contamination is the use of light-
activated antimicrobial agents (LAAAs) coatings. LAAAs are utilised in photodynamic 
therapy (PDT) (Zolfaghari et al., 2009). PDT is commonly used for the treatment of 
cancer to kill cancerous cells (Jori et al., 2006; Page et al., 2009). The therapy works as 
follows; a photosensitiser is injected into the bloodstream and accumulates in cancerous 
tissues. A visible light of a suitable wavelength is placed over the area of interest, which 
results in the transition of the photosensitiser to an excited singlet state (Hamblin and 
Hasan, 2004). The excited state singlet may then enter a triplet excited state and from 
then there are two possible pathways, Type I and Type II, for the reaction to proceed 
down (Hamblin and Hasan, 2004). The Type I pathway involves electron transfer; 
radical ions react with oxygen which results in the formation of superoxide and 
hydroxyl radicals (Hamblin and Hasan, 2004). The Type II pathway consists of energy 
transfer from the excited triplet state to a ground state that results in the production of 
an excited singlet oxygen (Hamblin and Hasan, 2004). It is the formation of reactive 
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radical species and singlet oxygen that can target and kill cancerous cells (Page et al., 
2009). 
 
1.9.1 LAAAs – laboratory findings 
 
The use of PDT to target microorganisms is an emerging field in antimicrobial therapy 
and antimicrobial surfaces (Jori et al., 2006). There have been numerous in vitro studies 
investigating the efficacy of LAAAs as potential antimicrobial surfaces. LAAAs are 
normally organic or inorganic dyes (Piccirillo et al., 2009). Examples of dyes tested in 
research include methylene blue, rose bengal and toluidine blue O. These can be 
incorporated into polymers and still retain their antimicrobial properties (Decraene et 
al., 2006). A study by Decraene et al. (2006) tested a variety of microorganisms 
including S. aureus, MRSA, C. difficile and Candida albicans against a cellulose 
acetate coating containing rose bengal and toluidine blue O upon exposure to white 
light. The results showed a 99.6 % reduction in S. aureus viable bacteria after 2 h and a 
100 % reduction after 6 h. C. difficile was also eliminated completely after 6 h. 
Piccirillo et al. (2009) reported the antimicrobial activity of methylene blue and 
toluidine blue O when covalently attached to separate silicone surfaces that had been 
modified to allow the binding of the photosensitisers. The organisms tested were E. coli 
and Staphylococcus epidermidis (S. epidermidis). Microbial suspensions were placed 
over the silicone surface and irradiated with a laser light. Silicone surfaces bound to 
toluidine blue O resulted in a greater decrease in viable count of E. coli than surfaces 
bound to methylene blue. However, both were significantly more effective in reducing 
the viable count of S. epidermidis than of E. coli (Piccirillo et al., 2009). 
 
In general Gram-positive bacteria are more susceptible to treatment by PDT due to the 
presence of pores within the peptidoglycan and lipoteichoic acid layers that allow the 
entry of photosensitisers into the cell (Jori et al., 2006). This was shown by Decraene et 
al (2006); E. coli was less susceptible to PDT than S. aureus was, as shown by the 100 
% kill times of 16 h and 6 h, respectively.  
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Studies have also shown the addition of gold nanoparticles to a methylene blue-
containing polymer can enhance the activity of the photosensitiser. Gold itself does not 
possess any antimicrobial properties but is thought to aid the formation of additional 
radical species other than singlet oxygen (Perni et al., 2009).  
 
1.9.2 Advantages and disadvantages of LAAAs 
 
There are several advantages of using LAAA-coated surfaces in the healthcare 
environment. Firstly LAAAs are effective against a range of microorganisms including 
bacteria, fungi, yeast and parasitic protozoa (Jori et al., 2006). The radical species that 
target microbial cells do not act at a specific site within a cell therefore bacterial 
resistance is not likely to develop to render the LAAA ineffective (Page et al., 2009). In 
addition, the cost of the light sources that excite the photosensitisers is low (Jori et al., 
2006).   
 
A concern with the long-term use of photosensitisers as antimicrobial surfaces is the 
photobleaching of the photosensiters. It has been suggested this can be prevented by 
regularly renewing the surface with a fresh coating containing a volatile solvent 
(Decraene et al., 2006). The aesthetics of antimicrobial surfaces containing 
photosensitisers dyes may be an issue in hospital wards. Piccirillo et al. (2009) suggest 
the use of polymers with covalently-bound dyes rather than physically-absorbed dyes; 
the colour of the dye is less obvious. In addition, their experimental work showed 
covalently-bound dyes were efficient at low concentrations and did not leach (Piccirillo 
et al., 2009). 
 
1.10 Factors affecting the efficacy of biocides 
 
Factors affecting the efficacy of biocides, including antimicrobial surfaces, are outlined 
in this chapter and further in Chapter 6, section 6.4. 
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1.10.1 Concentration 
 
Concentration has been identified as an important factor affecting the efficacy of 
biocides. It is important a biocide is prepared at a concentration sufficient enough to 
produce a bactericidal or bacteriostatic effect. For example, triclosan is bacteriostatic at 
low concentrations (minimum inhibitory concentration (MIC) 0.05 -3.1 µg/mL against 
S. aureus) but bactericidal at high concentrations (MIC of 25 – 100 µg/mL against S. 
aureus) (Russell and McDonnell, 2000; Maillard, 2002). The concentration exponent 
(η) is a measure of the antimicrobial activity of biocides (Russell and McDonnell, 
2000). The activity of biocides with a high η-value is affected by changes in 
concentration compared to biocides with a low η-value that are less affected (Russell 
and McDonnell, 2000). Biocides with a η<2 tend to bind strongly to their target by 
chemical or ionic binding whereas biocides with a η>4 interact weakly (Russell and 
McDonnell, 2000). It is important a suitable concentration of biocide is used in clinical 
settings; too high a concentration may present a hazard to staff and too low a 
concentration may not be sufficient for bacterial killing (Murtough et al., 2001). It has 
been suggested biocide usage in hospitals is rotated frequently to prevent the emergence 
of biocide and antibiotic resistance (Murtough et al., 2001). 
 
In terms of antimicrobial surfaces, the effect of copper concentration is discussed in 
section 1.8.1.1 and further in Chapter 6, section 6.4.5.  
 
1.10.2 Temperature and relative humidity 
 
Temperature and relative humidity are important factors influencing the efficacy of 
biocides.  
 
The antimicrobial efficacy of biocides generally increases with increasing temperature 
(Maillard, 2005a). The temperature co-efficient, θ, reflects the effect of a 1 °C rise in 
temperature on the efficacy of a biocide (Russell et al., 2003). As this value tends to 
normally be in the range of 1.0 to 1.5 the Q10 (θ
10
) value is used to determine the effect 
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of a 10 °C increase in temperature on biocide activity (Russell et al., 2003). The Q10 can 
be defined as: 
 
Q10 = Time to kill at T °C 
          Time to kill (T + 10) °C 
(Website 26, 2005). 
 
Relative humidity is expressed as a percentage of water vapour in the air and is 
calculated using the following equation: 
 
Relative Humidity = (Actual Vapour Density/Saturation Vapour Density) x 100 % 
(Website 27, publication date unavailable). 
 
An increase in relative humidity is generally associated with increased antimicrobial 
efficacy of copper-containing surfaces (Grass et al., 2011). 
 
Michels et al. (2009) have studied the effect of temperature and relative humidity on the 
efficacy of copper and silver surfaces against S. aureus. The study was carried out under 
the parameters of the Japanese Industry Standard (JIS Z 2801) (see section 1.11.1) and 
also under conditions typical of an indoor environment. The study showed copper and 
copper alloys were effective in reducing bacterial load at both high and low relative 
humidities (>90 % (high) and 20 and 24 % (low) respectively) and temperatures (35 °C 
(high) and 20 °C (low) respectively). In contrast, silver ions only caused a significant 
reduction in microbial load at > 90 % relative humidity and 35 °C suggesting silver may 
not be an ideal antimicrobial in hospitals where the relative humidity and temperature 
are much lower (Michels et al., 2009). A study investigating the efficacy of copper 
alloys showed copper was more efficient and faster-acting at room temperature than at 4 
°C when tested against strains of P. aeruginosa (Elguindi et al., 2009). 
More examples describing the effect of temperature and relative humidity on 
antimicrobial surface activity are detailed in Chapter 4, section 4.1.5. 
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1.10.3 Type and number of microorganisms 
 
When considering the choice of biocide it is important to take into account the target 
microorganisms (Maillard, 2005b). In general, bacterial spores, Gram-negative bacteria 
and mycobacteria present lower susceptibility to biocides than Gram-positive bacteria. 
This may be due to the differences in the composition of the outer cell wall (Maillard, 
2002).  
 
The number of bacterial cells can also influence the efficacy of a biocide. Generally, 
biocides tend to be more effective against a lower number of microorganisms (Russell 
et al., 2003). 
 
1.10.4 Antimicrobial surface properties 
 
It is important to take into account the chemical and physical properties of a surface 
when considering it for use in clinical settings. Stainless steel is used throughout 
hospitals on surfaces as it is long-lasting and, in comparison to copper does not oxidise 
upon exposure to air (Gould et al., 2009; Page et al., 2009). Oxidation may prevent the 
release of copper ions thus rendering the surface ineffective (Sattar, 2010). This should 
be taken into account when surfaces are disinfected as some disinfectants may contain 
oxidising agents (Sattar, 2010). Warnes and Keevil (2011) found copper(I) and 
copper(II) were important for cell toxicity affecting bacterial DNA and cell respiration 
in VRE. They recommend cleaning agents used for surface disinfection do not contain 
chelating substances that could impede the release of copper ions (Warnes and Keevil, 
2011). In addition pure copper may not be a favourable choice over copper alloys as it is 
highly corrosive and easily tarnished (Weaver et al., 2008). 
 
1.10.5 Organic load 
 
Organic load, or interfering materials, or soiling, can affect the efficacy of biocides 
(Maillard, 2005b). Organic load can include blood, serum, pus and dirt (Russell, 2003). 
Organic load may decrease the activity of biocides via two mechanisms; it may react 
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with the biocide resulting in a lower concentration of biocide, or organic load may 
protect the microorganism from biocide action by adsorbing the antimicrobial agent 
(Lambert and Johnson, 2001; Russell et al., 2003).  
 
Organic load may contribute to surface conditioning thus reducing the effectiveness of 
antimicrobial surfaces as investigated by Airey and Verran (2007). They looked at the 
role of interfering materials on the biocidal efficacy of copper. Copper, copper alloys 
and stainless steel (for comparison) were inoculated with S. aureus containing organic 
load (bovine serum albumin, BSA), dried for 5 min, then incubated for 24 h. Surfaces 
were then cleaned with wipes used in NHS hospitals. The cycle of soiling and cleaning 
was performed five times. After each procedure the levels of soil and live cells were 
determined by epifluorescence microscopy. After several cycles a high level of soil and 
cells was observed on copper surfaces whereas stainless steel surfaces were easily 
cleaned. From this is was concluded the cleaning agent used caused the organic load 
and bacteria mix to bond to the copper surfaces, resulting in resistance to the cleaning 
product (Airey and Verran, 2007).  
 
A different study investigating the survival of HA- and CA-MRSA on copper alloy 
coins found bacteria survived in the presence of soiling. The addition of pus and blood, 
examples of soiling in a hospital environment, to surfaces significantly enhanced the 
survival of bacterial cells (Tolba et al., 2007). 
 
1.11 Antimicrobial surface efficacy test protocols 
 
For the purpose of this study antimicrobial surface efficacy tests for non-porous 
materials only are discussed.  
 
1.11.1 Japanese Industry Standard - JIS Z 2801 
 
At present the most widely used and accepted standard test for determining 
antimicrobial surface activity and efficacy is the Japanese Industry Standard (JIS Z 
2801). This test is designed to provide quantitative data on the efficacy of surfaces. The 
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test protocol is described briefly in an official Organisation and Economic Co-operation 
and Development (OECD) 2007 document titled ‘Analysis and Assessment of Current 
Protocols to Develop Harmonised Test Methods and Relevant Performance Standards 
for the Efficacy Testing of Treated Articles/Treated Materials’.  
 
Firstly a cell suspension of 10
6
 colony forming units per millilitre (cfu/mL) cells is 
prepared and 400 µL is inoculated on to three test surfaces (50 x 50 mm). The surface is 
then covered with a 40 x 40 mm sterile polyethylene film and samples are incubated for 
24 hours at 35 °C and high relative humidity (>90 %).The viable count of the initial 
inoculum on surfaces is determined by removing the plastic film from the surface then 
placing the film and surface into a stomacher bag with a validated neutraliser to prevent 
further antimicrobial activity by the test surface. A suitable dilution plate count method 
is utilised for determining total viable counts. Viable inocula are enumerated in the 
same way for 24 h surfaces. A surface is antimicrobial if there is a >2 log10 difference 
between the viable counts of control and test materials (OECD, 2008).  
 
This test is the accepted efficacy test for testing antimicrobial-treated surfaces and is 
used by many manufacturers marketing surfaces as antimicrobial. Whilst it is a good 
screening test, it has been described as inappropriate for predicting the performance of 
surfaces in a healthcare setting. These points are considered in detail in Chapter 4, 
section 4.1.6 and Chapter 6, sections 6.2 and 6.3.  
 
1.11.2 International Organisation for Standardisation - ISO22196 
 
The ISO22196 test is an international standard for measuring antimicrobial activity on 
plastic surfaces. The test protocol is essentially the same as for the JIS Z 2801; indeed 
the ISO22196 is based on the JIS Z 2801 (OECD, 2008).  
 
1.11.3 American Society for Testing and Materials - ASTM E2180-01 
 
The ASTM E2180-01 test is a ‘standard test for determining the activity of incorporated 
antimicrobial agents in polymeric or hydrophobic materials’. In brief the test is carried 
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out as follows. A bacterial cell suspension of approximately 10
8
 cfu/mL is prepared. 
Then 1 mL of bacterial suspension is added to 100 mL molten agar and from this 500 - 
1000 μL is inoculated on to test surfaces. The reason for adding bacterial suspension to 
agar is that an ‘artificial biofilm’ is formed over the hydrophobic material. Surfaces are 
incubated for 24 h under humid conditions and at a temperature suitable for the test 
surfaces’ intended use. As for the JIS Z 2801 viable bacteria are determined on control 
and test surfaces; surfaces are transferred to neutraliser and sonicated to break away the 
biofilm from the surface then total viable counts performed (OECD, 2008).  
 
1.11.4 ASTM E2149-01 
 
The ASTM E2149-01 is a ‘standard test method for determining the antimicrobial 
activity of immobilised antimicrobial agents under dynamic contact conditions’. This 
test differs to the above mentioned standards in that test surfaces are placed directly into 
a bacterial cell suspension and agitated. The test surface is placed in the suspension for a 
specific time and the bacterial population is compared before and after (OECD, 2008). 
 
1.11.5 XP G 39-010 
 
This test is officially titled ‘Propriétés des étoffes - Étoffes et surfaces polymériques 
àpropriétés antibactériennes Caractérisation et mesure de l'activité antibactérienne’, 
which translates to ‘Properties of textiles – textile and polymeric surfaces having 
antibacterial properties - characterisation and measurement of antibacterial activity’. For 
this test four test surfaces are placed on an agar plate containing a specific volume of 
bacteria. Each surface is applied on to the agar plate for 1 min with a 200 g weight. 
Next, surfaces are incubated for 24 h and 37 °C under humid conditions. Duplicate 
samples are utilised for determining the initial viable count. The viable count of the 24 h 
surfaces is determined and the difference between initial and 24 h viable counts 
calculated (OECD, 2008).  
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1.11.6 Three-tier approach to evaluate the effectiveness of antimicrobial surfaces 
 
The OECD has suggested that a three-tiered approached is needed to precisely evaluate 
the effectiveness of antimicrobial surfaces and support antimicrobial claims. Tier 1 is a 
proof of principle test to compare treated materials with untreated materials. All the 
tests mentioned in this section are proof of principle tests. Tier 2 is a laboratory test and 
incorporates modified parameters that are more realistic and a reflection of in-use 
conditions. Factors such as strain selection, inoculum concentration, humidity, 
temperature, soiling and exposure time can be altered according to requirements. 
Finally, Tier 3 is an in-use evaluation of the efficacy claims. Field tests are performed to 
observe whether or not there is a reduction in microbial bioburden by antimicrobial 
surfaces (OECD, 2008). This draws parallels with Standards testing; Phase 1 tests are 
screening tests, Phase 2 tests predict antimicrobial action in simulated in-use conditions 
and Phase 3 are field trials. The tests described in sections 1.11.1 – 1.11.5 are all 
examples of Phase 1 tests. 
 
1.12 Aims and objectives 
 
The aims of this project were to address the following questions: 
 Is the JIS Z 2810 an appropriate test for evaluating the efficacy of antimicrobial 
surfaces? 
 Do the antimicrobial surfaces deliver antimicrobial activity when exposed to 
microbial aerosols? 
 Do the antimicrobial surfaces deliver antimicrobial activity when presented with 
dried microbial inocula? 
 What are the key factors affecting the efficacy of antimicrobial surfaces? 
 
In addition the main objectives of this project were to: 
 Provide robust in vitro data on the activity of antimicrobial surfaces used in 
clinical settings. 
 Establish an efficacy test method for testing antimicrobial surfaces using 
realistic parameters to provide to the NHS and industry.  
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CHAPTER 2 GENERAL MATERIALS AND METHODS 
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2.1 Bacterial strains 
 
Gram-positive, Gram-negative and spore-forming bacteria were utilised as test 
microorganisms. Table 2.1 details the strains used throughout this study.   
 
Table 2.1 - Bacterial strains tested throughout this project 
Type Strain 
Gram-positive Staphylococcus aureus NCIMB 9518 
Gram-negative Acinetobacter baumannii NCIMB 9214 
Spore-forming Clostridium difficile NCTC 12726 
 Bacillus subtilis NCTC 10400 
NCIMB = National Collections of Industrial Marine and Food Bacteria,  
NCTC = National Collection of Type Cultures 
 
2.2 Media 
 
Media were purchased from Oxoid (Basingstoke, UK) and Fisher Scientific 
(Loughborough, UK) unless otherwise stated. 
 
Tryptone Soya Broth (TSB) (17 g/L pancreatic digest of casein, 3 g/L enzymatic digest 
of soya bean, 5 g/L sodium chloride, 2.5 g/L dipotassium hydrogen phosphate, 2.5 g/L 
glucose) and Tryptone Soya Agar (TSA) (15 g/L pancreatic digest of casein, 5 g/L 
enzymatic digest of soya bean, 5 g/L sodium chloride, 15 g/L agar) were used 
throughout as media for bacterial growth of S. aureus and A. baumannii.  
 
C. difficile was grown in Brain Heart Infusion broth (12.5 g/L brain infusion solids, 5 
g/L beef heart infusion solids, 10 g/L proteose peptone, 2 g/L glucose, 5 g/L sodium 
chloride, 2.5 g/L disodium phosphate) and agar (same composition as broth plus 10 g/L 
agar). 
 
B. subtilis was grown in Luria-Bertani (LB) broth (10 g/L tryptone, 5 g/L yeast extract, 
10 g/L sodium chloride) and agar (as broth plus additional 15 g/L agar).   
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Tryptone Sodium Chloride (TSC) was used as a buffer throughout initial experiments 
and prepared by adding 0.4 g tryptone and 3.4 g sodium chloride to 400 mL deionised 
water. Maximum Recovery Diluent (MRD) (8.5 g/L sodium chloride, 1 g/L peptone) 
was the buffer of choice for the majority of later testing and is indicated in the text when 
used.  
 
All media were prepared according to manufacturer’s guidelines in deionised water and 
autoclaved at 121 °C for 15 min before use based on British Pharmacopeia guidelines 
(British Pharmacopeia Commission, 2006). Once opened, all media were used within 
their recommended shelf-life. 
 
2.3 Preparation of bacterial cultures 
 
2.3.1 Recovery of strains from freezer stocks 
 
All master stocks of strains were stored at -80 °C in glycerol stocks. Stocks for 
experimental use were stored on protect beads (Fisher Scientific, Loughborough, UK). 
A single bead was transferred to TSA for recovery of S. aureus and A. baumannii and to 
LB agar for B. subtilis. S. aureus and B. subtilis were grown at 37 °C; A. baumannii was 
grown at 25 °C.  Cultures were stored at 4 °C and utilised within two weeks of recovery.  
C. difficile recovery from freezer stocks is detailed in section 2.6.3. 
 
2.3.2 Preparation of bacterial broth cultures 
 
Bacterial broth cultures of S. aureus and A. baumannii were prepared for experimental 
procedures. A loopful of culture (as grown and described in section 2.3.1) was 
transferred to the required volume of TSB for S. aureus and A. baumannii. In general 
cultures were grown in 10 mL TSB for 24 h at the required temperature (37 °C for S. 
aureus, 25 °C for A. baumannii), unless otherwise stated. Every time a broth culture 
was prepared a control containing just TSB was also incubated to check for the sterility 
of the TSB batch utilised. 
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2.3.3 Bacterial suspension for testing 
 
This methodology applied to S. aureus and A. baumannii cultures. C. difficile and B. 
subtilis spore suspensions for testing were prepared as described in sections 2.6.4 and 
2.7.1, respectively. A broth culture was prepared as described in 2.3.2. After incubation 
for a maximum of 24 h the culture was centrifuged for 15 min at 2500 g at room 
temperature. The supernatant was discarded and the remaining pellet was re-suspended 
in either TSC or MRD.  
 
2.4 Bacterial viable counting using the drop count and spread plate methods 
 
The drop count method was utilised to enumerate bacteria from a 24 h grown culture 
(Miles and Misra, 1938). A culture was prepared in 10 mL TSB according to 2.3.2. The 
culture was centrifuged for 15 min at 2500 g, re-suspended in 10 mL TSC or MRD and 
serially diluted to a dilution factor of 10
-7
. Ten µL of each dilution was plated on to a 
TSA plate in triplicate. Plates were incubated for 24 h at 37 °C and the number of 
cfu/mL was determined. Enumeration was performed in triplicate. 
 
The spread plate method was also utilised for enumeration of bacteria. This method was 
used mainly in Chapters 4 and 5. A bacterial culture was prepared in 10 mL TSB as 
described in 2.3.2, centrifuged for 15 min at 2500 g and re-suspended in either TSC or 
MRD. The suspension was serially diluted down to 10
-7
. Next, 100 µL from each 
dilution was plated on to a TSA plate and spread with a sterile, plastic spreader. This 
was performed in triplicate. Plates were then incubated for 24 h at 37 °C and the number 
of cfu/mL was determined. 
 
2.4.1 Validation of drop count method 
 
In order to validate the drop count method as a suitable method for enumerating 
bacteria, ten separate dilution series were performed and the number of cfu/mL was 
calculated. Validation was performed with S. aureus. 
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An one-way analysis of variance (ANOVA) test showed there was no statistically 
significant difference between the number of counts of the ten repeats (P=0.326), which 
suggests the drop count method can be performed accurately and is a suitable and 
reproducible method for enumerating bacteria from suspension. Table 2.2 shows the 
average viable count with standard deviation (SD) per repeat. 
 
Table 2.2 –Validation of drop count method 
Repeat Log10 cfu/mL ± SD 
1 9.32 ± 0.04 
2 9.24 ± 0.09 
3 9.25 ± 0.09 
4 9.29 ± 0.06 
5 9.16 ± 0.08 
6 9.23 ± 0.03 
7 9.26 ± 0.04 
8 9.23 ± 0.06 
9 9.27 ± 0.04 
10 9.26 ± 0.08 
 
2.4.2 Validation of spread plate method 
 
As with the drop count method, the spread plate method for enumerating bacteria was 
validated with S. aureus. Ten separate dilutions were performed and the amount of 
cfu/mL was determined, see Table 2.3. Statistical analysis by a one-way ANOVA 
confirmed the suitability of the spread plate method for enumerating bacteria, P=0.163. 
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Table 2.3 – Validation of spread plate method 
Repeat Log10 cfu/mL ± SD 
1 9.18 ± 0.04 
2 9.26 ± 0.03 
3 9.23 ± 0.05 
4 9.17 ± 0.03 
5 9.19 ± 0.05 
6 9.21 ± 0.03 
7 9.22 ± 0.01 
8 9.26 ± 0.09 
9 9.21 ± 0.03 
10 9.23 ± 0.02 
 
2.5 Alteration of bacterial concentration using a spectrophotometer 
 
An optical density (OD) vs. total viable count graph for S. aureus was produced to help 
determine the OD required to obtain a particular bacterial concentration. A broth culture 
of S. aureus was prepared as described in 2.3.2. The culture was centrifuged at 2500 g 
for 15 min, re-suspended in 10 mL TSC and the OD measured at 600 nm (OD600) with 
an Ultrospec 3100 spectrophotometer (Amersham Biosciences, UK). This was serially 
diluted in TSC to a dilution factor of 10
-4
. The OD600 of each dilution was determined. 
In addition, 1 in 2 and 1 in 4 dilutions of the original culture were carried out to provide 
additional points to plot on the graph (see Figure 2.1). Each dilution (Neat to 10
-4
, 1 in 2 
and 1 in 4) was then serially diluted in TSC in order for total viable counts to be 
determined. Figure 2.1 shows the approximate OD600 required to obtain a particular 
bacterial concentration. The graph was a useful starting point for identifying what OD600 
reading was needed to yield a certain concentration of bacterial cells. Generally a 
reading of around 0.45 provided 10
8
 cfu/mL cells for S. aureus.  
 
An OD against total viable count graph was not produced for A. baumannii; an OD600 of 
approximately 0.5 was sufficient to give 10
8
 cfu/mL. This was first achieved by trial 
and error then utilised throughout for all A. baumannii suspensions required at 10
8
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cfu/mL. The concentration of C. difficile spore and B. subtilis spore suspensions were 
not determined by optical density readings. 
 
Figure 2.1 – Optical density against total viable count graph for S. aureus NCIMB 9518 
 
 
 
 
2.6 C. difficile  
 
2.6.1 Anaerobic growth requirement for C. difficile 
 
C. difficile is an anaerobic organism therefore growth is required in anaerobic 
conditions. An anaerobic incubator, Bugbox Plus (Ruskin Technology Limited, Leeds, 
UK), was utilised to grow cultures in media. The conditions in the incubator were as 
follows; 95 % N2, 10 % CO2, 5 % H2. Anaerobic indicator strips were placed inside the 
cabinet daily to ensure an anaerobic environment was maintained.  
 
2.6.2 Recovery from freezer stocks 
 
Master stocks of C. difficile NCTC 12726 were stored at -80 °C in glycerol stocks and 
on protect beads for experimental use.  
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The selective media of choice for the recovery of C. difficile from freezer stocks was 
Clostridium difficile moxalactam norfloxacin (CDMN). This consisted of the culture 
media supplements cysteine hydrochloride, norfloxacin and moxalactam (Oxoid, 
Basingstoke, UK) combined with Clostridium difficile Agar Base (Oxoid, Basingstoke 
UK) and 7 % (v/v) defibrinated horse blood (Oxoid, Basingstoke UK). The agar base 
was autoclaved at 121 °C for 15 min, cooled to 50 °C and the media supplements were 
added. Plates were then de-gassed for 24 h. Next, a single protect bead was transferred 
to CDMN selective agar and incubated for 48 h at 37 °C under anaerobic conditions.  
 
2.6.3 Preparation of C. difficile spores using the Clospore method 
 
Spores of C. difficile NCTC 12726 were prepared using a slightly adapted method by 
Perez et al. (2011), which the authors have named the ‘Clospore’ method. A freezer 
protect bead of C. difficile NCTC 12726 was streaked on to a de-gassed CDMN agar 
plate and incubated anaerobically for 48 h at 37 °C (as in 2.6.2). From this a few 
colonies were inoculated into de-gassed 4x 25 mL BHI broth and incubated 
anaerobically for 24 h. Next, 5 mL of culture was transferred to 500 mL Clospore media 
(10 g/L special peptone mix, 10 g/L yeast extract, 0.6 g/L (NH4)2SO4, 0.12 g/L 
MgSO4.7H20, 0.08 g/L CaCl2.2H20, 3.48 g/L K2CO3, 2.6 g/L KH2PO4, pH 7.9) for up to 
7 days. Spores were harvested by aliquoting the culture into 50 mL Falcon tubes, 
centrifugated at 5000 g for 15 min at 4 °C, washed three times in 30 mL cold, sterile, 
deionised water then pooled into one Falcon tube and stored at 4 °C for three days. 
Next, cultures were centrifuged at 5000 g for 15 min at 4 °C and re-suspended in 25 mL 
0.1 M sodium phosphate buffer, pH 7. Spore preparations were treated with two 
enzymes; lysozyme (20 µg/mg of wet weight of pellet) and trypsin (15 µg/mg of wet 
weight of pellet) to lyse vegetative cells and were then sonicated at 45 °C for 10 min 
every 2 h over a 6 h period. Prepared spore stocks were stored at 4 °C. 
  
2.6.4 Viable count of C. difficile spore suspensions 
 
Viable bacteria were enumerated by serial dilution in sterile, deionised water and plated 
via the drop count method on to BHI agar containing 0.1 % sodium taurocholate 
(Oxoid, Basingstoke, UK) to aid spore germination. Spores were grown under anaerobic 
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conditions as described in 2.6.1.  To be confident the purified cells were spores and not 
vegetative cells, 600 µL of culture was heated at 60 °C for 25 min (Heeg et al., 2012). 
This heat treatment killed any vegetative cells. The viable count of the spore suspension 
was compared before and after heat treatment. Table 2.4 shows the log10 viable count of 
five spore stocks before and after heat treatment. The log10 difference between the two 
counts is shown and is very small for all five stocks before and after heat treatment 
suggesting the stocks were mostly spore and not vegetative cells, therefore suitable for 
future testing.  
 
Table 2.4 – Viable count of C. difficile spore stock suspensions pre- and post-heat 
treatment  
Spore 
Stock 
Viable count pre-
heat treatment 
(log10 cfu/mL) 
Viable count post-
heat treatment 
(log10 cfu/mL) 
Difference 
1 7.33 7.58 -0.25* 
2 7.05 7.01 0.04 
3 7.10 7.13 -0.03 
4 7.99 8.00 -0.01 
5 7.99 7.98 0.01 
* negative difference denotes an increase in viable count. 
 
2.7 B. subtilis 
 
2.7.1 Preparation of B. subtilis spores  
 
Master stocks of B. subtilis NCTC 10400 were stored in glycerol and experimental 
stocks were stored on protect beads at -80 °C. 
 
The method used for preparing B. subtilis spores was adapted from an existing method 
(Nicholson and Setlow, 1990). A freezer bead of B. subtilis was streaked on to LB agar 
and incubated for 16 h at 37 °C. Then a single colony was inoculated into LB broth and 
incubated for 3 - 3.5 h at 37 °C with shaking until an OD600 of 1 - 2 was reached. Once 
the correct OD600 was obtained, 200 µL of culture was spread on to 2 x SG agar (16 g/L 
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nutrient broth, 13 mL/L 2M KCl, 2 mL/L 1 M MgSO4, 100 µL 1 M MnCl2, 3 µL/L 0.36 
M FeSO4, 15 g/L agar, 970 mL/L deionised water and 20 mL 50x Ca(NO3)2 (1.18 g 
Ca(NO3)2.4H2O, 5 g glucose, 100 mL deionised water)). Plates were incubated in a 
plastic bag to maintain high humidity for 3 days at 37 °C. This period was sufficient for 
spore release from the sporangia. Next, spores were scraped from plates using a sterile, 
plastic loop. Spores from 3 plates were placed into 30 mL cold, sterile water, sonicated 
for 1 min then cooled on ice for 1 min. This was repeated once. Spores were then 
centrifuged for 15 min at 5000 g and 4 °C, washed twice in cold, sterile water and re-
suspended in a final volume of 30 mL water. Spore stocks were stored at 4 °C. A viable 
count before and after heat treatment (60 °C, 25 min) was performed as with C. difficile 
spores (see section 2.6.4). Spores were grown on LB agar for 24 h under aerobic 
conditions. Table 2.5 shows the log10 viable count of five spore stocks before and after 
heat treatment. Log10 differences were minimal therefore spore stocks were suitable for 
testing. 
 
Table 2.5 – Viable count of B. subtilis spore stock suspensions pre- and post-heat 
treatment  
Spore 
Stock 
Viable count pre-
heat treatment 
(log10 cfu/mL) 
Viable count post-
heat treatment 
(log10 cfu/mL) 
Difference 
1 9.01 8.99 0.02 
2 9.08 9.02 0.06 
3 9.07 9.07 0 
4 9.15 9.14 0.01 
5 9.10 9.09 0.01 
 
 
2.8 Bacterial recovery from stainless steel discs by the carrier test method 
 
This test was carried out based on an adapted version of British Standard EN13697 
(Chemical disinfectants and antiseptics. Quantitative non-porous test for the evaluation 
of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, 
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domestic and institutional areas.  Test methods and requirements without mechanical 
action) to look at the survival of microorganisms on stainless steel over a period of 48 h. 
Stainless steel discs of grade 2B finish (see section 2.10 for composition) were obtained 
from Goodfellows Cambridge Ltd (Huntington, UK). Discs were cleaned following a 
general laboratory protocol; discs were soaked with 5 % Decon90 (Decon Laboratories 
Limited, Hove, UK) in deionised water for 60 min, rinsed, dried then autoclaved before 
use.  
 
2.8.1 Method  
 
S. aureus, A. baumannii, C. difficile spores and B. subtilis spores were tested. Cultures 
of S. aureus and A. baumannii were prepared as in 2.3.2 and standardised with TSC to 
produce approximately 10
9
 cfu/mL.  C. difficile and B. subtilis spores (approximately 
10
9
 cfu/mL) were prepared as in sections 2.6.3 and 2.7.1, respectively. Next, stainless 
steel discs were placed in a Petri dish, inoculated with 10 µL of bacterial or spore 
suspension and left to dry for 30 min at 37 °C. Once visibly dry, discs were incubated 
for 0 min, 30 min, 60 min, 120 min, 24 h and 48 h at room temperature. Following the 
required contact time discs were transferred to a 100 mL glass bottle containing 5 g of 3 
mm glass beads and 10 mL TSC (for S. aureus and A. baumannii) or sterile, deionised 
water (for spores). Bottles were shook for 1 min at 150 rpm to aid the removal of 
bacterial cells from the discs. Viable counts were then determined using the drop count 
method (see section 2.4). This was repeated in triplicate per contact time.  
 
The test was also carried out in the presence of organic load to represent dirty 
conditions. BSA was utilised as an organic load at a final concentration of 3 g/L. To 
achieve dirty conditions, 1 mL of the bacterial or spore suspension and 1 mL 0.6 % 
BSA were mixed and from this, 10 µL was inoculated on to the stainless steel discs. The 
test conditions were at room temperature and room relative humidity.  
 
 
 
 
64 
 
2.8.2 Results 
 
Table 2.6 shows the survival of the four tested microorganisms on stainless steel discs 
up to 48 h incubation at room temperature in the presence and absence of organic load. 
All statistical analysis was carried out by a General Linear Model using SPSS software. 
 
There was a 1.77 log10 cfu/mL reduction between the initial inoculum (amount 
inoculated on to the disc) and the amount of S. aureus with no organic load recovered at 
0 h. At 30, 60 and 120 min recovery was constant; between 5.40 and 5.89 log10 cfu/mL. 
There was a 1.29 and a 1.36 log10 cfu/mL reduction at 24 and 48 h respectively, in fact 
there was a significant difference (P<0.001) between the count at 0 h and 24 h and 
between 0 h and 48 h. No significant difference between the inoculum recovered at 24 h 
and at 48 h (P=0.565) was observed. In the presence of organic load there was also a 
significant difference between the counts at 0 h and at 24 h (P=0.015) and 48 h 
(P<0.001). There was a 2.33 and 2.78 log10 cfu/mL reduction after 24 h and 48 h, 
respectively, suggesting more of an effect with organic load. Indeed, there was a 
significant difference between the two conditions, P=0.021. 
 
For A. baumannii there was a difference of <3 log10 cfu/mL between the initial viable 
count and the amount recovered at 0 h, both with and without organic load. Up to 120 
min there was <1 log10 cfu/mL log10 reduction in relation to the 0 h count. After 48 h 
there was a 3.21 and 2.87 log10 cfu/mL reduction in the absence and presence of organic 
load, respectively. With organic load there was a significant difference between the 
counts from 0 h and both 24 h and 48 h (both P<0.001). In the presence of organic load 
there was a significant difference between in the counts at 0 h and all contact times 
(P<0.001), except 30 min (P=0.647).  Between the two conditions, organic load or no 
organic load, there was overall a significant difference (P<0.001). 
 
The difference between the initial inoculum of C. difficile spores and the amount 
recovered at 0 h was 2.2 log10 cfu/mL and 1.85 log10 cfu/mL, with and without organic 
load, respectively. After 48 h there was a 1.21 log10 cfu/mL reduction without organic 
load and a 0.9 log10 cfu/mL reduction with organic load present. In the absence of 
organic load there was no significant difference between 0 h counts and all other contact 
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time counts except at 48 h (P=0.039). In the presence of organic load a significant 
difference was observed between 0 h and 30 min counts (P=0.036) but with no other 
contact times. Overall, there was no significant difference between both conditions, 
P=0.486. 
 
Over the 48 h experimental period there was very little change B. subtilis spore 
viability. Between 0 h and 48 h there was less than a 0.2 log10 cfu/mL reduction both in 
the presence and absence of organic load; differences that were not significantly 
different (no organic load P=0.25, with organic load P=0.07). However, there was an 
overall significant difference between the counts with organic load and the counts 
without (P<0.001).  
 
It was apparent that S. aureus, A. baumannii, C. difficile spores and B. subtilis spores 
were able to survive on stainless steel for a long period of time; here at least up to 48 h. 
The results from this experiment were useful for future experiments where stainless 
steel was used as a negative control surface for antimicrobial surface testing. 
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Table 2.6 – Survival of S. aureus, A. baumannii, C. difficile and B. subtilis on stainless steel up to 48 h (n=3) 
  S. aureus   A. baumannii 
Contact time 
Log10 cfu/mL 
± SD without 
organic load 
Log10 cfu/mL 
± SD with 
organic load 
Log10 cfu/mL 
± SD without 
organic load 
Log10 cfu/mL 
± SD with 
organic load 
Initial viable count 7.38 ± 0.64  7.16 ± 0.32 9.01 ± 0.06  8.79 ± 0.13 
0 min 5.61 ± 0.17 5.69 ± 0.13 6.54 ± 0.11 5.93 ± 0.07 
30 min 5.40 ± 0.41 5.81 ± 0.03 6.18 ± 0.24 5.75 ± 0.08 
60 min 5.79 ± 0.13 5.97 ± 0.11 5.95 ± 0.14 5.19 ± 0.20 
120 min 5.86 ± 0.09 6.00 ± 0.11 6.03 ± 0.06 4.90 ± 0.13 
24 h 4.57 ± 0.18 4.83 ± 0.54 4.63 ± 0.62 3.77 ± 0.22 
48 h 4.25 ± 0.26 4.38 ± 0.24 3.33 ± 0.40 3.06 ± 0.08 
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Table 2.6 continued - Survival of S. aureus, A. baumannii, C. difficile and B. subtilis on stainless steel up to 48 h (n=3) 
  C. difficile B. subtilis 
Contact time 
Log10 cfu/mL 
± SD without 
organic load 
Log10 cfu/mL 
± SD with 
organic load 
Log10 cfu/mL 
± SD without 
organic load 
Log10 cfu/mL 
± SD with 
organic load 
Initial viable count 6.41 ± 0.03 6.14 ± 0.05 9.40 ± 0.16  9.01 ± 0.02 
0 min 4.21 ± 0.58 4.29 ± 0.35 6.97 ± 0.02 6.89 ± 0.02 
30 min 3.96 ± 0.54 3.10 ± 0.17 6.96 ± 0.02 6.72 ± 0.09 
60 min 4.16 ± 0.38 3.76 ± 0.62 6.89 ± 0.02 6.77 ± 0.04 
120 min 3.68 ± 0.43 4.12 ± 0.46 6.90 ± 0.04 6.87 ± 0.03 
24 h 3.43 ± 0.30 3.19 ± 0.18  7.06 ± 0.04  6.91 ± 0.08 
48 h 3.00 ± 0.14 3.39 ± 0.48  6.91 ± 0.03  6.73 ± 0.04 
 
68 
 
2.9 General characterisation of microorganisms 
 
Cell aggregation measurements and hydrophobicity tests were carried out to 
characterise the different bacteria used in this study. 
 
2.9.1 Particle size 
 
The particle size of all bacterial strains was determined using an N4Plus Dynamic Light 
Scattering machine (Beckman Coulter, Fullerton, USA). Particle size was measured in 
order to gain an insight to the approximate size of the bacterial strains in this study and 
to see if there was any bacterial cell or spore aggregation. Aggregation may act as a 
protective mechanism against biocidal activity.  
 
Cultures of S. aureus and A. baumannii were prepared as in section 2.3.2. Bacterial 
concentrations were adjusted to 10
8 
cfu/mL using water. Water was preferred to TSC to 
prevent interference in the determination of particle size. C. difficile and B. subtilis 
spores were already suspended in water following spore preparation (see sections 2.6.3 
and 2.7.1). One mL of each suspension was transferred to an UV cuvette. Samples were 
placed in the light scattering machine; each cycle ran for 200 sec at a laser angle of 90 °.  
This was repeated in triplicate. The machine determined the mean particle size in 
nanometres (nm) of the particles in suspension. The experiment was repeated under 
‘dirty’ conditions by adding BSA to the suspension at a final concentration of 3 g/L. 
 
Table 2.7 shows the mean particle size of S. aureus, A. baumannii, C. difficile spores 
and B. subtilis spores determined by light scattering. The diameter of S. aureus is 
normally between 0.5 – 1.5 μm, the data obtained from light scattering fits in this size 
range (Harris et al., 2002). A. baumannii is usually 0.9 - 1.6 μm in diameter 
(Vaneechoutte et al., 2011); the mean diameter of the strain in this study was greater 
than this range, which may suggest aggregation of cells. A study has shown C. difficile 
spores range in diameter from 0.5 - 0.7 μm (Snelling et al., 2012). The mean particle 
sizes of C. difficile spores in the presence and absence of organic load were greater than 
this suggesting spore aggregation. It has been reported B. subtilis spores are in the size 
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region of 0.41 - 0.67 μm in diameter (Carrera et al., 2007). B. subtilis spore diameters 
here were slightly higher than the top end of this range, both with and without BSA. 
 
Statistical analysis by means of a paired t-test using SPSS software showed there was 
no statistical difference (see Table 2.7) between the mean diameter of cells or spores 
with and without organic load. The P-values were determined by comparing the particle 
size for each strain in the presence and absence of BSA.  No significant difference 
suggests the addition of organic load did not influence cell aggregation for these 
particular strains.  
 
Table 2.7 – Mean particle size of microorganism with and without organic load (3 g/L 
BSA) (n=3) 
Microorganism 
Mean diameter 
(nm) ± SD (no BSA)  
Mean diameter  
(nm) ± SD (with BSA)  
P-value 
S. aureus 1332 ± 375 1251 ± 565 0.64 
A. baumannii 2612.6 ± 856.4 3288.0 ± 1032.4 0.26 
C. difficile 1730.4 ± 578.2 1500.2 ± 495.7 0.07 
B. subtilis 916.4 ± 277 858.9 ± 371.9 0.38 
 
2.9.2 Cell hydrophobicity 
 
The surface hydrophobicity of the microorganisms was tested using the Microbial 
Adhesion to Hydrocarbon (MATH) test based on that of Rosenberg et al. (1980). 
Hydrophobicity is an important factor affecting the efficacy of antimicrobial surfaces 
since the hydrophobicity of a bacterial suspension may affect its interaction with a 
surface (OECD, 2008).  The hydrocarbon used in this study was hexadecane (C16H34). 
The MATH test determined the percentage of bacterial cells adhered to a hydrocarbon; 
the higher the percentage the greater the hydrophobicity.  
 
S. aureus and A. baumannii cultures were prepared as in section 2.3.2, centrifuged for 
10 min at 940 g and pellets washed twice with phosphate buffered saline (PBS). Pellets 
were re-suspended in 10 mL PBS to yield approximately 10
8 
cfu/mL. C. difficile and B. 
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subtilis spore suspensions were prepared as in 2.6.3 and 2.7.1, respectively. Three mL 
of suspension was transferred to a McCartney bottle to which 800 µL hexadecane was 
added. Bottles were incubated for 10 min at 30 °C then vortexed for 1.5 min. The 
suspension was left to stand for 15 min then 1 mL of the aqueous layer was extracted 
with a Pasteur pipette and the OD600 was measured. The percentage adherence was 
calculated as follows: 
 
% adherence = ((ODinitial – ODhexadecane) / OD initial) x 100 
 
The percentage of bacterial cells’ adherence to hexadecane correlates to the level of 
hydrophobicity. A percentage adherence of >75 % means bacterial cells were 
hydrophobic. Adherence between 25 – 75 % suggests an intermediate 
hydrophobic/hydrophilic profile and adherence below 25 % suggest bacteria are 
hydrophilic (Cheeseman, 2010).  
 
Figure 2.2 shows the hydrophobicity profile (% adherence ± SD) of S. aureus, A. 
baumannii, C. difficile spores and B. subtilis spores. S. aureus and C. difficile spores 
presented an average intermediate percentage adherence. A. baumannii and B. subtilis 
spores showed an average hydrophilic profile. 
 
Figure 2.2 – Hydrophobicity profiles of S. aureus, A. baumannii, C. difficile spores and 
B. subtilis spores. Error bars represent the standard deviation. 
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2.10 Antimicrobial surfaces 
 
Copper alloy test surfaces were kindly provided by the CDA, Hemel Hempstead, UK. 
The copper alloys were as follows; CuSn5, CuZn30, CuDHP and CuNi10Fe1Mn. 
Coupons measured 22 mm by 22 mm. Table 2.8 shows the chemical composition of the 
copper alloys. After testing, surfaces were disinfected by immersion in 70 % ethanol, 
dried then stored in a sterile Petri dish to prevent contamination. Control experiments 
confirmed disinfection by 70 % ethanol was sufficient to ensure surfaces were not 
contaminated post-disinfection. (NB. Surfaces were not re-used after bacterial spore 
testing). 
 
Grade 2B finish stainless steel (Goodfellow Cambridge Ltd, Huntington, UK) with a 
composition of: C 0.08 %, Mn 2 %, P 0.045 %, S 0.03 %, Si 0.75 %, Cr 18-20 %, Ni 8-
12 %, N 0.1 %, Fe balance was used as a control surface throughout antimicrobial 
surface testing. Discs were cleaned as described in 2.8. Discs measured 1 cm
2
 in surface 
area. 
 
Table 2.8 – Chemical composition of copper alloys 
Metal 
type 
Formula Composition   
 
      
  
% Cu % Zn % Sn % Ni % Fe % Mn 
Copper CuDHP 99.99 
     
Brass CuZn30 70 30 
    
Bronze CuSn5 95 
 
5 
   
Copper 
nickel 
CuNi10Fe1Mn 86-89.7 
  
9.0-11.0 1.0-2.0 0.3-1.0 
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2.11 Neutraliser toxicity and efficacy tests 
 
2.11.1 Neutraliser toxicity 
 
A neutraliser was utilised throughout antimicrobial surface testing (see Chapters 4 and 
5) to neutralise the antimicrobial activity of surfaces. The neutraliser consisted of 3 g/L 
lecithin, 30 mL/L Tween 80, 5 g/L sodium thiosulphate, 1 g/L L-histidine, 10 mL 
phosphate diluent (34 g/L K2HPO4) and 30 g/L saponin all dissolved in 1 L deionised 
water. In order to be confident the neutraliser had no toxic effect on the tested 
microorganisms, a neutraliser toxicity test was initially carried out.  S. aureus and A. 
baumannii were grown as described in 2.3.2 and re-suspended in 10 mL MRD to give a 
bacterial concentration of 10
9
 cfu/mL. B. subtilis and C. difficile spore stocks were also 
tested. One mL of bacterial suspension was transferred into a 9 mL mix of neutraliser 
and MRD (9 mL MRD with 1 mL neutraliser). Water was used as a control; 1 mL of 
approximately 10
9
 cfu/mL bacterial suspension was transferred to 9 mL deionised 
water. Mixtures were left for 5 min, and then viable bacteria were enumerated via the 
drop count method. This was repeated in triplicate. Table 2.9 shows the results from the 
toxicity test and counts are represented by log10 cfu/mL values. Statistical analysis by 
means of a one-way ANOVA using SPSS software showed there were no significant 
differences between the use of water and neutraliser (all P-values comparing water vs. 
neutraliser counts were greater than 0.05). It was therefore safe to assume the tested 
neutralisers had no toxic effect on S. aureus, A. baumannii, C. difficile spores and B. 
subtilis spores. 
 
Table 2.9 – Neutraliser toxicity test results (n=3) 
Microorganism 
Water    
(Log10 cfu/ml) 
Neutraliser 
(Log10 cfu/mL) 
P-value 
S. aureus 8.47 ± 0.17 8.42 ± 0.06 0.57 
A. baumannii 8.42 ± 0.11 8.55 ± 0.09 0.133 
C. difficile 7.94 ± 0.02 7.99 ± 0.02 0.098 
B. subtilis 7.94 ± 0.03 7.99 ± 0.00 0.337 
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2.11.2 Neutraliser efficacy 
 
To be certain the neutraliser of choice neutralised the antimicrobial activity of test 
copper surfaces, a neutraliser efficacy test was performed using the method described 
by Wheeldon et al. (2008). In brief, 50 µL of 10
8
 cfu/mL S. aureus and 50 µL of 
neutraliser (1 mL neutraliser and 9 mL MRD) were mixed and inoculated on to CuDHP 
in triplicate for 30 min. CuDHP was chosen for testing as this surface contained the 
highest copper content of the four provided copper alloys. Five min was the maximum 
neutralisation time during surface testing (see Chapters 4 and 5), however, 30 min was 
tested in this experiment in order to observe antimicrobial activity by copper. Water was 
used as a control in place of the neutraliser for each test.  After 30 min exposure 
surfaces were transferred to a 100 mL bottle containing 5 g glass beads and 10 mL 
MRD. Viable bacteria were determined by serial dilution using the drop count method. 
A. baumannii and B. subtilis spores were also tested in the same way. C. difficile spores 
were not tested as they were not utilised during antimicrobial surface testing (see 
Chapter 4, section 4.2.3). 
 
Table 2.10 shows the viable counts of the initial suspension inoculated on to surfaces 
and the amount recovered from surfaces after exposure to bacteria containing neutraliser 
or water. There was less <1 log10 reduction between the bacterial counts after 
neutralisation with neutraliser and the initial viable count, confirming the suitability of 
the neutraliser as a neutraliser for antimicrobial copper surface testing. When water was 
used in place of neutraliser it is apparent there was antimicrobial activity by copper 
against S. aureus and A. baumannii but not against B. subtilis spores after 30 min. 
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Table 2.10 – Neutraliser efficacy test results (n=3) 
Microorganism  Test Average Log10 cfu/mL ± SD 
S. aureus Initial viable count 6.82 ± 0.06 
 Neutraliser 7.09 ± 0.10 
 Water 5.35 ± 0.34 
A. baumannii Initial viable count 7.54 ± 0.10  
 Neutraliser 7.35 ± 0.02 
 Water 5.60 ± 0.13 
B. subtilis Initial viable count 8.18 ± 0.27 
 Neutraliser 8.21 ± 0.04 
 Water 8.29 ± 0.03 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
75 
 
CHAPTER 3 HOSPITAL SAMPLING 
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3.1 Introduction 
 
The JIS Z 2801 test, as described in detail in Chapter 1, section 1.11.1 and Chapter 4, 
section 4.1.6, is the current recognised antimicrobial surface efficacy test. Its test 
conditions (35 °C and 100 % relative humidity (RH)) bear little relationship to in-use 
conditions, such as a UK hospital environment. Thus, the performance of antimicrobial 
surfaces in the laboratory under JIS Z 2801 test conditions does not guarantee the same 
antimicrobial efficacy in indoor conditions, where temperature and relative humidity are 
lower in the UK. Examples of varying efficacy of antimicrobial surfaces under varying 
relative and humidity temperature conditions have been reported and support the need 
for a new antimicrobial surface test using more appropriate environmental parameters 
(see Chapter 1, section 1.10.2).  
 
3.1.1 Recommended temperature and relative humidity conditions in NHS 
hospitals 
 
In the UK there are guidelines for minimum temperature conditions in the workplace. 
Although not a legal obligation, Workplace Regulations recommend the minimum 
temperature inside the workplace must be at least 16 °C or 13 °C if the indoor nature of 
the work involves physical activity. However, legally work places must be of 
‘reasonable’ temperature, which depends on the nature and environment of the work. 
There is no maximum indoor temperature limit. The Health and Safety Executive states 
this is due to other influences such as radiant temperature, relative humidity and air 
velocity that affect ones comfort (Website 28, publication date unavailable). 
 
Regarding temperature within the hospital environment the DH recommends a 
temperature range of 16 to 25 °C, which is flexible according to local needs. Ideally, 
temperatures in patient areas during summer should not be higher than 28 °C for 50 
hours per year. In terms of relative humidity, due to the high costs associated with 
running and maintaining humidifiers and de-humidifiers, humidification is normally 
only provided when necessary. If humidifiers are used output is normally set at 70 %. 
Incoming air, if higher than 70 % relative humidity, may not necessarily be reduced by 
the humidifier. The upper relative humidity limit is set to 70 % to reduce condensation 
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on surfaces, particularly in winter. Overall, the DH suggests a relative humidity between 
35 % and 70 % in hospital wards. In operating theatres the DH recommends stable 
conditions with temperature ranging from 19 - 23 °C and relative humidity from 35 - 60 
% (DH, 2007c). 
 
3.1.2 Defining high touch surfaces 
 
If antimicrobial surfaces are to be utilised in healthcare settings they are most likely to 
be placed in areas of high touch. High touch surfaces within a hospital environment are 
surfaces that are touched frequently (Huslage et al., 2010). Since such surfaces are 
touched frequently they may potentially harbour microorganisms and also play a role in 
their transmission (Huslage et al., 2010). As described in Chapter 1, section 1.6, the 
NHS has produced several guidance documents identifying surfaces in a hospital ward 
that require cleaning and the recommended frequency of cleaning. However, areas of 
high-touch are not clearly defined. Huslage et al. (2010) set out to identify, by 
quantitative assessment, which surfaces are high-touch. Over an 18 month period five 
ICUs and seven medical-surgical floors were observed in a large teaching hospital in 
North Carolina, USA. Common surfaces to all five ICUs and all seven medical-surgical 
floors were identified then observed for contact frequency. Overall five surfaces were 
found to be high-touch and they were; bed rails, bed surfaces, supply carts, over-bed 
tables, and intravenous pumps. In the ICUs bed rails, bed surfaces and supply carts were 
high touch. Bed rails, over-bed tables, intravenous pumps, and the bed surface were 
found to be high touch in the medical-surgical wards (Huslage et al., 2010).  
 
3.1.3. Surface bioburden 
 
An aspect considered in this chapter is surface bioburden in hospital wards. One way to 
measure levels of surface contamination is with ATP bioluminescence monitors. The 
use of these as part of infection control measures and their advantages and 
disadvantages are introduced in Chapter 1, section 1.6.2.  ATP bioluminescence 
monitors work by providing a Relative Light Unit (RLU) reading that corresponds to 
the amount of ATP collected on a swab used to swab a surface of interest. The swab 
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contains a liquid-stable luciferin-substrate/luciferase-enzyme system that emits light in 
direct proportion to the amount of ATP collected on the swab. Light is emitted by the 
oxidation of luciferin by luciferase, which requires oxygen and ATP. Once luciferin is 
oxidised photons are released, which are detected by the ATP monitor and quantified as 
RLU (Website 29, 2014 and Website 30, publication date unavailable). The chemical 
reaction that takes place is as follows (Boyce et al., 2009): 
 
Luciferase + D-luciferin + O2 + ATP   
Luciferase + oxyluciferin + CO2 + AMP + PPi + light 
 
NB.  AMP = adenosine monophosphate  
PPi = inorganic pyrophosphate 
 
The RLU reading provided can be classed as a ‘pass’ or ‘fail’ in relation to surface 
cleanliness, depending on the set benchmarks.  
 
3.1.5 Aims and Objectives 
 
The aim of this section was to gain information about the relative humidity, temperature 
and bioburden on a number of surfaces in a hospital environment by regular 
environmental sampling. This information was necessary to develop the in vitro surface 
efficacy tests described in Chapters 4 and 5 to investigate the efficacy of antimicrobial 
surfaces using appropriate physical parameters that mimic conditions found in practice. 
This will help assess the performance and suitability of surfaces for potential use in a 
UK hospital environment. 
 
 
3.2 Materials and Methods 
 
3.2.1 Selection of wards and surfaces for environmental sampling 
 
The University Hospital of Wales (UHW), Cardiff, UK was the hospital site of choice 
for sampling of surfaces. Gastroenterology and Adult Critical Care Services (ACC) 
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wards were selected for surface temperature, relative humidity and bioburden sampling. 
In addition, surfaces in one of the hospital’s theatre rooms were sampled. It was not 
possible to sample the same theatre room on each occasion. As a local hospital rule, one 
operating theatre room is free at any given time to accommodate emergency procedures, 
and this room was normally allocated for sampling. Sampling took place every two 
months over a one year period to allow for any seasonal variations. In total there were 
six sampling sessions. Sampling took place in the morning after normal cleaning. On 
one occasion (fourth sampling session, October 2011) sampling in theatre was not 
possible at all due to restrictions by theatre staff. 
 
On each occasion surfaces sampled in gastroenterology included door handles (n=2), 
door push plates (n=2), computer keyboard (n=1) and mouse (n=1), trolleys (n=2), light 
switch (n=1), tap (n=1), wall panels (n=2), waste bin (n=1), bed grab rails (n=3), chairs 
(n=3) and tables (n=2).  
 
In ACC the surfaces sampled were; door handles (n=2), door push plates (n=2), 
computer keyboard (n=1) and mouse (n=1), bed grab rails (n=2), chairs (n=3), trolleys 
(n=2), tables (n=2), light switch (n=1), wall panels (n=2) and waste bin (n=1).  
 
In theatre, door handles (n=2), door push plates (n=2), computer keyboard (n=1), 
trolleys (n=3), anaesthetists stand (n=1), light switch (n=1), tap (n=1), wall panels (n=2) 
and waste bin (n=1) were sampled.  
 
When possible the same surface was sampled on each occasion. These surfaces were 
selected based on general knowledge of frequently touched areas, surfaces within 
patient vicinity and from the study by Huslage et al. (2010).  
 
3.2.2 Surface relative humidity and temperature measurements 
 
A Protimeter Moisture Measurement System (MMS) (GE Sensing, Taunton, UK) was 
used to take relative humidity and air, surface and dew point temperature readings 
according to the manufacturer’s guidelines. An image of the device is shown in Figure 
3.1. Relative humidity is defined earlier (see Chapter 1, section 1.10.2). The dew point 
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temperature can be described as ‘the temperature to which the air would have to cool (at 
constant pressure and constant water vapour content) in order to reach saturation’. The 
dew point temperature is always lower than the air temperature. If the dew point is equal 
to the air temperature the air is saturated. If there is a small difference in the air 
temperature and dew point temperature then the relative humidity is high. If the 
difference between the two temperatures is great the relative humidity is low (Website 
31, 2010). 
 
The Protimeter MMS device has three measurement modes, all of which were utilised. 
Firstly the instrument was used in search mode; relative moisture readings of surfaces 
were measured. A reading of 60 – 1000 and an indication of whether a surface was in a 
dry, wet or at risk condition were provided. For this mode the Protimeter MMS was 
placed directly on the surface of interest.  
 
Next the hygrometer mode of the device was used to take readings of the mixing ratio 
(AbS), surface relative humidity (% RH), surface air temperature (TAIR, °C) and surface 
dew point temperature (TDEW, °C). Here a hygrostick attachment was added to the 
Protimeter MMS and this was placed directly on the sampled surface. The hygrometer 
mode has a relative humidity measurement range of 30 - 100 %.  
 
The condensator mode provided an indication of whether there was a risk of 
condensation on a surface. Surface relative humidity (% RH), surface air temperature 
(TAIR, °C), surface dew point temperature (TDEW, °C), surface temperature (TS, °C) and 
temperature difference (TDIFF, °C) were measured with the condensator mode. For this 
mode a surface temperature probe was attached to the Protimeter MMS and placed over 
the area of interest. The temperature difference reading was helpful as this reading 
indicated whether a surface is at risk of condensation. The temperature difference 
reading is the difference between the dew point temperature and the surface 
temperature. If the difference is more than 3 °C a ‘no condensation’ reading is given. If 
the difference is 3 °C or less an ‘at risk, no condensation’ message is given. Finally, if 
the surface temperature equals or is less than the dew point temperature a 
‘condensation’ message is given. These are the guidelines provided in the device’s 
instruction manual. 
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Figure 3.1 – Picture of Protimeter MMS   
 
 
 
 
 
 
 
 
3.2.3 Surface bioburden measurements 
 
Levels of surface bioburden were determined using a SystemSURE Plus ATP Hygiene 
Monitoring System (Hygiena, Watford, UK), which measured ATP levels (Figure 3.2a). 
The device was utilised according to the manufacturer’s guidelines. The swabs used, 
Ultrasnap, (Hygiena, Watford, UK) contained a liquid-stable luciferase/luciferin agent 
that emitted light in direct proportion to the amount of ATP collected on the swab. The 
user is then provided with one of three readings; pass, caution or fail depending on the 
cleanliness of a surface. According to the device’s instruction manual, a reading of less 
than 10 indicated that the surface was clean (pass). A reading between 11 - 29 indicated 
that the surface was not adequately clean (caution) and a reading over 30 suggested a 
surface was dirty (fail). The minimum possible RLU value was 0. Where possible a 10 
cm x 10 cm area of the sampled surface was swabbed in a zig-zag motion, as shown in 
Figure 3.2b. 
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Figure 3.2 – ATP bioluminescence monitor (a) and the zig-zag pattern used for 
swabbing surfaces (b) 
 
a) ATP bioluminescence monitor b) zig-zag motion for swabbing surfaces 
 
 
 
 
 
 
 
 
3.2.4 Statistical analysis 
 
Data were analysed statistically by ANOVA with SPSS software. Post-hoc analysis by 
means of a Tukey test allowed identifying specifically where, if any, significant 
differences were. P-values, mean differences and 95 % confidence intervals (CI) are 
provided with the analysis. 
 
 
3.3 Results 
 
A comprehensive data set of surface temperature, relative humidity and bioburden was 
obtained from six sampling sessions over a period of one year. Sampling in theatre was 
not possible on the fourth sampling occasion due to hospital restrictions. 
 
Table 3.1 is a summary of data collected showing average and range readings from the 
surfaces sampled in each ward on each sampling occasion.  The average readings from 
the three wards combined per sampling session (numbers in bold) are also noted. The 
data shown are average and range relative humidities and surface air temperatures 
measured by the hygrometer mode. Dew point temperatures, surface temperatures and 
temperature differences measured using the condensator mode of the Protimeter MMS 
are also shown. Average and range RLU readings from the surfaces sampled in each 
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ward on each occasion are also shown Table 3.1. For raw data see Appendix 1, Tables 1 
- 17. 
 
Surface relative humidity, surface air temperature, surface temperature and bioburden 
data were analysed statistically. Statistical analysis of data was carried out to see if there 
were significant differences in the data collected across wards and across sampling 
sessions; one-way ANOVAs were used to analyse data across wards and across 
sampling sessions. P-values and 95 % CIs for the mean differences between wards or 
sampling sessions are provided, with a P<0.05 showing significance. Post-hoc analysis 
by means of a Tukey analysis allowed for identifying specific differences between 
sessions or wards. Differences in surface relative humidity, surface air temperature, 
surface temperature and surface bioburden across sampling sessions were analysed. 
Tables 3.4, 3.7, 3.10 and 3.14 show the post-hoc Tukey analysis results that allowed for 
identifying differences between the six sampling sessions, with significant differences 
highlighted in red. 
 
Analysis of differences in relative humidity, surface air temperature, surface 
temperature and surface bioburden across wards over the entire sampling period was 
also conducted. Post-hoc analysis results are shown in Tables 3.3, 3.6, 3.9 and 3.13 and 
significant differences are highlighted. 
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Table 3.1 – Data collected from environmental sampling of surfaces at UHW 
  
HYGROMETER MODE  
Date Ward Mean RH ±SD (%) RH range (%) Mean TAIR ±SD (°C) TAIR range (°C) 
19/04/2011 Gastroenterology 34.6 ± 3.8 30.4 – 41.2 24.6 ± 1.7 21.0 – 28.5 
 
ACC 31.4 ± 0.5 30.5 – 32.6 24.3 ± 0.5 23.6 – 25.5 
 
Theatre Room 41.4 ± 2.3 37.2 – 44.7 22.3 ± 1.4 20.6 – 25.1 
 
Average 35.8 ± 5.1  23.8 ± 1.3  
17/06/2011 Gastroenterology 50.6 ± 2.4 46.7 – 58.2 22.8 ± 1.3 19.9 – 24.5 
 
ACC 45.4 ± 1.7 42.0 – 48.2 22.3 ± 0.7 21.2 – 23.7 
 
Theatre Room 46.5 ± 3.2 43.8 – 56.9 21.8 ± 0.7 21.1 – 23.1 
 
Average 47.5 ± 2.7  22.3 ± 0.5  
16/08/2011 Gastroenterology 63.6 ± 0.4 62.6 – 64.2 22.4 ± 0.6 20.4 – 23.1 
 
ACC 58.0 ± 1.8 54.2 – 61.4 24.2 ± 0.5 23.2 – 25.3 
 
Theatre Room 54.4 ± 4.2 47.7 – 61.8 20.9 ± 1.3 19.0 – 23.3 
 
Average 58.7 ± 4.6  22.5 ± 1.7  
18/10/2011 Gastroenterology 44.8 ± 3.3 39.2 – 52.1 21.8 ± 0.7 20.5 – 22.6 
 
ACC 38.5 ± 3.4 33.8 – 44.2 22.9 ± 0.5 22.1 – 23.8 
 
Average 41.7 ± 4.5  22.4 ± 0.8  
15/12/2011 Gastroenterology 42.1 ± 2.7 36.7 – 45.7 23.1 ± 1.0 21.2 – 24.6 
 
ACC 33.7 ± 2.2 31.3 – 38.1 23.1 ± 0.8 21.7 – 24.1 
 
Theatre Room 34.4 ± 0.7 32.9 – 35.1 20.2 ± 0.5 19.8 – 21.4 
 
Average 36.7  ± 4.7  22.2  ± 1.7  
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Table 3.1 continued – Data collected from environmental sampling of surfaces at UHW 
  HYGROMETER MODE    
Date Ward Mean RH ±SD (%) RH range (%) Mean TAIR ±SD (°C) TAIR range (°C) 
14/02/2012 Gastroenterology 37.6  ±  4.5 31.3 – 42.9 22.9  ± 0.9 21.8 – 25.2 
 
ACC 36.8 ± 3.8 31.3 – 43.0 24.0 ± 1.1 22.9 – 28.0 
 
Theatre Room 46.2 ± 0.9 43.8 – 47.6 21.8 ± 0.5 21.1 – 23.1 
 
Average 40.2 ± 5.2  22.9 ± 1.1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
Table 3.1 continued – Data collected from environmental sampling of surfaces at UHW 
  
CONDENSATOR MODE      
Date Ward Mean TDEW ±SD (°C) TDEW range (°C) Mean TS±SD (°C) TS range (°C) Mean TDIFF ±SD (°C) TDIFF range (°C) 
19/04/2011 Gastroenterology 7.1 ± 2.1 4.3 – 11.7 24.3 ± 1.4 22.0 – 26.8 17.2 ± 1.6 13.3 – 19.4 
 
ACC 6.1 ± 0.3 5.5 – 6.7 23.8 ± 0.3 23.3 – 24.3 18.0 ± 0.2 17.7 – 18.3 
 
Theatre Room 8.3 ± 0.4 7.7 – 8.7 22.4 ± 1.2 20.9 – 24.3 14.1 ± 1.0 13.0 -15.9 
 
Average 7.2 ± 1.1  23.5 ± 1.0  16.5 ± 2.1  
17/06/2011 Gastroenterology 11.7 ± 0.5 11.0 – 12.6 23.2 ± 0.7 21.9 – 24.2 11.4 ± 0.5 10.3 – 12.2 
 
ACC 9.6 ± 0.3 9.2 – 10.0 22.0 ± 0.9 20.9 – 23.2 12.4 ± 0.8 11.4 – 13.6 
 
Theatre Room 9.3 ± 0.2 9.0 – 9.6 20.9 ± 0.4 20.2 – 21.3 11.5 ± 0.6 10.2 – 12.2 
 
Average 10.2 ± 1.3  22.0 ± 1.1  11.8 ± 0.6  
16/08/2011 Gastroenterology 15.3 ± 0.2 15.0 – 15.9 22.4 ± 0.5 21.6 – 24.0 7.0 ± 0.4 6.3 – 8.2 
 
ACC 15.3 ± 1.9 15.0 – 15.9 23.2 ± 0.2 22.8 – 23.6 7.7 ± 0.4 7.0 – 8.3 
 
Theatre Room 11.5 ± 0.4 11.1 – 12.7 19.7 ± 1.0 18.2 – 21.3 8.2 ± 0.9 7.0 – 9.7 
 
Average 14.1 ± 2.2  21.8 ± 1.1  7.6 ± 0.5  
18/10/2011 Gastroenterology 9.5 ± 1.7 6.2 – 11.7 22.3 ± 0.4 21.6 – 23.2 13.5 ± 1.2 10.4 – 15.1 
 
ACC 7.9 ± 1.5 5.6 – 10.6 22.2 ± 0.4 21.5 – 22.9 13.9 ± 1.7 11.0 – 16.7 
 
Average 8.7 ± 1.2  22.3 ± 0.0  13.7 ± 0.3  
15/12/2011 Gastroenterology 9.4 ± 2.0 6.1 – 11.4 23.9 ± 1.0 21.9 – 25.3 14.4 ± 1.7 11.7 – 17.4 
 
ACC 5.8 ± 1.0 4.9 – 9.3 22.7 ± 0.3 21.9 – 23.1 16.9 ± 1.1 13.7 – 18.0 
 
Theatre Room 3.7 ± 0.4 3.2 - 4.4 20.2 ± 0.6 19.2 – 21.4 16.5 ± 0.8 15.5 – 18.5 
 
Average 6.3  ± 2.9  22.3  ± 1.9  15.9 ± 1.3  
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Table 3.1 – Data collected from environmental sampling of surfaces at UHW 
  CONDENSATOR MODE      
Date Ward Mean TDEW ±SD (°C) TDEW range (°C) Mean TS±SD (°C) TS range (°C) Mean TDIFF ±SD (°C) TDIFF range (°C) 
14/02/2012 Gastroenterology 8.5  ± 1.6 6.0 – 10.7 23.1  ± 1.1 20.7 – 24.6 14.6 ± 3.1 7.8 – 17.8 
 
ACC 8.5 ± 1.8 5.3 – 10.9 23.8 ± 0.4 23.3 – 24.7 15.3 ± 1.6 13.5 – 18.1 
 
Theatre Room 10.4 ± 0.7 9.9 – 12.6 22.6 ± 0.3 22.2 – 23.0 12.9 ± 0.4 12.2 – 13.3 
 
Average 9.1 ± 1.1  23.2 ± 0.6  14.3 ± 1.2  
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Table 3.1 continued – Data collected from environmental sampling of surfaces at UHW 
  
BIOBURDEN  
Date Ward Mean RLU RLU range 
19/04/2011 Gastroenterology 110 ± 146  0 - 601 
 
ACC 149 ± 241 4 - 890 
 
Theatre Room 87 ± 78 1 – 199 
 
Average 115 ± 31  
17/06/2011 Gastroenterology 46 ± 79 0 - 365 
 
ACC 68 ± 76 2 - 249 
 
Theatre Room 19 ± 25 1 - 96 
 
Average 44 ± 24  
16/08/2011 Gastroenterology 165 ± 359 0 - 1456 
 
ACC 30 ± 26 1 -87 
 
Theatre Room 26 ± 17 4 - 64 
 
Average 74 ± 79  
18/10/2011 Gastroenterology 30 ± 38 2 - 77 
 
ACC 26 ± 22 0 - 140 
 
Average 28 ± 3  
15/12/2011 Gastroenterology 103 ± 121 9 - 431 
 
ACC 45 ± 67 1 - 281 
 
Theatre Room 52 ± 35 7 - 117 
 
Average 67 ± 32  
14/02/2012 Gastroenterology 54 ± 65 0 - 277 
 
ACC 78 ± 151 6 – 615 
 
Theatre Room 42 ± 27 5 – 95 
 
Average 58 ± 18  
 
Key 
RH – relative humidity  
TAIR – air temperature  
TDEW – dew point temperature  
TS – surface temperature  
TDIFF – temperature difference  
RLU – relative light units 
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3.3.1 Surface relative humidity findings 
 
Surface relative humidity observations were measured using the hygrometer mode of the 
Protimeter MMS. Mean ± SD and median values are shown in Table 3.2. Mean surface 
relative humidity readings were similar in gastroenterology and theatre. Mean relative 
humidity in ACC was slightly lower at 40.6 ± 9.3 %. Across the six sampling sessions 
surface relative humidity ranged from 30.4 – 64.2 % in gastroenterology, 30.5 - 61.4 % in 
ACC and 32.9 – 61.8 % in theatre, see Table 3.2. The ranges are approximately similar. 
For all three wards the overall range in surface relative humidity readings from all six 
sampling session was high, which suggests there was great variability between sample 
sessions. 
 
Table 3.2 – Range, mean and median relative humidity readings from each ward across 
the six sampling sessions 
Ward 
RH range 
(%) 
Mean RH ± SD 
(%) 
Median RH 
(%) 
Gastroenterology (n=124) 30.4 – 64.2 45.4 ± 10.1 44 
ACC (n=114) 30.5 – 61.4 40.6 ± 9.3 38.2 
Theatre (n=69) 32.9 – 61.8 44.6 ± 7.1 45.4 
 
Surface relative humidity ranges per ward, per sample session ranges are shown in Table 
3.1. From all six sampling sessions in gastroenterology the highest relative humidity of 
64.2 % was recorded from a bed rail (August 2011) and the lowest, 30.4 %, from a wall 
panel (April 2011). The highest surface relative humidity of 61.4 % in ACC was from a 
wall panel (August 2011) and the lowest, 30.5 %, was observed on a door push plate 
(April 2011). In theatre, the highest surface relative humidity, 61.8 %, was from a wall 
panel (August 2011) and the lowest, 32.9 %, from a door handle (December 2011).  
 
In gastroenterology, the greatest range in surface relative humidity readings was observed 
during the fourth sampling session (39.2 – 52.1 %) and the smallest on the third sampling 
occasion (62.6 – 64.2 %). The greatest range in surface relative humidity in ACC was 
observed on the sixth sampling occasion (31.3 – 43 %) and the lowest on the first occasion 
(30.5 – 32.6 %). Finally in theatre, the greatest range in surface relative humidity was on 
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the third sampling occasion (47.7 – 61.8 %) and the smallest from the fifth occasion (32.9 
– 35.1 %). 
 
In terms of average surface relative humidity observations, overall averages from 
individual wards ranged from 31.4 ± 0.5 % (ACC, April 2011) to 63.6 ± 0.4 % 
(gastroenterology, August 2011). Average relative humidity readings of all the three wards 
from each session ranged from 35.7 ± 5.1% (April 2011) to 58.7 ± 4.6 % (August 2011).  
 
Surface relative humidity readings recorded from the hygrometer mode were analysed 
statistically. Overall, over the sampling period the ward type had a significant effect on 
surface relative humidity observations (ANOVA, P=0.044). However, comparisons by a 
post-hoc Tukey test showed no significant difference between wards, shown in Table 3.3. 
All P-values are >0.05, suggesting no significant differences in surface relative humidity 
between wards. 
 
Table 3.3 – Surface relative humidity comparisons across wards over the six sampling 
sessions 
Ward comparison P-value Mean difference 95 % CI 
Gastroenterology vs. ACC 0.061 2.77 -0.10 – 5.64 
ACC vs. Theatre 0.127 2.80 -0.58 – 6.18 
Gastroenterology vs. Theatre >0.999 0.03 -3.38 – 3.32 
 
Overall there was a significant difference in surface relative humidity between the 
sampling sessions in all three wards combined (ANOVA, P<0.001). Post-hoc analysis 
allowed identification of differences in surface relative humidity readings between 
sampling sessions. Significant differences were observed between all sessions except 
between April 2011 and December 2011, October 2011 and February 2012 and between 
December 2011 and February 2012, see Table 3.4. 
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Table 3.4 – Post-hoc analysis to show comparisons in surface relative humidity between 
sampling sessions. Significant differences (P<0.05) are highlighted in red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Session comparison P-value Mean difference 95 % CI 
April 2011  vs. June 2011 P<0.001 12.49 9.98 – 15.00 
April 2011  vs. August 2011 P<0.001 24.29 21.79 – 26.81 
April 2011  vs. October 2011 P<0.001 6.70 3.99 – 9.41 
April 2011  vs. December 2011 0.250 1.91 -0.60 – 4.42 
April 2011  vs. February 2012 P<0.001 4.41 1.91 – 6.91 
June 2011  vs. August 2011 P<0.001 11.80 9.29 – 14.31 
June 2011  vs. October 2011 P<0.001 5.79 3.08 – 8.50 
June 2011  vs. December 2011 P<0.001 10.58 8.07 – 13.09 
June 2011  vs. February 2012 P<0.001 8.09 5.59 – 10.58 
August 2011  vs. October 2011 P<0.001 17.60 14.89 – 20.30 
August 2011  vs. December 2011 P<0.001 22.39 19.88 – 24.90 
August 2011  vs. February 2012 P<0.001 19.89 17.39 – 22.39 
October 2011  vs. December 2011 P<0.001 4.79 2.09 – 7.50 
October 2011  vs. February 2012 0.146 2.29 -0.40 – 4.99 
December 2011  vs. February 2012 0.05 2.50 -0.00 -5.00 
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3.3.2 Air and surface temperature findings 
 
3.3.2.1 Air temperature 
 
Air temperature readings of surfaces were recorded using the hygrometer mode of the 
Protimeter MMS. Mean ± SD and median values are shown in Table 3.5. Mean surface air 
temperature was highest in ACC and lowest in theatre. Across the six sampling sessions 
surface air temperature ranged from 19.9 – 28.5 °C in gastroenterology, 21.2 – 28.0 °C in 
ACC and 19.0 – 25.1 °C in theatre.  
 
Table 3.5 – Range, mean and median air temperature readings from each ward across the 
six sampling sessions 
Ward 
Mean air temp. 
range (°C) 
Mean air temp. 
± SD (°C) 
Median air 
temp. (°C) 
Gastroenterology (n=124) 19.9 – 28.5 22.9 ± 1.4 22.8 
ACC (n=114) 21.2 – 28.0 23.5 ± 1.0 23.5 
Theatre (n=69) 19.0 – 25.1 21.4 ± 1.2 21.4  
 
Table 3.1 shows surface air temperature ranges per ward, per sample session. Taking into 
account all six sampling sessions, the highest air temperature in gastroenterology, 28.5 °C 
was taken from a tap (April 2011) and the lowest, 19.9 °C from a door handle (June 2011). 
The highest surface air temperature of 28.0 °C in ACC was obtained from a computer 
keyboard (February 2011) and the lowest, 21.2 °C, from a table (June 2011). In theatre the 
highest surface air temperature reading, 25.1 °C, was taken from a door handle (April 
2011) and the lowest, 19.0 °C, from a wall panel (December 2011).  
 
In gastroenterology, the greatest range in surface air temperature readings was observed in 
the first sampling session (21.0 – 28.5 °C) and the smallest on the fourth sampling 
occasion (20.5 – 22.6 °C). The greatest range in ACC was observed on the sixth session 
(22.9 – 28.0 °C) and the lowest on the fourth occasion (22.1 – 23.8 °C). The greatest range 
in surface air temperature observed in theatre was during the first sampling session (20.6 – 
25.1 °C) and the smallest on the fifth occasion (19.8 – 21.4 °C). 
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Also noted in Table 3.1 are mean surface air temperatures values. Overall mean surface air 
temperatures from individual wards ranged from 20.2 ± 0.5 °C (theatre, December 2011) 
to 24.6 ± 1.7 °C (gastroenterology, April 2011). Average temperature readings of all the 
three wards from each sampling session ranged from 22.2 ± 1.7 °C (December 2011) to 
23.8 ± 1.3 °C (April 2011).  
 
Over the one year period there was a significant difference in air temperature across the 
three wards sampled (ANOVA, P<0.001). Post-hoc analysis by means of a Tukey test to 
identify differences between groups showed there were significant differences between all 
three wards (all comparisons P<0.05), as shown in Table 3.6. 
 
Table 3.6 – Air temperature comparisons across wards over the six sampling sessions 
Ward comparison P-value Mean difference 95 % CI 
Gastroenterology vs. ACC 0.002 0.54 0.16 – 0.91 
ACC vs. Theatre <0.001 2.09 1.65 – 2.53 
Gastroenterology vs. Theatre <0.001 1.55 1.12 – 2.00 
 
Overall there were significant differences in surface air temperature between the six 
sampling sessions (ANOVA, P<0.001).  Post-hoc analysis of surface air temperature data 
allowed for comparisons between the different sampling sessions, as shown in Table 3.7. 
Statistically there were significant differences between the first sampling session (April 
2011) and all other sampling occasions. No other significant differences were observed. 
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Table 3.7 – Post-hoc analysis to show comparisons in air temperature between sampling 
sessions. Significant differences (P<0.05) are highlighted in red. 
 
 
 
 
 
 
 
 
 
 
 
Session comparison P-value Mean difference 95 % CI 
April 2011  vs. June 2011 <0.001 1.61 0.86 – 2.36 
April 2011  vs. August 2011 <0.001 1.29 0.55 – 2.04 
April 2011  vs. October 2011 <0.001 1.60 0.79 – 2.41 
April 2011  vs. December 2011 <0.001 1.59 0.84 – 2.34 
April 2011  vs. February 2012 0.004 0.95 0.21 – 1.70 
June 2011  vs. August 2011 0.882 0.32 -0.43 – 1.07 
June 2011  vs. October 2011 >0.999 0.01 -0.80 – 0.82 
June 2011  vs. December 2011 >0.999 0.02 -0.73 – 0.77 
June 2011  vs. February 2012 0.116 0.66 -0.09 – 1.41 
August 2011  vs. October 2011 0.880 0.31 -0.50 – 1.11 
August 2011  vs. December 2011 0.860 0.30 -0.45 – 1.05 
August 2011  vs. February 2012 0.776 0.34 -0.40 – 1.08 
October 2011  vs. December 2011 >0.999 0.01 -0.80 – 0.82 
October 2011  vs. February 2012 0.191 0.65 -0.15 – 1.46 
December 2011  vs. February 2012 0.140 0.64 -0.11 – 1.39 
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3.3.2.2 Surface temperature 
 
Surface temperature observations were recorded using the condensator mode of the 
Protimeter MMS as this mode allows one to identify if a surface was at risk of 
condensation. It is worth noting that the sample size for surfaces tested for surface 
temperature was lower than the other parameters; this was due to difficulties experienced 
with the surface temperature probe. For this reason surface air temperature readings 
obtained with the hygrometer mode were also analysed, (see previous section, 3.3.2.1). 
Over the six sampling sessions surface temperatures ranged from 20.7 – 26.8 °C in 
gastroenterology, 20.9 – 24.7 °C in ACC and 18.2 – 24.3 °C in theatre, see Table 3.8. 
Mean and median values are also shown in Table 3.8. The lowest mean surface 
temperature reading was obtained in theatre, and the highest in gastroenterology.  
 
Table 3.8 – Range, mean and median surface temperature readings from each ward across 
the six sampling sessions 
Ward 
Surface temp. 
range (°C) 
Mean surface 
temp. ± SD (°C) 
Median surface 
temp. (°C) 
Gastroenterology (n=110) 20.7 – 26.8 23.2 ± 1.1 22.9 
ACC (n=95) 20.9 – 24.7 22.9 ± 0.9 22.9 
Theatre (n=56) 18.2 – 24.3 21.2 ± 1.4 21.2  
 
Surface temperature ranges per ward, per sample session are shown in Table 3.1. Across 
all six sampling sessions the highest surface temperature measured in gastroenterology 
was 26.8 °C, on a bed rail (April 2011), and the lowest, 20.7 °C from a chair (February 
2012). The highest surface temperature reading of 24.7 °C in ACC was taken from a chair 
(February 2011) and the lowest, 20.9 °C, from a bed rail (June 2011). In theatre, the 
highest surface air temperature reading, 24.3 °C, was observed on a door handle (April 
2011) and the lowest, 18.2 °C, on a waste bin (August 2011).  
 
In gastroenterology, the greatest range in surface temperature readings was seen on the 
first sampling session (22.0 – 26.8 °C) and the smallest on the fourth (21.0 – 23.2 °C). The 
greatest range in ACC was seen during the second session (20.9 – 23.2 °C) and the 
smallest on the third occasion (22.8 – 23.6 °C). Finally, in theatre the greatest range in 
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surface temperature readings was from the first sampling session (20.9 – 24.3 °C) and the 
smallest from the sixth occasion (22.2 – 23.0 °C). 
 
Average surface temperature ranged from 19.7 ± 1.0 °C (Theatre room, August 2011) to 
24.3 ± 1.4 °C (gastroenterology, April 2011), see Table 3.1. Overall average readings from 
the three wards from each sampling session ranged from 21.8 ± 1.1 °C (August 2011) to 
23.5 ± 1.0 °C (April 2011).  
 
There was a significant difference in surface temperature across the three wards over the 
one year sampling period (ANOVA, P<0.001). Post-hoc analysis showed comparisons 
between the three wards, as shown in Table 3.9. Significant differences in surface 
temperatures were observed between theatre and all other wards (both P<0.05) but not 
between gastroenterology and ACC (P=0.150). 
 
Table 3.9 - Surface temperature comparisons across wards over the six sampling sessions 
Ward comparison P-value Mean difference 95 % CI 
Gastroenterology vs. ACC 0.150 0.30 -0.07 – 0.67 
ACC vs. Theatre <0.001 1.68 1.23 – 2.13 
Gastroenterology vs. Theatre <0.001 1.99 1.54 – 2.41 
 
One-way ANOVA analysis of differences in surface temperature over the sampling period 
showed an overall significance difference between sessions, (ANOVA, P<0.001). Post-
hoc Tukey analysis showed significant differences between particular sessions, 
highlighted in red, in Table 3.10. 
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Table 3.10 – Post-hoc analysis to show comparisons in surface temperature between 
sampling sessions. Significant differences (P<0.05) are highlighted in red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Session comparison P-value Mean difference 95 % CI 
April 2011  vs. June 2011 <0.001 1.35 0.59 – 2.13 
April 2011  vs. August 2011 <0.001 1.89 1.13 – 2.64 
April 2011  vs. October 2011 <0.001 1.42 0.62 – 2.22 
April 2011  vs. December 2011 <0.001 1.11 0.38 – 1.85 
April 2011  vs. February 2012 0.478 0.45 -0.28 – 1.18 
June 2011  vs. August 2011 0.335 0.53 -0.23 – 1.29 
June 2011  vs. October 2011 >0.999 0.07 -0.73 – 0.87 
June 2011  vs. December 2011 0.937 0.24 -0.50 – 0.99 
June 2011  vs. February 2012 0.006 0.90 0.17 – 1.63 
August 2011  vs. October 2011 0.545 0.46 -0.33 – 1.26 
August 2011  vs. December 2011 0.033 0.78 0.04 – 1.51  
August 2011  vs. February 2012 <0.001 1.43 0.71 – 2.16 
October 2011  vs. December 2011 0.866 0.31 -0.47 – 1.09 
October 2011  vs. February 2012 0.005 0.97 0.20 – 1.73 
December 2011  vs. February 2012 0.085 0.66 -0.05 – 1.36 
98 
 
3.3.2.2.1 Temperature difference data 
 
Temperature difference data is how many degrees a surface is above or below its dew 
point temperature. Range, mean and median temperature difference data are shown in 
Table 3.11. The highest mean temperature difference was in ACC and the lowest in 
theatre. The greatest range in temperature difference data was observed in 
gastroenterology; 6.3 – 19.4 °C. The smallest range was measured in theatre 13.0 – 18.5 
°C. 
 
Table 3.11 – Range, mean and median temperature difference readings from each ward 
across the six sampling sessions 
Ward 
Temp. 
difference 
range (°C) 
Mean temp. 
difference 
± SD (°C) 
Median temp. 
difference (°C) 
Gastroenterology (n=109) 6.3 – 19.4 13.0 ± 3.7 13.1 
ACC (n=95) 7.0 – 18.3 14.3 ± 3.2 14.4 
Theatre (n=54) 13.0 – 18.5 12.6 ± 2.9 13.0 
 
Overall the lowest temperature difference value was 6.3 °C (gastroenterology, August 
2011). This reading was taken from a wall panel. The highest temperature difference value 
observed was 19.4 °C, from a table in gastroenterology (April 2011). Other surfaces that 
showed relatively low temperature difference values included; a trolley (6.5 °C), waste bin 
(6.6 °C), bed rail (6.7 °C) and wall panel (6.7 °C), all gastroenterology, August 2011. 
Average temperature difference readings from all three wards on each sampling occasion 
ranged from 7.6 ± 0.5 (August 2011) to 16.5 ± 2.1 (April 2011), see Table 3.1. When 
ranking average surface temperatures and average temperature difference values from 
each sampling session the general trend was the higher the surface temperature the higher 
the temperature difference reading. 
  
Data obtained confirmed all surfaces sampled were not at risk of condensation as all 
surface temperatures exceeded their dew point temperatures by more than 3 °C. 
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3.3.3. Surface bioburden findings 
 
Surface bioburden measurements were recorded with an ATP bioluminescence monitor. 
Mean and median values for each ward are shown in Table 3.12. The lowest mean RLU 
observation was in theatre and the highest in gastroenterology. Over the one year sampling 
period, surface bioburden ranged from 0 - 1456 RLU in gastroenterology, 0 - 890 RLU in 
ACC and 1 – 199 in theatre.  
 
Table 3.12 – Range, mean and median surface bioburden readings from each ward across 
the six sampling sessions 
Ward RLU range 
Mean ± SD 
(RLU) 
Median 
(RLU) 
Gastroenterology (n=124) 0 – 1456 84 ± 175 30 
ACC (n=113) 0 – 890 66 ± 127 23 
Theatre (n=70) 1 - 199  45 ± 46 28 
 
In gastroenterology, the greatest range in surface bioburden readings was from the third 
sampling session (0 – 1456 RLU) and the smallest on the fourth sampling occasion (2 – 77 
RLU). The greatest range in RLU readings in ACC was seen in the second session (4 – 
890 RLU) and the lowest on the third occasion (1 – 87 RLU). Finally, in theatre the 
greatest range in surface bioburden was from the first sampling session (1 – 199 RLU) and 
the smallest from the third occasion (4 – 64 RLU). 
 
Surface bioburden ranges per ward, per sample session are shown in Table 3.1. The 
highest surface bioburden reading measured in gastroenterology was 1456 RLU from a 
trolley (August 2011). The lowest RLU, 0, was observed on several sampling occasions. 
Surfaces that presented an RLU value of 0 included a waste bin, chairs, wall panel, door 
handle and computer keyboard. The highest surface bioburden reading in ACC was 890 
RLU from a table (April 2011) and the lowest, 0 RLU, from a wall panel (October 2011). 
In theatre, the highest surface bioburden reading was 199 RLU, this was taken from a door 
push plate (April 2011). The lowest RLU, 1, was recorded from a tap on two occasions 
(April 2011 and June 2011).  
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Table 3.1 also shows the average surface bioburden measurements for each ward on each 
sampling occasion. The standard deviations of the means for each ward are great showing 
the high variability in bioburden on surfaces. Surface bioburden averages from individual 
wards ranged from 19 ± 25 (theatre, June, 2011) to 165 ± 359 (gastroenterology, August, 
2011). Overall averages from all three wards on each sampling occasion ranged from 28 ± 
3 (October 2011) to 115 ± 31 (April 2011). 
 
Over the sampling period there was no significant difference in RLU values across the 
three wards (ANOVA, P=0.156). Post-hoc analysis of the test by Tukey analysis to find 
specific, if any, differences between groups showed no significant differences between all 
wards (all P>0.05), as shown in Table 3.13. 
 
Table 3.13 – Surface bioburden comparisons across wards over the six sampling sessions 
Ward comparison P-value Mean difference 95 % CI 
Gastroenterology vs. ACC 0.569 18.07 -23.95 – 60.09 
ACC vs. Theatre 0.564 21.31 -27.78 – 70.45 
Gastroenterology vs. Theatre 0.135 39.37 -8.93 – 87.68 
 
Overall there was a significant difference in RLU across the six sampling sessions 
(ANOVA, P=0.035), however, post-hoc Tukey analysis showed there was only a 
significant difference between sessions on one occasion; April 2011 and October 2011 
(P=0.026). Between all other sessions there were no significant differences (all P>0.005), 
see Table 3.14. 
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Table 3.14 – Post-hoc analysis to show comparisons in surface bioburden between 
sampling sessions. Significant differences (P<0.05) are highlighted in red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Session comparison P-value Mean difference 95 % CI 
April 2011  vs. June 2011 0.095 69.30 -6.47 – 145.07 
April 2011  vs. August 2011 0.778 34.52 -40.90 – 109.94 
April 2011  vs. October 2011 0.026 88.20 6.50 – 169.90 
April 2011  vs. December 2011 0.474 47.28 -28.49 – 123.05 
April 2011  vs. February 2012 0.261 56.72 -18.70 – 132.14 
June 2011  vs. August 2011 0.772 34.78 -40.64 – 110.20 
June 2011  vs. October 2011 0.986 18.90 -62.79 – 100.59 
June 2011  vs. December 2011 0.961 22.02 -53.75 – 97.79 
June 2011  vs. February 2012 0.997 12.58 -62.84 – 88.00 
August 2011  vs. October 2011 0.409 53.68 -27.69 – 135.05 
August 2011  vs. December 2011 0.997 12.76 -62.65 – 88.18 
August 2011  vs. February 2012 0.958 22.20 -52.86 – 97.27 
October 2011  vs. December 2011 0.705 40.92 -40.78 – 122.61 
October 2011  vs. February 2012 0.877 31.48 -49.89 – 112.85 
December 2011  vs. February 2012 0.999 9.44 -84.86 – 65.98 
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3.4 Discussion 
 
Hospital sampling of surfaces for observing changes in surface relative humidity, 
temperature and bioburden was completed over a one year period. These sessions 
provided an insight into environmental conditions inside wards in a UK hospital in 
terms of surface relative humidity, surface temperature and surface bioburden. To date 
there have been no studies assessing surface relative humidity and surface temperature 
conditions in a UK hospital. 
 
As mentioned in section 3.1.1, it is recommended that the minimum temperature in a 
workplace should be at least 16 °C or 13 °C if one’s work involves physical activity. 
The air temperatures of surfaces sampled in all wards on all occasions were above 16 
°C; in compliance with the HSE recommendations. The DH does not have specific 
recommendations for surface temperatures within a hospital environment but does 
suggest a temperature of 16 – 25 °C in hospital wards. When taking into account the 
overall average air (measured by hygrometer mode of Protimeter MMS) and surface 
temperatures (measured by the condensator mode) recorded per ward and per sampling 
session all averages were within this recommended guideline (see Table 3.1) (DH, 
2007c). With an overall surface air temperature (hygrometer mode) range of 19.9 - 28.5 
°C recorded in both gastroenterology and ACC, a total of 14 of the 237 surfaces 
sampled in total in the two wards were above 25 °C. The surface temperatures recorded 
(condensator mode) ranged from 20.7 - 26.8 °C in gastroenterology and ACC; 6 
surfaces of the total sampled surfaces presented a surface temperature >25 °C.  A lower 
temperature range guideline for theatre rooms of 19 – 23 °C is recommended. Again, 
this is a general guideline and not specific to surface temperatures. However, average 
surface air and surface temperatures per theatre room and per sample session did fall 
within this range (see Table 3.1) (DH, 2007c). Overall surface air temperatures 
(hygrometer mode) in theatre ranged from 19 - 25.1 °C; 6 of the 68 total sampled 
surfaces were >23 °C. Surface temperatures (condensator mode) recorded in theatre 
ranged from 18.2 - 24.3 °C; 2 surfaces were below and 5 were above the recommended 
temperature limit. Significant differences in surface air and surface temperatures in 
wards combined between sampling sessions showed that temperature was variable over 
the one year sampling period. 
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In general hospital wards the DH recommends a relative humidity in the range of 35 – 
70 % (DH, 2007c). As with temperature guidelines, these recommendations are generic 
and there are no specific surface guidelines. Nevertheless, all surfaces sampled in both 
gastroenterology and ACC were within this range. In theatre a relative humidity 
between 35 – 60 % is advised (DH, 2007c). Only one of the total number of surfaces 
sampled presented a relative humidity greater than 60 %.  Significant differences in 
relative humidity between sampling sessions and the large range of surface relative 
humidities observed in each ward warrants the testing of antimicrobial surfaces, for use 
in hospital environments, under a range of varying relative humidities. It is apparent 
there are seasonal variations in relative humidity, which should be accounted for.  
 
Temperature difference data showed all surfaces tested were not at risk of condensation 
since surface temperatures exceeded their dew point temperatures by more than 3 °C. 
The risk of a surface to condensation is worth considering in terms of the introduction 
of antimicrobial surfaces in the healthcare setting. For example, if a particular surface is 
at risk of condensation, and is in an area of high-touch then this surface could be an 
ideal candidate as an antimicrobial surface. The presence of condensation on the surface 
will likely boost the surfaces’ antimicrobial activity. In this study no surfaces were at 
risk of condensation; however, of all the surfaces sampled those at the lower end of the 
range and thus relatively close to being at risk included wall panels, trolleys, waste bins 
and bed rails. Despite all surfaces tested in this study not presenting a risk of 
condensation they should not be dismissed for potential replacement with antimicrobial 
surfaces, as a range of other contributing factors to a surface’s efficacy are important 
too (see Chapter 6, section 6.4). 
 
According to the manufacturer guidelines of the ATP monitor a RLU reading of <11 is 
a ‘pass’, 11-29 a ‘caution’ and >30 a ‘fail’, in terms of surface cleanliness. With these 
guidelines in mind, overall in gastroenterology 25 % of surfaces passed the cleanliness 
test, 25 % were ‘caution’ and 50 % failed. In ACC the same proportion passed, 35 % of 
surfaces were ‘caution’ and 40 % failed. Finally in theatre 20 % of surfaces sampled 
passed, 31 % were ‘caution’ and 49 % failed. In the hospital environment <250 RLU 
has been identified as a ‘pass’ (Lewis et al., 2008). Previously <500 RLU was regarded 
a ‘pass’ (Griffith et al., 2000).  If the <250 RLU pass/fail benchmark were to be applied 
104 
 
to this study then 92 % of surfaces in gastroenterology, 94 % of surfaces in ACC and 
100 % of surfaces in theatre would have passed. Thus, it is important when using ATP 
bioluminescence monitors to set pass/fail thresholds according to the type of 
environment that is being tested. ATP monitoring systems are useful for applying clean, 
caution and fail criteria according to RLU values obtained immediately after cleaning. 
ATP bioluminescence monitors are convenient for screening surfaces after cleaning as 
results can be achieved very quickly (<2 min) compared to standard microbiological 
screening (>24 h) (Griffith et al., 2000).  
 
On each occasion sampling of surfaces commenced at around 9 am in gastroenterology, 
at around 10.30 am in ACC and at approximately 12 pm in theatre. All wards at UHW 
are cleaned in the morning, usually starting between 8 - 9 am (personal communication, 
Senior Infection Control Nurse, UHW). Thus, it is likely the values obtained from 
gastroenterology represented cleaned surfaces. Values obtained from ACC and theatre 
were likely to be taken a short while after cleaning, therefore, do not represent cleaned 
surfaces. With this in mind, despite statistical analysis showing no significant 
differences between wards, the fact that the range of values represented different times 
on the cleaning/soiling cycle should be taken into account. The nature of sampling in 
this study across the three wards was at random points during the soiling/cleaning cycle 
thus the data obtained only provided a rough indication of the level of surface 
bioburden, not an indication of the efficacy of surface cleaning. This may also explain 
the high variability of the results observed. Nevertheless, the level of surface bioburden 
in the hospital environment from this study has been established, which will allow for 
setting up a test surface with similar RLU bioburden values for experimental work. 
 
When considering the potential use of antimicrobial surfaces in healthcare settings it is 
important to test surfaces under in-use conditions. Michels et al. (2009) and Ojeil et al. 
(2013) observed reduced antimicrobial activity of silver and copper, respectively under 
in-use relative humidity and temperature conditions. The influence of temperature and 
humidity on biocidal activity are described in detail elsewhere, see Chapter 1, section 
1.10.2 and Chapter 4, section 4.1.5. 
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Despite gaining a comprehensive data set of surface relative humidity and surface 
temperature conditions within a UK hospital there were limitations to this study. Firstly, 
sampling was limited to one hospital site in the UK. It is possible that different regions 
in the UK may present different surface relative humidity and surface temperature data. 
Initially, approval was granted for sampling at a second site; a university hospital in 
London, but unfortunately this was eventually not followed through. A second data set 
may have provided comparable results to those obtained at UHW. Secondly, the data 
obtained in this study should not be used to set parameters for antimicrobial surface 
efficacy testing for predicting the performance of antimicrobial surfaces in non-UK 
hospitals where climate and weather may vary greatly, in turn influencing indoor 
hospital conditions. For example, a study in Sweden to investigate relative humidity and 
temperature in an orthopaedic ward showed an average relative humidity of 22 % in 
winter and 46.2 % in summer. The measurements were recorded next to a patient bed 
(Skoog, 2006). In this study the surface relative humidities recorded were comparatively 
higher in both winter and summer. Finally, this was a small study limited to a one year 
period. More comprehensive sampling, for example at a more frequent rate than once 
every two months, may provide a greater insight into environmental conditions within 
hospitals.  
 
Nevertheless, the data obtained was very useful for setting parameters in the 
antimicrobial surface efficacy tests developed in Chapters 4 and 5. Based on mean, 
median and range observations from the six sampling sessions it was decided that that 
relative humidities 40 % and 50 % and a temperature of 20 °C ([20°C-50% RH] and 
[20°C-40% RH]) would be used in experiments to reflect conditions observed at UHW.  
 
The work in this thesis was focused on the potential use of antimicrobial surfaces in 
clinical areas. However, the potential use of such surfaces is not limited to the hospital 
environment. This project was carried out in collaboration with Campden BRI, a food 
and drinks research company. In this collaboration their research was geared towards 
the potential use of antimicrobial surfaces in food factories. As with this study Campden 
BRI believe the test conditions of the JIS Z 2801are not always reflective of the 
environment of intended antimicrobial surface use. Thus, environmental sampling of 
surfaces in food factories to gain an insight into environmental conditions within a 
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variety of food factories was carried out.  Five different food factories were sampled on 
one occasion. Surfaces sampled and relative humidity and temperature observations are 
provided in Appendix 3a, Tables 1-5. Additionally, Table 6 (Appendix 3a) summarises 
overall findings in each food factory.  
 
There was an apparent difference in surface relative humidity and surface temperature 
between hospital and food factory sites. Although comparisons are limited since only 
one hospital site was sampled compared to five food factories it appears that, overall, 
surface relative humidities were higher and surface temperatures were lower in food 
factory settings. The exception is the brewery factory; the average surface temperature 
was greater than the average surface temperatures observed from each of the six 
sampling sessions at UHW.  
 
The lower end of surface relative humidity ranges from dairy 1, dairy 2 and the meat 
processing factories showed measurements observed in the hospital setting. Likewise 
the top end values of surface temperature ranges in dairy 1, dairy 2 and the meat 
processing factories were not dissimilar to surface temperature observations at UHW. In 
comparison to the conditions within UHW, surface temperature variations were greater 
in the food factories, particularly in dairy 2, meat processing and the brewery. Surface 
relative humidity ranges in each factory were also great, which suggests conditions were 
variable in different areas within the factory. This was not observed in the three wards 
sampled at UHW. Variations, particularly in surface relative humidity, were apparent 
over the one year hospital sampling period; however, variations within each session 
were low. In addition, compared to hospital conditions, surface relative humidities in 
food factories were higher; in two of the factories some surfaces presented a relative 
humidity of 100 %. This was not observed at UHW. From their environmental sampling 
Campden BRI decided the following conditions were appropriate for Phase 2 testing of 
their antimicrobial surfaces of interest: 
 
 25 °C and 33 % relative humidity 
 25 °C and 75 % relative humidity 
 10 °C and 33 % relative humidity 
 10 °C and 75 % relative humidity 
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 4 °C and 75 % relative humidity 
 
The potential use of antimicrobial surfaces is not limited to the hospital environment; 
their introduction in the food industry and other settings is discussed in Chapter 6, 
section 6.6. Campden BRI’s findings re-emphasise that the test conditions (relative 
humidity and temperature) in antimicrobial surface efficacy tests need to be flexible. 
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CHAPTER 4 THE ANTIMICROBIAL EFFICACY OF 
ANTIMICROBIAL SURFACES WHEN EXPOSED TO MICROBIAL 
AEROSOLS 
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4.1 Introduction 
 
4.1.1 Airborne transmission of microorganisms 
 
A multidisciplinary review defined the airborne transmission of pathogens as ‘passage 
of microorganisms from a source to a person through aerosols, resulting in infection of 
the person with or without consequent disease’ (Li et al., 2007). 
 
There are several well-known airborne pathogens including M. tuberculosis, 
Mycoplasma pneumoniae, Streptococcus spp., Bordetella pertussis, Neisseria 
meningitidis, S. aureus and Aspergillus spp. (Siegel et al., 2007). Such pathogens can be 
transmitted directly from an infected patient to another person, or indirectly via 
contaminated surfaces (HPA, 2012). It is thought the incidence rate of airborne 
infections in hospitals is around 10 %, though more recent studies are lacking (Schaal, 
1991).  
 
There is evidence MRSA is an airborne pathogen; a study in an ITU found MRSA 
infected six patients, four whom were in the same bed, one after the other. A patient in a 
single occupancy side-room was isolated due to MRSA infection. In an adjacent room, 
was a ventilation system, which at the time of the study had a faulty exhaust grille. This 
meant airborne pathogens, from the infected patient in isolation, passed through the 
ventilation system and were released into the nearby main ward area through an opened 
window. This window was situated above the bed where four of the six infected patients 
were positioned. The authors suggested the faulty ventilation system became 
contaminated with MRSA and dust carrying the MRSA was released into the air and 
then travelled into the ward via the opened window (Cotterill et al., 1996). A later study 
by Gehanno et al. (2009) also found MRSA present in the air in a hospital environment. 
The study showed that of 24 MRSA-infected patient rooms sampled, 21 were positive 
for MRSA in the air. In each room there was at least one identical match between the 
patients’ MRSA sample and that collected in the environment (Gehanno et al., 2009).  
 
Acinetobacter was first identified as an airborne pathogen in 1985, during an infection 
outbreak at a district general hospital. Before this Acinetobacter was not known to be 
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transmitted by air and the authors suggested this airborne transmission contributed to 
the outbreak (Allen and Green, 1987). A recent article by Munoz-Price et al. (2013) 
found A. baumannii to be present in an aerosolised state in a trauma ICU unit in the 
United States. During the study 53 patient bed areas were air sampled and 12 of these 
were A. baumannii positive. 91.6 % of the 12 A. baumannii positive air samples came 
from bed areas occupied by A. baumannii positive patients (Munoz-Price et al., 2013).   
 
A clinical study has identified C. difficile as an airborne pathogen. Spores were detected 
in the air on two different occasions in an elderly care bay in a UK hospital and it was 
proposed C. difficile spores can disseminate aerially (Roberts et al., 2008). The authors 
suggested better ventilation in hospitals may contribute to the control of C. difficile-
associated diarrhoea. 
 
The monitoring of bacterial aerosols is important in healthcare settings, particularly 
during infection outbreaks, to help with future control of airborne pathogens (Li and 
Hou, 2003) 
 
4.1.2 Sources of airborne microorganisms 
 
Aerosols are generated by humans when breathing, talking, coughing, sneezing and 
vomiting (Cole and Cook, 1998; Eames et al., 2009). Coughing can produce between 5 
x 10
1
 - 1 x 10
4
 droplets (Fiegel et al., 2006). Sneezing can generate 40,000 droplets and 
particles can range from 0.01 to 500 µm in size, and in infected patients from 0.05 to 
500 µm (Cole and Cook, 1998; Gralton et al., 2011). Breathing produces aerosols which 
can be projected up to 1 m in the air whilst during sneezing, a stronger activity, aerosols 
can be projected several metres (Tang et al., 2006).  
 
Other sources of airborne microorganisms in hospitals include fabrics, textiles, dry skin, 
hair, floors, furniture, nebulisers and ventilation and air-conditioning systems (Schaal, 
1991). The abrasion created during activities such as preparing beds, showering and 
dressing can generate aerosols in a hospital environment; thus desquamated skin is a 
source of staphylococcal aerosols (Spendlove and Fannin, 1983). It is estimated HCWs 
111 
 
and patients shed approximately 3 x 10
8
 skin squame a day (Noble, 1975). A study 
showed MRSA aerosols were generated during bed making at a hospital and 
subsequently contaminated the hospital environment (Shiomori et al., 2002). A study in 
2005 found bacterial and viral aerosols can be disseminated by the simple action of 
flushing a toilet (Barker and Jones, 2005).  
 
Bacterial aerosols are a particular concern in dental surgeries as they are easily formed 
from instruments used in routine procedures (Rautemaa et al., 2006). Bacteria form 
biofilms on surfaces that may produce aerosols; P. aeruginosa and Pseudomonas 
cepacia are examples of microbial aerosols formed in this manner (Rautemaa et al., 
2006).  
 
4.1.3 Survival of microbial aerosols in the air and deposition on surfaces 
 
The fate of an aerosol in the air is dependent upon many factors including gravity, air 
friction, electrical forces and Brownian motion (Morawska, 2006; Tang et al., 2006). 
Droplet transmission of particles is the transmission of large particles (>100 µm) that 
are likely to settle on the ground whereas small particles (<100 µm) evaporate, become 
droplet nuclei and suspend in the air to become airborne. These are the key findings 
from Wells’ study on airborne pathogens and are widely accepted by the scientific 
community (Wells and Stone, 1934; Eames et al., 2009). Droplet nuclei are defined as 
<5 µm in size (Siegel et al., 2007). Droplet nuclei can stay airborne for a long time and 
are able to travel considerable distances, dependent on air movements (Beggs, 2003).  
 
The transmission of bacterial aerosols can be divided into two classes; short-range and 
long-range, in terms of the distance an infectious aerosol travels (Tang et al., 2006). 
Short-range is classed as <1 m from source to host and an example includes the use of 
oxygen-masks that may result in aerosol release from a patient to others individuals 
within the vicinity (Hui et al., 2006). Long-range is >1 m from source to host and 
generally applies to droplet nuclei (Tang et al., 2006).  
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Bacterial aerosols are deposited on to surfaces by gravitational sedimentation or simple 
diffusion (Morawska, 2006; Meschke et al., 2009). Gravitational sedimentation of 
bacterial aerosols occurs when aerosols are produced close to a surface for deposition. 
Deposition of particles by diffusion can occur at a further distance from the source, as 
particles are suspended in the air and travel (Morawska, 2006).  The electrostatic charge 
on surfaces has an important role in aerosol deposition on to surfaces. Bacterial cells are 
electrically charged both naturally and by the dispersion process (Mainelis et al., 2002). 
The nature of a surface can influence the amount of attracted bacterial aerosols; for 
example a polyethene plastic apron worn by HCWs attracts more bacteria than 
aluminium foil aprons. This is due to a static charge on the plastic apron that attracts 
bacterial aerosols (Allen et al., 2006). Becker et al. (1996) found the simple action of a 
surgeon wearing gloves and pointing to within 4 cm of a video recording monitor 
during an operation resulted in contamination of the gloves. This was due to the 
electrostatic field generated by the video monitor, which led to the transfer of 
microorganisms to the surgeons’ gloves (Becker et al., 1996). 
 
The survival of aerosols in the air and on surfaces depends on a number of 
environmental factors including temperature, relative humidity and the nature of the 
surface. For example, relative humidity can influence the size of a droplet and 
consequently the speed it falls to the ground. In dry conditions, droplets evaporate 
quickly thus become smaller and take longer to deposit on surfaces, whereas increased 
relative humidity may decrease the rate of evaporation (Tang et al., 2006; Gralton et al., 
2011). Reduced relative humidity is thought to affect the trajectory of a particle (Gralton 
et al., 2011). Survival on surfaces under varying relative humidity conditions is detailed 
in section 4.1.5. In terms of the effect of temperature on airborne microorganisms, a 
temperature greater than 24 °C has been known to reduce survival (Tang, 2009).  
 
4.1.4 Control of transmission of airborne microorganisms 
 
The transmission of bacterial aerosols can be controlled to prevent the dissemination of 
airborne pathogens. The HPA has published its own guidelines regarding measures to 
reduce the transmission of respiratory pathogens from an infected patient to other 
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susceptible patients. These include patient isolation, control of the movement of patients 
in isolation and information for infected patients (such as the Catch it, Bin it, Kill it 
NHS campaign). If single occupancy rooms are unavailable, the HPA recommends 
infected patients are grouped together and beds are separated by >1 m.  The guidance 
document also emphasises the importance of hand hygiene for HCWs. Basic hygiene 
such as covering one’s nose when sneezing and using a tissue when coughing or 
sneezing can control transmission from infected patients. HCWs can protect themselves 
from infected patients by wearing Personal Protective Equipment, such as gloves and 
facemasks (HPA, 2012).  
 
In the case of infected patients, such as tuberculosis carriers, the isolation of patients in 
a negative-pressure room may help reduce transmission (Cole and Cook, 1998). Other 
interventions include placing patients in laminar flow beds or encouraging the wearing 
of respirators (Cole and Cook, 1998). 
 
The proper cleaning and disinfection of medical equipment, such as nebulisers used by 
patients, is encouraged to also help prevent transmission (Schultsz et al., 2013).  
 
Ventilation systems help control the dissemination of aerosols and work by ‘diluting the 
concentration of droplets in the air by removing the circulating droplets via air 
exchange’ (Fiegel et al., 2006). Ventilation can be mechanical, natural or a mix of the 
two (World Health Organisation, 2007). It is recommended the air around infected 
patients is changed 10 - 12 times an hour (Eames et al., 2009). The quality of outdoor 
air (if outdoor air is used for dilution) is important and air should flow from clean to 
dirty areas within a hospital (Eames et al., 2009). Advantages of mechanical ventilation 
include the environment can be controlled and it can be used in all climates (World 
Health Organisation, 2007). Advantages of natural ventilation are the lower associated 
costs and high ventilation rates (World Health Organisation, 2007). A drawback of 
mechanical ventilation is the cost of mechanical equipment, and of natural ventilation is 
the unpredictable nature of weather, for example too hot or too cold (Fiegel et al., 2006; 
World Health Organisation, 2007).  
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Air purification, by using high-efficiency particulate air (HEPA) filters can remove 
around 99.97 % of airborne particles of  ≥0.3 µm in size as the air they are in passes 
through such filters (Fiegel et al., 2006; British Standards Institution (BSI), 2010). 
HEPA filters are a very effective form of air disinfection, however, a drawback is they 
need to cleaned or replaced if they become blocked (Aliabadi et al., 2011).  
 
Ultraviolet germicidal irradiation (UVGI) is another method of air purification that is 
mainly found in upper areas of rooms and is sometimes used in combination with 
filtration (Mermarzadeh et al., 2010). The UV light emitted is responsible for killing 
microorganisms (Fiegel et al., 2006). Advantages of UVGI include it is relatively cheap 
and easier to install and maintain, relative to filtration methods (Fiegel et al., 2006). In 
addition, small bacterial particles that are too small for filtration may be susceptible to 
UVGI (Mermarzadeh et al., 2010). Limitations include bacterial spores may be resistant 
to UVGI, room air must be mixed for UVGI to effectively work and UV lamps and light 
bulbs must be checked regularly as age and cleanliness can influence efficacy 
(Mermarzadeh et al., 2010). Also, the distance and level of irradiation influence the 
activity of UVGI against microorganisms (Mermarzadeh et al., 2010).  
 
Negative air ionisation is also an example of an airborne disinfection system used 
within the NHS. One study found the use of negative air ionisation units resulted in 
repulsion of Acinetobacter spp. to plastic surfaces. These surfaces would normally hold 
an electrostatic charge but the negative air ioniser causes surfaces to develop a negative 
charge (Shepherd et al., 2010).   
 
Following a study investigating C. difficile aerosol production after the flushing of a 
toilet, Best et al. (2012) highlighted the importance of closing toilet lids during flushing 
to reduce microbial aerosol transmission, since surface contamination by C. difficile was 
detectable after 90 min of flushing when the lid was open as opposed to closed (Best et 
al., 2012). C. difficile was detected in the air 25 cm above the toilet when the toilet was 
flushed with its lid open (Best et al., 2012). 
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4.1.5 Microbial aerosol studies 
 
A study investigating the survival of S. epidermidis by a Goldberg drum found aerosols 
could be recovered when subject to a range of relative humidities; <20 %, 40 – 60 %, 70 
– 80 % and >90 %. A Goldberg drum is a large, aluminium drum that rotates (in this 
study at 3.5 rpm). It contains baffles that ensure aerosols remain airborne within the 
drum. At 76 % relative humidity aerosols survived for up to 5 days (Thompson et al., 
2011).  
 
A study of the survival of Enterococcus faecalis (E. faecalis) on stainless steel surfaces 
found that lethality was directly proportional to relative humidity. Bacteria survived on 
surfaces at relative humidities of 0 and 31 % but were completely inactivated at 85 % 
relative humidity (Robine et al., 2002). 
 
A study by Decraene et al. (2008) showed S. aureus aerosols could be significantly 
reduced in number when deposited on LAAAs containing toluidine blue O and rose 
bengal. 
 
4.1.6 JIS Z 2801 – a wet inoculum antimicrobial surface efficacy test 
 
The main aim of this project was to suggest alternatives to the current JIS Z 2801 test 
procedure, also referred to as the ISO22196 test, to incorporate more realistic 
temperature and relative humidity conditions. The JIS Z 2801 assesses the antimicrobial 
activity of surfaces at 35 °C and >90 % relative humidity. Many antimicrobial surface 
manufacturers utilise the test on their products to confirm antimicrobial activity before 
making them commercially available (see Chapter 1, section 1.7, Table 1.1).  However, 
this test has been described as inappropriate to validate in-use performance since the 
parameters used (temperature, relative humidity, and presentation of the inocula) do not 
reflect conditions found in practice in UK hospitals. The JIS Z 2801 is a useful 
screening test for surfaces with antimicrobial claims but the NHS Rapid Review Panel, 
who has the responsibility for the preliminary evaluation of product claims before 
recommending infection control technologies to NHS practitioners, recognises the 
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absence of a suitable test for predicting clinical efficacy (personal communication, 
Rapid Review Panel).  
 
4.1.7 Aims and Objectives 
 
The aim of this chapter was to develop a method for delivering and depositing microbial 
aerosols on to antimicrobial surfaces. The antimicrobial efficacy of these surfaces could 
then be determined under parameters reflecting indoor hospital conditions based on 
observations from sampling sessions at UHW. 
 
4.2 Materials and Methods 
 
4.2.1 JIS Z 2801 testing 
 
The JIS Z 2801 is considered the accepted international test for assessing the activity 
and efficacy of products with antimicrobial claims.  The method carried out in this study 
was a slightly modified version of the original test procedure. Here the test was based 
on the method utilised by Campden BRI.  
 
A TSA slope of S. aureus was prepared and stored for a maximum of one month at 4 
°C. From this a fresh slope was prepared before the test was carried out by transferring a 
loopful of culture from the master slope to the new slope and incubating for 24 h at 37 
°C. This was the first sub-culture. The day before testing another fresh TSA slope was 
inoculated with culture from the first sub-culture and incubated for 24 h at 37 °C. This 
was the working culture. On the day of testing 9 mL of MRD and 5 g 3 mm glass beads 
were added to the slope to recover the microorganism. The bottle was shook and 
vortexed for three minutes. The OD600 of the suspension was determined and adjusted to 
give a bacterial concentration of 2 – 8 x 108 cfu/mL. This was then serially diluted to 
give 2 – 8 x 106 cfu/mL. The viable count of the suspension was determined using the 
pour plate method in duplicate. One mL of the dilution was transferred to a Petri dish, 
20 mL TSA was added and the plates were left to set. Plates were incubated for 24 h at 
37 °C and cfu on dilutions containing 30 – 300 cfu was recorded.  
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The test surfaces used were copper alloys; CuSn5, CuZn30, CuDHP and 
CuNi10Fe1Mn. The control surface was stainless steel. All surfaces were tested in 
triplicate. Each surface was inoculated with 50 µL of bacterial suspension then covered 
completely with a plastic film. Test and control surfaces were incubated in a box for 24 
h at 37 °C and a relative humidity of 100 %. This high percentage of relative humidity 
was achieved by covering surfaces with a plastic film and by also placing several 
beakers of saturated zinc sulphate solution in the box. 
 
The inoculum levels at 0 h on the stainless steel control were next determined. Surfaces 
were placed in an individual stomacher bag to which 9 mL MRD and 1 mL neutraliser 
were added. The film over the surface was removed (by hand through the stomacher 
bag) and both were massaged by hand for 30 sec to recover the inoculum. One mL of 
this solution was serially diluted to 10
-4
 in MRD and bacterial counts were enumerated 
via the pour plate method. This was carried out in duplicate for each dilution. Plates 
were incubated at 37 °C for 24 h and the cfu/mL determined.  This was repeated for the 
24 h test surfaces. 
 
Although the JIS Z 2801 does not test the activity of microbial aerosols against test 
surfaces; for the purpose of this study the JIS Z 2801 and the new antimicrobial test 
developed in this chapter were both ‘wet’ tests so were therefore comparable. The new 
test developed (section 4.4.2) was assessed in relation to the JIS Z 2801. 
 
4.2.2 Development of a new antimicrobial surface efficacy test based on exposure 
of microbial aerosols 
 
4.2.2.1 Use of a nebuliser to generate microbial aerosols 
 
A Porta-neb VentStream Nebuliser (Philips Respronics, Best, The Netherlands) was 
used to generate bacterial aerosols (Figure 4.1). Nebulisers are medical devices 
commonly used to medicate drugs in an aerosolised state to patients with respiratory 
diseases. The nebuliser was connected to an Andersen cascade impactor (Westech 
Instrument Services Ltd, Bedfordshire, UK), of which Stages 0 and F only were used, as 
shown in Figure 4.1. A vacuum pump was connected to the cascade impactor. In 
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addition, a Copley Scientific DFM2000 (Nottingham, UK) flow meter, placed between 
the cascade impactor and vacuum pump (not shown) measured flow rate. Ten runs of 
the set-up presented an average flow rate of 4.86 ± 0.44 L/min.  
 
Figure 4.1– Image of test set-up for delivering microbial aerosols on to antimicrobial 
surfaces   
 
a=vacuum pump, b=Andersen cascade impactor, c=nebuliser 
 
4.2.2.2 Recovery of microbial aerosols from stainless steel discs 
 
An overnight culture of S. aureus NCIMB 9518 was prepared as in 2.3.2 and re-
suspended in 10 mL TSC as described in 2.3.3. The OD600 of the suspension was 
adjusted to give a bacterial cell concentration of approximately 10
8 
cfu/mL. 
 
The recovery of microbial aerosols from stainless steel discs was determined in cfu/cm
2
 
to be able to compare different sized surfaces with each other in future experiments. In 
order to find out how many bacterial cells can be recovered from the discs the nebuliser 
was switched on for three test periods; 10, 20 and 30 min. Three stainless steel discs 
were placed on a collecting plate that was positioned over Stage F of the cascade 
impactor (see Figure 4.2) and the nebuliser ran for 10 min. Stainless discs were 
immediately transferred to a 100 mL bottle containing 5 g 3 mm glass beads and 10 mL 
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TSC. Bottles were placed on a shaking platform for 1 min and left to stand for 5 min. 
Next 100 µL of the suspension was added to 900 µL TSC and serially diluted to 10
-4
. 
The spread plate method was utilised to enumerate viable bacteria; 100 µL of each 
dilution was placed onto pre-poured TSA plates, spread with a sterile spreader and 
incubated at 37 °C for 24 h. This was carried out in triplicate for each dilution. The 
process was repeated after the nebuliser when switched on for 20 min and 30 min. 
 
Figure 4.2 – Position of three stainless steel discs within cascade impactor 
 
 
It was decided the nebuliser would run for 30 min for all future experiments to enable 
maximal bacterial deposition on to the disc surface (see Table 4.2). The method of 
recovering bacterial aerosols was validated by depositing bacterial aerosols of S. aureus 
NCIMB 9518 on to nine stainless steel discs (Figure 4.3) and determining viability. The 
discs were arranged as follows: 
 
Figure 4.3 – Position of stainless steel discs on collecting plate within the cascade 
impactor for validation of recovery of microbial aerosols 
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4.2.2.3 Development of method used to recover viable bacteria on surfaces 
 
In order to make this protocol similar to that of the JIS Z 2801, MRD plus neutraliser 
was used as a recovery medium. The neutraliser was previously validated for its toxicity 
and efficacy (see Chapter 2, section 2.11). 
 
Six stainless steel discs were placed on the collecting plate. An overnight culture was 
centrifuged and re-suspended in MRD to an OD600 that provided approximately 10
8 
cfu/mL. Ten mL of the suspension was placed in the nebuliser and aerosolised for 30 
min. Next, three discs were transferred individually to a 100 mL bottle containing 10 
mL TSC and 5 g 3 mm glass beads. The remaining three discs were transferred to a 
bottle with 9 mL MRD, 1 mL neutraliser and 5 g 3 mm glass beads. Bottles were shook 
for 1 min at 150 rpm and viable bacteria were enumerated by the spread plate method.  
 
4.2.3 New antimicrobial surface efficacy test method 
 
After the set-up had been established the efficacy of all four test copper alloy surfaces 
against microbial aerosols of S. aureus, A. baumannii and B. subtilis spores was tested. 
Aerosols generated were exposed to copper alloy surfaces and subjected to a range of 
temperatures and relative humidities at varying contact times. This was to determine 
whether temperature and relative humidity had an effect on antimicrobial activity. 
Stainless steel was utilised as a control surface. 
 
All surfaces were tested at 0 h (i.e. immediately after 30 min nebulisation) and after 30 
min, 60 min and 24 h incubation at the required temperature and relative humidity 
conditions. Surfaces were exposed to the following conditions; [37°C-100% RH], 
[20°C-50% RH] and [20°C-40% RH]. The lower relative humidities (40 % and 50 %) 
and temperature (20 °C) were chosen to simulate in-use conditions observed at UHW 
throughout hospital sampling sessions (see Chapter 3, section 3.3). 
 
S. aureus NCIMB 9518 was grown as described in 2.3.2 and prepared for testing as in 
2.3.3 with MRD used as the re-suspending medium. The OD600 of the culture was 
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adjusted to give a bacterial concentration of 10
8 
cfu/mL. Ten mL of culture was placed 
in the nebuliser. Nebulisation time was 30 min. The combination of surfaces tested was 
random within each run; stainless steel and copper alloy surfaces were mixed. Six 
surfaces were placed around the edge of a large stainless steel collecting plate, which 
was placed over Stage F of the cascade impactor, allowing aerosols to be passed 
through Stage 0. Immediately after nebulisation (0 h) all 0 h test surfaces were 
transferred to bottle containing 9 mL MRD, 1 mL neutraliser and 5 g 3 mm glass beads. 
Bottles were shaken at 150 rpm for 1 min then left to stand for 5 min. Viable bacteria 
were enumerated by serial dilution in MRD to 10
-4
 and plated via the spread plate 
method; 100 µl of each dilution was spread in triplicate on pre-poured TSA plates. All 
other surfaces were placed in individual Petri dishes and incubated at the required 
temperature, relative humidity and contact time. Following incubation at the required 
contact time viable bacteria were recovered and enumerated as described above. Each 
surface was tested in triplicate for each contact time and relative humidity and 
temperature condition. As with the JIS Z 2801 test high relative humidity was created 
by covering the test surface with a plastic film and by placing beakers of saturated 
solutions of zinc sulphate in the incubating box. PROsorb™ silica gel cassettes 
(Conservation by Design Ltd., UK) were used to stabilise relative humidity at 40 % and 
50 %, no film was placed over the surfaces.   
 
The experiment was repeated at [37°C-100% RH] and [20°C-40% RH] in the presence 
of organic load for S. aureus. A higher initial concentration (5 x 10
8 
- 1 x 10
9 
cfu/mL) of 
bacterial suspension was prepared and mixed with 0.6 % BSA in a 1:1 ratio resulting in 
a final concentration of 0.3 % BSA.  
 
A. baumannii NCIMB 9214 was also tested. A. baumannii was prepared as in 2.3.2 and 
2.3.3 with MRD used as the re-suspending buffer. Viable bacteria recovered from 
surfaces were grown at 25 °C for 24 h on TSA. C. difficile NCTC 12726 spores, as an 
example of an HCAI, were initially tested. However, recurrent issues with spore 
aggregation resulted in uneven deposition of the inoculum on to surfaces. This was 
unacceptable for further testing. Therefore B. subtilis NCTC 10400 spores were tested 
instead. B. subtilis spores were prepared as in 2.7.1 (NB. Spores were in suspension in 
water, not MRD). Viable bacteria recovered from surfaces were grown at 37 °C for 24 h 
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on LB agar. Surfaces exposed to A. baumannii and B. subtilis spore aerosols were 
incubated at [20°C-40% RH], the most realistic condition based on hospital sampling, 
for 30 min, 60 min and 24 h as previously described.  
 
4.2.4. Statistical analysis 
 
Statistical analysis was carried using SPSS or R software. In general, a one-way 
ANOVA or a General Linear Model were used to analyse data statistically.  
 
4.3 Results 
 
4.3.1 JIS Z 2801 results 
 
The antimicrobial efficacy of test surfaces was determined by the JIS Z 2801 test using 
a method adapted by Campden BRI.  
 
The log10 reductions (Table 4.1) represent the amount of viable bacteria on surfaces at 
24 h subtracted from the 0 h count on stainless steel. All copper alloy surfaces presented 
a >4 log10 cfu/mL reduction after 24 h at [37°C-100% RH], suggesting they possessed 
antimicrobial properties. In contrast, the stainless steel control surfaces produced a 0.31 
log10 increase after 24 h. This negative log10 reduction means there was a slight increase 
in viable bacteria on the surface after 24 h.  The very little change in viable count 
indicates stainless steel had no antimicrobial activity.  
 
Table 4.1– JIS Z 2801 test results showing the amount of viable bacteria on each 
surface at 24 h subtracted from the 0 h viable count on stainless steel (n=3) 
Surface Log10 reductions cfu/mL 
Stainless steel 
CuSn5 
-0.31 ± 0.07* 
>5.11 ± 0.35 
CuDHP >4.91 ± 0.00 
CuZn30 >5.11 ± 0.00 
 CuNi10Fe1Mn >4.85 ± 0.00 
*denotes an increase in number rather than log10 reduction 
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4.3.2 Development of a new antimicrobial surface efficacy test based on the 
exposure of microbial aerosols 
 
4.3.2.1 Recovery of microbial aerosols from stainless steel discs 
 
To decide how long the nebuliser should run for to deposit a suitable concentration of 
bacterial cells, the nebuliser was tested for 10, 20 and 30 min, and recovery from 
stainless steel discs was determined. Table 4.2 shows the log10 cfu/cm
2
 recovered from 
stainless steel discs after nebulisation times of 10, 20 and 30 min. A 10 min nebulisation 
time was not chosen for future experiments because the amount of bacteria recovered 
was too low to allow for adequate log reductions for disinfection studies.  The longest 
time was selected to allow recovery of the highest inoculum to enable the elucidation of 
antimicrobial differences between surfaces. Therefore, 30 min was chosen as the 
designated time length for the nebuliser to run in all future experiments. 
 
Table 4.2 - Testing nebuliser for 10, 20 and 30 min to assess the concentration of 
microbial aerosols deposited on surfaces (n=3) 
  Repeat Log10 cfu/cm
2
 ± SD Mean ± SD 
10 min 1 3.25 ± 0.02  
 
2 3.40 ± 0.14 3.46 ± 0.24 
 
3 3.73 ± 0.04  
20 min 1 4.22 ± 0.27  
 
2 4.18 ± 0.05 4.24 ± 0.10 
 
3 4.39 ± 0.11  
30 min 1 4.70 ± 0.04  
 
2 4.66 ± 0.04 4.59 ± 0.15 
  3 4.42 ± 0.00  
 
 
The effect of the position of the stainless steel discs within the large collecting plate in 
the cascade impactor on the amount of bacteria recovered was assessed (see Figure 4.3). 
The lowest bacterial count was that recovered from disc 9 (Table 4.3). The log10 cfu/cm
2
 
range of recoveries from discs 1 to 8 was 4.62 – 5.26. The average recovery of discs 1 – 
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8 was 5.40 log10 cfu/cm
2
 with a standard deviation of 0.24. From these preliminary 
results surfaces will not be placed in the centre for future experiments (position 9, see 
Figure 4.3) as recovery was the lowest here. Statistical analysis by a one-way ANOVA 
showed there was no significant difference in the counts obtained when discs were 
placed in positions 1 - 8, P=0.684.  
 
Table 4.3 - Validation of recovery of microbial aerosols from stainless steel discs (n=1) 
Disc Log10 cfu/cm
2 
± SD 
1 5.26 ± 0.05 
2 5.45 ± 0.02 
3 4.97 ± 0.01 
4 4.84 ± 0.00 
5 5.20 ± 0.11 
6 4.86 ± 0.02 
7 5.18 ± 0.08 
8 4.62 ± 0.09 
9 4.09 ± 0.28 
 
4.3.2.2 Use of MRD plus neutraliser vs. TSC for recovery of viable bacteria 
 
Although it appears the recovery was slightly lower when the MRD and neutraliser mix 
was utilised compared to TSC (Table 4.4), there was no significant difference (P=0.672) 
when tested by an one-way ANOVA. From this point onwards it was decided MRD 
plus neutraliser was to be utilised for future experiments, and to keep in line with the 
JIS Z 2801 test protocol. 
 
Table 4.4 – Amount of viable bacteria recovered from stainless steel discs when using 
TSC or MRD plus neutraliser as a recovery medium (n=3) 
 
 
Recovery medium  Log10 cfu/cm
2
 
TSC 5.93 ± 0.26 
MRD plus neutraliser 5.75 ± 0.59 
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4.3.3 New antimicrobial surface efficacy test results  
 
4.3.3.1 S. aureus results 
The copper alloy (test) and stainless steel (control) surfaces were exposed to bacterial 
aerosols of S. aureus then incubated for 30 min, 60 min and 24 h at [37°C-100% RH], 
[20°C-50% RH] and [20°C-40% RH]. Tables 4.5 - 4.7 show the log10 reductions 
calculated as the counts at 30 min, 60 min and 24 h subtracted from the 0 h count for 
each surface.  
 
After 30 min nebulisation 6.56 ± 0.05 to 6.71 ± 0.14 log10 cfu/cm
2 
was recovered from 
stainless steel discs. The amount of deposited aerosols recovered from copper alloys at 
0 h was around 1 log10 lower, which might suggest antimicrobial activity by copper over 
the 30 min deposition period. After 24 h all copper alloy surfaces showed a >4 log10 
reduction in viable bacteria at all temperature and relative humidity conditions. CuSn5, 
CuDHP and CuZn30 all displayed a >4 log10 reduction after 30 min incubation at 
[37°C-100% RH]. At [20°C-50% RH] and [20°C-40% RH] a >4 log10 reduction was 
only observed after 60 min by CuSn5, CuDHP and CuZn30 and CuDHP and CuZn30, 
respectively. At both [20°C-50% RH] and [20°C-40% RH] CuNi10Fe1Mn log10 
reductions were >3 but <4 log10 after 60 min. At [20°C-40% RH] 24 h incubation was 
required for a >4 log10 reduction by CuSn5; although a >3.65 log10 reduction at 60 min 
was apparent. Stainless steel worked well as a control presenting a <1 log10 reduction 
after 30 min and 60 min at all conditions. After 24 h the greatest log10 reduction on 
stainless steel was 2.17 at [37°C-100% RH].  
 
Data were transformed (natural log + 1) and analysed by a General Linear Model using 
R software. In terms of incubation conditions, there were significant differences 
between [20ºC-40% RH] and [37ºC-100% RH] and between [20ºC-50% RH] and 
[37ºC-100% RH] (both P<0.001). There was no significant difference between [20ºC-
50% RH] and [20ºC-40% RH] (P=0.27). There was a significant difference between all 
contact times for all copper alloys (P<0.001) when all three test conditions were 
analysed together. The counts on all copper alloy surfaces were significantly different to 
the counts on stainless steel (P<0.001). No significant differences were observed 
between the copper alloy surfaces, except between CuZn30 and CuNi10FeMn (P=0.04).  
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When analysing each condition alone, at [37ºC-100% RH] there was a significant 
difference between stainless steel and all copper alloys. Between the copper alloys there 
were significant differences between CuNi10Fe1Mn and CuDHP (P=0.004), 
CuNi10Fe1Mn and CuZn30 (P<0.001) and CuNi10Fe1Mn and CuSn5 (P<0.001).  
There was a significant difference between each contact time. All P-values were <0.001 
except between 30 min and 60 min (P=0.015) and between 60 min and 24 h (P=0.003). 
For both [20ºC-50% RH] and [20ºC-40% RH] there were no significant differences 
between the copper alloys (all P>0.05). There was a difference between stainless steel 
and each copper alloy (P<0.001). In terms of contact time, there were significant 
differences between all contact times (all P<0.001).  
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Table 4.5 – Recovery of S. aureus from deposited aerosols at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at [37°C-100% 
RH] (n=3) 
  
Stainless steel 
Log10 cfu/cm
2
 
CuSn5 
Log10 cfu/cm
2
 
CuDHP 
Log10 cfu/cm
2
 
CuZn30 
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h  6.56 ± 0.05 5.33 ± 0.29 5.75 ± 0.36 5.05 ± 0.67 5.01 ± 0.38 
Log10 reductions 
     
30 min 0.23 ± 0.19 > 4.49 ± 0.00 > 4.91 ± 0.00 > 4.21 ± 0.00 2.34 ± 1.12 
60 min 0.54 ± 0.60 > 4.49 ± 0.00 > 4.91 ± 0.00 > 4.21 ± 0.00 3.63 ± 0.47 
24 h 2.17 ± 0.21 > 4.49 ± 0.00 > 4.91 ± 0.00 > 4.21 ± 0.00 > 4.17 ± 0.00 
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Table 4.6 - Recovery of S. aureus from deposited aerosols at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at [20°C-50% 
RH] (n=3) 
 
Stainless steel 
Log10 cfu/cm
2
 
CuSn5 
Log10 cfu/cm
2
 
CuDHP 
Log10 cfu/cm
2
 
CuZn30 
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h  6.60 ± 0.20 5.67 ± 0.38 5.70 ± 0.35 5.52 ± 0.08 5.45 ± 0.02 
Log10 reductions 
     
30 min 0.12 ± 0.35 2.97 ± 0.48 2.98 ± 0.39 2.86 ± 0.24 2.60 ± 0.19 
60 min 0.57 ± 0.49 > 4.29 ± 0.57 4.26 ± 0.30 4.01 ± 0.18 3.54 ± 0.25 
24 h 1.38 ± 0.36 > 4.83 ± 0.00 > 4.76 ± 0.17 > 4.68 ± 0.00 4.25 ± 0.10 
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Table 4.7 - Recovery of S. aureus from deposited aerosols at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at [20°C-40% 
RH] (n=3) 
 
Stainless steel 
Log10 cfu/cm
2
 
CuSn5 
Log10 cfu/cm
2
 
CuDHP 
Log10 cfu/cm
2
 
CuZn30 
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h  6.71 ± 0.14 5.45 ± 0.15 5.59 ± 0.40 5.96 ± 0.42 5.13 ± 0.70 
Log10 reductions 
     
30 min 0.44 ± 0.42 2.91 ± 0.51 3.79 ± 0.35 3.64 ± 1.04 2.73 ± 0.71 
60 min 0.26 ± 0.15 > 3.65 ± 0.83 > 4.36 ± 0.36 > 4.96 ± 0.28 3.23 ± 0.13 
24 h 1.23 ± 1.07 > 4.61 ± 0.00 > 4.75 ± 0.00 > 5.12 ± 0.00 > 4.29 ± 0.00 
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Tables 4.8 and 4.9 display results from experiments where copper alloy and stainless 
steel surfaces were exposed to microbial aerosols containing organic load then 
incubated for 30 min, 60 min and 24 h at [37°C-100% RH] and [20°C-40% RH]. The 
addition of BSA to the aerosolised suspension to mimic dirty conditions showed 
surprising results; some surfaces presented faster antimicrobial activity when exposed to 
aerosols containing BSA than in the absence of BSA.  
 
After 24 h all copper alloy surfaces presented a >4 log10 reduction at both conditions. 
Activity at [37°C-100% RH] was quick with three copper alloys showing a >4 log10 
reduction after 30 min and all showed this reduction after 60 min. At [37°C-100% RH] 
CuNi10Fe1Mn presented greater antimicrobial activity in the presence of organic load 
in comparison to in the absence of organic load, with reductions of >4 log10 and 2.34 ± 
1.12, respectively. At [20°C-40% RH] three of the four copper alloys displayed a >4 
log10 reduction after 60 min. CuSn5, like CuNi10Fe1Mn at [37°C-100% RH] was more 
antimicrobial in the presence of organic load. A >4 log10 reduction was observed after 
30 min compared to after 24 h in the absence of organic load. 
  
At [37°C-100% RH] there was no significant difference in the recovered amount of 
deposited aerosols between in the absence or in the presence of BSA (P=0.653). In 
contrast, at [20°C-40% RH] there was a significant difference (P<0.001).
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Table 4.8 - Recovery of S. aureus from deposited aerosols at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at [37°C-100% 
RH] in the presence of organic load (n=3) 
  
Stainless steel 
Log10 cfu/cm
2
 
CuSn5  
Log10 cfu/cm
2
 
CuDHP  
Log10 cfu/cm
2
 
CuZn30  
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h  6.36 ± 0.16 5.31 ± 0.32 5.40 ± 0.20 5.44 ± 0.34 5.48 ± 0.34 
Log10 reductions           
30 min 0.28 ± 0.36 > 4.47 ± 0.00 > 4.56 ± 0.00 > 3.79 ± 0.19 > 4.38 ± 0.24 
60 min 0.40 ± 0.25 > 4.47 ± 0.00 > 4.46 ± 0.00 > 4.60 ± 0.00 > 4.64 ± 0.00 
24 h 1.04 ± 0.74 > 4.47 ± 0.00 > 4.56 ± 0.00 > 4.60 ± 0.00 > 4.64 ± 0.00 
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Table 4.9 - Recovery of S. aureus from deposited aerosols at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at [20°C-40% 
RH] in the presence of organic load (n=3) 
 
  
Stainless steel 
Log10 cfu/cm
2
 
CuSn5  
Log10 cfu/cm
2
 
CuDHP  
Log10 cfu/cm
2
 
CuZn30  
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h 6.08 ± 0.15 5.46 ± 0.10 5.41 ± 0.40 5.50 ± 0.13 5.40 ± 0.38 
Log10 reductions           
30 min 0.23 ± 0.57 > 4.32 ± 0.75 2.96 ± 0.30 2.88 ± 0.51 3.30 ± 0.58 
60 min 0.80 ± 0.32 > 4.62 ± 0.00 > 4.41 ± 0.28 > 4.46 ± 0.35 3.56 ± 0.23 
24 h 1.82 ± 0.2 > 4.62 ± 0.00 > 4.57 ± 0.00 > 4.66 ± 0.00 > 4.56 ± 0.00 
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4.3.3.2 A. baumannii results 
To confirm the newly developed antimicrobial surface test worked against a range of 
microorganisms, aerosols of A. baumannii were exposed to the copper alloy surfaces. 
Results are displayed in Table 4.10. After 30 min nebulisation the initial count 
recovered from the copper alloys was 4.77 ± 0.27 to 5.24 ± 0.27 log10 cfu/cm
2
. In 
contrast, a higher bacterial amount (6.14 ± 0.16 log10 cfu/cm
2
)
 
was recovered from 
stainless steel 0 h. After 30 min at [20°C-40% RH] high log10 reductions were observed 
on the copper alloy surfaces with three of the four displaying a >4 log10 reduction. For 
CuSn5, the log10 reduction after 24 h was not >4 log10, due to the low initial count onto 
surfaces at 0 h in comparison to the other three copper alloys.  
 
Data were transformed (natural log + 1) and analysed by a General Linear Model using 
SPSS software. Statistically, there were no significant differences between the four 
copper alloys (P>0.05). There were significant differences between all copper alloys 
and stainless steel (P<0.001). Regarding contact time, there were significant differences 
in counts between all time points except between 30 and 60 min (P=0.672). 
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Table 4.10 - Recovery of A. baumannii from deposited aerosols at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at [20°C-
40% RH] (n=3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stainless steel 
Log10 cfu/cm
2
 
CuSn5  
Log10 cfu/cm
2
 
CuDHP  
Log10 cfu/cm
2
 
CuZn30  
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h  6.14 ± 0.16 4.77 ± 0.27 5.03 ± 0.71 5.05 ± 0.19 5.24 ± 0.27 
Log10 reductions 
     
30 min 0.07 ± 0.56 >3.83 ± 0.17 >4.09 ± 0.17 >4.21 ± 0.00 >4.40 ± 0.00 
60 min 0.57 ± 0.17 >3.93 ± 0.00 >4.19 ± 0.17 >4.21 ± 0.00 >4.40 ± 0.00 
24 h 2.24 ± 0.55 >3.93 ± 0.00 >4.19 ± 0.17 >4.21 ± 0.00 >4.40 ± 0.00 
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4.3.3.3 B. subtilis spore results 
The antimicrobial activity of copper alloys against B. subtilis spores was very low (see 
Table 4.11). Even after 24 h exposure, <1 log10 reductions on all copper alloys were 
evident. Data were transformed (natural log + 1) for statistical analysis by a General 
Linear Model using SPSS software. There was a significant difference between all 
copper alloys (P<0.05), except between CuSn5 and CuZn30 (P=0.999). In fact, of the 
copper surfaces CuSn5 and CuZn30 presented the lowest reduction and highest log10 
reductions after 24 h, respectively. The counts on all copper alloys, bar CuDHP 
(P<0.001), were not significantly different than the counts on stainless steel (P>0.05). In 
terms of contact time, overall there were significant differences between all time points 
(all P>0.05) except between 0 h and 30 min (P>0.999).  
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Table 4.11 – Recovery of B. subtilis spores from deposited aerosols at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at 
[20°C-40% RH] (n=3) 
  
Stainless Steel 
Log10 cfu/cm
2
 
CuSn5  
Log10 cfu/cm
2
 
CuDHP  
Log10 cfu/cm
2
 
CuZn30  
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h 7.29 ± 0.15 7.06 ± 0.46 6.26 ± 0.45 7.50 ± 0.20 6.79 ± 0.53 
Log10 reductions           
30 min 0.08 ± 0.42 -0.35 ± 0.17* 0.08 ± 0.27 0.40 ± 0.42 -0.21* ± 0.62 
60 min 0.68 ± 0.35 -0.33 ± 0.11* 0.21 ± 0.60 0.48 ± 0.18 0.01 ± 0.04 
24 h 0.66 ± 0.34 0.45 ± 0.40 0.60 ± 0.28 0.70 ± 0.37 0.46 ± 0.99 
*denotes an increase in number rather than log10 reduction 
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4.4 Discussion 
 
All copper alloy surfaces presented a >4 log10 reduction in viable S. aureus indicating 
they were antimicrobial under JIS Z 2801 test conditions. The JIS Z 2801 served as an 
initial, basic screening test to confirm antimicrobial activity. However, the test 
methodology contains several drawbacks. Firstly, the incubation conditions of 35 °C 
and >90 % relative humidity (NB. 37 °C and 100 % relative humidity conditions were 
utilised as JIS Z 2801 tests conditions in this study) are not reflective of an indoor, 
environment. They are too high, particularly for UK hospital conditions. Antimicrobial 
activity by surfaces observed in the laboratory may not necessarily translate to in-use 
antimicrobial activity. Michels et al. (2009) found this to be the case when testing 
silver-containing surfaces; surfaces were antimicrobial under JIS Z 2801 test conditions 
but when tested under conditions reflecting an indoor environment the surfaces did not 
present the same antimicrobial activity. Secondly, since test surfaces are covered with a 
plastic film over the entire contact period, surfaces tend to remain wet and this allows 
for optimum conditions of biocide diffusion (e.g. copper ions in this study) from the 
surface to the bacterial cells. Again, this is not indicative of real-life conditions, surfaces 
are ostensibly dry and if wet, do not remain wet for up to 24 h. This essentially makes 
the JIS Z 2801 a ‘wet’ surface efficacy test. The new antimicrobial surface test 
developed here was based on the exposure of surfaces to bacterial aerosols, to mimic 
actions such as sneezing, coughing, talking etc. In comparison to the JIS Z 2801, where 
a large volume inoculum is presented on to surface, the use of aerosolised bacteria in 
this new antimicrobial efficacy test might be a better reflection of how a wet inoculum, 
such as cough or sneeze particles, is deposited on to surfaces (Ojeil et al., 2013). 
 
The JIS Z 2801 test and the test developed in this chapter were simple to carry out and 
allow one to determine the antimicrobial efficacy of surfaces with antimicrobial claims 
(Ojeil et al., 2013). In this study copper has shown to be an effective antimicrobial 
against Gram-positive and Gram-negative bacteria but not bacterial spores. The new test 
here was more discriminatory than the JIS Z 2801 test at other conditions enabling the 
distinction of efficacy between different copper alloys. For S. aureus there was no 
significant difference (at all conditions) between the activities of the tested copper 
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alloys but except for between CuZn30 and CuNi10Fe1Mn. This suggests a copper 
content as low as 70 % is just as efficacious as a copper content of 99.99 %, which is 
promising for practical reasons; copper alloys are generally stronger and less prone to 
oxidation than pure copper surfaces.  
 
At present there is very little information in the scientific literature on the effect of 
antimicrobial surfaces against microbial aerosols. A study by Robine et al. (2002) 
showed E. faecalis aerosol viability on pure copper surfaces decreased with increasing 
relative humidity; aerosols were completely killed after 24 h at 100 % relative humidity 
but survived at 0 % relative humidity up to 96 h (Robine et al., 2002). This shows some 
resemblance to the new test developed in this chapter; the quickest kill by copper alloys 
was at [37°C-100% RH]. The data from this chapter and from Robine et al.’s (2002) 
study suggests high relative humidity and an aqueous inoculum aids the diffusion of 
copper towards the bacterial cell.  
 
MRD, which contains peptone (1 g/L), was used to act as soiling to the test and reflect 
the level of bioburden observed from hospital sampling sessions (see Chapter 3) (Ojeil 
et al., 2013). The ATP levels measured on surfaces was a measure of all organic matter; 
not just microbial bioburden (Chapter 3, section 3.2). MRD alone and MRD with 
organic load (BSA) were used to reflect different levels of organic load. The addition of 
3 g/L BSA to the bacterial suspensions is referred to as ‘dirty’ conditions in many 
standards. The quick rate of copper antimicrobial activity against an inoculum 
containing organic load was unusual; normally organic matter acts as a barrier between 
biocides and microorganisms (Lambert and Johnston, 2001). The study by Robine et al. 
(2002) highlighted the importance of surface fouling which enhanced bacterial survival 
regardless of the relative humidity, which they hypothesised to act as a barrier to copper 
release. In this chapter the addition of organic load (at the concentration tested) did not 
appear to protect the microbial aerosols from the antimicrobial activity of copper, which 
suggests that copper is effective even in the presence of organic matter. 
 
At in-use conditions the majority of antimicrobial activity against S. aureus and A. 
baumannii occurred within 60 min, which correlated to the drying time of microbial 
aerosols since surfaces were wet at 0 h and at 30 min. Up to this time point surfaces 
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were still moist; the aerosols had not completely dried. This further suggests copper is 
antimicrobial in the presence of a liquid on a surface.  
 
The little antimicrobial activity against B. subtilis was not surprising due to the highly 
resistant nature of spores. Galeano et al. (2003) also found little activity against Bacillus 
spores when exposed to a surface coated with silver- and zinc-containing zeolite 
formulation (Galeano et al., 2003). On the other hand Weaver et al. (2008) and 
Wheeldon et al. (2008) have demonstrated antimicrobial copper activity against C. 
difficile spores. The former observed activity after 24 - 48 h whilst the latter only saw 
significant reductions in spore viability upon the addition of a spore germinant (Weaver 
et al., 2008; Wheeldon et al., 2008). Additionally, the relatively similar level of survival 
after deposition at 0 h for all surface types for B. subtilis may suggest there is death of 
S. aureus and A. baumannii during the 30 min nebulisation period.   
 
In conclusion, the new antimicrobial surface test developed in this chapter provides a 
realistic, second-tier test that simulates in-use conditions. The test conditions of the JIS 
Z 2801 bear little relationship to an indoor environment, such as a hospital, thus it is not 
an ideal surface efficacy test method. In addition, the presentation of the inoculum and 
the ‘wet’ nature of the JIS Z 2801 test do not reflect how a surface could become 
contaminated in practice. The new test in this chapter presents the inoculum to a surface 
in a more realistic manner. It also allows for discrimination between surfaces, in turn 
allowing for better selection of surfaces for potential use in healthcare settings (Ojeil et 
al., 2013).  
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CHAPTER 5 THE ANTIMICROBIAL ACTIVITY OF 
ANTIMICROBIAL SURFACES WHEN PRESENTED WITH DRIED 
MICROBIAL INOCULA 
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5.1 Introduction 
 
5.1.1 Dry microbial inoculum 
 
Most antimicrobial surface studies are performed with bacteria in suspension; i.e. as a 
wet inoculum. In this chapter the focus was geared towards the efficacy of antimicrobial 
surfaces against a dry inoculum; inoculum without the presence of liquid. A dry surface 
is a surface free from visible moisture. Environmental monitoring of the relative 
humidity of surfaces in a hospital setting (Chapter 3) were taken from visibly dry 
surfaces; however observations did indicate a surface relative humidity range of 30.4 – 
64.2 %.  
 
Contamination of surfaces within the hospital environment is described in Chapter 1, 
section 1.6. The persistence of microorganisms on surfaces is well documented and is 
described in Chapter 1, section 1.7. Many microorganisms including S. aureus, A. 
baumannii and C. difficile spores are known to survive well, up to 7 months, in a dry 
environment (Kramer et al., 2006; Otter et al., 2011). Thus, if antimicrobial surfaces are 
to be utilised in hospitals it is important to assess their efficacy against dry bacterial 
inocula.  
 
Environmental studies have shown that in a hospital environment the amount of bacteria 
on dry surfaces in patient areas, such as bed rails, trolleys and door handles, ranged 
from 0 – 80 cfu/cm2 (Griffith et al., 2000; Airey and Verran, 2007). Other studies have 
found loads of <10 cfu/cm
2 
on a nurse workstation in an ICU and <1 - >250 cfu/cm
2 
across 27 high-touch surfaces in both paediatric and surgical wards (Cooper et al., 2007; 
Hardy et al., 2007).  
 
Jawad et al. (1996) investigated the effect of relative humidity on the survival of 
Acinetobacter spp. on surfaces. A range of species were inoculated on to glass cover 
slips then placed in boxes of varying relative humidity; 10 %, 31 % and 93 %. The 
inocula dried quickest at 10 % (3 – 4 h) and slowest at 93 % (10 – 16 h). Survival of A. 
baumannii was greatest at relative humidities of 31 % or greater (11 days) compared to 
at 10 % relative humidity (4 days). In addition, the influence of organic load on survival 
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was investigated. BSA increased survival from 11 days to 60 days at 23 – 34 % relative 
humidity (Jawad et al., 1996).  
 
5.1.2 Dry microbial inoculum surface efficacy tests 
 
Many studies that have reported the antimicrobial activity of copper usually inoculated a 
volume (e.g. 20 µL) of bacterial suspension on to test surfaces; thus testing the 
effectiveness of copper against a wet inoculum (Grass et al., 2011). However, it has 
been noted that this does not reflect the nature of surfaces in a hospital environment, 
thus more recent studies have geared their focus towards the performance of dry copper 
surfaces. Currently there is no international standard test method for testing the efficacy 
of surfaces against a dry microbial inoculum. Santo et al. (2008) and Warnes and Keevil 
(2011) have both developed dry inoculum surface efficacy tests, with reduced inocula 
volume to assist faster drying, which are described in section 5.1.3. 
 
Despite the stringency of the newly developed antimicrobial test based on the exposure 
of microbial aerosols in this thesis (Chapter 4), it is also essentially a wet test. The use 
of dry inocula would be ideal to allow simulation of the antimicrobial performance of 
test surfaces when contaminated under dry conditions and will help confirm whether 
wet contact is required for the antimicrobial activity of copper. It is important that the 
efficacy of antimicrobial surfaces is tested against dry inocula as this would simulate 
dry-touch contamination in a healthcare setting.  
 
5.1.3 Efficacy of antimicrobial surfaces against a dry microbial inoculum and 
mechanism of action of copper 
 
To date there are very few published studies describing the presentation of antimicrobial 
surfaces with a dry microbial inoculum. Santo et al. (2008) have developed a test 
method for dry inocula using a swab moistened with bacterial suspension. The swab is 
spread on to a test surface and the inoculum dries within 5 s. Warnes and Keevil (2011) 
have also developed a dry surface efficacy test. They inoculate a low volume (1 µL), 
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high concentration drop on to surfaces, which they describe also dried within 5 s 
(Warnes and Keevil, 2011). 
 
Santo et al. (2008) showed E. coli (at a high initial concentration of 9 log10) exposed to 
99 % copper was inactivated after 1 min at 23 °C and within 5 min at 5.5 °C when 
presented as a dry inoculum. Stainless steel was utilised as a control. The authors 
dismissed the role of desiccation or osmotic stress due to the survival of E. coli on 
stainless steel. However, this statement is questionable as the authors later described an 
initial 10-fold decrease in viable E. coli observed on stainless steel that occurred within 
the first 2 min, which they state may be due to plating stress. Copper-nickel-zinc alloy 
and brass were also tested. An initial 2-3 log10 reduction was observed, followed by a 
plateau, then a 6 log10 reduction within 2 min that killed all remaining viable cells. The 
authors stated a similar biphasic decrease in viability was observed on 99 % copper, but 
within a shorter time frame. Santo et al. (2008) believe the rapid reduction in viability in 
the last 2 min may be due to a stressor, such as copper ion, that needs to reach a lethal 
concentration before exuding its effect.  
 
In another study Santo et al. (2011) investigated the efficacy of dry metallic copper 
surfaces compared to moist copper surfaces against E. coli. Surfaces were presented 
with a dry inoculum using the method described above, and with a 40 µL droplet to 
represent a wet inoculum. They found cells accumulated copper ions faster in cells 
when E. coli was presented as a dry rather than wet inoculum; 3.8 ± 1.3 x 10
9
 Cu 
atoms/cell accumulated within 5 sec (time 0 h, drying time) compared to 1.8 ± 0.5 x 10
4
 
Cu atoms/cell at 0 h. After 1 min exposure of dry inoculum to copper the amount of 
copper accumulation remained constant at 4.1 ± 2.9 x 10
9
 Cu atoms/cell, which 
correlated with a 99.99 % reduction in viable cells. For cells exposed to copper as a dry 
inoculum, the authors claim cell death was caused by membrane and cell envelope 
damage and copper ion accumulation but cannot conclude whether the fast copper ion 
accumulation observed was the main cause of cell death or as a result of already 
damaged membranes. Membrane damage was confirmed by Live/Dead staining of 
copper exposed cells. Stainless steel was utilised as a control surface; Live/Dead 
staining showed intact membranes thus the authors suggest desiccation did not cause 
membrane damage to copper exposed cells. They suggest accumulation of copper was 
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quicker in dry rather than wet E. coli due to the absence of a buffering medium. The 
study also suggested no DNA damage to E. coli occurred on dry copper surfaces since 
Deinococcus radiodurans, a bacterium possessing many DNA repair mechanisms, was 
susceptible to dry copper surfaces. This suggests no DNA damage was induced since 
the bacterium would be able to repair such damage (Santo et al., 2011).  
 
A later study by Santo et al. (2012) suggests copper acts at the cell membrane and does 
not target genes to induce cell damage in Staphylococci. Staphylococcus haemolyticus 
was investigated in this study. Cells were found to accumulate a high concentration of 
copper within 5 min exposure (Santo et al., 2012). In addition, the authors stated that 
when cells were exposed to media containing D-cycloserine, which interferes with cell 
wall biosynthesis, they did not develop an aapA gene mutation required for growth on 
the media. This gene codes for the protein AapA, a D-serine/D-alanine/glycine 
transporter that takes up D-cycloserine. However, the authors state that if the gene is 
inactivated, D-cycloserine is not taken up and cells do not grow unless they acquire 
mutations. In this study, the number of resistant mutants detected on stainless steel 
(control) and copper surfaces was similar suggesting cells exposed to copper did not 
develop mutations (Santo et al., 2012). 
 
Warnes and Keevil (2011) demonstrated that copper alloy surfaces were able to produce 
a 6 log10 reduction in viable VRE (Enterococcus faecalis (E. faecalis) or Enterococcus 
faecium (E. faecium)) within 10 min when presented as a dry inoculum (1 µL, high 
concentration inoculum, dries within 5 s). Stainless steel was utilised as a control; less 
than a 0.5 log10 reduction was observed after 3 h. In contrast, a wet inoculum of similar 
concentration was killed after 1 h exposure to copper alloys (Warnes and Keevil, 2011). 
In terms of the mechanism of action of copper Warnes and Keevil (2011) found 
membrane depolarisation did not occur until after cell death, which is a discrepancy 
from Santo et al.’s (2011) findings. Copper ions and the generation of superoxide were 
found to be primarily responsible for cell death resulting in DNA damage and arrested 
cell respiration; again the DNA damage is something Santo et al. (2011) did not 
observe. These findings were obtained by staining cells exposed to control and test 
surfaces with a variety of fluorescent dyes that indicate membrane depolarisation, DNA 
damage and arrested cell respiration. 
145 
 
In a similar study Warnes et al. (2012) investigated the mechanisms of copper toxicity 
in E. coli and Salmonella Typhimurium as Gram-negative model organisms, compared 
to previous work with Gram-positive Enterococci. They utilised the same dry inoculum 
method as Warnes and Keevil (2011), described in section 5.1.2. E. coli was killed 
within 10 min (laboratory strain) and 20 min (pathogenic strain). Salmonella was killed 
within 5 min. Similar methods were used to Warnes and Keevil’s (2011) methods to 
identify the mechanisms of action of copper. It was found that unlike in Enterococci, 
membrane depolarisation occurred immediately followed by a slower rate of DNA 
damage. Outer membrane disruption and arrested respiration were also apparent. 
Copper (I) and copper (II) ionic species and hydroxyl radicals were found to be 
responsible for the cellular damage observed (Warnes et al., 2012). 
 
5.1.4 Aims and Objectives 
 
The aim of this chapter was to develop a new test method for delivering dried microbial 
inocula on to surfaces to assess their antimicrobial efficacy against a dry inoculum. In 
comparison to Santo et al.’s (2008) and Warnes and Keevil’s (2011) methods, the new 
test will aim to inoculate surfaces with a completely dried inoculum. The test developed 
by Warnes and Keevil (2011) was carried out as it is a published method and acted as a 
comparison to the new antimicrobial surface efficacy test developed in this chapter. In 
addition, the mechanisms of action of copper as an antimicrobial were explored to 
understand how copper acts against a dried microbial inoculum.  
 
5.2 Materials and Methods 
 
5.2.1 Preliminary testing for development of a new dry inoculum antimicrobial 
surface efficacy test 
 
Preliminary experiments were carried out to develop a new test method for delivering a 
dry inoculum on to surfaces. Two methods were explored and are described in sections 
5.2.1.1 and 5.2.1.2. The final test set-up is described in section 5.2.2. 
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5.2.1.1 Method One: Preparation of dried microbial inoculum by freeze-drying and 
use of an inhaler for delivery of inoculum on to surfaces 
 
5.2.1.1.1 Principle of method 
 
This method was based on the production of a dried microbial inoculum by freeze-
drying. Freeze-drying, or lyophilisation, is defined as ‘a controllable method for 
dehydrating labile products by vacuum desiccation’ (Day and Stacey, 2007). Freeze-
drying is commonly used for the long-term preservation and storage of culture 
collections (Day and Stacey, 2007). Cryoprotectants are required when freezing 
microorganisms to protect the microorganism from damage during the freezing process. 
They can prevent osmotic injury during freezing and thawing and reduce the 
development of ice crystals (Cleland et al., 2004). 
 
The principle of this method was that a freeze-dried inoculum was prepared and loaded 
into a capsule placed in an inhaler, which was connected to a cascade impactor. The 
inoculum is then deposited on to surfaces. Starch was chosen as a protective medium in 
favour of more obvious choices including 10 % skimmed milk as the latter may act as 
organic load. Starch was prepared in deionised water and autoclaved at 121 °C for 15 
min then cooled before use. 
 
5.2.1.1.2 Method of preparing a freeze-dried inoculum and delivery on to surfaces using 
an inhaler 
 
Dried bacterial inoculum was prepared as follows; an overnight culture of S. aureus 
NCIMB 9518 was prepared in triplicate. The following day the culture was centrifuged 
at 2500 g for 15 min at room temperature. The pellet was washed twice with buffer. 
MRD and TSC were both tested as suitable buffers. Next, the pellet was re-suspended in 
10 mL starch, which was tested at 0.5 %, 1 %, 2 % and 5 % (v/w). A viable count was 
performed by serial dilution then the culture was snap-frozen by liquid nitrogen and 
stored for a maximum of two hours at -20 °C. The samples were freeze-dried in an EF 4 
Modulyo freeze-dryer (Edwards, West Sussex, UK) for 24 h. Samples were rehydrated 
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to their original volume and enumerated by serial dilution. Deionised water, TSB and 
MRD were tested as rehydration media. Samples were re-hydrated in either deionised 
water or MRD for 1 h at 20 °C, or in TSB for 15 min at 20 °C. Survivability was 
determined as follows: 
 
Viability % = (log10 cfu/mL after freeze-drying / log10 cfu/mL before freeze-drying) x 
100 
 
A similar set-up to that of delivering microbial aerosols on to antimicrobial surfaces was 
considered for the delivery of dried microbial inocula. An inhaler was used in place of 
the nebuliser.  The inhaler utilised, Flowcaps (Hoviove, Loures, Portugal) is a single-
dose dry-powder inhaler. One capsule containing freeze-dried inoculum was placed 
inside the inhaler. The set-up is shown in Figure 5.1a and a close-up image of the 
inhaler in Figure 5.1b. 
 
Figure 5.1 – Initial test set-up for delivering dried microbial inocula on to antimicrobial 
surfaces (a) and close-up photo of inhaler (b) 
a) Initial test set-up for delivering dried microbial inocula on to antimicrobial surfaces 
 
a=vacuum pump, b=Andersen cascade impactor, c=Flowcaps inhaler 
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b) Close-up photo of inhaler 
 
 
 
 
 
 
 
 
5.2.1.1.3 Results 
 
TSC and MRD were both tested as buffers during the wash steps of preparing samples 
for freeze-drying (see Table 5.1). Starch was tested at 0.5 % (v/w). The same buffer was 
utilised for rehydration after freeze-drying. The survival percentage was greater when 
MRD was utilised for the wash steps and rehydration. There was a significant difference 
in the survival percentages when MRD was used as opposed to TSC (one-way 
ANOVA, P=0.023). Thus it was decided MRD would be used for the wash steps. 
 
Table 5.1 – Testing different buffers for wash steps and rehydration during the 
preparation of freeze-dried S. aureus (n=3) 
Buffer Survival percentage (%) ± SD 
MRD 97.00 ± 0.84 
TSC 92.51 ± 2.60 
 
Three different rehydration media were tested for rehydrating samples after freeze-
drying. Samples were rehydrated to their original volume in MRD, deionised water or 
TSB and viable counts were performed and compared to the viable counts prior to 
freeze-drying. Starch was utilised at 0.5 % (v/w). Results are shown in Table 5.2. The 
survival percentage was lowest when cells were rehydrated in TSB and highest when 
rehydrated in deionised water. As survivability was slightly higher when the dried 
inoculum was rehydrated with deionised water than in MRD it was decided water would 
be utilised for rehydration for subsequent experiments. Statistical analysis by a one-way 
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ANOVA, however, showed there was no significant difference in survival percentage of 
freeze-dried cells when rehydrated in MRD, deionised water or in TSB (P=0.195). 
 
Table 5.2 – Testing different rehydration media for the rehydration of freeze-dried S. 
aureus (n=3) 
Rehydration medium Survival percentage (%) ± SD 
MRD 97.00 ± 0.84 
Deionised water 98.08 ± 0.96 
TSB 95.43 ± 2.97 
 
Next, different starch concentrations were tested; 0.5 %, 1 %, 2 % and 5 % (v/w). 
Survival percentages ranged from 92.19 % to 98.08 % with varying starch 
concentrations. There was no apparent correlation between starch concentration and 
survival percentage (see Table 5.3). The highest survival percentages were observed 
with starch at 0.5 % and 2 %, whereas the lowest survival percentages were seen when 
starch was utilised at 1 % and 5 %. Statistical analysis by a one-way ANOVA 
confirmed concentration did not have an effect on survivability, P>0.05. Therefore, 
since 0.5 % starch provided the highest survival percentage, starch was utilised at this 
concentration for subsequent testing. In addition when starch was autoclaved it 
gelatinised: the higher the starch concentration the greater the level of gelatinisation, 
which made preparation difficult. 
 
Table 5.3 – Effect of starch concentration on the survivability of freeze-dried S. aureus 
(n=3) 
Starch concentration 
(w/v %) 
Survival percentage (%) ± SD 
0.5 98.08 ± 0.96 
1 92.19 ± 2.88 
2 97.67 ± 1.85 
5 92.53 ± 3.91 
 
150 
 
5.2.1.1.4 Discussion 
 
A freeze-dried inoculum of S. aureus NCIMB 9518 was prepared using 0.5 % starch as 
a cryoprotectant. Trial runs of delivering the dried inoculum on to surfaces from an 
inhaler connected to an Andersen cascade impactor proved unsuccessful. The dried 
inoculum did pass through the neck of the impactor, however, it did not fully pass 
through Stage 0 of the impactor. Instead, the inoculum collected in the middle of the 
Stage 0 plate and thus did not pass through the holes through to the next plate where the 
stainless steel sample collecting plate was placed. The most likely explanation for this 
was that aggregation of the particles affected the flow rate within the test set-up 
(personal communication, Glyn Taylor and James Birchall, Cardiff School of Pharmacy 
and Pharmaceutical Sciences). This method was not developed further. 
 
5.2.1.2 Method Two: Generation of dry microbial aerosols using a nebuliser 
 
5.2.1.2.1 Principle of method 
 
Microbial aerosols generated by a nebuliser are dried before deposition on to control 
and antimicrobial surfaces.  
 
5.2.1.2.2 Method development 
 
Step 1 - Initial test set-up 
 
A S. aureus NCIMB 9518 culture was grown as described in Chapter 2, section 2.3.2. 
The culture was centrifuged for 15 min at 2500 g and re-suspended in MRD to provide 
a bacterial concentration of 10
9
 cfu/mL. Ten mL of the suspension was placed in a 
nebuliser (Philips Respronics, Best, The Netherlands) to aerosolise the suspension. The 
nebuliser was connected to a 15 cm stainless steel tube wrapped with a 0.9 m heating 
tape (HT9 Fibre Glass Heating Tape, Electrothermal, Essex, UK). The temperature of 
the heating tape was maintained with a digital temperature controller (MC810B Digital 
Heating Controller, Electrothermal, Essex, UK). The heating tape was heated to a 
temperature high enough to dry the aerosols passing through, which were then passed 
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through an Andersen cascade impactor and deposited on to sample surfaces (as with the 
wet aerosol experiments, Chapter 4). Figure 5.2 shows the experimental test set-up.  
  
Figure 5.2 – Test set-up for delivery of dried microbial aerosols on to antimicrobial 
surfaces 
 
a=vacuum pump, b=Andersen cascade impactor, c=heating tape, d=temperature 
controller, e=nebuliser 
 
Step 2 - Experiments to find a suitable temperature to dry aerosols 
 
Tables 5.4 – 5.7 show the temperature the temperature controller was set to, the amount 
of inoculum recovered from stainless steel discs and the state of surfaces (‘dry’, ‘wet’ or 
‘condensation’). A ‘dry’ surface indicates surfaces were visibly dry after 30 min of 
inoculum nebulisation, drying and deposition. Thus a dry inoculum has been deposited 
on to surfaces. ‘Wet’ means aerosols had not dried during the drying process and wet 
droplets were visible. ‘Condensation’ indicates a slight layer of condensation was 
present on surfaces after 30 min of inoculum nebulisation, drying and deposition. This 
layer of condensation, in most cases, evaporated immediately to then give the 
appearance that a dry inoculum had been deposited on to surfaces. However, a surface 
with condensation was considered wet. It was not possible to take a picture of the 
condensation layer present on surfaces as the condensation evaporated quickly.  
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The original length of the stainless steel tube placed between the cascade impactor and 
nebuliser was 15 cm. The original length of heating tape was 0.9 m. A bacterial 
suspension of S. aureus NCIMB 9518 was prepared and adjusted to a final 
concentration of 10
9
 cfu/mL in MRD. The suspension was nebulised and passed through 
the stainless steel tube wrapped with heating tape and particles were deposited on to 
three stainless steel discs. The heating tape was tested once at a range of temperatures 
(60 - 100 °C). The temperature was set using the temperature controller shown in Figure 
5.2 to see what temperature was required to completely dry the inoculum. After 
deposition, discs were transferred to a 100 mL bottle containing 5 g glass beads, 1 mL 
neutraliser and 9 mL MRD, shaken for 1 min at 150 rpm and viable bacteria 
enumerated. Table 5.4 shows the tested temperatures did not completely dry the 
nebulised bacterial suspension, as the discs were visibly wet after the inoculum was 
nebulised, dried and deposited.  
 
Table 5.4 – Dry inoculum method optimisation: original stainless steel tube (15 cm) 
and heating tape (0.9 m) with starting inoculum 10
9
 cfu/mL 
Temperature 
(°C) 
Recovery from stainless steel 
(n=3) (log10 cfu/cm
2
) 
Dry, wet or 
condensation? 
60 5.45 ± 0.32 Wet 
70 5.03 ± 0.14 Wet 
80 4.72 ± 0.24 Wet 
90 4.73 ± 0.32 Wet 
100 4.96 ± 0.59 Wet 
 
Step 3 - New test set-up with longer stainless steel tube 
 
It was decided a longer stainless steel tube, 23 cm in length, would be placed between 
the cascade impactor and nebuliser to increase the opportunity for aerosols to dry. As 
before, the heating tape was heated to a range of temperatures to determine which was 
sufficient to dry aerosolised particles.  Each temperature was tested in three separate 
runs. A 10
9
 cfu/mL S. aureus suspension was prepared in MRD, the suspension was 
nebulised, passed through the stainless steel tube and the inoculum was deposited over 
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three stainless steel discs. Viable bacteria on discs were enumerated as previously 
described. 
 
The use of a longer stainless steel tube produced a dried inoculum on surfaces.  60 °C 
was not sufficient to dry aerosolised particles (see Table 5.5). At 70 °C and 80 °C 
inconsistent results were produced; wet and dry inocula, in addition to condensation 
were apparent on surfaces. At 90 °C two of the three repeats presented a dry inoculum 
on surfaces, one run presented a fine layer of condensation. The discs were checked 
every 5 min during the 30 min nebulisation process. It was during the final check at 30 
min that condensation on previously dry surfaces (between 0 - 25 min) developed. In 
terms of cfu/cm
2 
of recovered dried inoculum from discs there was no significant 
difference in counts when the inoculum was dried at 90 °C (one way ANOVA, 
P=0.957). 
 
Table 5.5 – Dry inoculum method optimisation: longer stainless steel tube (23 cm) and 
original heating tape (0.9 m) with starting inoculum 10
9
 cfu/mL (n=3) 
Temperature 
(°C) 
Recovery from stainless steel 
(n=3) (log10 cfu/cm
2
) 
Dry, wet or 
condensation? 
60 4.77 ± 0.14 Wet 
 
4.48 ± 0.09 Wet 
 
5.11 ± 0.20 Wet 
70 4.54 ± 0.23 Dry 
 
4.18 ± 0.09 Wet 
 
4.14 ± 0.10 Condensation 
80 4.73 ± 0.03 Dry 
 
5.14 ± 0.65 Wet 
 
4.02 ± 1.17 Condensation 
90 3.74 ± 0.51 Condensation 
 
3.74 ± 1.34 Dry 
  3.53 ± 0.80 Dry 
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Figure 5.3 shows images of wet and dry inocula deposits. It is apparent that the 
inoculum deposited in Figure 5.3a had not completely dried thus was a wet inoculum. 
The image in Figure 5.3b is of a dry inoculum; there were no visible wet aerosols.  
 
Figure 5.3 – Image of wet (a) and dry (b) microbial inocula deposits 
 
a) Wet     b) Dry 
  
 
 
 
 
 
 
 
 
Step 4 - New test set-up with longer stainless steel tube, longer heating tape and 
addition of silica bead sachets 
 
Since a longer stainless steel tube was used, the heating tape, when wrapped around the 
tube, did not fully and tightly cover the entire length of the tube. This might perhaps 
explain the inconsistent results observed previously (Table 5.5). Therefore, a longer 
heating tape (2.4 m long) was obtained, which fitted nicely around the stainless steel 
tube (see Figure 5.2). In addition, to overcome the problem of condensation that 
developed on surfaces within the final few minutes of nebulisation, five 1 g silica bead 
sachets were placed below the collecting plate within the cascade impactor (see Figure 
5.4a). One sachet was also placed in the centre of Stage 0 of the cascade impactor (see 
Figure 5.4b).  As before, a 10
9
 cfu/mL suspension of S. aureus NCIMB 9518 was 
prepared, a range of temperatures tested and the amount of bacteria recovered from 
stainless steel discs was enumerated. 
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Figure 5.4 – Arrangement of silica bead sachets on a) Stage F and b) Stage 0 of cascade 
impactor 
 
a) Stage F    b) Stage 0 
  
 
 
 
 
 
 
Setting the temperature controller at 50 °C was not high enough to dry aerosolised 
particles; thus it was tested only once. It was apparent the temperature controller at 60 
°C was sufficient to dry aerosolised bacteria; however there was still condensation on 
surfaces (see Table 5.6). A range of 4.17 to 5.15 log10 cfu/cm
2
 of inocula (see Table 5.6) 
was recovered from stainless steel discs from these three runs; there was a significant 
difference in the amount of bacteria recovered from stainless steel discs from the three 
runs (one-way ANOVA, P=0.017) 
 
Table 5.6 - Dry inoculum method optimisation: Longer stainless steel tube (23 cm), 
longer heating tape (2.4 m) and silica bead sachets to aid removal of moisture. Starting 
inoculum 10
9
 cfu/mL 
Temperature 
(°C) 
Recovery from stainless steel 
(n=3) (log10 cfu/cm
2
) 
Dry, wet or 
condensation? 
50 5.24 ± 0.51 Wet 
60 5.15 ± 0.13 Dry 
 
4.17 ± 0.23 Condensation 
  4.94 ± 0.45 Condensation 
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Step 5 - Modification of new test set-up – holding cascade impactor at 40 °C before 
nebulisation 
 
In addition to the use of silica bead sachets, the cascade impactor was held at 40 °C for 
up to one hour before the nebulisation process to further overcome condensation issues. 
This was to reduce the temperature difference between the stainless steel tube and 
cascade impactor thus preventing the build-up of condensation within the cascade 
impactor. 60 °C was tested in triplicate and all three runs presented a dried inoculum 
without the presence of condensation. Recovery from stainless steel discs ranged from 
4.34 to 4.57 log10 cfu/cm
2
, which showed no significant difference between counts 
obtained from the three repeats (one-way ANOVA, P=0.727) (see Table 5.7). 
 
Table 5.7 - Dry inoculum method optimisation: longer stainless steel tube (23 cm), 
longer heating tape (2.4 m), silica bead sachets and holding cascade impactor and discs 
for approx. 45 min at 40 °C before nebulisation. Starting inoculum 10
9
 cfu/mL (n=3) 
Temperature 
(°C) 
Recovery from stainless steel 
(n=3) (log10 cfu/cm
2
) 
Dry or 
wet? 
60 4.50 ± 0.44 Dry 
 
4.56 ± 0.16 Dry 
  4.34 ± 0.33 Dry 
 
 
Step 6 - Modification of new test set-up – higher starting inoculum concentration 
 
At this stage the amount of dried bacterial inocula recovered from stainless steel was 
between 4.34 and 4.57 log10 cfu/cm
2
. Ideally recovery should be higher. During wet 
inoculum testing the amount recovered from stainless steel discs and copper alloy 
surfaces at 0 h were around 6 and 5 log10 cfu/cm
2
, respectively. For comparison to wet 
inoculum testing and to have a similar level of bacterial recovery from stainless steel 
discs at 0 h (immediately after nebulisation and drying of particles) the starting 
inoculum of S. aureus was increased from 10
9
 cfu/mL to 10
10
 cfu/mL.  
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An overnight culture of S. aureus NCIMB 9518 was grown in 100 mL TSB for 24 h 
with shaking, centrifuged at 5000 g then re-suspended in 10 mL MRD. The suspension 
was nebulised; particles dried and deposited over three stainless steel discs. Setting the 
heating tape to 70 °C was sufficient to dry the aerosolised suspension. Table 5.8 
confirms the higher starting inoculum of 10
10
 cfu/mL presented a higher level of 
bacterial recovery from stainless steel discs. 
 
Table 5.8 – Recovery of dried inoculum from stainless steel discs using a longer 
stainless steel tube  (23 cm), longer heating tape (2.4 m), silica bead sachets, holding 
cascade impactor and discs for approx. 45 min at 40 °C before nebulisation and high 
starting inoculum of 10
10
 cfu/mL 
Temperature 
(°C) 
Recovery from stainless 
steel (n=3) (log10 cfu/cm
2
) 
Dry or 
wet? 
70 6.39 ± 0.31 Dry 
 
 
5.2.1.2.3 Validation of recovery of dried microbial inoculum from stainless steel discs 
 
The method of depositing and recovering dried bacterial aerosols was validated by 
depositing dried bacterial aerosols of S. aureus on to eight stainless steel discs, as 
positioned in Figure 5.5, and determining viability. The amount of viable bacteria 
recovered from each surface is shown in Table 5.9. This was performed once. 
 
Figure 5.5 – Position of stainless steel discs on collecting plate within the cascade 
impactor for validation of recovery of dried microbial inoculum  
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Statistical analysis by means of a one-way ANOVA showed the positioning of a 
stainless steel disc had no effect on the amount of viable bacteria recovered. Table 5.9 
shows the amount of viable bacteria recovered from each disc, which was calculated in 
triplicate. There was no significant difference in the amount of bacteria recovered 
between the eight discs, P=0.472.  
 
Table 5.9 – Validation of recovery of dried microbial inoculum from stainless steel 
discs (n=1) 
Disc Log10 cfu/cm
2 
± SD 
1 7.40 ± 0.02 
2 7.27 ± 0.06 
3 7.12 ± 0.03 
4 7.32 ± 0.08  
5 7.73 ± 0.04 
6 7.74 ± 0.02 
7 7.82 ± 0.03 
8 7.70 ± 0.05 
 
5.2.1.2.4 Discussion 
 
This method of presenting a dried microbial inoculum was acceptable. A temperature 
setting of 70 °C was established to be sufficient to dry nebulised aerosols. The 
deposition of dried inoculum was validated with S. aureus. This test set-up and method 
was next used for assessing test and control surfaces against a dried inoculum 
(complete, final set-up and method described in section 5.2.2). 
 
5.2.2 New antimicrobial surface test for testing dried microbial inocula – use of a 
nebuliser to generate dry microbial aerosols 
 
5.2.2.1 Final test set-up 
Test equipment was set-up as shown in Figure 5.2. A 2.4 m heating tube was wrapped 
around a 23 cm stainless steel tube that was connected to the nebuliser at one end and to 
the cascade impactor at the other end. Test and control surfaces were placed on the 
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collecting plate within the cascade impactor. In addition, five silica bead sachets were 
placed under the collecting plate on Stage F and one sachet was placed in the centre of 
Stage 0. Before testing commenced, the cascade impactor was held at 40 °C for up to 
one hour to help prevent the build-up of condensation during the dry inoculum 
deposition period. The temperature controller attached to the heating tape was set to 70 
°C during the process. The actual temperature inside the stainless steel tube was 
measured using temperature probes described in section 5.2.2.3. A Copley Scientific 
DFM2000 (Nottingham, UK) flow meter was placed between the cascade impactor and 
vacuum pump (not shown in Figure 5.2). Ten runs of the set-up presented an average 
flow rate of 2.18 ± 0.54 L/min. 
 
5.2.2.2 Final test method 
An overnight culture of S. aureus NCIMB 9518 was grown in 100 mL TSB at 37 °C 
with shaking. The culture was centrifuged at 5000 g and re-suspended in 10 mL MRD, 
nebulised, dried and deposited over a total of six control stainless steel discs and test 
copper alloys surfaces. The combination of surfaces tested was random within each run; 
stainless steel and copper alloy surfaces were mixed After 30 min inoculum 
nebulisation, drying and deposition (0 h), surfaces were transferred to a 100 mL bottle 
with 5 g 3mm glass beads containing 1 mL neutraliser and 9 mL MRD and shook for 1 
min at 150 rpm. Viable bacteria were then determined by the spread plate method. As 
with wet inoculum testing, surfaces were incubated for 30 min, 60 min and 24 h after 
deposition of dried inoculum and viable bacteria then determined as mentioned above. 
Unlike wet inoculum testing, surfaces were only subject to one incubation condition, 
[20°C-40% RH]. This was the most realistic incubation condition reflective of an indoor 
hospital environment based on conditions observed during hospital sampling sessions 
(see Chapter 3). Each surface and contact time were tested in triplicate.  
 
Copper alloy and control surfaces were also tested at [20°C-40% RH] against a dried 
inoculum of A. baumannii NCIMB 9214 as a Gram-negative model. The inoculum was 
prepared by growing an overnight culture of A. baumannii in 100 mL TSB for 24 h at 
25 °C with shaking. The culture was then centrifuged at 5000 g and re-suspended in 10 
mL MRD for testing.  
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5.2.2.3 Temperature and relative humidity conditions within test set-up 
To gain information regarding temperature and relative humidity conditions within the 
test set-up, probes were placed within the cascade impactor and stainless steel tube that 
was wrapped with heating tape. Three SL54TH probes (Signatrol.com, Gloucestershire, 
UK) measuring 17 mm in diameter and 6 mm in thickness were positioned on the 
collecting plate, where test and control surfaces are normally placed. This probe 
measured temperature and relative humidity. Three SL53T probes (Signatrol.com, 
Gloucestershire, UK) of the same size as the SL54TH model were placed inside the 
stainless steel tube that connects the nebuliser to the cascade impactor. This probe 
recorded temperature only, up to a maximum of 125 °C. One probe was placed at the 
nebuliser end of the tube (position 1), a second was placed half way across the tube 
(position 2) and the third probe was placed at the cascade impactor end of the tube 
(position 3), see schematic diagram Figure 5.6. All three probes were set to log data 
every 30 sec. The test was set up and carried out as usual as described in 5.2.2.1 and 
5.2.2.2 to mimic a normal run of the procedure. S. aureus was utilised as the test 
microorganism. This was repeated in triplicate. 
 
Figure 5.6 – Schematic diagram of position of temperature probes (1, 2, and 3) within 
stainless steel tube 
 
 
 
 
 
5.2.3 Efficacy of antimicrobial surfaces against a dry microbial inoculum – use of 
an existing, published method 
 
5.2.3.1 Method 
A modified method of Warnes and Keevil’s (2011) test, which aims to simulate dry- 
touch contamination, for testing the efficacy of antimicrobial surfaces against a dry 
microbial inoculum was carried out. The idea of this test was that a low volume, high 
concentration inoculum was inoculated on to surfaces, which dried quickly. Surfaces 
   3 2 1 
 To 
cascade 
impactor 
To 
nebuliser 
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were then incubated under the required conditions and time points and viable bacteria 
were recovered from surfaces. This test was carried out using S. aureus only. Firstly S. 
aureus NCIMB 9518 was grown in 10 mL TSB for 24 h at 37 °C. The grown culture 
was centrifuged at 2500 g for 15 min and re-suspended in 500 µL MRD (yielding 
approximately 10
10 
cfu/mL). From this 1 µL (around 10
7 
cfu) was inoculated and spread 
evenly using the end of the pipette tip on to control stainless steel and test copper alloy 
surfaces. The inoculum was bench dried within 5 s; no visible moisture was apparent on 
the surface. To keep in line with the contact times used throughout this thesis, the 
contact times tested were 30 min, 60 min and 24 h. Surfaces were then incubated for 
these times at [20°C-40% RH]; the most realistic conditions based on observations from 
hospital sampling sessions (Chapter 3). The level of inoculum on surfaces at 0 h was 
determined by transferring surfaces to a 100 mL bottle containing 5 g 3 mm glass beads, 
9 mL MRD and 1 mL neutraliser. Bottles were placed on a shaking platform for 1 min 
then left to stand for 5 min. Viable bacteria were determined by serial dilution down to 
10
-4
; 100 µL of each dilution was spread on to a TSA plate in triplicate and incubated 
for 24 h at 37 °C and cfu counted. Viable bacteria on surfaces incubated for the other 
contact times were recovered in the same way as at 0 h. Each surface and contact time 
were tested in triplicate.  
 
5.2.3.2 Temperature and relative humidity conditions of test 
Temperature and relative humidity conditions on surfaces during this test method were 
determined using a S154TH temperature and relative humidity probe. One probe was 
placed on a test surface and then the surface was inoculated with 1 µL of 10
7
 S. aureus, 
as prepared in 5.2.3.1. This was repeated in triplicate. The probes were set to record 
temperature and relative humidity at 0 min (before inoculation). Surfaces were 
inoculated at 1.5 min and probes were removed after 5 min. Measurements were 
recorded every 30 sec, which was the minimum interval possible. 
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5.2.4 Understanding the mechanism of action of copper against a dry microbial 
inoculum 
 
To understand the antimicrobial effect, if any, of copper against a dry microbial 
inoculum, fluorescence-activated cell sorting (FACS) experiments were carried out to 
determine the physiological state of cells after copper exposure. In addition, the effect 
of the drying process on bacteria inocula, and any damage that may have been amplified 
by copper, was determined. 
 
5.2.4.1 Dyes and surfaces tested 
Propidium iodide (PI) and Bis (1,3-dibarbituric acid) trimethine oxanol (BOX) (both 
from Sigma-Aldrich, Poole, UK) were utilised in combination to assess membrane 
damage and changes in membrane potential, respectively. PI stains the DNA of cells 
with damaged membranes and BOX stains cells with collapsed membrane potentials. PI 
was prepared in sterile water at 200 µg/mL) to be used at a working concentration of 5 
µg/mL.  BOX was prepared in dimethyl sulfoxide (DMSO) at 10 mg/mL and diluted in 
phosphate buffered saline (PBS) to a working concentration of 10 µg/mL. 100 µL 
ethylenediaminetetraacetic acid (EDTA) at 4 mM was added to 9.9 mL working 
concentration of BOX to help with the staining of cells.  
 
5-cyano-2,3-ditolyl tetrazolium chloride (CTC) purchased from Sigma-Aldrich, Poole, 
UK) was a dye used to detect respiring cells. During electron transport respiring cells 
reduce CTC to insoluble formazan, which fluoresces. SYTO9 (Invitrogen, UK) was 
used to assess DNA damage in cells; SYTO9 stains cells with intact DNA. CTC was 
prepared in sterile water at a stock concentration of 100 mM and used at 5 mM final 
concentration. SYTO9 was prepared at 5 mM in DMSO and diluted in sterile water for 
use at 5 µM final concentration. These two dyes were used in combination. 
 
The effect of copper on dried inocula of S. aureus and A. baumannii was investigated at 
0 h and after 24 h at [20°C-40% RH]. S. aureus was exposed to stainless steel (control 
surface), CuSn5 (presented lowest log10 reduction after 24 h, see Table 5.10) and 
CuZn30 (presented highest log10 reduction after 24 h, see Table 5.10). A. baumannii 
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was exposed to stainless steel (control surface), CuSn5 (presented lowest log10 
reduction after 24 h, see Table 5.11) and CuNi10Fe1Mn (the counts from this surface 
were significantly different to the other three copper alloy surfaces, see Table 5.11).  
 
5.2.4.2 Method of preparing bacterial cells for FACS analysis 
Dry inoculum testing was carried out as described in section 5.2.2 for S. aureus and A. 
baumannii. Surfaces were tested at 0 h and after 24 h incubation at [20°C-40% RH]. 
After the required contact time surfaces were transferred to a 100 mL glass bottle 
containing glass beads, 9 mL MRD and 1 mL neutraliser and shook for 1 min at 150 
rpm. The 10 mL mixture was then divided into 2x 5 mL and transferred to Universal 
tubes. Tubes were then centrifuged at 2500 g for 10 min. One 5 mL test sample was re-
suspended in 500 µL PBS for PI and BOX staining, and the other 5 mL test sample was 
re-suspended in 500 µL sterile water for CTC and SYTO9 staining. 50 µL of each 
sample was added to 1 mL FACSFlow buffer (BD, UK) and the dyes were added at the 
required concentration as described in section 5.2.4.1.  
 
PI and BOX were added together and left for 5 min in the dark before FACS analysis 
using a FACS ARIA II (BD, UK) machine. CTC was added first to samples and 
samples were incubated for 90 min in the dark at 37 °C. SYTO9 was then added; 
samples were incubated for 30 min in the dark at room temperature before FACS 
analysis. 
 
Ethanol was used as a positive control to show membrane damage. Ethanol, heat shock 
and hydrogen peroxide (H2O2) treatment of cells were also used as positive controls to 
show arrested cellular respiration and DNA damage. Cultures of S. aureus and A. 
baumannii were prepared as in Chapter 2, section 2.3.2. One mL of each culture was 
centrifuged for 1 min at 13,000 g and re-suspended in 500 µL of 100 % ethanol for 10 
min, or 500 µL of PBS for heat shock treatment at 100 °C for 30 min, or 500 µL of 10 
% H202 for 30 min. After each treatment the suspension was centrifuged for 1 min at 
13,000 g and the pellet re-suspended in 500 µL PBS for PI and BOX staining or 500 µL 
sterile water for CTC and SYTO9 staining. As above, 50 µL was transferred to 1 mL 
FACSFlow buffer, dyes added and samples loaded into the FACS machine. 
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Additionally, a sample containing just cells from an overnight culture that had been 
centrifuged and re-suspended in PBS (no treatment) was stained with the dyes as 
another control.   
 
Cell samples were loaded individually into the FACS Aria II illuminated with a 488 nm 
laser and data from 10,000 particles were collected. Fluorochromes already calibrated to 
the FACS Aria II were used. PI fluorescence (red) was collected at an excitation-max 
482 nm/emission-max 678 nm and BOX fluorescence (green) was at an excitation-max 
494 nm/emission-max 519 nm. CTC fluorescence (green) was collected at an excitation-
max 494 nm/emission-max 519 nm and SYTO9 fluorescence (yellow) at an excitation-
max 496 nm/emission-max 578 nm.  
 
The combination of testing PI and BOX together to assess membrane damage was based 
on the methods described by Whitehead et al. (2011). The use of CTC and SYTO9 was 
based on several publications by Warnes and co-workers (Warnes et al., 20120, Warnes 
and Keevil, 2011). 
 
Each experiment was repeated twice on different occasions.  
 
5.2.5 Relative humidity of surfaces following hand-touch 
 
A small experiment to gain an insight into the effect of hand-touch on surface relative 
humidity was carried out. Sl54TH probes mentioned in section 5.2.2.3, which measure 
relative humidity were utilised as test surfaces. The probes were set to record relative 
humidity every 30 sec. Eight participants were asked to pick up a probe and hold it for 1 
min. This time frame is longer than a typical contact between a person and a surface 
(e.g. a person gripping a door handle in a hospital ward), however, since the probes can 
only log data at a minimum of 30 sec intervals, it was decided that a 1 min contact time 
would be tested. Each participant performed the experiment in triplicate. This 
experiment was performed over a 24 h period in a biosafety level 2 cabinet. 
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5.2.6 Statistical analysis 
 
Statistical analysis was carried using SPSS software. In general, a General Linear 
Model or chi-squared test were used to analyse data statistically.  
 
5.3 Results 
 
5.3.1 Temperature and relative humidity conditions within the new dry inoculum 
test set-up 
 
5.3.1.1 Temperature distribution within the stainless steel drying tube wrapped with 
heating tape 
Figure 5.7 shows the temperature profile inside the stainless steel tube during the 30 
min aerosol drying process. The probe at position 1 was placed inside the tube at the 
end connected to the nebuliser. The probe at position 2 was situated in the middle of the 
tube and the probe at position 3 was placed at the end of the tube connected to the 
cascade impactor.  It is apparent that at position 1 the temperature decreased over 
approximately the first 10 min then remained constant for the final 20 min. At positions 
2 and 3 there was a similar decrease in the first 10 min followed by approximately a 10 
°C decrease during the last 20 min. At position 1 the highest temperature recorded was 
95.7 °C at 0 min. The lowest recorded temperature was 26.8 °C during the 23
rd
 min. The 
highest temperature recorded at position 2 was 90.7 °C, also at 0 min. The lowest 
temperature was 37.9 °C recorded within the 30
th
 min. At position 3 the highest and 
lowest temperatures recorded were 88.5 °C at 0 min and 27.3 °C within the 30
th
 min, 
respectively. The average temperatures recorded over three repeats at position 1 was 
40.0 ± 17.3 °C, at position 2 was 56.0 ± 16.0 °C and at position 3 was 48.9 ± 12.9 °C. 
Overall, across all three positions, the average temperature inside the tube was 48.3 ± 
14.0 °C. 
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Figure 5.7 – Temperature profile within the stainless steel tube during nebulisation and drying of dry microbial inoculum (n=3). Error bars 
represent the standard deviation. 
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5.3.1.2 Temperature and relative humidity within the cascade impactor 
Figure 5.8 shows the temperature and relative humidity conditions within the cascade 
impactor during the 30 min inoculum nebulisation, drying and deposition period. Three 
probes that measured both temperature and relative humidity were placed on a 
collecting plate, where test and control surfaces would normally be positioned. Three 
runs were performed. Over the three runs the highest temperature recorded was 36.3 °C 
during the 30
th
 min. The lowest temperature was 30.9 °C recorded within the 1
st
 min. 
The average temperature over the 30 min was 34.0 ± 1.2 °C. The relative humidity 
recorded ranged from 32.1 to 71.3 %, recorded during the 1
st
 and 30
th
 min, respectively. 
The average relative humidity was 56.6 ± 11.4 % over the 30 min. It appears the 
temperature profile within the cascade impactor is quite similar from three repeat runs. 
The three lines on the graph (see Figure 5.8) follow a similar patter, particularly from 
the 6
th
 min onwards, showing only slight variability in the temperature recorded. On the 
other hand, the relative humidity profile showed more variability. Two runs (runs 1 and 
3) showed a similar pattern, relative humidity rose sharply between 0 min to 
approximately the 5
th
 min, then rose slowly and remained constant to approximately the 
20
th
 min before rising again during the final 10 min. In contrast, the relative humidity 
readings recorded during run 2 showed a very different pattern. Firstly the overall 
average was lower at 42.6 % compared to 65.3 % and 62.0 % for runs 1 and 2, 
respectively. Here, relative humidity stayed constant until approximately the 4
th
 min, the 
decreased before peaking around the 8
th
 min. Relative humidity then decreased until the 
12
th
 min before remaining constant until the 30
th
 min. The variation observed during run 
2 may be due to differences in ambient conditions on that particular day of testing. 
Relative humidity readings from run 2 were very different from runs 1 and 3; run 2 
appears to have been an anomaly. If relative humidity readings from run 2 were to be 
dismissed the average relative humidity from runs 1 and 3 would be 63.7 ± 2.3 %.  
 
 
 
 
 
 
168 
 
Figure 5.8 – Temperature and relative humidity within cascade impactor during nebulisation, drying and deposition of dry inoculum (n=3). 
Error bars represent the standard deviation. 
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5.3.2 Antimicrobial efficacy of copper alloy surfaces against a dried microbial 
inoculum 
 
The method described in section 5.2.2 was the final protocol developed for testing a 
dried microbial inoculum against test and control surfaces.  
 
5.3.2.1 S. aureus results 
Table 5.10 summarises the log10 reductions observed after 30 min, 60 min and 24 h 
exposure of dried S. aureus aerosols to copper alloy and stainless steel discs at [20°C-
40% RH]. Dry bacterial recovery from stainless steel over the three replicates averaged 
at 7.02 ± 0.28 log10 cfu/cm
2
 at 0 h. In contrast, recovery from copper alloy surfaces was 
1.61-1.85 log10 cfu/cm
2 
lower. Within 30 min at [20°C-40% RH] the log10 reductions 
presented by copper alloys were <1 log10. For CuDHP and CuNi10Fe1Mn the average 
log10 reductions at 30 min were less than the log10 reduction observed on stainless steel 
at the same time point. After 60 min incubation two copper alloys, CuDHP and 
CuZn30, presented a >1 log10 reduction. CuSn5 and CuNi10Fe1Mn showed lower log10 
reductions of 0.99 ± 0.07 and 0.73 ± 0.45, respectively. These reductions were greater 
than that presented by stainless steel at 60 min. After 24 h CuSn5 and CuNi10Fe1Mn 
displayed a >1 log10 reduction. CuDHP and CuZn30 showed continued antimicrobial 
activity but reductions remained >1 and <2 log10.
 
 
Data were analysed statistically using SPSS software. Data were transformed (natural 
log + 1) and analysed by a General Linear Model. There were significant differences 
between all copper alloy surfaces and stainless steel (P<0.001). CuSn5 was significantly 
different to all other copper alloys (P<0.001). There was no significant difference 
between CuDHP and CuZn30 (P>0.999), CuDHP and CuNi10Fe1Mn (P=0.771) and 
CuZn30 and CuNi10Fe1Mn (P=0.817). Overall, there were significant differences 
between all time points (P<0.001).  
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Table 5.10 - Recovery at 0 h and log10 reductions of a dried S. aureus inoculum after 30 min, 60 min and 24 h incubation at [20°C-40% RH] 
(n=3) 
  
Stainless steel 
Log10 cfu/cm
2
 
CuSn5  
Log10 cfu/cm
2
 
CuDHP  
Log10 cfu/cm
2
 
CuZn30  
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h 7.02 ± 0.28 5.20 ± 0.50 5.37 ± 0.40 5.41 ± 0.15 5.17 ± 0.21 
Log10 reductions 
   
30 min 0.45 ± 0.13 0.53 ± 0.09 0.34 ± 0.20 0.43 ± 0.40 0.33 ± 0.22 
60 min 0.56 ± 0.19 0.99 ± 0.07 1.24 ± 0.20 1.19 ± 0.28 0.73 ± 0.45 
24 h 0.70 ± 0.38 1.29 ± 0.11 1.67 ± 0.21 1.80 ± 0.22 1.59 ± 0.10 
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5.3.2.2 A. baumannii results 
Table 5.11 shows the log10 reductions observed after exposure of A. baumannii dried 
inoculum to stainless steel and copper alloy surfaces. Recovery of dried inoculum from 
stainless steel averaged 5.28 ± 0.25 log10 cfu/cm
2
 at 0 h. Recovery from copper alloy 
surfaces was lower ranging from 3.38 ± 0.03 to 4.07 ± 0.23 log10 cfu/cm
2 
at 0 h. After 
30 min there was little additional antimicrobial activity by copper; all four alloys 
presented a <1 log10 reduction. The reduction observed on stainless steel after 30 min 
was lower than on the copper alloys, although the standard deviation was high. After 60 
min CuDHP presented the highest log10 reduction. The average log10 reduction by 
CuZn30 remained constant after 60 min. The log10 reduction for CuNi10Fe1Mn and 
CuSn5 remained <1 log10 after 60 min. The stainless steel log10 reduction of 0.59 ± 0.75 
at 60 min was lower than all copper alloys except for that of CuSn5. After 24 h all 
copper alloys presented a >1 log10 reduction. CuDHP presented the greatest reduction 
(1.46 ± 0.59 cfu/cm
2
) and CuSn5 the lowest (1.01 ± 0.38 cfu/cm
2
). The log10 reduction 
on stainless steel after 24 h was lower than on all copper alloys but the high standard 
deviation shows the variability in data obtained across the replicates. 
 
Data were transformed (natural log + 1) and analysed by a General Linear Model using 
SPSS software. There were significant differences between all copper alloys and 
stainless steel (P<0.001). CuNi10Fe1Mn was significantly different to all other copper 
alloys (CuSn5 P<0.001, CuDHP P<0.001 and CuZn30 P=0.011). There was no 
significant difference between CuSn5 and CuDHP (P=0.996), CuSn5 and CuZn30 
(P=0.302) and CuDHP and CuZn30 (P=0.149). There were significant differences 
between all time points (P<0.001) except between 30 min and 60 min (P=0.639).  
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Table 5.11 - Recovery at 0 h and log10 reductions of a dried A. baumannii inoculum after 30 min, 60 min and 24 h incubation at [20°C-40% RH] 
(n=3) 
  
Stainless steel 
Log10 cfu/cm
2
 
CuSn5  
Log10 cfu/cm
2
 
CuDHP  
Log10 cfu/cm
2
 
CuZn30  
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h 5.28 ± 0.25 3.38 ± 0.03 3.67 ± 0.67 3.83 ± 0.39 4.07 ± 0.23 
Log10 reductions    
30 min 0.39 ± 0.72 0.48 ± 0.34 0.75 ± 0.11 0.90 ± 0.15 0.52 ± 0.47 
60 min 0.59 ± 0.75 0.38 ± 0.11 1.03 ± 0.44 0.90 ± 0.25 0.64 ± 0.10 
24 h 0.99 ± 0.93 1.01 ± 0.38 1.46 ± 0.59 1.29 ± 0.05 1.44 ± 0.25 
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5.3.3 Antimicrobial efficacy of copper alloy surfaces against a dry microbial 
inoculum using an existing test method 
 
5.3.3.1 Results 
The dry inoculum test method described by Warnes and Keevil (2011) was modified 
and carried out. Within 30 min all copper alloy surfaces presented a >4 log10 cfu/cm
2 
reduction in bacteria after incubation at [20°C-40% RH]. Two surfaces, CuSn5 and 
CuDHP, presented a >5 log10 cfu/cm
2
 reduction after 30 min.  After 24 h incubation all 
surfaces showed a >5 log10 cfu/cm
2 
reduction. The stainless steel count only decreased 
by 0.79 ± 0.23 log10 cfu/cm
2
 after 24 h (see Table 5.12) 
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Table 5.12 – Recovery of dry S. aureus from low volume inoculum at 0 h and log10 reductions after 30 min, 60 min and 24 h incubation at 
[20°C-40% RH] (n=3) 
 
Stainless steel 
Log10 cfu/cm
2
 
CuSn5  
Log10 cfu/cm
2
 
CuDHP  
Log10 cfu/cm
2
 
CuZn30  
Log10 cfu/cm
2
 
CuNi10Fe1Mn 
Log10 cfu/cm
2
 
0 h 6.96 ± 0.17 6.50 ± 0.31 6.60 ± 0.09 6.14 ± 0.45 6.85 ± 0.04 
Log10 reductions 
   
30 min 0.51 ± 0.06 > 5.66 ± 0.00 5.33 ± 0.74 4.77 ± 0.92 4.41 ± 0.79 
60 min 0.50 ± 0.17 > 5.66 ± 0.00 5.76 ± 0.00 4.72 ± 0.50 5.30 ± 0.21 
24 h 0.79 ± 0.23 > 5.66 ± 0.00 5.76 ± 0.00 5.30 ± 0.00 5.28 ± 0.68 
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5.3.3.2 Temperature and relative humidity conditions of test 
Figure 5.9 shows the temperature and relative humidity conditions of Warnes and 
Keevil’s (2011) dry inoculum surface efficacy test. Surfaces were inoculated with 1 µL 
bacterial suspension at 1.5 min and the relative humidity and temperature probe was 
removed at 6.5 min after 5 min of logging data. Despite variations between triplicate 
results it appears that relative humidity increased upon surface inoculation. At the 
inoculation time point (1.5 min) the average relative humidity of the three surfaces was 
57.6 ± 2.4 %. Within 30 sec it increased to 66.9 ± 11.2 %. Over the 5 min recording 
period the average relative humidity was 74.7 ± 7.9 %. In terms of temperature, a small 
decrease was apparent upon surface inoculation. At the inoculation time point (1.5 min) 
the temperature was 24.6 ± 0.5 °C. During the 5 min recording period the temperature 
decreased slightly to 24.1 ± 0.5 °C. 
 
 
 
 
 
 
 
 
 
 
176 
 
Figure 5.9 – Temperature and relative humidity of surfaces following inoculation of 1 µL bacterial suspension. Error bars represent the standard 
deviation 
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5.3.4 FACS analysis of dry microbial inocula exposed to test and control surfaces 
 
Data were analysed using FACS BD software. For each repeat a sample of bacterial 
cells recovered from surfaces and stained with the appropriate dyes was placed in the 
FACS machine. 10,000 events were recorded and a plot of forward scatter against side 
scatter was produced. Within this plot the area of highest intensity was gated for cells 
only to eliminate any small debris particles from any analysis. This gating was then 
applied for subsequent samples to select cells for FACS analysis. Despite setting the 
FACS machine to record 10,000 events, the actual number of cells counted per sample 
was less than this. This may be due to there being less than 10,000 events to count, or 
due to cells falling outside the gated area set previously, since removing any 
background noise was likely to decrease the number of events. The numbers of events 
recorded per sample are shown next to each FACS plot (see Appendix 2a, Figures 1-8).  
 
5.3.4.1 Division of FACS plots into quadrants 
 
Plots were produced for each dye combination tested. Figure 5.10 is a template of a PI 
vs. BOX plot. The lower-left quadrant represents ‘healthy’ cells (PI-BOX-) with an 
intact membrane and membrane potential. Cells in the upper-left quadrant have an intact 
membrane but interrupted membrane potential (PI
-
BOX
+
). The upper-right quadrant 
represents ‘damaged’ cells since they have a disrupted membrane and membrane 
potential (PI
+
BOX
+
). Cells in the lower-right quadrant (PI
+
BOX
-
) signify a disrupted 
membrane but maintained membrane potential. 
 
 
 
 
 
 
 
 
 
178 
 
Figure 5.10 – PI vs. BOX plot template 
 
 
 
 
 
A positive control was used to aid the division of FACS plots into quadrants. The 
arbitrary separation of plots into quadrants provided an indication of the state of cells 
(i.e. healthy or damaged) according to their fluorescence profile based on the dyes 
utilised. This aided analysis of data. Ethanol was utilised as a control for PI and BOX 
stained cells.  
 
Figure 5.11 shows the effect of ethanol treatment on S. aureus; cells shifted from the 
lower-left, healthy cells quadrant (Figure 5.11a) to the upper-right, damaged cells 
quadrant (Figure 5.11b).  Cells with no treatment were 76.5 % healthy but after ethanol 
treatment for 10 min 96.8 % were damaged.  
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Figure 5.11 – Example of separation of quadrants based on ethanol treatment of S. 
aureus subsequently stained with PI and BOX 
 
a) no treatment   b) ethanol treatment 
 
 
 
 
 
 
 
 
 
Figure 5.12 shows the effect of ethanol treatment on A. baumannii. 85.6 % of cells with 
no treatment were in the lower-left, healthy cells quadrant (Figure 5.12a). After ethanol 
treatment (10 min) 99.3 % of cells were in the upper-right, damaged cells quadrant 
(Figure 5.12b).   
 
Figure 5.12 – Example of separation of quadrants based on ethanol treatment of A. 
baumannii subsequently stained with PI and BOX 
 
a) no treatment   b) ethanol treatment 
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Figure 5.13 is a template of a CTC vs. SYTO9 plot. The lower-left quadrant (CTC
-
SYTO9
-) represents ‘damaged’ cells; cells negative for both CTC and SYTO9, 
suggesting respiration and DNA integrity are compromised. The upper-left quadrant 
(CTC
+
SYTO9
-
) indicates respiring cells with DNA damage. Cells represented in the 
upper-right quadrant (CTC
+
SYTO9
+) are ‘healthy’ as they are respiring and their DNA 
is intact. Finally, cells in the lower-right quadrant (CTC
-
SYTO9
+
) have intact DNA but 
are not respiring. 
 
Positive controls were also used to help the separation of FACS plots into quadrants. 
Ethanol was utilised as a control. H2O2 and heat shock were also tested but did not 
provide sufficient damage to be utilised as positive controls. 
 
Figure 5.13 – CTC vs. BOX plot template 
     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14 shows the shift of cells from the upper-right, healthy cells quadrant to the 
lower-left, damaged cells quadrant after 10 min ethanol treatment of S. aureus. 99.7 % 
of cells (no treatment) were in the upper-right quadrant (Figure 5.14a). Exposure to 
ethanol resulted in 15 % of cells being placed in the lower-left quadrant (Figure 5.14b).  
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Figure 5.14 – Example of separation of quadrants based on ethanol treatment of S. 
aureus subsequently stained with CTC and SYTO9 
 
a) no treatment    b) ethanol treatment 
 
 
 
 
 
 
 
 
 
Figure 5.15 also shows the shift of cells from the upper-right, healthy to lower-left, 
damaged quadrant following ethanol treatment. In Figure 5.15a 100 % of cells are 
healthy. After ethanol treatment for 10 min 59.8 % of cells are damaged (Figure 5.15b).  
 
Figure 5.15 – Example of separation of quadrants based on ethanol treatment of A. 
baumannii subsequently stained with CTC and SYTO9 
 
a) no treatment    b) ethanol treatment 
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5.3.4.2 FACS results 
Results presented and analysed in this section are from a combination of the two repeats 
carried out. For each surface, time point and dye combination the average percentage of 
cells in each FACS plot quadrant was calculated. All FACS plots are shown in 
Appendix 2a. Tables 5.13 – 5.16 show the average percentage of healthy and damaged 
cells for each bacterial strain and dye combination. For raw data from each repeat see 
Appendix 2b, Tables 1 - 4. 
 
Data were analysed statistically by a chi-squared test using SPSS software. The test 
looked for a relationship between surfaces and the physiological state of cells (i.e. 
healthy or damaged). For PI and BOX stained cells those showing only a collapsed 
membrane potential were not analysed statistically; only healthy or completely damaged 
cells were. It is worth noting that overall data between repeats 1 and 2 showed great 
variability. Average percentages are highlighted (with a *) when repeats 1 and 2 values 
displayed variability (Tables 5.13 – 5.16). Since only two repeats were performed and 
variability between results was evident, results from the statistical analysis of data need 
to be approached with caution. 
 
5.3.4.2.1 S. aureus results 
 
Table 5.13 shows the average percentage of healthy (membrane intact, membrane 
potential unaffected, damaged (membrane damaged and collapsed membrane potential) 
and collapsed membrane potential cells from PI and BOX staining of dried S. aureus 
inoculum exposed to stainless steel, CuSn5 and CuZn30 at 0 h and then for 24 h at 
[20°C-40% RH]. From the two repeats the average values show an increase in the 
percentage of damaged cells over 24 h for all surfaces; although this increase was small 
(<10 %). The percentage of damaged cells was greater at both 0 h and 24 h on copper 
alloy surfaces than on stainless steel. For stainless steel and CuSn5 the percentage of PI
-
BOX
+
 cells was mostly unchanged. For CuSn5 at both 0 h and 24 h there were large 
differences between repeats 1 and 2, as indicated by the asterisk.  
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Table 5.13 – Summary of S. aureus PI and BOX results 
Surface and time 
PI
-
BOX
-
 
(healthy) 
(% of cells) 
PI
+
BOX
+
 
(damaged) 
(% of cells) 
PI
-
BOX
+
  
(collapsed membrane 
potential) (% of cells) 
SS 0 h 50.0 22.5 34.3* 
SS 24 h 46.9 27.0 34.8 
CuSn5 0 h 30.1* 42.0* 26.2 
CuSn5 24 h 23.3* 48.3* 20.5 
CuZn30 0 h 34.9 35.0 27.1 
CuZn30 24 h 35.4 43.2 13.8 
 
At 0 h there was a significant relationship between surface and the effect on membrane 
damage (combined membrane damage and collapsed membrane potential) (chi squared 
with two degrees of freedom = 12.599, P=0.002). At 24 h there was also a significant 
association between surface and membrane damage (combined membrane damage and 
collapsed membrane potential), (chi-squared with two degrees of freedom = 14.320, 
P=0.001). 
 
Table 5.14 shows the average percentage of healthy (unaffected cellular respiration, 
DNA intact) and damaged (arrested cellular respiration, DNA damaged) cells from CTC 
and SYTO9 staining of dried S. aureus inoculum exposed to stainless steel, CuSn5 and 
CuZn30 at 0 h and then for 24 h at [20°C-40% RH]. It is apparent that there was great 
variation between repeats 1 and 2; many average values are labelled with an asterisk to 
signify this. The percentage of healthy cells remained constant on the copper alloys but 
increased on stainless steel over 24 h. In turn, the percentage of damaged cells on the 
copper alloys remained unchanged and decreased on stainless steel over 24 h. The 
highest percentage of damaged cells at 24 h was on CuSn5 and the lowest on stainless 
steel.  
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Table 5.14 – Summary of S. aureus CTC and SYTO9 results 
Surface and time 
CTC
+
SYTO9
+
 
(healthy) 
CTC
-
SYTO9
- 
(damaged) 
(% of cells) (% of cells) 
SS 0 h 50.9* 42.4* 
SS 24 h 79.0 15.7* 
CuSn5 0 h 62.7* 34.6* 
CuSn5 24 h 62.8* 32.0* 
CuZn30 0 h 67.6* 31.6* 
CuZn30 24 h 70.0* 26.5* 
 
There was no significant association between surface and the effect on DNA and 
cellular respiration at 0 h (chi squared with two degrees of freedom = 3.755, P=0.153). 
Conversely, at 24 h there was a significant relationship between surface and the state of 
cells (chi-squared with two degrees of freedom = 7.200, P=0.027). 
 
5.3.4.2.2 A. baumannii results 
 
Table 5.15 shows the average percentage of healthy, damaged and membrane potential 
collapsed cells from PI and BOX staining of dried A. baumannii inoculum exposed to 
stainless steel, CuSn5 and CuNi10Fe1Mn at 0 h and then for 24 h at [20°C-40% RH]. 
The percentage of healthy and collapsed membrane potential cells decreased after 24 h 
for all surfaces. This resulted in an increased in the percentage of damaged cells on all 
surfaces over 24 h. At 24 h the percentage of damaged cells were similar on all surfaces 
ranging from 50.1 – 59.5 %; the lowest from CuNi10Fe1Mn and the greatest from 
stainless steel. All surfaces presented variable results between repeats 1 and 2, as 
indicated by the asterisks next to average percentage values.  
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Table 5.15 – Summary of A. baumannii PI and BOX results 
Surface and time 
PI
-
BOX
-
 
(healthy)  
(% of cells) 
PI
+
BOX
+
 
(damaged) 
(% of cells) 
PI
-
BOX
+
  
(collapsed membrane 
potential) (% of cells) 
SS 0 h 30.9 17.1 24.3* 
SS 24  7.2 59.5 21.2* 
CuSn5 0 h 18.7* 33.8* 22.6* 
CuSn5 24 h 9.6* 58.6* 1.1 
CuNi10Fe1Mn 0 h 30.7 31.4* 26.4* 
CuNi10Fe1Mn 24 h 24.2 50.1* 3.1 
 
At both 0 h and 24 h there were significant relationships between surface and the effect 
on membrane damage (membrane damage and collapsed membrane potential). At 0 h; 
chi-squared with two degrees of freedom = 8.323, P=0.016. At 24 h; chi-squared with 
two degrees of freedom = 12.472, P=0.002). 
 
The average percentage of healthy and damaged cells from CTC and SYTO9 staining of 
dried A. baumannii inoculum exposed to stainless steel, CuSn5 and CuNi10Fe1Mn at 0 
h and then for 24 h at [20°C-40% RH] are shown in Table 5.16. The percentage of 
healthy and damaged cells at both 0 h and 24 h were very similar for CuNi10Fe1mN. 
The percentage of healthy cells increased after 24 h on stainless steel and CuSn5; 
CuSn5 presented the greatest increase. At 24 h the greatest damage was observed on 
stained cells exposed to CuNi10Fe1Mn and the least damage on CuSn5. Variable results 
between repeats 1 and 2 were apparent for stainless steel at 0 h and 24 h and for CuSn5 
at 0 h (as noted by the asterisks).  
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Table 5.16 – Summary of A. baumannii CTC and SYTO9 results 
Surface and time 
CTC
+
SYTO9
+ 
(healthy) 
CTC
-
SYTO9
- 
(damaged) 
(% of cells) (% of cells) 
SS 0 h 48.9* 50.4* 
SS 24 h 59.9* 38.6* 
CuSn5 0 h 44.6* 55.0* 
CuSn5 24 h 68.9 29.2 
CuNi10Fe1Mn 0 h 29.5 69.5 
CuNi10Fe1Mn 24 h 28.7 68.1 
 
At 0 h there was a significant association between surface and the effect on DNA 
damage and arrested cellular respiration (chi-squared with two degrees of freedom = 
8.560, P=0.014). At 24 h there was also a significant relationship between surface and 
the effect on DNA and cellular respiration (chi-squared with two degrees of freedom = 
35.011, P<0.001).  
 
5.3.5 Relative humidity of surfaces following hand-touch 
 
Eight participants were asked to hold a Sl54TH probe that measured relative humidity 
every 30 sec. The probe was used to represent a person touching a surface in real-life. 
Figure 5.16 shows the average relative humidity profile from three probes handled by 
each participant. At 0 sec the probes were issued to start logging data. At 30 sec 
participants held the probe and at 90 sec they released the probe. It is apparent that for 
each probe between 0 sec and 30 sec (before hand-touch) relative humidity remained 
constant. Between 30 sec and 60 sec there was an increase of between 7.9 - 19 % in 
relative humidity. During the next 30 sec interval relative humidity increased slightly. 
Finally, during the last 30 sec (after hand-touch), relative humidity decreased.  Overall, 
at the 60 sec time point (half-way point of hand contact) the highest relative humidity 
recorded by all participants was 93.4 % and the lowest was 61.4 %. The average relative 
humidity at 60 sec was 71.2 ± 10.0 %.  
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Figure 5.16 – Relative humidity of surfaces before, during and after hand-touch.  
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5.4 Discussion 
 
There is a need for a standard test to assess the antimicrobial activity of surfaces against 
a dried microbial inoculum to simulate touch contamination in the healthcare setting 
under in-use conditions. Several protocols were employed in this chapter to develop 
such a method. The use of a nebuliser to generate aerosols that were subsequently dried 
and deposited was the method of choice for presenting a dry inoculum on to surfaces. 
This method was validated and provided a novel way of testing the antimicrobial 
efficacy of a dry inoculum deposited on to a surface. Due to the inactivity of copper 
alloys against a wet inoculum of B. subtilis spores (see Chapter 4, section 4.3.3.3) and 
the slow activity presented against dried inocula of S. aureus and A. baumannii, it was 
decided not to test copper against dry B. subtilis spores. It is highly likely copper would 
present no antimicrobial activity against the highly resistant nature of spores. 
 
In this study the antimicrobial activity of copper against a dry inoculum was slow 
compared to the activity observed against a wet inoculum described in Chapter 4.  A <2 
log10 reduction in both S. aureus and A. baumannii after 24 h exposure at [20°C-40% 
RH] was observed. Despite a potential loss of almost 2 log10 through nebulisation as a 
copper effect, the overall effect due to copper was still much lower than that achieved 
by Santo et al. (2008) or Warnes and Keevil (2011), who observed very rapid action by 
copper using their respective dry surface test methods. Santo et al. (2008) observed a 9 
log10 reduction within 1 min against E. coli, and Warnes and Keevil (2011) saw a 6 
log10 reduction of VRE in less than 10 min. It could be argued that both of these were 
not strict ‘dry’ inoculum surface tests; Santo et al. (2008) presented the inoculum on to 
surfaces via a moistened swab, and Warnes and Keevil (2011) as a 1 µL drop. In both 
cases the initial inoculum presented on to the surface is wet, despite drying in a matter 
of seconds, whereas the inoculum presented on to surfaces in the new method 
developed in this chapter was dry. Their results may suggest that the initial wet contact 
between the inoculum and the copper surface is crucial for fast-acting antimicrobial 
action, something that was not observed in this study. Thus, the test developed in this 
chapter is a genuine ‘dry’ surface efficacy test. 
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The low volume inoculum test method by Warnes and Keevil (2011) was carried out in 
this study and based on their results, the results against the four copper alloys tested 
here were not surprising; >4 log10 reductions were observed after 30 min at [20°C-40 
RH%]. This is in agreement with Warnes and Keevil’s (2011) findings, who observed 
quick antimicrobial activity, although a direct comparison of results cannot be made due 
to differing contact times and incubation conditions. In comparison to the dry inoculum 
test method developed in this chapter, Warnes and Keevil’s (2011) method was tested 
and demonstrated greater activity by all four copper alloys. Interestingly, in contrast to 
the wet inoculum test method in Chapter 4, all four copper surfaces performed better 
against a low volume, high concentration inoculum than against microbial aerosols 
under the same conditions (see Chapter 4, section 4.3.3.1).  
 
Despite the low antimicrobial activity by copper, there was an obvious difference 
between the amount of dry inocula (for both S. aureus and A. baumannii) recovered 
from stainless steel and from the four copper alloys at 0 h. For S. aureus the amount 
recovered from stainless steel was 7.02 ± 0.28 log10 cfu/cm
2
 compared to a range of 
5.17 ± 0.21 to 5.41 ± 0.15 log10 cfu/cm
2
 from copper alloy surfaces. Interestingly, for A. 
baumannii, the amount recovered from both stainless steel and the copper alloys was 
lower. The amount recovered from stainless steel averaged 5.28 ± 0.25 log10 cfu/cm
2
 
and was even lower on the copper alloys, ranging from 3.38 ± 0.03 to 4.07 ± 0.23 log10 
cfu/cm
2
.  These low initial counts could possibly be due to cell aggregation or perhaps 
A. baumannii was more susceptible to drying. Monitoring of temperature and relative 
humidity conditions within the cascade impactor during the 30 min nebulisation period 
showed average readings of 34.0 ± 1.2 °C and 56.6 ± 11.4 %, respectively. It could be 
hypothesised that the high temperature and high relative humidity observed within the 
cascade impactor may have increased copper’s antimicrobial activity, which may 
possibly have contributed to differences in the 0 h counts between stainless steel and the 
copper alloy surfaces. Inside the cascade impactor the average temperature and relative 
humidity recorded were higher than the conditions ([20°C -40% RH]) that surfaces were 
subsequently exposed to when assessing antimicrobial activity at varying contact times. 
Coupled with the high temperatures nebulised particles pass through (through the 
stainless steel tube) during the drying process, these conditions were likely to damage 
some cells thus potentially making them more sensitive to antimicrobial copper. It is 
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worth noting that the conditions within the cascade impactor during the 30 min 
nebulisation period were lower than that during the inoculation of surfaces using 
Warnes and Keevil’s (2011) dry inoculum method.  Over the 5 min recording period of 
Warnes and Keevil’s (2011) test method the average relative humidity on surfaces was 
74.7 ± 7.9 %. However, since the recording probes were only capable of taking 
measurements every 30 sec it was difficult to ascertain the exact conditions between the 
point of surface inoculation and the 5 s drying period. The differences in relative 
humidity between the test developed in this chapter (both during inoculum deposition 
and subsequent incubation conditions) and Warnes and Keevil’s (2011) test may 
possibly have contributed to the differences in antimicrobial activity observed between 
the two methods. 
 
Since only a >1 log10 reduction was achieved by all copper alloys against S. aureus and 
A. baumannii, FACS analysis was carried out to understand copper’s antimicrobial 
activity in a dry state or whether simply drying of microorganisms in the experimental 
set-up resulted in reductions in viable bacteria. Warnes and Keevil (2011) suggest DNA 
damage and arrested cell respiration are the initial stages of cell death, followed by 
membrane damage in Gram-positive bacteria, whereas membrane depolarisation was 
observed before DNA damage in Gram-negative bacteria (Warnes et al., 2012). This 
agrees with findings by Santo et al. (2008) who also observed membrane damage to be 
the first stage of cell death in E. coli. These studies suggest bacterial morphology 
influences the mechanism of action of copper.  
 
In this study the aim of FACS analysis was geared more towards the role of desiccation 
and to find out if copper was antimicrobial against dried microbial inocula, rather than 
investigating the sequence of events that lead to cell death. FACS experiments were 
carried out in duplicate for both S. aureus and A. baumannii. Unfortunately, results did 
not provide a clear explanation of the exact mechanism of action of copper due to 
variability between repeats for each microorganism. It was apparent that the drying 
process had an effect on the nebulised bacterial suspension; membrane damage, arrested 
bacterial respiration and DNA damage were all evident at 0 h on all surfaces. The level 
of damage during the drying process can be assessed by looking at the percentage of 
damaged cells on stainless steel at 0 h. The highest average percentage of membrane 
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damaged cells was 22.5 % and the highest average percentage of DNA 
damaged/arrested cellular respiration cells was 50.4 %. However, once the effect of 
drying was teased out, using stainless steel 0 h results, it was possible to assess the 
activity of copper. In addition, the percentage of damaged cells at 24 h on copper alloys 
vs. the percentage of damaged cells at 24 h on stainless steel provided an indication, if 
any, of antimicrobial activity by copper. 
 
Taking into account average results from repeats 1 and 2 it is likely that exposure of S. 
aureus dried inoculum to copper alloys resulted in loss of membrane integrity and a 
collapsed membrane potential after 24 h at [20°C-40% RH]. Despite all surfaces 
showing an increase in the average percentage of damaged cells after 24 h, the average 
percentage of damaged cells from copper alloys were greater than stainless steel, 
probably due to the antimicrobial properties of copper. The effect of copper on bacterial 
respiration and DNA integrity was perhaps limited; the percentage of damaged cells at 0 
h and 24 h was lower than the percentage of healthy cells. However, damage at 24 h 
was greater on copper alloys than on stainless steel, which might imply some 
antimicrobial activity by copper.  
 
Exposure of dried A. baumannii to stainless steel and copper alloy surfaces showed an 
increase in cells showing membrane damage after 24 h. As the average percentage of 
damaged cells was similar on stainless steel and on the copper alloy surfaces at 24 h it 
cannot be concluded that copper alone resulted in membrane damage. It should be noted 
that for this experiment variability between repeats was high for the majority of surfaces 
and time points. In terms of the effect of copper on bacterial respiration and DNA 
integrity, it is likely that copper did have an antimicrobial effect.  Whilst the average 
percentage of damaged cells was greater on stainless steel than on CuSn5 at 24 h, the 
average percentage of damaged cells on CuNi10Fe1Mn was even greater. The 
antimicrobial activity of CuNi10Fe1Mn was apparent once the effect of drying on cells 
was teased out.  
 
Statistical analysis to look for associations between surfaces and the percentage of 
healthy and damaged cells showed a significant relationship for all bacterial strains, dye 
combinations and time points (except S. aureus, CTC-SYTO9, 0 h). However, due to 
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the variability between repeats 1 and 2, the statistical analysis must be taken with 
caution.  
 
Keevil and co-workers observed membrane depolarisation, DNA damage and arrested 
cellular respiration in terms of the mechanism of action of copper (Warnes and Keevil, 
2011; Warnes et al., 2012). Some individual results from the FACS work carried out in 
this study agreed with Keevil and co-worker’s findings (results in this study assessed 
complete membrane damage as well as membrane depolarisation). These are shown in 
Table 5.17 (see Appendix 2 for complete data set). Loss of membrane integrity and a 
collapsed membrane potential are apparent in S. aureus and A. baumannii. Arrested 
bacterial respiration and DNA damage by copper were also evident in A. baumannii. 
For all of the examples shown in Table 5.17 there was an increase in damaged cells 
after 24 h and the damage was greater than that observed on stainless steel at the same 
time point (see Appendix 2b, Tables 1-4). 
 
Table 5.17 – Individual FACS results showing loss of membrane integrity and a 
collapsed membrane potential (PI-BOX staining) and DNA damage and arrested 
respiration (CTC-SYTO9 staining) by copper alloys  
Microorganism Surface and time 
Dye 
combination 
Repeat 
% 
healthy 
cells 
% 
damaged 
cells 
S. aureus CuSn5 0 h PI-BOX 2 55.7 15.4 
 
CuSn5 24 h PI-BOX 2 24.3 51.9 
S. aureus CuZn30 0 h PI-BOX 2 60.2 14.4 
 
CuZn30 24 h PI-BOX 2 46.1 39.4 
A. baumannii CuSn5 0 h PI-BOX 2 2.3 54.5 
 
CuSn5 24 h PI-BOX 2 3.2 94.8 
A. baumannii CuNi10Fe1Mn 0 h PI-BOX 2 20.1 55 
 
CuNi10Fe1Mn 24 h PI-BOX 2 16.5 74.3 
A. baumannii CuNi10Fe1Mn 0 h CTC-SYTO9 1 38.7 59.6 
 
CuNi10Fe1Mn 24 h CTC-SYTO9 1 20.4 74.9 
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A limitation of the FACS work presented here was that only two repeats were 
performed. Additional repeats would be necessary to fully understand the mechanism of 
action of copper against a dried microbial inoculum. Some variability in the results 
might have been generated from the arbitrary separation of FACS plots into four 
separate quadrants based on the use of a positive control. Although ethanol worked well 
when used with PI and BOX, it was clear that ethanol was not an ideal positive control 
for CTC and SYTO9 (see Appendix 2a, Figure 6d). The FACS protocol would benefit 
from optimisation of the positive control. 
 
Despite the potential for cell damage during the test set-up, both S. aureus and A. 
baumannii were still viable after 24 h on all copper alloys as shown by low log10 
reductions. This implies copper alloy surfaces do not provide quick kill against a dry 
inoculum. This also brings in the important question of whether wet contact between an 
inoculum and copper-containing surface is vital for antimicrobial activity.  The results 
from this study suggest a liquid interface is crucial. The small investigation in this study 
to see the effect of hand-touch on the relative humidity of surfaces showed relative 
humidity increased upon contact. However, it is worth noting that the length of contact 
was exaggerated during this study. In practice, contact is likely to be variable depending 
on the surface, its use and how frequently it is touched. In turn, this may influence any 
changes in relative humidity due to hand contact and consequently the antimicrobial 
activity of surfaces.  
 
Upon contact with air copper oxidises to form copper oxide. There are very few studies 
assessing the effect of copper oxide formation on the antimicrobial efficacy of 
copper/copper alloy surfaces. Most investigations have focused on the efficacy of 
copper oxide nanoparticles. However, a study by Hans et al. (2013) found that found 
that CuO, which is the common copper oxide formed under wet conditions, was less 
antimicrobial against Enterococcus hirae than Cu2O that forms normally under dry, 
ambient conditions. Cu2O was found to be as efficacious as pure copper (however, this 
was with a wet inoculum). In terms of copper ion release from surfaces, the copper 
oxides released less ions than pure copper but of the two oxides, release was higher 
from Cu2O than CuO. They suggested the reason for high antimicrobial activity by 
Cu2O was due to the release of Cu
+
 ions, which are more antimicrobial than Cu
2+  
(Hans 
194 
 
et al., 2013). In a different study Santo et al. (2008) believed copper oxidation may have 
resulted in copper ion release from surfaces and the generation of reactive oxidative 
species, in particular hydroxyl radicals, which led to cell toxicity in E. coli. These 
findings were observed with the previously described dry inoculum method developed 
by Santo et al. (2008).   
 
To conclude, a novel method for presenting a dry inoculum on to surfaces has been 
developed and validated. Culture and FACS analysis have shown evidence of copper 
toxicity against S. aureus and A. baumannii. FACS analysis did show that damage 
occurred during the drying process; however, once this effect was teased out the 
antimicrobial activity of copper was evident. Overall culture analysis showed a >90 % 
to <99 % in reduction in viable bacteria on copper over 24 h; a significant difference to 
stainless steel. Whilst FACS analysis did show cell damage by copper, culture work 
showed that this damage was not sufficient for complete kill. This study has highlighted 
the importance of testing the efficacy of surfaces against dried inocula to assess the 
performance of such surfaces for potential use in healthcare settings.  
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CHAPTER 6 GENERAL DISCUSSION 
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6.1 HCAI rates in the UK are decreasing but further exploration of control 
measures is required 
 
HCAIs are a continuous cause for concern for the NHS. Surveillance, both mandatory 
and voluntary, of certain bacteraemia cases including MRSA, C. difficile and A. 
baumannii has shown a general decrease in their number since their peak in the mid-
2000s. However, there is still a need to explore control measures; this will not only 
improve patient outcome but also decrease the heavy financial burden HCAIs pose to 
the NHS. Many national campaigns have targeted the role of hand hygiene to promote 
improved infection control; however, interestingly there has been no focus on the need 
to control the indirect infection routes via surfaces.  
 
The survival of microorganisms on surfaces is well documented and may act as a 
reservoir for the dissemination of HCAIs (Dancer, 2004; Kramer et al., 2006). 
Consequently, a number of antimicrobial surfaces have been commercialised that claim 
to reduce surface bioburden. The potential use of antimicrobial surfaces, primarily 
copper and copper alloys, has been extensively tested in the laboratory and numerous 
trials in clinical settings have been reported (Chapter 1, section 1.8.1). This study also 
focused on copper alloys. 
 
6.2 Is the JIS Z 2801 an appropriate antimicrobial surface efficacy test? 
 
This study first addressed whether the JIS Z 2801 test is an appropriate test for testing 
the efficacy of antimicrobial, hard surfaces. The high relative humidity (>90 %) and 
high temperature (35 °C) of the JIS Z 2801 are ideal for increasing the activity of any 
antimicrobial effect of surfaces as they allow maximum biocide diffusion. The JIS Z 
2801 test is thus an effective first-tier screening test, to determine any antimicrobial 
activity in optimal environmental conditions. 
 
Sampling of high-touch surfaces over a one year period at a UK hospital in three areas 
(gastroenterology, ACC and theatre) showed a surface relative humidity range of 30.4 – 
64.2 % and a surface temperature range of 18.2 – 26.8 °C. Significant differences in 
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surface relative humidity were observed between different sampling occasions; 
however, all surfaces sampled throughout the entire sampling period were not at risk of 
condensation. Thus, perhaps the variations in relative humidity may not be important 
practically. In addition, experiments in this study showed that the relative humidity of 
surfaces increased upon hand-touch. Sampling of surface bioburden in the three wards 
selected was performed at random; not directly after cleaning. The results showed 
varying bioburden levels, though not limited to microbial contamination, which adds to 
the potential usefulness of antimicrobial surfaces in clinical settings.   
 
Environmental sampling of surfaces in a UK hospital confirmed the relative humidity 
and temperature parameters of the JIS Z 2801 are not realistic; indoor conditions were 
much lower (Chapter 3, section 3.3). The lack of a current surface efficacy test standard 
that incorporates realistic parameters to simulate in-use conditions is a concern. In 
addition, surfaces are covered with a plastic film throughout the test to maintain high 
relative humidity (i.e. > 90%), thus surfaces remain wet; in practice a wet inoculum 
would dry well within 24 h. From this study and others it can be concluded that the JIS 
Z 2801 is not an appropriate test for screening the antimicrobial efficacy of surfaces for 
use in healthcare settings (Michels et al., 2009; Ojeil et al., 2013). It should only be 
used during product development to determine whether a surface might have some 
potential antimicrobial activity, but under no circumstances should it be used to support 
a claim for activity in the field (such as those listed in Table 6.1). 
 
Thus it appears important that these in vivo parameters are reflected in an efficacy test 
protocol. This led to the development of second-tier tests that utilise in-use conditions. 
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Table 6.1 – Examples of antimicrobial claims by companies based on JIS Z 2801 testing of antimicrobial surfaces/coatings  
Company Biocide Applications 
Antimicrobial 
claim 
Reference 
Corning 
Gorilla Glass 
Silver ion 
Glass doors and windows, 
protective screen cover glass 
(mobile phones, laptops, 
medical displays) 
> 99.9 % 
reduction 
Website 32, 2014 
Resco 
BioCote 
Silver 
Technology 
Laminate panel 
up to 99.99 %  
reduction 
Website 33, 2013 
SustainHygen Silver 
Coating for use in hospital 
patient areas, food 
manufacturing areas, assisted 
care facilities 
> 99.9 % 
reduction 
Website 34, publication date unavailable 
CuTouch Copper 
Healthcare furniture e.g door 
handles, bedrails, switches 
> 5 log 
reduction 
Website 35, 2012 
Lamitech 
Nano silver 
ions 
Laminate for use in hospitals, 
gyms, kitchens, bathrooms 
99.99 % 
reduction 
Website 36, publication date unavailable 
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6.3 Development of new antimicrobial surface efficacy tests to measure 
activity against microbial aerosols and dry microbial inocula 
 
It appeared logical to test the deposition of microbial contaminants following 
aerosolisation or as dried contaminants. Thus, the next aim of this study was to assess 
the antimicrobial activity of antimicrobial surfaces when exposed to microbial aerosols 
(wet inoculum) and a dry microbial inoculum. Two new surface efficacy tests were 
developed providing second-tier tests that incorporated more realistic parameters, based 
on those reflective of hospital conditions. It is crucial to develop antimicrobial surface 
efficacy tests for surfaces using parameters that simulate the intended environment (e.g. 
healthcare, food, public buildings, see Table 6.5) to confidently predict their efficacy. 
The two tests developed in this study were flexible; parameters can be easily changed 
according to the intended in-use conditions of surfaces thus making the tests suitable for 
a wide range of applications. 
 
Table 6.2 is a summary table that lists the pros and cons of some of the existing 
antimicrobial surface efficacy tests. This includes standards mentioned in Chapter 1 
section 1.11, current dry inoculum published methods and the two new antimicrobial 
surface efficacy tests developed in this study. 
 
The wet inoculum test developed was based on the exposure of microbial aerosols to 
test and control surfaces. The use of a nebuliser to produce aerosols aimed to mimic 
actions such as coughing, sneezing and flushing of toilets. Aerosols dried within 60 min 
at in-use conditions and were more realistic than the high volume inoculum of the JIS Z 
2801. The testing of surfaces against microbial aerosols under specific parameters 
reflecting in-use conditions allowed the distinction of activity between copper alloys. 
Activity was significantly reduced at in-use conditions compared to JIS Z 2801 test 
conditions, which highlighted the importance of testing surfaces under realistic 
parameters. In turn, this will allow for the better selection of surfaces for use in clinical 
areas. The test set-up was not as cheap as the JIS Z 2801 in terms of the equipment 
required; however, overall this new test is more appropriate for predicting the efficacy 
of antimicrobial surfaces in real-life settings.  
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The development of an antimicrobial surface efficacy test to incorporate a dry bacterial 
inoculum aimed to mimic hand-touch contamination. All existing antimicrobial surface 
efficacy tests, described in Chapter 1, sections 1.11.1 – 1.11.5, are based on the 
presentation of a wet inoculum to surfaces. It has been acknowledged that antimicrobial 
surface efficacy tests utilising a wet inoculum are not suffice to test for the potential 
efficacy of antimicrobial surfaces in clinical areas (Santo et al., 2008; Warnes and 
Keevil, 2011; Ojeil et al., 2013). The method developed in this study was unique and 
based on the presentation of a dried aerosol on to surfaces, compared to other attempts 
that utilise an initial low volume inoculum (see Table 6.2). Dry inoculum testing 
highlighted the difference between the activity of copper against wet and dry inocula; 
activity was slower and reduced against a dry inoculum. 
 
The drying process of the dry inoculum method inevitably caused some damage to 
bacterial cells (confirmed by FACS analysis of cells collected from test and control 
surfaces at 0 h); however, this did not hinder the ability to assess damage caused by 
copper. Another drawback of this new method was that a lot of equipment was required 
for the test set-up, some of which was expensive. 
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Table 6.2 – Table showing the pros and cons of antimicrobial surface efficacy tests 
Antimicrobial 
surface efficacy test 
Pros Cons Comments 
JIS Z 2801 (Japan) 
/ISO22196 
(International) 
 Quantitative 
 Ideal for screening 
surfaces – ‘proof of 
principle test’ 
 Simple, inexpensive set-
up 
 
 Incubation conditions (35 °C and >90 % relative 
humidity) not reflective of in-use conditions 
 Surfaces covered with a plastic film thus remain 
wet during entire incubation period – not reflective 
of practice 
 
 In this study all copper 
alloys presented a >4 
log10 reduction in S. 
aureus after 24 h 
ASTM E2180-01 
(USA) 
 Quantitative 
 Incorporates an artificial 
biofilm 
 Surfaces are incubated 
under temperatures 
suitable for test surfaces’ 
intended use  
 Surfaces incubated under humid conditions – may 
not reflect practice 
 
ASTM E2149-01 
(USA) 
 Quantitative 
 Dynamic contact test 
ideal for testing surfaces 
where prolonged wet 
contact is expected  
 Not appropriate for testing surfaces for use in 
healthcare settings 
 
XP G 39-010 
(France) 
 Quantitative  Surfaces are placed on an agar plate containing a 
specific volume of bacteria – not reflective of 
practice (e.g. healthcare setting) 
 Surfaces incubated under humid conditions at 37 °C 
– not reflective of in-use conditions  
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Table 6.2 continued - Table showing the pros and cons of antimicrobial surface efficacy tests 
Antimicrobial 
surface efficacy test 
Pros Cons Comments 
Santo et al.’s dry 
inoculum test (2008) 
 Quantitative 
 Simple 
 Cheap 
 Dry inoculum mimics 
hand-touch 
contamination 
 Initial inoculum presented to surfaces is wet 
but claimed to dry within 5 s 
 Santo et al. (2008) showed 9 
log10 E. coli reduction in 1 
min at 23 °C 
 
Warnes and Keevil’s 
dry inoculum test 
(2011) 
 Quantitative 
 Simple 
 Cheap 
 Dry inoculum mimics 
hand-touch 
contamination 
 Initial inoculum presented to surfaces is wet 
but claimed to dry within 5 s 
 Warnes and Keevil showed 
6 log10 VRE reduction in 10 
min 
 In this study, copper alloys 
presented a >4 log10 
reduction in S. aureus 
within 30 min at [20°C-40% 
RH] 
Wet inoculum test in 
this study (Chapter 
4) 
 Quantitative 
 Second-tier test to JIS Z 
2801 
 Use of microbial aerosols 
mimics coughing, 
sneezing etc. 
 Incubation parameters 
reflective of in-use 
conditions  
 Lot of equipment required 
 Set-up expensive 
 30 min deposition time required to deposit 
sufficient amount of bacteria on to surfaces 
 
 >4 log10 reduction in S. 
aureus within 30 min at 
[37°C-100% RH] 
At in-use conditions: 
 >4 log10 reduction in S. 
aureus within 60 min  
 >4 log10 reduction in A. 
baumannii in 30 min 
 <1 log10 reduction in B. 
subtilis spores after 24 h 
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Table 6.2 continued - Table showing the pros and cons of antimicrobial surface efficacy tests 
Antimicrobial surface 
efficacy test 
Pros Cons Comments 
Dry inoculum test in 
this study (Chapter 5) 
 Quantitative 
 Second-tier test to JIS Z 
2801 
 Inoculum deposited on to 
surfaces is visibly dry 
 Dry inoculum mimics 
hand-touch 
contamination 
 Incubation parameters 
reflective of in-use 
conditions 
 Lot of equipment required 
 Set-up expensive 
 Optimisation necessary to establish 
temperature sufficient enough to dry 
nebulised inoculum 
 30 min deposition time required to deposit 
sufficient amount of bacteria on to surfaces 
 Drying process likely to cause some damage 
to bacterial cells 
 >1 log10 reduction 
observed in S. aureus and 
A. baumannii within 60 
min at [20°C-40% RH] 
 >1 but <2 log10 reduction 
in S. aureus and A. 
baumannii after 24 h at 
[20°C-40% RH] 
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6.4 What are the key factors affecting the efficacy of antimicrobial surfaces? 
 
This study has naturally led to the understanding of the key factors that affect the 
activity of antimicrobial surfaces. Such factors taken into consideration in this study 
included temperature, relative humidity, contact time, the presentation of a wet or dry 
bacterial inoculum to surfaces, bacterial cell type, organic load and copper 
concentration. These factors and how they affect biocides and/or antimicrobial surface 
efficacy are introduced in Chapter 1, section 1.10. 
 
6.4.1 Temperature and relative humidity 
 
The effects of temperature and relative humidity on the efficacy of antimicrobial 
surfaces are described previously in Chapter 1, section 1.10.2 and Chapter 4, section 
4.1.5. In general, increased temperature and increased relative humidity favours 
increased antimicrobial surface activity (Grass et al., 2011). 
 
In this study it was apparent that copper alloys were more effective at the high 
temperature and relative humidity conditions of the JIS Z 2801 than at hospital in-use 
conditions, which were considerably lower. Indeed, significant differences in viability 
of S. aureus deposited aerosols between the different conditions suggested a higher 
temperature and relative humidity increased copper’s efficacy. Michels et al. (2009) did 
not observe a difference in copper’s efficacy under JIS Z 2801 conditions and under in-
use conditions, however, the only contact time tested was 24 h. On the other hand, other 
studies are in agreement with the findings from this study; increased temperature (room 
temperature compared to 4 °C) favoured increased antimicrobial copper activity (Noyce 
et al., 2006a; Elguindi et al., 2009). 
 
Copper alloy surfaces in this study were tested under conditions reflective of a UK 
hospital environment. It is important that when tests and ultimately standards are 
developed (e.g. British or European) that they incorporate test conditions that simulate 
in-use conditions for the targeted environment. For parameters such as surface 
temperature and relative humidity in hospital settings, variability between countries is 
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likely; therefore, a British standard would perhaps be more appropriate in the UK. For 
EU standard tests, differences in different country’s environmental conditions are 
usually incorporated into the standard on a worst case scenario. Therefore, an EU 
antimicrobial surface test would have to be based on the lowest relative humidity and 
temperature found in hospitals throughout Europe.  
 
6.4.2 Contact time 
 
In practice, antimicrobial surfaces differ from other biocides, such as liquid 
disinfectants, in that they provide continuous disinfection. However, generally, the 
longer the contact time between a biocide and a microorganism, the greater the 
antimicrobial efficacy (Maillard, 2005b).  
 
In this study, the overall general trend observed was that increased contact time 
correlated with increased microbial reduction for both wet and dry inocula, except for 
some surfaces against wet inocula of S. aureus and A. baumannii. In such instances 
complete kill was observed at the shortest contact time tested. 
 
6.4.3 Wet vs. dry bacterial inoculum 
 
Overall, the activity of copper alloy surfaces was reduced at in-use conditions when 
presented with a dry inoculum (<2 log10 after 24 h) compared to microbial aerosols (>4 
log10 after 24 h). It is likely that the wet contact between the inoculum and the copper 
alloy surfaces was crucial for fast antimicrobial activity; in fact the majority of 
antimicrobial activity by copper against microbial aerosols took place within 60 min 
whilst surfaces were still visibly wet. This is in contrast to Warnes and Keevil (2011), 
who found copper alloys were more efficacious against a dry rather than wet inoculum.  
However, Warnes and Keevil (2011) used different test microorganisms and wet and 
dry inoculum testing methods to those in this study. 
 
Whilst it could be argued that the log10 reductions presented by copper against a dry 
inoculum were low relative to a wet inoculum; in clinical trials copper alloys have 
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mostly only presented a 1 - 2 log10 reduction compared to standard fittings (Weber and 
Rutala, 2013). In real-life settings surface contamination is likely to be a mix of wet 
(e.g. aerosol) and dry contamination. 
 
6.4.4. Type of microorganism 
 
The Spaulding classification is a categorisation of surfaces, such as surgical and medical 
devices into critical, semi-critical and non-critical items. The classification also 
incorporates the subsequent minimum disinfection requirements per category. Critical 
items include those that make contact with a sterile area of the human body. Since these 
devises pose a high risk of infection it is advised that they are sterilised to kill all types 
of microorganisms present on a surface. Semi-critical items make contact with mucous 
membranes or broken skin, thus present a lower infection risk. High-level disinfection, 
sufficient to kill bacterial spores, mycobacteria and vegetative bacteria, is recommended 
for semi-critical devices. Finally, non-critical items pose the lowest risk since contact 
with intact skin is made. Low- or intermediate-level disinfection is recommended for 
such devices, which are not effective against bacterial spores. Intermediate-level 
disinfection is sufficient to kill mycobacteria and vegetative bacteria, whereas low-level 
disinfection is only suitable for vegetative bacteria (McDonnell and Burke, 2011). 
 
Nowadays a similar classification is utilised as outlined in Figure 6.1. The diagram 
shows that with increasing resistance of microorganisms to biocides, increasing 
sterilisation or disinfection is required. Important hospital pathogens, such as C. difficile 
spores, require high level disinfection. On the other hand other hospital pathogens such 
as Enterococcus and Staphylococcus require low-level disinfection. In the food 
industry, important microorganisms such as E. coli would also require low-level 
disinfection. 
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Figure 6.1 – Diagram showing the susceptibility profile of microorganisms to biocides 
and the level of disinfection required (adapted from McDonnell and Burke, 2011) 
 
 
 
This study has emphasised the highly resistant nature of bacterial spores to 
antimicrobials. B. subtilis spores were tested in the form of a wet inoculum as it was not 
possible to test C. difficile spores due to aggregation of spores, which resulted in uneven 
deposition of aerosols on to surfaces. Copper alloys did not present antimicrobial 
activity after 24 h against B. subtilis spores, in agreement with Santo et al. (2010), who 
showed Bacillus spores persisted and germinated on pure copper surfaces one month 
after exposure, whereas Bacillus vegetative cells were killed following less than 24 h 
exposure to copper. In addition, the fact that three of the four copper alloys tested in this 
study showed no significant differences between stainless steel perhaps indicates a 
limited role for copper as an effective sporicidal surface. 
 
At in-use conditions copper alloy surfaces were more efficacious against microbial 
aerosols of A. baumannii, a Gram-negative microorganism than of S. aureus, a Gram-
positive bacterium. This is unusual because Gram-positive bacteria are considered more 
sensitive to biocides, according to Figure 6.1. However, similar activity by copper 
alloys was observed against both microorganisms in the dried form. 
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6.4.5 Copper concentration 
 
It has widely been reported the greater the copper content of copper alloy surfaces, the 
greater the antimicrobial efficacy (Grass et al., 2011). In general, copper alloys 
containing between 55 - 100 % have shown significant antimicrobial efficacy 
(O'Gorman and Humphreys, 2012).  
 
In this study, at in-use conditions no significant differences were observed between 
copper alloy surfaces of ranging copper contents when presented with microbial 
aerosols of S. aureus and A. baumannii. When presented with S. aureus dried inoculum, 
CuSn5 (95 % Cu) was significantly different to all other alloys, however, this surface 
contained neither the highest nor lowest copper content of all four tested. Similarly, 
CuNi10Fe1Mn (86 – 89.7 % Cu) was significantly different to all other copper alloys 
after exposure to A. baumannii dried inoculum, however this alloy contained the second 
lowest copper concentration. Overall, there was no apparent link between copper 
concentration and antimicrobial efficacy, which agrees with findings by Elguindi et al. 
(2009) but disagrees with others who reported that the higher the copper content the 
greater the antimicrobial efficacy (Wilks et al., 2005; Noyce et al., 2006a, b). 
 
6.4.6 Organic load 
 
Organic load is added to bacterial suspensions in antimicrobial efficacy tests to mimic 
‘dirty’ conditions, which aims to simulate organic matter found in environments such as 
hospitals (see Chapter 1, section 1.10.5) . 
 
Examples of the effect of organic matter on the activity of copper are detailed in 
Chapter 1, section 1.10.5. Most findings to date have shown organic matter (e.g. BSA, 
blood, pus) enhanced the survival of microorganisms on copper-containing surfaces 
(Airey and Verran, 2007; Tolba et al., 2007; Zhu et al,. 2012). The addition of organic 
load to the wet inoculum in this study resulted in significant differences in viable 
bacteria at in-use conditions of [20°C-40% RH] but not at [37°C-100% RH]. Here 
organic load did not appear to have a detrimental effect on copper’s antimicrobial effect. 
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In fact, copper was more antimicrobial upon the addition of soiling. Although this may 
seem unusual and may require further investigation, Wheeldon et al. (2008) also 
observed no reduced activity by copper against C. difficile spores in the presence of a 
germinant and organic load. However, the germinant may have contributed to the 
observed copper activity. No other examples of enhanced antimicrobial activity by 
copper in the presence of organic load have been reported to date. 
 
6.4.7 Recommendations 
 
Based on the known factors affecting biocide efficacy and key findings from this study, 
the recommended parameters to be tested for potential surfaces in healthcare settings are 
outlined in Table 6.3. These recommended parameters are applicable to many 
environments where antimicrobial surfaces may be introduced; such as in the food 
industry or in public areas (see Table 6.5). The actual conditions, for example 
temperature and relative humidity, can be modified according to the intended 
application. 
 
Table 6.3 Recommended parameters for antimicrobial surface efficacy testing 
Parameters 
 Temperature  (e.g. 20 °C in a UK hospital) 
 Relative humidity (e.g. 40 %, 50 % in a UK hospital) 
 Contact time  
 Inoculum type (i.e. wet and dry) 
 Microorganism/s of interest 
 Biocide concentration  
 Organic load (e.g. 3 g/L BSA) 
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6.5 Future of antimicrobial surfaces in the healthcare setting 
 
Antimicrobial surfaces, in particular copper-containing surfaces have proven to present 
antimicrobial activity in a wide range of laboratory studies. Many factors need to be 
taken into account before antimicrobial surfaces are introduced in clinical settings. 
 
There is evidence that improved surface cleaning in hospital wards and intervention, 
particularly during infection outbreaks, can reduce surface contamination and may also 
have a role in reducing HCAIs (Donskey, 2013). There is also increasing evidence that 
copper can reduce microbial loads in clinical settings (Casey et al., 2010; Karpanen et 
al., 2012; Schmidt et al., 2012). However, the role of antimicrobial surfaces in reducing 
HCAI rates needs to be explored further. To date, there has been one published pilot 
study investigating the association between antimicrobial surfaces and infection rates. In 
a large trial across three hospitals in the US, patients admitted to ICUs were randomly 
placed in rooms containing EPA-registered copper alloy surfaces or in control rooms 
with no copper alloy surfaces. Six copper alloy surfaces were introduced in high-touch 
areas (selected on the basis of findings from previous studies) in all three ICUs. Four 
surfaces were common to all four hospitals; bed rails, overbed tables, IV poles and arms 
of the visitor’s chair. Other surfaces included nurses’ call button, computer mouse, 
bezel of touchscreen monitor and palm rest of laptop computer. The trial was conducted 
over one year and copper alloy surfaces were introduced nine months prior. The study 
showed a significantly reduced incident rate of HCAIs and/or MRSA or VRE 
colonisation in rooms containing copper alloys than in rooms without copper alloys 
(Salgado et al., 2013). The authors claimed that copper alloy surfaces decreased the risk 
of an HCAI by more than 50 % but stated more trials were required, particularly to 
assess the role of reduced surface contamination in controlling HCAI rates (Salgado et 
al., 2013). However, others have criticised the trial by stating the majority of HCAI-
causing bacteria are endogenous, whereas copper alloy surfaces are more likely to kill 
exogenous bacteria (Harbarth et al., 2013; Humphreys, 2014). In addition, validity of 
the authors claims have been questioned due to the fact that only 10 % of surfaces in the 
ICUs were copper alloys and that 13 % of patients in control rooms had some exposure 
to copper alloy surfaces (Harbarth et al., 2013).  It is certainly clear that more trials are 
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necessary to fully understand whether or not antimicrobial surfaces can contribute to 
reducing HCAI rates.  
 
A major advantage of antimicrobial surfaces is that they provide continuous disinfection 
and since they are self-disinfecting their activity is not reliant upon effective surface 
cleaning  (Weber and Rutala, 2013). To date the majority trials in clinical areas have 
been conducted with concurrent, non-copper-containing control surfaces or as a 
crossover study (Weber and Rutala, 2013). Examples are mentioned in Chapter 1, 
section 1.8.1.3. In all the cases described copper alloys presented significantly reduced 
microbial counts compared to control surfaces. In addition, trials in clinical settings 
have shown copper to be effective against a wide range of microorganisms including 
MRSA, MSSA, VRE, E. coli and coliforms (Casey et al., 2010; Karpanen et al., 2012; 
Schmidt et al., 2012). Finally, the use of antimicrobial surfaces as part of infection 
control does not require staff training that is necessary for other technologies (e.g. HPV) 
(Humphreys, 2014).  
 
Although trials have shown promising results regarding the continuous disinfection by 
copper alloy surfaces, it is important that HCWs are aware of the limitations of 
antimicrobial surfaces. Firstly, they must not replace, but rather work in conjunction, 
with current cleaning methods (Page et al., 2009). Indeed, all trials conducted to date 
have tested the efficacy of copper alloy surfaces alongside normal cleaning regimes. 
Good hand hygiene must be maintained too at all times as antimicrobial surfaces do not 
reduce the direct transmission of microorganisms between individuals (Page et al., 
2009).  
 
An important factor that has not been reported in any trials is the cost of purchasing and 
installing antimicrobial surfaces (Weber and Rutala, 2013). It would not be feasible to 
replace all surfaces in a hospital ward with an antimicrobial coating or surface (Weber 
and Rutala, 2013), therefore, more studies are required to determine which wards or 
areas within wards would benefit most from their introduction.  In light of the current 
reduction in bacteraemia rates of HCAIs such as MRSA and A. baumannii, the cost of 
installing copper fittings needs to be justified. For example, if copper alloys can reduce 
surface contamination and subsequently further decrease infection rates, the question of 
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what additional decrease in infection rates by copper would make their installation a 
viable option needs to be addressed. In addition, based on findings in this study, copper 
alloys are not likely to be antimicrobial against C. difficile spores, whereas others have 
demonstrated slow (24 – 48 h) activity (Weaver et al., 2008). Thus, the introduction of 
copper alloy surfaces may not influence C. difficile infection rates. Also, whilst activity 
against a wide range of microorganisms has been reported in clinical settings, it could 
be argued that the reductions in microbial bioburden (1 - 2 log10) produced by copper 
alloys compared to standard fittings are small (Weber and Rutala, 2013). 
 
The York Health Economics Consortium has developed a cost-benefit model to assess 
the cost of installing copper surfaces against the benefits from reduced HCAI rates. It is 
based on the installation of copper surfaces including over-bed table, bed rail, chair, call 
button, data device and IV stand in a 20-bed ICU. The findings of a 5 year model are 
summarised in Table 6.4. The cost of fittings, number of infections, cost of infections 
and total cost were taken into account and showed a saving of £1,926,600 if copper 
surfaces were to be introduced. The model also claims 390 bed days would be saved a 
year (cost of one bed day £78.41). Overall, it is estimated that the cost of copper fittings 
would be recovered within two months (Website 37, 2013). 
 
Table 6.4 - Cost-benefit model analysis of copper vs. standard fittings in a 20-bed ICU 
over a 5 year period (Website 37, 2013) 
  Copper Standard 
Cost of fittings £105,000 £74,400 
Estimated number of infections 1301 1626 
Cost of infections £7,804,800 £9,756,000 
Total cost of intervention £7,905,000 £9,830,400 
Saving £1,926,600   
 
It is assumed that the cleaning costs (including time, staff numbers and chemicals) of 
copper surfaces are the same as non-antimicrobial surfaces; however, this is something 
that should be determined in cost-benefit analyses.  
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It is important too that any cleaning products used for routine disinfection do not 
contain chemicals that may interfere with or reduce the antimicrobial efficacy of 
surfaces (Warnes and Keevil, 2011). The properties of the antimicrobial surface should 
be taken into account; copper is corrosive and oxidises. Studies have shown that 
lowered corrosion and an oxide layer resulted in decreased antimicrobial activity against 
E. coli and E. faecium (Elguindi et al., 2011). In addition, the long-term efficacy and 
durability of copper alloy surfaces has not been fully explored, although surface 
conditioning from repeated soiling/cleaning has been observed (see Chapter 1, 1.11.5) 
(Airey and Verran, 2007; Weber and Rutala, 2013). It is vital that antimicrobial surfaces 
are durable and are not affected by repeated soiling and cleaning (Humphreys, 2014).  
 
The emergence of bacterial resistance to antimicrobials is a challenge to infection 
control (Touati et al., 2010). The exact mechanisms of action of copper are not fully 
understood, however, it is thought to act at several different sites within the bacterial 
cell. Having multiple target sites reduces the likelihood of resistance. Nevertheless, 
prolonged survival of copper-ion resistant E. faecium (2 - 3 log10) has been observed 
after repeated inoculations every 3 h over a 24 h period with recurrent culture analysis. 
In contrast, copper-ion resistant E. coli was not detectable over the 24 h period 
(Elguindi et al., 2011). In a different study in a clinical setting, 62 isolates of 
Enterobacteriaceae were recovered from 428 surfaces from three hospitals over a four 
month period. From these isolates 16 were found to be extended spectrum β-lactamase-
producing and all were copper-resistant too with MICs of >1600 µg/mL (Touati et al., 
2010). The authors state this resistance may limit the antimicrobial efficacy of copper-
containing surfaces against such strains (Touati et al., 2010).   
 
Ultimately the decision regarding the widespread use of antimicrobial surfaces in 
clinical areas will be down to a range of factors. Worthington et al. (2012) recommend a 
pragmatic approach in the selection of areas where antimicrobial surfaces would be 
useful alongside routine infection control procedures. Within the NHS the cost of 
antimicrobial surfaces is likely to be a major limiting factor. Cost-benefit analyses 
should be conducted and more studies carried out to assess the clinical efficacy of 
antimicrobial surfaces. If the overall outcome is positive, there may be a future role for 
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antimicrobial surfaces to control surface contamination and work alongside other 
infection control measures to reduce HCAI rates.  
 
6.6 Application of antimicrobial surfaces in food factories and other settings  
 
This project was carried out in collaboration with Campden BRI. Campden BRI’s focus 
in this collaboration was geared towards antimicrobial surfaces in food settings. Phase 1 
– 3 tests were carried out to assess the potential use of antimicrobial surfaces in food 
factories. Environmental sampling of surfaces in food factories similar to the hospital 
sampling in this study was carried to set parameters for phase 2 testing, which also 
indicated the temperature and relative humidity conditions of the JIS Z 2801 test are not 
appropriate.  
 
As in healthcare settings, the majority of hard, metal surfaces in food settings are 
composed of stainless steel since they can be easily cleaned (Wilks et al., 2005). The 
use of antimicrobial surfaces in food factory settings has been considered. In one study 
pure copper produced complete kill of E. coli O157:H7, a foodborne pathogen, after 90 
min at 20 °C (to mimic room temperature) and after 270 min at 4 °C (to mimic 
refrigeration temperature) (Wilks et al., 2005). The authors of this study suggest pure 
copper should not be used in food settings as it corrodes and tarnishes easily. They 
recommend that copper alloys are utilised, which are less corrosive and more durable 
(Wilks et al., 2005). In an environment such as a food factory, food safety is a key issue 
during preparation. It is important that if antimicrobial surfaces were to be introduced in 
food settings that they do not have an effect on food safety. One study found copper 
ions were released into meat after 50 min contact (Faúndez et al., 2004). Food contact 
with copper surfaces should be controlled to ensure minimal copper release. Examples 
of antimicrobial surfaces found in the food industry are given in Table 6.5.  
 
Campden BRI tested a range of surfaces under JIS Z 2801 conditions and four (copper 
nickel, grapefruit extract, silver and photo-oxidative), that presented a >4 log10 
reduction in E. coli and/or S. aureus, proceeded to phase 2 testing against S. aureus. 
Phase 2 conditions were reflective of food factory conditions (4, 10 and 25 °C at 33 and 
75 % relative humidity). Overall, only copper nickel presented a >4 log10 reduction after 
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24 h under all conditions except at 4 and 10 °C at 33 % relative humidity. During phase 
3 testing the same four surfaces were introduced into food factories. They were tested 
over 83 days in a dairy factory to test the long-term efficacy of surfaces, and over 24 h 
in a potato processing environment to mimic every day cleaning in factories. Overall, all 
surfaces were not significantly different to standard fittings in terms of total aerobic 
count. See Appendix 3 for complete results. 
 
Camdpen BRI stated their study highlighted the importance of not only testing surfaces 
under in-use conditions in the laboratory but also in situ under the real conditions of 
use. Their results suggested the use of antimicrobial surfaces in the specific food factory 
environment conditions tested is limited (personal communication, Colette Jermann, 
Campden BRI).  
 
The potential use of antimicrobial surfaces is not just limited to healthcare and food 
settings. Examples of areas that may benefit from their introduction include public 
transport, public buildings and sports facilities amongst others. Table 6.5 highlights the 
large range of existing applications for antimicrobial surfaces.
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Table 6.5 – Examples of various antimicrobial surface applications 
 
Application Example surfaces Reference 
Food industry 
and hospitality 
Copper kitchen drainer trough Website 38, 2014 
 Copper table tops and air conditioning units in 
a South Korean restaurant 
Website 39, 2013 
Public transport Copper handrails and poles on trains in Chile Website 40, 2013 
 Copper handrails in subways in Chile Website 41, 2011 
 Copper handrails, counter tops and elevator 
guards at an airport in Brazil 
Website 42, 2012 
Public buildings Copper door handles, rails and banisters at a 
school in Greece 
Website 43, 2012 
 Copper taps, handrails, door handles and push 
plates at a kindergarten in Japan 
Website 44, 2012 
 Copper desks at a school in Chile Website 45, 2012 
Veterinary Copper tables, light switches, vaccine fridge 
door, operation light handles and table 
handles at a practice in South Africa 
Website 46, 2012 
 Copper horseshoes Website 47, 2012 
Personal items Copper mobile phone cover Website 48, 2013 
 Protective screen glass for mobile phones, 
laptops etc. (silver ions) 
Website 32, 2014 
Sports facilities EPA-approved antimicrobial coating for gym 
equipment 
Website 49, 2014 
 Laminate for use in gyms (nano silver ions) Website 36, 
publication date 
unavailable 
Miscellaneous Copper door furniture in a laboratory that 
assists companies that develop disinfectants 
Website 50, 2013 
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6.7 Limitations of this study and future work 
 
Both antimicrobial surface efficacy tests developed in this study required a long 
nebulisation time of 30 min to recover a sufficient amount of bacteria from surfaces. 
During this 30 min differences were observed between the amount recovered from 
stainless steel and the amount from copper alloys, for both wet and dry inocula. The 
most likely explanation for this observation against the wet inoculum is that the copper 
alloy surfaces were antimicrobial during the nebulisation process due to continuous wet 
contact. For the dry inoculum the reasons are uncertain. It could be that the drying 
process combined with the high temperature and relative humidity conditions within the 
set-up rendered some cells more sensitive to copper, in addition to the existing 
antimicrobial activity of copper.   To overcome this issue for the dry inoculum set-up, 
the inoculum could be deposited on to an inanimate surface (e.g. latex) then transferred 
to test and control surfaces. The test and control surfaces could then be incubated at the 
required conditions and viability determined after necessary contact times (see Figure 
6.2). This transfer from a latex surface to a copper alloy surface would mimic, for 
example, hand touch contamination by a HCW. The key points would be to ensure the 
reproducibility of the inoculum deposited and transfer to the antimicrobial surface.  
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Figure 6.2 – Schematic diagram showing possible modifications to the dry inoculum 
test method developed in Chapter 5 
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count 
Deposit dry inoculum 
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Transfer inanimate 
surface to test and 
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More work should be carried out to further investigate the mechanisms of action of 
copper against both wet and dry inocula. In this study the mechanisms of action of 
copper were only assessed after exposure to dry inocula and only two repeats were 
carried. Studies utilising FACS to determine the mechanism of action of copper are 
limited in number. Similar to this study, Quaranta et al. (2011) utilised the fluorescent 
dye BOX to assess changes in membrane potential following copper exposure and 
observed rapid membrane depolarisation in yeast. FACS protocols should be optimised, 
particularly the positive control to confidently enable the separation of FACS plots into 
quadrants. Other techniques could be utilised too, scanning electron microscopy could 
be used to visualise the bacterial inocula deposited on to surfaces and the effect caused 
to individual cells after incubation under parameters representing conditions found in 
situ. In addition, antimicrobial release from copper alloy surfaces should be assessed to 
compare activity against wet and dry inocula using methods from Santo et al. (2011). 
They utilised Coppersensor11, a membrane-permeable fluorescent dye that increases in 
fluorescence when bound to Cu(I) to determine copper ion uptake in cells. Further 
studies should attempt to measure the available concentration of a biocide at the surface 
 
As mentioned in section 6.5 the durability of copper alloy surfaces has not been fully 
assessed; existing techniques should be used to accelerate wear of surfaces. Aged 
surfaces should then be used re-tested to observe, if any, loss of antimicrobial efficacy.  
 
More work should be carried out to determine the role of water in the antimicrobial 
efficacy of copper. Warnes and Keevil (2011) demonstrated quick kill when a low 
volume, 1 µL bacterial inoculum was presented on to surfaces. Since relative humidity 
appears to be an important factor affecting antimicrobial surface and copper alloys have 
shown to elicit an antimicrobial effect against a low volume inoculum, further studies 
should attempt to look at the role of water levels at a micro scale. Measuring water 
levels on surfaces should also confirm that the dry aerosol test developed in Chapter 5 is 
dryer on the surface than the dry inoculum method by Warnes and Keevil (2011). 
 
Finally, this study has been limited to assessing the antimicrobial efficacy of copper 
alloys. The new antimicrobial surface efficacy tests could be tested against different 
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antimicrobial surfaces; many commercial products exist containing a variety of 
antimicrobial coatings. 
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Appendix 1 – Hospital sampling data 
 
NB.  NR = no reading 
 MR = missing reading 
 
Table 1 – April 2011, Gastroenterology 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 166 Dry 30.5 23 4.7 5.31 
Door handle 173 At risk 33.4 23.3 5.5 5.58 
Door push plate 216 Wet 38.1 21 4.4 5.34 
Door push plate 238 Wet 33.8 21.8 4.5 5.2 
Computer keyboard 75 Dry 38.2 22.8 7.3 6.25 
Computer mouse 75 Dry 31.4 24.4 6.2 5.97 
Bed rail 64 Dry 40.6 26.1 11 8.61 
Bed rail 63 Dry 38.2 26.9 10.7 8.11 
Bed rail 63 Dry 38.8 25.7 10.4 7.87 
Chair 112 Dry 32.9 24.3 6.2 5.91 
Chair 65 Dry 31.4 24.8 6.4 5.96 
Chair 65 Dry 39.4 24.4 9.1 7.19 
Trolley 74 Dry 32.6 24.1 6.1 5.85 
Trolley 217 Wet 38.1 24.2 7.9 6.66 
Table 73 Dry 31.2 24.6 6.1 5.81 
Table 111 Dry 41.2 24.2 10.1 7.72 
Light switch 134 Dry 31.1 25.1 7 6.24 
Tap 179 At risk 31.4 28.5 7.2 6.42 
Wall panel 146 Dry 30.4 24.4 5.9 5.78 
Wall panel 176 At risk 31.9 26.4 8.3 7.07 
Waste bin 236 Wet 31.5 26.2 7.4 6.4 
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Table 1 continued – April 2011, Gastroenterology 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface % RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 29.9 23.8 5.1 22.4 17.3 17 Caution 
Door handle 31.2 23.2 5.1 22.2 17.3 17 Caution 
Door push plate 32.3 21.8 4.4 22.2 17.7 156 Fail 
Door push plate 31.6 21.7 4.3 22 17.3 86 Fail 
Computer keyboard 32.3 23.8 6.3 24.2 18 75 Fail 
Computer mouse 32.2 24.2 6.3 24.1 18 86 Fail 
Bed rail 41.3 25.5 11.7 25.1 13.3 150 Fail 
Bed rail 37.4 26.6 10.5 26.8 16.4 2 Pass 
Bed rail 37.5 26 10.4 26.1 15.6 9 Pass 
Chair 30.3 24.9 6.2 24.1 18 367 Fail 
Chair 30.4 24.5 6 24.1 18.2 12 Caution 
Chair 39.4 24.1 9 23.9 15 252 Fail 
Trolley 32.2 24 6.1 24.1 18.2 95 Fail 
Trolley 35.9 24.4 8 24.4 17.2 173 Fail 
Table 29.9 24.4 5.5 24.8 19.4 601 Fail 
Table 38.3 24.1 9.6 24.6 14.5 55 Fail 
Light switch 30.6 25.4 6.8 24.8 18.2 66 Fail 
Tap 31.4 25.7 7.6 26.5 18.8 72 Fail 
Wall panel 30.1 24.8 6.1 NR NR 2 Pass 
Wall panel 33.2 26.1 8 24.6 18.6 10 Pass 
Waste bin 30 25.5 6.7 NR NR 0 Pass 
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Table 2 – April 2011, ACC 
 
MOISTURE 
MODE   HYGROMETER MODE 
Surface  
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle  155 Dry 31.1 23.6 5.6 5.64 
 Door handle 166 Dry 31.9 23.7 5.9 5.82 
Door push plate 206 Wet 30.5 25.5 6.6 6 
 Door push plate 206 Wet 31.4 24.1 6.1 5.86 
Computer keyboard 70 Dry 31 24.3 5.9 5.77 
Computer mouse 84 Dry 31.4 23.6 5.6 5.66 
Bed rail  105 Dry 31.3 24 5.9 5.82 
 Bed rail 106 Dry 32.6 24.5 6.4 6 
Chair 68 Dry 31.4 24.4 6.2 5.92 
 Chair 70 Dry 31.5 24.8 6.6 6.08 
 Chair 195 At risk 31.3 24.1 5.8 5.79 
Trolley 73 Dry 30.9 24.1 5.8 5.8 
 Trolley 90 Dry 31.3 24.2 6 5.9 
Table 63 Dry 32.4 24.1 6.1 5.84 
 Table 78 Dry 31 24.1 5.8 5.8 
Light switch 108 Dry 31.4 24.4 6.2 5.92 
Wall panel 171 At risk 30.9 24.3 6 5.84 
 Wall panel 143 Dry 31.7 24.9 6.7 6.13 
Waste bin  186 At risk 31.5 25.1 6.5 6.05 
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Table 2 continued – April 2011, ACC 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface  
% 
RH 
TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle  30.7 23.9 5.5 23.5 18.1 13 Caution 
 Door handle 31.9 23.8 6 24.3 18.3 11 Caution 
Door push plate 30.4 24.4 5.7 23.3 17.7 20 Caution 
 Door push plate 31.9 23.8 6.3 24.1 17.9 46 Fail 
Computer keyboard 30.4 24 5.6 23.9 18.1 388 Fail 
Computer mouse 30.9 23.8 5.6 23.7 18.1 25 Caution 
Bed rail  30.9 24.2 5.9 23.9 18 27 Caution 
 Bed rail 31.8 24.5 6.7 23.7 17.7 4 Pass 
Chair 31.1 24.5 6.3 NR NR 393 Fail 
 Chair 30.9 24.8 6.4 NR NR 32 Fail 
 Chair  MR MR MR  MR MR MR  MR  
Trolley 30.9 24.4 6 NR NR 21 Caution 
 Trolley 30.9 24.2 6.1 23.9 17.7 247 Fail 
Table 31.2 24.3 6.1 23.9 17.9 78 Fail 
 Table 31.4 24.2 6 23.9 18.2 890 Fail 
Light switch 30.6 24.5 6.3 23.9 17.7 11 Caution 
Wall panel 30.8 24.5 6.1 NR NR 7 Pass 
 Wall panel 30.9 24.8 6.3 NR NR 4 Pass 
Waste bin  31.3 24.8 6.4 NR NR 464 Fail 
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Table 3 – April 2011, Theatre 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 153 Dry 38.1 25.1 9 7.06 
Door handle 176 At risk 37.2 24.1 8.6 7.08 
Door push plate 209 Wet 41.5 22.1 8.3 6.9 
Door push plate 405 Wet 43.1 21.7 8.6 7.03 
Computer keyboard 155 Dry 41.3 21.8 8.2 6.84 
Trolley 1000 Wet MR MR MR MR 
Trolley 219 At risk 41.3 22.4 8.5 6.96 
Trolley 186 At risk 38.2 24.4 8.4 6.77 
Anaesthetics stand 65 Dry 44.1 20.7 8 6.7 
Light switch 1000 Wet 41.6 21.8 8.1 6.79 
Tap 179 At risk 42 21.7 8.2 6.88 
Wall panel 178 At risk 42.1 22.4 8.3 6.81 
Wall panel 146 Dry 43.1 20.6 7.7 6.65 
Waste bin NR NR 44.7 20.6 8 6.7 
 
Table 3 continued – April 2011, Theatre 
 
CONDENSATOR 
MODE     
BIOBURDEN  
Surface 
 
% RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 37.4 24.2 8.2 24.1 15.9 128 Fail 
Door handle 38.4 23.7 8.7 24.3 15.5 191 Fail 
Door push plate 42.3 21.7 8.4 21.3 13.1 199 Fail 
Door push plate 44.1 21.3 8.6 22.2 13.4 181 Fail 
Computer keyboard 38.1 23.1 8.1 23.2 14.7 107 Fail 
Trolley 38.8 23 8.6 23.3 13.8 35 Fail 
Trolley 41.6 22.3 8.6 23.3 14.9 12 Caution 
Trolley 39.6 22.5 8.2 NR NR 4 Pass 
Anaesthetics stand 44.1 20.6 7.9 21.2 13 127 Fail 
Light switch 40.7 22.3 8.6 NR NR 12 Caution 
Tap 42 22.3 8.6 NR NR 1 Pass 
Wall panel 40.7 21.9 7.9 22.2 14.2 7 Pass 
Wall panel 41.6 21.3 7.7 20.9 13.2 33 Fail 
Waste bin 44.4 20.5 7.8 21.4 13.5 127 Fail 
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Table 4 – June 2011, Gastroenterology 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 173 At risk 58.2 19.9 11.5 8.48 
Door handle 166 At risk 56.4 20.4 11.6 8.44 
Door push plate 220 At risk 53.6 20.9 11.1 8.25 
Door push plate 211 At risk 52.3 21.1 10.9 8.32 
Computer keyboard 78 Dry 51.8 22.1 11.5 8.49 
Computer mouse 65 Dry 48.8 22.7 11.3 8.39 
Bed rail 65 Dry 48.9 23.8 12.2 9.01 
Bed rail NR NR 47.7 23.8 12.1 8.68 
Bed rail 65 Dry 48 22.9 11.2 8.4 
Chair 63 Dry 48.7 23 11.5 8.5 
Chair 65 Dry 49.6 23.5 12.5 9.07 
Chair 187 At risk 50.2 22.5 11.8 8.68 
Trolley 241 Wet 46.7 23.5 11.2 8.44 
Trolley 99 Dry 48.2 24.5 12.6 9.15 
Table 112 Dry 48.7 23.5 11.8 8.76 
Table 499 Wet 51.5 24.1 12.9 9.3 
Light switch 152 Dry 50.2 23.5 12.5 9.06 
Tap 174 At risk 51.5 23.7 12.7 9.13 
Wall panel 156 Dry 48.6 23.1 11.8 8.65 
Wall panel 181 At risk 49.2 22.7 11.4 8.4 
Waste bin 173 At risk 58.2 19.9 11.5 8.48 
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Table 4 continued – June 2011, Gastroenterology 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface % RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 48.3 22.9 11.3 22 48.3 31 Fail 
Door handle 48.1 22.8 11.1 22.3 48.1 5 Pass 
Door push plate 47.9 22.7 11.2 22.3 47.9 41 Fail 
Door push plate 48.4 22.6 11 22.3 48.4 29 Caution 
Computer keyboard 50.8 22.8 12.1 24.1 50.8 36 Fail 
Computer mouse 49.3 22.6 11.7 23.6 49.3 106 Fail 
Bed rail 45.4 24.9 12.1 23.9 45.4 7 Pass 
Bed rail 45.6 24.8 11.9 23.9 45.6 25 Caution 
Bed rail 48.8 22.5 11.3 22.9 48.8 33 Fail 
Chair 48.8 23 11.7 23.6 48.8 0 Pass 
Chair 46.4 23.3 11.1 23.2 46.4 8 Pass 
Chair 50.7 22.4 11.8 22.6 50.7 365 Fail 
Trolley 46.2 23.1 11.2 NR 46.2 11 Caution 
Trolley 48.8 23.7 12.2 23.4 48.8 67 Fail 
Table 47.9 23.6 12 23.2 47.9 43 Fail 
Table 47.9 24.2 12.2 23.3 47.9 17 Caution 
Light switch 50.7 24 12.6 24.2 50.7 41 Fail 
Tap 50.6 23.5 12.5 23.9 50.6 13 Caution 
Wall panel 48.7 23.3 11.8 23.2 48.7 13 Caution 
Wall panel 49.9 22.4 11.5 21.9 49.9 21 Caution 
Waste bin 48.3 22.9 11.3 22 48.3 31 Fail 
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Table 5 – June 2011, ACC 
 
MOISTURE 
MODE   HYGROMETER MODE 
Surface  
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle  158 Dry 46.6 21.8 9.9 7.64 
 Door handle 158 Dry 47.9 21.6 9.9 7.61 
Door push plate 211 Wet 44.1 23.2 9.7 7.48 
 Door push plate 209 Wet 47.3 21.6 9.9 7.62 
Computer keyboard 76 Dry 44.8 22.7 10 7.65 
Computer mouse 78 Dry 48.2 22.4 10.6 7.84 
Bed rail  68 Dry 47.2 21.3 9.3 7.5 
 Bed rail 215 Wet 44.1 22.5 9.6 7.48 
Chair 176 At risk 46.5 21.4 9.3 7.34 
 Chair 125 Dry 44.1 22.8 9.7 7.52 
 Chair 96 Dry 43.5 22.5 9.4 7.4 
Trolley 99 Dry 44.4 22.3 9.4 7.38 
 Trolley 84 Dry 45.8 22 9.8 7.53 
Table 148 Dry 46.4 21.2 9.2 7.32 
 Table 73 Dry 44.1 22.4 9.6 7.49 
Light switch 925 Wet 44.9 23 10.2 7.7 
Wall panel 1000 Wet 46.7 22 9.8 7.57 
 Wall panel 186 At risk 44.8 22.6 9.9 7.61 
Waste bin  65 Dry 42 23.7 9.6 7.44 
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Table 5 continued – June 2011, ACC 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface  
% 
RH 
TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle  46.1 22 10 21.3 11.6 7 Pass 
 Door handle 47.6 22.1 9.9 21.3 11.4 6 Pass 
Door push plate 43.7 22.5 9.4 21.1 11.8 8 Pass 
 Door push plate 45.3 21.8 9.3 20.9 11.6 3 Pass 
Computer keyboard 46.5 21.8 9.7 22.9 13.1 123 Fail 
Computer mouse 46.4 21.8 9.8 22.9 13.2 177 Fail 
Bed rail  46.4 21.3 9.4 20.9 11.5 34 Fail 
 Bed rail 43.6 22.7 9.8 23.2 13.6 140 Fail 
Chair 46.2 21.3 9.3 21.3 12.1 129 Fail 
 Chair 43.3 22.8 9.7 22.5 12.8 27 Caution 
 Chair 43.4 22.5 9.6 22.9 13.4 82 Fail 
Trolley 44.3 21.6 9.2 21.3 12 187 Fail 
 Trolley 45.6 22.1 9.9 NR NR 38 Fail 
Table 45.5 21.6 9.2 21.3 12 18 Caution 
 Table 44.8 22.5 9.7 23.2 13.6 32 Fail 
Light switch 43.8 22.6 9.7 NR NR 3 Pass 
Wall panel 45.8 21.8 9.6 22.3 12.5 26 Caution 
 Wall panel 45.1 22.3 9.8 NR NR 2 Pass 
Waste bin  42.2 23.1 9.4 21.9 12.6 249 Fail 
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Table 6 – June 2011, Theatre 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 173 At risk 44.8 23.1 10 7.63 
Door handle 155 Dry 46.5 21.1 9.1 7.24 
Door push plate 191 At risk 47.4 21.4 9.7 7.46 
Door push plate 181 At risk 47.1 21.3 9.6 7.44 
Computer keyboard 89 Dry 44.8 22.1 9.5 7.43 
Trolley 1000 Wet 46.2 21.4 9.4 7.43 
Trolley 1000 Wet 44.3 22.5 9.6 7.5 
Trolley 1000 Wet 45.7 21.7 9.4 7.53 
Anaesthetics stand 1000 Wet 47.1 21.4 9.6 7.52 
Light switch 225 At risk 44.6 22.3 9.6 7.51 
Tap 214 At risk 43.8 22.7 9.8 7.55 
Wall panel 178 At risk 45.3 21.8 9.5 7.43 
Wall panel 153 Dry 56.9 21.1 9.3 7.33 
Waste bin NR NR 46.3 21.1 9.5 7.42 
 
Table 6 continued – June 2011, Theatre 
 
CONDENSATOR 
MODE     
BIOBURDEN  
Surface 
 
% RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 48.4 21 9.6 21.1 11.3 4 Pass 
Door handle 46.7 21 9.1 20.7 11.5 8 Pass 
Door push plate 46.1 21.1 9 21.3 12.2 2 Pass 
Door push plate 46.7 21 9.1 20.9 11.7 16 Caution 
Computer keyboard 47.5 21.1 9.4 20.2 10.2 18 Caution 
Trolley 46.5 21.2 9.2 21.2 12 24 Caution 
Trolley 47.2 21 9.2 NR NR 96 Fail 
Trolley 48.3 20.6 9.2 NR NR 15 Caution 
Anaesthetics stand 46.9 20.8 9.1 NR NR 24 Caution 
Light switch 47.1 21.1 9.6 21.2 11.4 8 Pass 
Tap 48.1 21.1 9.6 NR NR 1 Pass 
Wall panel 47.3 21.1 9.3 NR NR 12 Caution 
Wall panel 46.8 21.1 9.3 NR NR 41 Fail 
Waste bin 47.6 20.7 9 NR NR 3 Pass 
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Table 7 – August 2011, Gastroenterology 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 178 At risk 63.7 20.4 15 10.92 
Door handle 173 At risk 63.6 21.3 13.5 11.04 
Door push plate 266 Wet 63.4 21.8 15.4 10.98 
Door push plate 402 Wet 63.3 21.7 15.4 11.02 
Computer keyboard 87 Dry 63.2 22.3 15.9 11.42 
Computer mouse 117 Dry 63 22.3 15.7 11.21 
Bed rail 112 Dry 62.8 23 15.7 11.23 
Bed rail 70 Dry 64 22.5 15.5 11.18 
Bed rail 74 Dry 64.2 22.5 15.4 11.01 
Chair 202 Wet 63.4 23 15.9 11.27 
Chair 199 Wet 63.8 22.8 15.5 10.9 
Chair 186 At risk 63.5 22.5 15.2 10.93 
Trolley 1000 Wet 63.5 23 15.3 10.89 
Trolley 249 Wet 63.6 22.5 15.4 10.98 
Table 119 Dry 63.5 22.6 15.2 10.9 
Table 118 Dry 62.6 23.1 15.7 11.21 
Light switch 768 Wet 63.5 22.8 15.2 10.88 
Tap 190 At risk 63.9 22.5 15.5 11.11 
Wall panel 156 Dry 64 22.5 15.2 10.89 
Wall panel 151 Dry 64.1 22.5 15.4 10.98 
Waste bin NR NR 63.9 22.4 15.3 10.9 
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Table 7 continued – August 2011, Gastroenterology 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface % RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 64.1 22.4 15.3 22.1 6.9 4 Pass 
Door handle 64 22.5 15.3 22.2 6.9 4 Pass 
Door push plate 63.5 22.5 15.3 22.2 6.9 104 Fail 
Door push plate 63.4 22.5 15.2 22.3 7.2 67 Fail 
Computer keyboard 59.6 23.5 15.5 NR NR 0 Pass 
Computer mouse 59.7 23.5 15.4 NR NR 15 Caution 
Bed rail 62.6 23.4 15.8 24 8.2 862 Fail 
Bed rail 66.1 22.8 15.9 22.6 6.7 87 Fail 
Bed rail 63.1 22.7 15.3 22.4 7.1 129 Fail 
Chair 62.5 22.8 15.3 22.5 7.2 25 Caution 
Chair 62.8 22.7 15.2 22.5 7.1 8 Pass 
Chair 63.3 22.4 15.1 22.3 7 0 Pass 
Trolley 63.5 22.4 15.1 22.2 6.9 459 MR 
Trolley 64.3 22.3 15.4 22.2 6.5 1456 MR 
Table 60.6 23 15 22.5 7.3 16 Caution 
Table 62.6 23.1 15.5 22.9 7.2 13 Caution 
Light switch 61.6 22.9 15.1 22.6 7.4 11 Caution 
Tap 64.6 22.7 15.6 22.6 7 14 Caution 
Wall panel 63.4 22.6 15.3 21.6 6.3 6 Pass 
Wall panel 63.6 22.5 15.2 21.9 6.7 0 Pass 
Waste bin 63.8 22.4 15.3 21.9 6.6 182 Fail 
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Table 8 – August 2011, ACC 
 
MOISTURE 
MODE   HYGROMETER MODE 
Surface  
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle  125 Dry 56.6 24.8 15.7 11.27 
 Door handle 214 At risk 54.4 24.7 14.9 10.65 
Door push plate 193 At risk 54.2 25.3 15.5 11.19 
 Door push plate 240 Wet 58.2 24.6 15.8 11.39 
Computer keyboard 93 Dry 59.3 23.8 15.3 10.98 
Computer mouse 70 Dry 59.2 23.8 15.3 10.9 
Bed rail  61 Dry 57.2 24.2 15.4 10.97 
 Bed rail 90 Dry 58.2 24.1 15.4 10.98 
Chair 97 Dry 58.4 24.2 15.5 11.09 
 Chair 63 Dry 57.9 24.6 15.7 11.3 
 Chair 141 Dry 57.8 24.5 15.7 11.21 
Trolley 1000 Wet 57.3 24.2 15.2 11.08 
 Trolley 75 Dry 58.4 24.2 15.6 11.14 
Table 118 Dry 58.8 24 15.4 11.01 
 Table 90 Dry 60.5 23.5 15.3 10.95 
Light switch 235 Wet 56.8 24.6 15.3 10.89 
Wall panel 162 Dry 58.4 24.1 15.4 11.03 
 Wall panel 148 Dry 61.4 23.2 15.3 10.91 
Waste bin  1000 Wet 59.2 24 15.8 11.34 
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Table 8 continued – August 2011, ACC 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface  
% 
RH 
TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle  61.9 23.1 15.3 NR NR 10 Pass 
 Door handle 57.8 23.9 15.2 NR NR 6 Pass 
Door push plate 57.2 24.2 15.2 NR NR 2 Pass 
 Door push plate 61.9 23.1 15.3 NR NR 9 Pass 
Computer keyboard 60.8 23 15 23.6 8.3 45 Fail 
Computer mouse 60.7 23.1 15.1 23.3 8.1 60 Fail 
Bed rail  58.5 23.5 15.9 23.2 7.9 24 Caution 
 Bed rail 59.2 23.6 15.2 23.2 7.9 49 Fail 
Chair 60.6 23.5 15.4 23.3 7 22 Caution 
 Chair 60.7 23.4 15.4 23.2 7.8 65 Fail 
 Chair 62.1 23.1 15.4 NR NR 26 Caution 
Trolley 60.4 23.2 15.2 22.8 7.1 12 Caution 
 Trolley 61 23.3 15.3 23.2 7.7 26 Caution 
Table 62.5 23 15.4 NR NR 31 Fail 
 Table 62.2 23 15.3 NR NR 87 Fail 
Light switch 59.2 23.5 15.4 22.9 7.7 14 Caution 
Wall panel 61.4 23.4 15.4 NR NR 11 Caution 
 Wall panel 60.4 23.1 15.1 23.2 7.7 1 Pass 
Waste bin  61.6 23 15.2 23 7.9 70 Fail 
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Table 9 – August 2011, Theatre  
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 166 Dry 47.7 23.3 11.8 8.74 
Door handle 162 Dry 49.6 19.7 11.6 8.68 
Door push plate 482 Wet 57.5 20.4 12.2 8.84 
Door push plate 778 Wet 57.8 20.1 11.5 8.55 
Computer keyboard 166 Dry 53.3 20.9 11.1 8.29 
Trolley 1000 Wet 54.7 21.4 11.7 8.62 
Trolley 209 Wet 56.9 20.2 11.5 8.54 
Trolley 825 Wet 58.9 19.6 12.4 9.06 
Anaesthetics stand 74 Dry 56 20 11.2 8.43 
Light switch 657 Wet 49.4 22.9 11.9 8.93 
Tap 276 Wet 50.4 22.5 11.8 8.79 
Wall panel 182 At risk 50.9 22 11.5 8.51 
Wall panel 161 Dry 61.8 19 11.5 8.56 
Waste bin NR NR 56.4 20.4 11.4 8.52 
 
Table 9 continued – August 2011, Theatre  
 
CONDENSATOR 
MODE     
BIOBURDEN  
Surface 
 
% RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 58.7 20.6 12.7 20.9 7.8 17 Caution 
Door handle 60.9 19.2 11.5 19.5 7.8 42 Fail 
Door push plate 61.9 19.2 11.6 19.6 8.1 15 Caution 
Door push plate 61 19.2 11.6 19.4 7.7 10 Pass 
Computer keyboard 59.8 19.1 11.4 19.3 7.8 64 Fail 
Trolley 56.1 20.3 11.2 19 7.2 22 Caution 
Trolley 57.1 19.9 11.3 18.9 NR 13 Caution 
Trolley 59.1 19.6 11.4 NR NR 17 Caution 
Anaesthetics stand 60.4 19.3 11.6 19.3 7.8 53 Fail 
Light switch 52.1 21.7 11.5 21.3 9.7 23 Caution 
Tap 53.5 21.7 11.9 21.2 9.6 4 Pass 
Wall panel 52.3 21.3 11.1 20.7 9.6 28 Caution 
Wall panel 61.5 18.9 11.3 19.3 7.9 37 Fail 
Waste bin 53.8 20.7 11.2 18.2 7 23 Caution 
 
 
276 
 
Table 10 – October 2011, Gastroenterology 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 186 At risk 44.9 20.5 8.7 7.05 
Door handle 181 At risk 43.7 20.7 7.9 6.67 
Door push plate 207 At risk 41.4 21 7.3 6.45 
Door push plate 240 At risk 40 21 7 6.13 
Computer keyboard 105 Dry 44.9 22.3 10.2 7.73 
Computer mouse 93 Dry 45.9 22.3 10.2 7.73 
Bed rail 68 Dry 50 22 11.5 8.47 
Bed rail 63 Dry 49.7 22.6 11.9 8.71 
Bed rail 73 Dry 42.2 22.4 11.5 8.56 
Chair 75 Dry 46.8 22 10.5 8.05 
Chair 167 Dry 42.3 22.4 8.9 7.26 
Chair 73 Dry 42.2 22.4 8.9 7.19 
Trolley 355 Wet 44 21.3 8.1 6.71 
Trolley 207 Wet 44.3 22.3 9.6 7.42 
Table 141 Dry 46.5 21.6 9.7 7.66 
Table 148 Dry 42.1 22.5 8.9 7.23 
Light switch 592 Wet 39.2 21 7.2 6.3 
Tap 158 Dry 52.1 22.3 11.8 8.82 
Wall panel 161 Dry 47.2 21.8 9.9 7.61 
Wall panel 179 At risk 45.7 21.8 11.2 6.33 
Waste bin 208 Wet 46.3 21.5 9.9 7.67 
 
 
 
 
 
 
 
 
 
 
 
 
 
277 
 
Table 10 continued – October 2011, Gastroenterology 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface % RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 39.7 22.8 8.8 21.8 15.1 4 Pass 
Door handle 38.8 22.8 7.8 22 15 6 Pass 
Door push plate 37.2 22.7 7.4 22.3 14.6 75 Fail 
Door push plate 35.7 22.5 6.2 22.2 14.6 29 Caution 
Computer keyboard 42.3 22.4 8.8 22.9 14 42 Fail 
Computer mouse 41.7 22.5 8.7 22.9 14.5 9 Pass 
Bed rail 49.9 22.5 11.7 NR NR 2 Pass 
Bed rail 49.8 22.5 11.6 NR NR 12 Caution 
Bed rail 50.4 22.4 11.7 22 10.4 36 Fail 
Chair 44.4 23 10.6 22.6 14.7 6 Pass 
Chair 40.3 22.3 8 22.2 13.5 77 Fail 
Chair 41.2 22.4 8.7 21.9 13.6 32 Fail 
Trolley 46 22.8 11 21.7 12.7 35 Fail 
Trolley 44.9 23 10.8 21.6 12.7 42 Fail 
Table 44.1 22.5 9.6 22.3 13.7 52 Fail 
Table 41.6 22.5 9 23.2 13.4 23 Caution 
Light switch 38.2 22.3 7.2 NR NR 4 Pass 
Tap 48.7 23 11.7 22.2 12.3 14 Caution 
Wall panel 45.1 22.5 10.2 22.2 13.2 15 Caution 
Wall panel 47.4 22.6 11.2 22.6 12.2 13 Caution 
Waste bin 43.4 22.3 9.3 NR NR 17 Caution 
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Table 11 – October 2011, ACC 
 
MOISTURE 
MODE   HYGROMETER MODE 
Surface  
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle  227 Wet 39.4 23.3 8.8 7.06 
 Door handle 148 Dry 42.6 22.8 9.3 7.17 
Door push plate 209 Wet 40.8 22.4 8.8 7.28 
 Door push plate 139 Dry 43.3 22.5 9.7 7.34 
Computer keyboard 68 Dry 33.8 22.1 5.3 5.57 
Computer mouse 73 Dry 34.2 22.3 5.4 5.68 
Bed rail  96 Dry 34.9 23.3 7.6 6.62 
 Bed rail 87 Dry 34.9 23.1 6.3 5.98 
Chair 186 At risk 36.7 23.8 8.7 6.9 
 Chair 96 Dry 34.8 22.5 7.8 6.31 
 Chair 78 Dry 36.8 22.5 8.1 6.79 
Trolley 150 Dry 40.2 23.4 9.4 7.31 
 Trolley 65 Dry 38.2 23.5 8.9 7.46 
Table 161 Dry 44.2 23.5 10.4 7.86 
 Table 115 Dry 43 23.6 10.2 7.74 
Light switch 397 Wet 39.3 22.6 9.5 7.2 
Wall panel 143 Dry 34.5 22.5 5.8 5.73 
 Wall panel 90 Dry 39.5 22.5 8.1 6.74 
Waste bin  NR NR 40 23.5 11.5 7.71 
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Table 11 continued – October 2011, ACC 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface  
% 
RH 
TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle  43.6 23 10.4 22.2 12.2 16 Caution 
 Door handle 46.1 22.5 10.6 22.2 11 8 Pass 
Door push plate 39.9 22.5 9.2 21.9 12.4 5 Pass 
 Door push plate 43.6 22.6 9.7 22.2 11.9 7 Pass 
Computer keyboard 35.8 22.5 6.2 22.9 16.6 24 Caution 
Computer mouse 35.8 22.6 6.7 22.9 16.7 6 Pass 
Bed rail  34.3 22.8 6.6 22.6 14 15 Caution 
 Bed rail 34.1 22.6 5.9 22.5 16.7 12 Caution 
Chair 33.9 22.4 5.6 22.7 16.3 10 Pass 
 Chair 33.1 22.3 7.9 22.2 13.9 23 Caution 
 Chair 37.5 22.8 7.2 21.9 14.8 51 Fail 
Trolley 37.4 22.3 6.7 22.2 15.1 30 Caution 
 Trolley 38.1 22.4 7.5 22.2 14.2 96 Fail 
Table 43.6 22.5 9.4 22.6 12.9 140 Fail 
 Table 37.5 22.5 7.2 21.9 14.4 87 Fail 
Light switch 40.3 22.2 8.8 21.9 12.8 15 Caution 
Wall panel 43.3 22.5 8.2 22.2 12.6 0 Pass 
 Wall panel 38.2 22.7 7.7 21.9 12.6 0 Pass 
Waste bin 38.9 22.5 8.1 21.5 13.8 22 Caution 
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Table 12 – December 2011, Gastroenterology 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 203 Wet 41.3 21.2 7.4 6.47 
Door handle 193 At risk 41.3 21.4 7.6 6.62 
Door push plate 257 Wet 40.1 21.7 7.2 6.3 
Door push plate 240 Wet 38.1 22 7.1 6.14 
Computer keyboard 84 Dry 36.7 24.5 8.8 7.03 
Computer mouse 73 Dry 38.2 24.4 9.1 7.04 
Bed rail NR NR 44.8 24.6 11.8 8.64 
Bed rail 64 Dry 44.9 24.5 11.6 8.57 
Bed rail 73 Dry 44.2 23.2 10.4 7.82 
Chair 65 Dry 44.2 23.2 10.4 7.81 
Chair 61 Dry 44 23.1 10.1 7.74 
Chair 200 Wet 43.5 23.1 10 7.72 
Trolley 182 At risk 44.9 23.4 10.4 7.94 
Trolley 141 Dry 44.1 22.8 9.9 7.59 
Table 139 Dry 40.5 23.6 9.3 7.33 
Table 1000 Wet 40.2 23.4 9.4 7.43 
Light switch 162 Dry 45.7 23.4 11.5 8.62 
Tap 178 At risk 40 22.4 8.1 6.91 
Wall panel 131 Dry 40.2 22.5 8.3 6.86 
Wall panel 249 At risk 44.3 23.3 10.5 7.92 
Waste bin 203 Wet 41.3 21.2 7.4 6.47 
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Table 12 continued – December 2011, Gastroenterology 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface % RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 33.6 23.5 6.5 22.9 15.4 13 Caution 
Door handle 35.5 23.5 7 23 16.5 23 Caution 
Door push plate 32.6 23.5 6.1 23.3 17.1 49 Fail 
Door push plate 32.7 23.5 6.1 23.5 17.4 410 Fail 
Computer keyboard 37.5 23.8 9.4 25.3 16.3 431 Fail 
Computer mouse 37.4 24 9.7 25.3 15.4 120 Fail 
Bed rail 45.9 23.6 11.4 24.4 13.1 147 Fail 
Bed rail 46.4 23.8 11.4 24.4 12.8 33 Fail 
Bed rail 43 24.2 11.3 24.6 11.7 27 Caution 
Chair 43.3 24.2 11.2 24.4 13.3 36 Fail 
Chair 44.4 23.8 11.1 24.1 13 60 Fail 
Chair 41.3 24.2 10.3 24.3 13.6 147 Fail 
Trolley 36.7 24.2 7.6 NR NR 190 Fail 
Trolley 40.7 24.4 10.4 24.3 14 118 Fail 
Table 39.3 23.8 9.2 21.9 12.9 107 Fail 
Table 44.1 23.9 10.8 24.1 13.5 25 Caution 
Light switch 44.5 23.8 11 24.8 14 12 Caution 
Tap 37.4 23.7 8.4 22.3 14.2 9 Pass 
Wall panel 35.8 23.6 7.1 22.5 15.8 18 Caution 
Wall panel 43.1 24.5 11.1 NR NR 81 Fail 
Waste bin 33.6 23.5 6.5 22.9 15.4 13 Caution 
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Table 13 – December 2011, ACC 
 
MOISTURE 
MODE   HYGROMETER MODE 
Surface  
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle  158 Dry 32.5 24.1 6.5 6.04 
 Door handle 207 Wet 34.3 22.1 5.5 5.63 
Door push plate 640 Wet 32.2 24 6.2 5.85 
 Door push plate 229 Wet 31.5 23.8 5.9 5.88 
Computer keyboard 73 Dry 32.5 23.7 5.6 5.72 
Computer mouse 75 Dry 31.5 23.4 5.4 5.58 
Bed rail  65 Dry 32.7 24 6.2 5.93 
 Bed rail 73 Dry 31.4 23.4 5.5 5.66 
Chair 70 Dry 35.9 23 6.5 6.17 
 Chair 150 Dry 35.2 22.9 6.7 6.11 
 Chair 65 Dry 33.8 21.7 4.9 5.37 
Trolley 237 Wet 37.8 22.6 7 6.37 
 Trolley 139 Dry 35.7 22.7 6.6 6.06 
Table 121 Dry 38.1 22.5 7.5 6.31 
 Table 150 Dry 33.8 22.1 4.8 5.32 
Light switch 150 Dry 35.6 22.3 5.9 5.81 
Wall panel 121 Dry 32 24 6 5.79 
 Wall panel 142 Dry 31.3 23.5 5.6 5.85 
Waste bin  65 Dry 31.7 23.4 5.4 5.59 
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Table 13 continued – December 2011, ACC 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface  
% 
RH 
TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle  32.7 22.5 5.3 22.9 17.4 21 Caution 
 Door handle 33.5 21.8 4.9 21.9 16.9 2 Pass 
Door push plate 32.6 22.7 5.3 23 17.8 1 Pass 
 Door push plate 33 22.8 5.5 22.9 17.5 3 Pass 
Computer keyboard 31.6 23.1 5.1 22.9 17.6 55 Fail 
Computer mouse 32.4 22.8 5.2 22.9 17.7 14 Caution 
Bed rail  33.2 22.5 6.4 23 17.1 281 Fail 
 Bed rail 32.9 22.5 5.3 22.6 17 113 Fail 
Chair 32.8 23 5.6 22.7 17.2 24 Caution 
 Chair 34.3 22.1 5.7 NR NR 89 Fail 
 Chair 35.6 21.7 5.3 22.5 17.3 14 Caution 
Trolley 33.5 22.9 6.2 22.6 15.2 17 Caution 
 Trolley 37.4 23.1 6.9 23.2 16.6 70 Fail 
Table 36.5 22.8 6.6 22.2 15.5 26 Caution 
 Table 35 22.8 9.3 22.3 13.7 13 Caution 
Light switch 35.8 22.1 6.1 22.9 16.1 5 Pass 
Wall panel 32.6 22.4 5.2 23.2 18 10 Pass 
 Wall panel 32.4 22.4 5 22.6 17.7 5 Pass 
Waste bin 32.7 22.4 5.2 22.7 17.6 100 Fail 
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Table 14 – December 2011, Theatre 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 176 At risk 32.9 21.4 4.4 5.16 
Door handle 164 At risk 33.5 21 4.1 5.05 
Door push plate 408 Wet 33.5 20.9 4 5.03 
Door push plate 238 Wet 34.2 20.3 3.9 5.06 
Computer keyboard 121 Dry 34.3 20.1 4.1 5.24 
Trolley 202 Wet 34.9 20 4 5.09 
Trolley 900 Wet 35 20 3.9 5.12 
Trolley 152 Dry 34.8 19.8 4 5.11 
Anaesthetics stand 173 At risk 35.1 20 4.1 5.12 
Light switch 156 Dry 34.8 20 4.2 5.11 
Tap 275 Wet 34.7 19.8 4.1 5.13 
Wall panel 159 Dry 34.8 20.1 3.9 5.15 
Wall panel 134 Dry 34.9 20.1 4 5.03 
Waste bin 1000 Dry 34 19.9 3.6 4.94 
 
Table 14 continued – December 2011, Theatre 
 
CONDENSATOR 
MODE     
BIOBURDEN  
Surface 
 
% RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 34.9 19.8 4 20.3 16.3 113 Fail 
Door handle 34.7 19.8 3.9 20.3 16.3 41 Fail 
Door push plate 35.2 19.8 3.9 20.3 15.7 74 Fail 
Door push plate 36.3 19.7 4.4 20.4 15.5 59 Fail 
Computer keyboard 35.8 19.7 4.1 20.2 16.4 117 Fail 
Trolley 35.1 19.6 3.5 19.4 16 19 Caution 
Trolley 34.6 19.6 3.6 20.1 16.8 28 Caution 
Trolley 37.4 19.7 4.4 20.4 16.5 52 Fail 
Anaesthetics stand 34.4 19.7 3.3 20.2 17 46 Fail 
Light switch 34.2 19.6 3.2 NR NR 54 Fail 
Tap 34.3 19.3 3.4 21.4 18.5 23 Caution 
Wall panel 34.3 19.4 3.3 19.2 NR 7 Pass 
Wall panel 34.4 19.6 3.4 NR NR 11 Caution 
Waste bin 34.2 19.5 3.2 NR NR 79 Fail 
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Table 15 – February 2012, Gastroenterology 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 193 At risk 38.2 22.8 7.1 6.09 
Door handle 186 At risk 34.8 22.8 6.4 5.91 
Door push plate 496 Wet 33 22.8 5.4 5.55 
Door push plate 240 Wet 32.1 22.8 5.3 5.52 
Computer keyboard 96 Dry 33.1 23.1 5.8 5.79 
Computer mouse 121 Dry 36.5 23 6.2 5.85 
Bed rail 200 At risk 31.6 25.2 6.9 6.21 
Bed rail 1000 Wet 31.3 24.9 6.8 6.17 
Bed rail 107 Dry 31.4 24.7 6.8 6.17 
Chair 70 Dry 42.9 21.8 8.6 7.02 
Chair 146 Dry 35.3 22.8 6.8 6.14 
Chair 156 Dry 39.4 22.9 8.6 7.03 
Trolley 100 Wet 42.1 22 8.7 7.08 
Trolley 179 At risk 32.9 22.8 5.9 6.11 
Table 171 At risk 42.5 21.8 8.5 7.03 
Table 121 Dry 41.5 22.4 8.5 6.96 
Light switch 163 Dry 42.4 22.2 8.8 7.17 
Tap 147 At risk 42.6 22.3 9.4 7.42 
Wall panel 155 Dry 41.4 22.8 9.2 7.43 
Wall panel 156 Dry 42.2 22.8 9.2 7.22 
Waste bin 255 At risk 41.4 22.4 8.6 7.06 
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Table 15 continued – February 2012, Gastroenterology 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface % RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 38.2 23.5 9.7 24.6 16.9 2 Pass 
Door handle 34.8 23.8 8.1 23.9 16.5 0 Pass 
Door push plate 32.4 23.8 6.7 24.4 17.7 28 Caution 
Door push plate 35.6 23.9 7.5 24 17.8 60 Fail 
Computer keyboard 32.9 23.8 7.4 24.3 17.7 72 Fail 
Computer mouse 31.5 23.8 6 24.3 16.8 105 Fail 
Bed rail 31.4 24.1 6.3 22.7 16.4 52 Fail 
Bed rail 31.7 24.1 6.1 22.6 16.6 13 Caution 
Bed rail 31.9 24.1 6.2 22.9 16.8 144 Fail 
Chair 42.9 22.9 10 20.7 10.3 32 Fail 
Chair 39.1 23.7 8.6 NR NR 1 Pass 
Chair 35.3 23.7 7.3 24.1 17.6 56 Fail 
Trolley 42.7 23.5 10.3 22.4 11.9 66 Fail 
Trolley 39.4 23.7 7.9 NR NR 29 Caution 
Table 43.3 23 9.8 21.6 11.9 53 Fail 
Table 40.5 24 9.6 NR NR 277 Fail 
Light switch 42.9 23.1 10.1 22.2 7.8 10 Pass 
Tap 41.8 23.5 10.1 22.6 12.4 10 Pass 
Wall panel 41.9 23.7 10 22.9 12.9 3 Pass 
Wall panel 40.1 23.8 9.4 23.3 12.8 5 Pass 
Waste bin 41.8 23.8 10.7 23.1 12.6 115 Fail 
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Table 16 – February 2012, ACC 
 
MOISTURE 
MODE   HYGROMETER MODE 
Surface  
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle  155 Dry 43 23.8 10.5 7.89 
 Door handle 179 At risk 42.3 23.8 10.7 7.81 
Door push plate 243 Wet 38.2 23.3 8.6 6.94 
 Door push plate 213 At risk 39.7 23.5 9.4 7.36 
Computer keyboard 73 Dry 32 28 7.8 6.57 
Computer mouse 73 Dry 32.4 22.9 5.4 5.59 
Bed rail  90 Dry 31.9 24.2 6.2 5.95 
 Bed rail 108 Dry 31.7 24.1 6 5.84 
Chair 63 Dry 40 23.3 8.9 7.14 
 Chair 68 Dry 34.7 24.1 8 6.6 
 Chair 64 Dry 36.7 24.1 8.3 6.76 
Trolley 200 Wet 32.9 25.2 7.3 6.32 
 Trolley 134 Dry 31.3 23.6 5.6 5.67 
Table 141 Dry 38.2 23.4 8.3 6.91 
 Table 139 Dry 39.4 23.3 8.8 7.08 
Light switch 211 Wet 38.8 23.5 8.2 6.72 
Wall panel 167 Dry 38.2 23.5 7.7 6.36 
 Wall panel 158 Dry 37.3 24.4 8.1 6.67 
Waste bin  241 Wet 40.4 23.3 8.6 6.82 
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Table 16 continued – February 2012, ACC 
 
CONDENSATOR 
MODE     
BIOBURDEN 
 
Surface  
% 
RH 
TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle  37.4 22.8 6.2 23.3 17.3 47 Fail 
 Door handle 43.4 23.4 9.6 24.3 14.2 6 Pass 
Door push plate 41.8 23.1 9.7 23.9 13.6 19 Caution 
 Door push plate 42.2 23.5 9.6 24.1 14.5 86 Fail 
Computer keyboard 33.2 23.4 6.1 23.4 17.6 18 Caution 
Computer mouse 32.6 23.3 5.8 23.3 17.5 39 Fail 
Bed rail  32.5 22.7 5.4 23.6 18.1 14 Caution 
 Bed rail 32.8 22.5 5.3 23.6 17.9 35 Fail 
Chair 40.9 23.5 9.1 23.3 14.7 30 Caution 
 Chair 37.4 23.5 8.8 23.5 14.6 49 Caution 
 Chair 44.1 23.3 10.6 24.7 14.3 25 Caution 
Trolley 33.3 22.5 8.2 23.3 14.8 615 Fail 
 Trolley 44.5 23.4 10.9 24.3 13.8 349 Fail 
Table 42.4 23.5 9.8 24.1 14.2 20 Caution 
 Table 43.3 23.4 10.1 23.6 13.5 58 Fail 
Light switch 38.4 23.5 8.4 24.3 15.4 13 Caution 
Wall panel 38 23.6 8.9 23.6 15.4 18 Caution 
 Wall panel 37.4 23.7 8.6 23.6 15.5 19 Caution 
Waste bin  43.3 23.1 9.9 24.3 14.1 14 Caution 
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Table 17 – February 2012, Theatre 
 
MOISTURE 
MODE   
HYGROMETER 
MODE   
Surface 
 
Relative 
reading 
Dry, at risk 
or wet? 
% RH TAIR TDEW AbS 
Door handle 183 At risk 47.1 21.1 9.3 7.35 
Door handle 179 At risk 46.3 21.8 9.7 7.62 
Door push plate 267 At risk 46.2 21.8 9.7 7.55 
Door push plate 218 At risk 46 21.8 9.6 7.49 
Computer keyboard 173 At risk 45.8 21.8 9.6 7.46 
Trolley 114 Dry 45.7 21.9 9.6 7.47 
Trolley 1000 Wet 46.1 21.8 9.6 7.49 
Trolley 1000 Wet 45.4 22 9.6 7.46 
Anaesthetics stand 69 Dry 43.8 23.1 9.9 7.58 
Light switch 1000 Wet 47.6 21.4 9.6 7.46 
Tap 197 At risk 46.9 21.2 9.4 7.45 
Wall panel 159 Dry 46.9 21.6 9.6 7.45 
Wall panel 161 Dry 45.8 21.8 9.6 7.45 
Waste bin NR NR 46.7 21.7 9.7 7.49 
 
Table 17 continued – February 2012, Theatre 
 
CONDENSATOR 
MODE     
BIOBURDEN  
Surface 
 
% RH TAIR TDEW TS TDIFF RLU 
Pass, 
caution 
or fail? 
Door handle 46.3 22.4 12.6 22.3 12.9 51 Fail 
Door handle 44.6 22.6 10.3 23 13.1 34 Fail 
Door push plate 45.9 22.5 11 22.5 12.2 31 Fail 
Door push plate 46 22.5 10.6 22.6 12.6 27 Caution 
Computer keyboard 43.3 23 9.9 22.3 12.5 30 Caution 
Trolley 41.3 24.2 10 22.2 12.7 10 Pass 
Trolley 43.4 23.3 10.1 22.2 13.3 72 Fail 
Trolley 46.2 22.3 9.9 22.9 13.2 95 Fail 
Anaesthetics stand 45.7 22.4 10.4 22.6 12.7 5 Pass 
Light switch 42.7 23.7 10.3 22.7 12.5 88 Fail 
Tap 46 23.3 10 22.6 12.7 50 Fail 
Wall panel 43.3 24.1 10.6 22.6 13.2 45 Fail 
Wall panel 40.8 23.8 10.3 22.9 13.2 23 Caution 
Waste bin 46 22.1 10.1 22.3 13.3 33 Fail 
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Appendix 2 - FACS data 
 Appendix 2a – FACS plots 
 Appendix 2b – Tabulated FACS results 
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Appendix 2a – FACS plots 
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Appendix 2b – Tabulated FACS results 
 
Table 1 – S. aureus PI and BOX 
Surface and 
time 
Repeat 
PI
-
BOX
- 
(healthy) 
(% of cells) 
PI
+
BOX
+ 
(damaged) 
(% of cells) 
PI
-
BOX
+ 
(collapsed 
membrane potential) 
(% of cells) 
SS 0 h 1 55.9 15.4 7.8 
 
2 44 29.5 26.5 
 
Average 50.0 22.5 34.3 
SS 24 h 1 40.6 29.7 12.3 
 
2 53.1 24.2 22.5 
 
Average 46.9 27.0 34.8 
CuSn5 0 h 1 4.4 68.6 23.9 
 
2 55.7 15.4 28.4 
 
Average 30.1 42 26.2 
CuSn5 24 h 1 22.3 44.7 19 
 
2 24.3 51.9 21.9 
 
Average 23.3 48.3 20.5 
CuZn30 0 h 1 9.6 55.6 29 
 
2 60.2 14.4 25.1 
 
Average 34.9 35.0 27.1 
CuZn30 24 h 1 24.7 47 16.3 
 
2 46.1 39.4 11.2 
  Average 35.4 43.2 13.8 
 
 
 
 
 
 
 
 
 
311 
 
Table 2 – S. aureus CTC and SYTO9 
Surface and 
time 
Repeat 
CTC
+
SYTO9
+  
(healthy)  
(% of cells) 
CTC
-
SYTO9
- 
(damaged) 
(% of cells) 
SS 0 h 1 34.7 64.9 
 
2 67.1 19.8 
 
Average 50.9 42.4 
SS 24 h 1 68.8 28.1 
 
2 89.2 3.2 
 
Average 79.0 15.7 
CuSn5 0 h 1 32.7 66.5 
 
2 92.6 2.7 
 
Average 62.7 34.6 
CuSn5 24 h 1 44 52 
 
2 81.6 11.9 
 
Average 62.8 32.0 
CuZn30 0 h 1 50.3 49.3 
 
2 84.9 13.9 
 
Average 67.6 31.6 
CuZn30 24 h 1 47.1 49 
 
2 92.8 4 
  Average 70.0 26.5 
 
 
 
 
 
 
 
 
 
 
 
312 
 
Table 3 – A. baumannii PI and BOX 
Surface and time Repeat 
PI
-
BOX
- 
(healthy) 
(% of cells) 
PI
+
BOX
+ 
(damaged) 
(% of cells) 
PI
-
BOX
+ 
(collapsed 
membrane potential) 
(% of cells) 
SS 0 h 1 31.8 10.3 2.3 
 
2 29.9 23.8 46.2 
 
Average 30.9 17.1 24.3 
SS 24 h 1 6.4 66.8 2.3 
 
2 7.9 52.1 40.0 
 
Average 7.2 59.5 21.2 
CuSn5 0 h 1 35 13.1 2.0 
 
2 2.3 54.5 43.2 
 
Average 18.7 33.8 22.6 
CuSn5 24 h 1 15.9 22.4 0.1 
 
2 3.2 94.8 2.0 
 
Average 9.6 58.6 1.1 
CNi10Fe1Mn 0 h 1 41.2 7.7 1.6 
 
2 20.1 55 24.8 
 
Average 30.7 31.4 26.4 
CNi10Fe1Mn 24 h 1 31.9 25.8 0 
 
2 16.5 74.3 9.1 
  Average 24.2 50.1 3.1 
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Table 4 – A. baumannii CTC and SYTO9  
Surface and time Repeat 
CTC
+
SYTO9
+  
(healthy)  
(% of cells) 
CTC
-
SYTO9
- 
(damaged)  
(% of cells) 
SS 0 h 1 15 83.8 
 
2 82.8 16.9 
 
Average 48.9 50.4 
SS 24 h 1 79 19.8 
 
2 40.8 57.3 
 
Average 59.9 38.6 
CuSn5 0 h 1 7.8 91.7 
 
2 81.3 18.3 
 
Average 44.6 55.0 
CuSn5 24 h 1 69.2 28.3 
 
2 68.5 30.1 
 
Average 68.9 29.2 
CNi10Fe1Mn 0 h 1 38.7 59.6 
 
2 20.3 78.5 
 
Average 29.5 69.1 
CNi10Fe1Mn 24 h 1 20.4 74.9 
 
2 37 61.3 
  Average 28.7 68.1 
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Appendix 3 – Campden BRI’s results 
 
Appendix 3a – Environmental sampling in food factories 
 
Campden BRI selected five sites for environmental sampling (surface temperature and 
surface relative humidity); two dairy factories, one fruit and vegetable processing 
factory, one brewery and one meat processing factory. Sampling was conducted on one 
occasion at each site. The Protimeter MMS was used to take surface relative humidity 
and surface temperature measurements. The condensator mode of the Protimeter MMS 
was utilised. 
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Table 1 – Campden BRI’s environmental sampling of surfaces in a fruit and vegetable 
processing factory.  
Surface 
Temperature 
(°C) 
Relative humidity 
(%) 
Worktop 10.6 78.6 
Metal rejects 10.8 100 (wet) 
Scale 10.7 / 
Horizontal bar next to platform 
mixer 
8.7 76 
Vertical bar next to platform mixer 8.7 76 
Surface of mixer 9.4 88.2 
Control panel 10.4 88.6 
Fridge wall 6.2 82.1 
Main coleslaw room – surface of the 
table with packaging on top. Line 2 
7.4 88.3 
Main coleslaw room - scale 7.5 87.2 
Dairy line room - depositor top 9.2 90.8 
Dairy line room - can opener 9 93.6 
Panel feeder 7.9 87.1 
Mayonnaise lid top 7.2 85.7 
Plastic curtain in mayonnaise room 7.2 84.3 
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Table 2 – Campden BRI’s environmental sampling of surfaces in a dairy factory (1) 
Surface 
Temperature 
(°C) 
Relative humidity 
(%) 
Open product zone - conveyor belt 14.3 65 
Line 1 cutter blade 15.3 67.1 
Line 1 surface before cutter blade 14.8 66.3 
Line 1 door after cutter blade 15.4 66.8 
Line 1 PFM infeed 15.5 65.1 
Machine top 19.3 66.8 
Transparent door before PFM infeed 17.5 68.4 
Packaging part of food line 1 18.3 67.5 
Close to the heat sealer line 1 17.9 66.6 
Top of control panel 19.7 56.3 
Platform under leak tester 14.9 78.3 
Glove stand 14.8 78.9 
Control panel 14.1 78.7 
Side of conveyor belt 13.9 79 
Wall beside sink 13.8 77.9 
Screen beside a sink 13.6 77.8 
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Table 3 – Campden BRI’s environmental sampling of surfaces in a dairy factory (2) 
Surface 
Temperature 
(°C) 
Relative humidity 
(%) 
Ingredient room preparation and 
weighing - entry of frozen products 
area  
12.5 69.5 
Ingredient room preparation and 
weighing - balance 
13 72.5 
Ingredient room preparation and 
weighing - table  
13.2 76.6 
Ingredient room preparation and 
weighing - control screen area of 
computer  
20.5 57 
Ingredient room preparation and 
weighing – sink 
14.3 86.5 
Under control panel of a machine 16.3 75.6 
Line 2 table  12.3 73.6 
Transport box 13.2 78.2 
Line 2 horizontal surface of 
machine 
17.3 69 
Bottom shelf of a cheese trolley 13.8 72.6 
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Table 4 – Campden BRI’s environmental sampling of surfaces in a meat processing 
factory 
Surface 
Temperature 
(°C) 
Relative humidity 
(%) 
Ham log entry stage 8.3 83.8 
Trolley holding ham logs 9.2 73.4 
Outside wall of ham filler 9.8 69.8 
Metal part (handle) of guard 10 68.2 
Plastic guard near slicer 10.6 68.2 
Table 10 64.9 
Scale 10.2 65.3 
Metal under blue belt 11.4 66.7 
Metal waste catch under cut ham 
belt 
14.8 55 
Beside packing where ham is placed 
in plastic trays 
19.4 45.4 
Vertical surface 16.9 50.3 
Control panel to move trays on to be 
sealed 
15.6 52.4 
Wall above sink 11 65.8 
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Table 5 – Campden BRI’s environmental sampling of surfaces in a brewery factory 
Surface 
Temperature 
(°C) 
Relative humidity 
(%) 
Ceiling of hot loft 27.5 37 
Lid of ike tipping point 40.5 28 
Ceiling of ike tipping room 38.8 27 
Grain milling sampling point 27 35 
Hot can dosing point 19.8 100 (in fluid) 
Filter powder dosing point 23.5 Dry (no measure) 
Fermantation room - valve of 
GYV17 
20.6 Dry (no measure) 
Process room - under parts of pipes 17.5 100 (wet) 
Drain 17.5 100 (wet) 
Green part of inverted keg belt 16.3 
>66 (higher during 
operation) 
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Table 6 – Summary table showing relative humidity and temperature profile of surfaces sampled in five food factories 
 
Factory 
Surface relative 
humidity range 
(%) 
Mean surface 
relative 
humidity (%) 
Median surface 
relative 
humidity (%) 
Surface 
temperature 
range (°C) 
Mean surface 
temperature 
(°C) 
Median surface 
temperature 
(°C) 
Fruit and vegetable 76.0 - 100 86.2 ± 6.6 87.2 6.2 - 10.8 8.7 ± 1.5 8.7 
Dairy 1 56.3 - 79.0 70.4 ± 7.0 67.3 13.6 - 19.7 15.8 ± 2.0 15.1 
Dairy 2 57.0 - 86.5 73.1  ± 7.6 73.1 12.3 - 20.5 14.6 ± 2.6 13.5 
Meat processing 45.4 - 83.8 63.8 ± 10.8 65.8 8.3 - 19.4 12.1 ± 3.4 10.6 
Brewery 27.0 - 100 56.1 ± 32.7 37.0 16.3 - 40.5 25.7 ± 8.8 23.5 
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Appendix 3b – Phase 1 results 
 
Fifteen test surfaces were tested under ISO22196 conditions against S. aureus NCIMB 
8625 and E. coli NCIMB 8545. Log10 reductions are shown after 24 h, in relation to a 
stainless steel control surface. The log10 reductions are a mean of two tests for each 
microorganism. 
 
Table 1 – Campden BRI’s Phase 1 ISO22196 results 
Active agent 
S. aureus 
(log10 cfu/cm
2
 
reduction) 
E. coli 
(log10 cfu/cm
2
 
reduction) 
Silver 1.85 4.68 
Silver 0.90 2.16 
Silver 0.11 0.61 
Silver 4.65 4.71 
“Nitrogen spears” < control < control 
“Nitrogen spears” < control < control 
Zinc complex 5.09 5.30 
Zinc complex 4.62 5.40 
Copper 0.86 1.61 
Coppernickel 1.69 -0.16 
SilverNickel 1.16 0.98 
Photo-oxidative surface 4.12 4.00 
Liquid glass < control < control 
Grapefruit extract >4 >4 
Water soluble quaternary ammonium 
compound 
>4 >4 
NB:  Log reduction calculated in comparison to stainless steel control surface 
>4 log reduction = pass, can proceed to phase 2 testing 
<4 log reduction = fail 
<control = increase in cfu/cm
2
 from 0 h samples (fail) 
Grapefruit extract is a surface coating 
 
322 
 
Appendix 3c – Phase 2 results 
 
Copper nickel, grapefruit extract, silver and photo-oxidative surface were tested against 
S. aureus NCIMB 8625 (with 0.03 % BSA) at a range of relative humidities and 
temperatures reflective of conditions in food factories. Stainless steel, plastic and glazed 
tile surfaces were utilised as control surfaces. 
 
Table 1 – Campden BRI’s Phase 2 results – ISO22196 with modified parameters  
 
Relative Humidity: 75 %,  S. aureus (0.03 % BSA) 
 
Controls 4 °C 10 °C 25 °C 
 
0h 5h 24h 5h 24h 5h 24h 
Stainless steel control 
(counts) 
5.90 5.58 5.81 5.63 6.02 5.83 5.77 
Copper nickel 
(log10 reduction) 
0.01 0.41 >4.81 1.36 >4.28 2.57 >4.77 
Grapefruit extract 
(log10 reduction) 
0.10 0.09 0.14 0.01 0.38 -0.29 0.22 
 
Controls 4 °C 10 °C 25 °C 
 
0h 5h 24h 5h 24h 5h 24h 
Plastic control 
(counts) 
4.72 4.92 4.35 4.84 4.23 4.92 5.01 
Silver 
(log10 reduction) 
-0.13 -0.95 -0.96 -1.00 -1.67 -1.03 0.09 
 
Controls 4 °C 10 °C 25 °C 
 
0h 5h 24h 5h 24h 5h 24h 
Glazed tile control 
(counts) 
4.95 5.99 5.05 5.89 5.70 6.25 5.66 
Photo-oxidative  
(log10 reduction) 
-1.43 0.31 -0.77 -0.05 -0.33 -0.05 -0.59 
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Table 1 continued - Campden BRI’s Phase 2 results – ISO22196 with modified 
parameters 
 
Relative Humidity: 33 %,  S. aureus (0.03 % BSA) 
 
Controls 4 °C 10 °C 25 °C 
 
0h 5h 24h 5h 24h 5h 24h 
Stainless steel control 
(counts) 
4.72 4.92 4.35 4.84 4.23 4.92 5.01 
Copper nickel 
(log10 reduction) 
-0.04 0.72 >3.29 >1.69 1.52 >1.95 >4.01 
Grapefruit extract 
(log10 reduction) 
-0.07 0.24 0.72 1.02 0.94 0.40 2.28 
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Appendix 3d - Phase 3 results 
 
The final phase of tests involved placing surfaces in a factory and regularly swabbing 
them for total aerobic bacteria count.  
 
Long-term tests were carried out in dairy factory 1, where conditions ranged from 39 – 
74 % relative humidity and 13.4 - 16.5 °C during phase 2 testing. Short-term tests were 
carried out in a potato processing environment where the relative humidity varied 
between 56 % and 72.3 % and temperature maintained at 21.2 °C throughout the day.  
 
Table 1 – Surfaces used during phase 3 testing 
Surface Control used 
Long-term 
test 
Short-term 
test 
Silver 
Plastic A 
(provided) 
√ √ 
Copper nickel 
Stainless 
steel 
√ √ 
Photo-oxidative 
surface 
Uncoated 
glazed tile 
√ √ 
Grapefruit extract on 
stainless steel 
Uncoated 
stainless steel 
√ √ 
 
Samples were tested at different time intervals depending on the test performed (see 
Table 2). For the long term test, the total experimental time was 83 days and samples 
were tested 12 times during this period. The short term tests were testing samples 5 
times over a period of 24 hours. There were two sets of times due to tests being 
performed over two different days: one day silver and grapefruit extract coating and the 
following day with copper nickel and photo-oxidative. Surfaces were swabbed in 
duplicate for the long-term tests and in triplicate for the short-term tests. 
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Table 2 – Sampling times for each test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
Short-term tests 
 
All graphs (Figures 1- 7) show the total aerobic bacteria count on test surfaces and 
control surfaces over the testing period (short- and long-term). The means and ranges 
are shown on the graphs. 
 
 
 
 
 
 
 
Long term 
test (Days) 
Short term test (silver 
and grapefruit extract 
coating) (hours) 
Short term test (copper 
nickel and photo-
oxidative) (hours) 
0 0 0 
1 2 1 
2 4 3.5 
6 6 5 
8 24 24 
12   
16   
22   
34   
48   
64   
83   
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Over 24 h there was no statistical difference between the silver surface and its standard, 
see Figure 1 (P=0.878). 
 
Figure 1 Total aerobic bacteria count on silver and on control surface 
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Figure 2 shows the total aerobic bacteria count on the grapefruit extract coated surface 
compared to the standard surface. There was no statistical difference between the 
antimicrobial surface and its standard (P=0.818).  
 
Figure 2 Total aerobic bacteria count on grapefruit extract coated surface and on 
control surface 
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Over 24 h there was no statistical difference between the copper nickel surface and its 
standard, see Figure 3 (P=0.259). 
 
Figure 3 Total aerobic bacteria count on copper nickel and on control surface 
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Figure 4 shows the total aerobic bacteria count on the photo-oxidative surface compared 
to the standard surface. There was no statistical difference between the photo-oxidative 
surface and its standard (P=0.201).  
 
Figure 4 Total aerobic bacteria count on photo-oxidative surface and on control surface 
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Long-term tests 
 
Over 83 days there was no statistical difference between the copper nickel surface and 
its standard, see Figure 5 (P=0.709). 
 
Figure 5 Total aerobic bacteria count on copper nickel and on control surface 
day 8364483422161286210
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Over 83 days there was no statistical difference between the grapefruit extract coated 
surface and its standard (P=0.787).  
 
Figure 6 Total aerobic bacteria count on grapefruit extract coated surface and on 
control surface 
day 8364483422161286210
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There was no statistical difference between the silver surface and its standard over 83 
days of testing (P=0.849), see Figure 7. 
 
Figure 7 Total aerobic bacteria count on silver and on control surface 
day 8364483422161286210
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There was no statistical difference between the photo-oxidative surface and its standard 
over 83 days of testing (P=0.703), see Figure 7. 
 
Figure 8 Total aerobic bacteria count on photo-oxidative and on control surface 
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